Sentence,class,file
"Original Article J Gastric Cancer 2016;16(4):215-220  https://doi.org/10.5230/jgc.2016.16.4.215 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction The detection of early gastric cancer (EGC) has increased  with advances in diagnostic methods and routine follow-up programs.",Non-OADS,/arxiv_data1/oa_pdf/56/3f/jgc-16-215.PMC5206311.pdf
"Original Article J Gastric Cancer 2016;16(4):221-229  https://doi.org/10.5230/jgc.2016.16.4.221 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Gastric cancer is the fourth most common cancer and one  of the leading causes of cancer-related deaths in the world1  (and the second most common cancer and the third most com-mon cause of cancer deaths 2 in Korea).",Non-OADS,/arxiv_data1/oa_pdf/7e/d4/jgc-16-221.PMC5206312.pdf
"Original Article J Gastric Cancer 2016;16(4):230-239  https://doi.org/10.5230/jgc.2016.16.4.230 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Gastric cancer is one of the most common malignancies  worldwide, being the fourth most common cancer and the sec-ond leading cause of cancer-related death.",Non-OADS,/arxiv_data1/oa_pdf/5a/92/jgc-16-230.PMC5206313.pdf
"Original Article J Gastric Cancer 2016;16(4):240-246  https://doi.org/10.5230/jgc.2016.16.4.240 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction During the last decade, developments in laparoscopic in- struments and technologies have led to major surgical break-throughs, and many reports have demonstrated the clinical advantages of laparoscopic gastrectomy for gastric cancer com-pared with open surgery.",Non-OADS,/arxiv_data1/oa_pdf/0c/b2/jgc-16-240.PMC5206314.pdf
Electronic Supplementary Material The online version of this article (doi: https://doi.org/  10.5230/jgc.2016.16.4.240) contains supplementary materials.,Non-OADS,/arxiv_data1/oa_pdf/0c/b2/jgc-16-240.PMC5206314.pdf
"Original Article J Gastric Cancer 2016;16(4):247-253  https://doi.org/10.5230/jgc.2016.16.4.247 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction The main treatment of gastric cancer is surgical resection and  lymph node dissection.",Non-OADS,/arxiv_data1/oa_pdf/87/b8/jgc-16-247.PMC5206315.pdf
"Original Article J Gastric Cancer 2016;16(4):254-259  https://doi.org/10.5230/jgc.2016.16.4.254 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction With increased life expectancy and an increasing elderly  population, the prevalence of various types of cancer is increa s- ing.1 The older population ( >65 years old) in South Korea steadi- ly increased from 12.2% in 2013 to 13.2% in 2015, and, by 2020,   the average life expectancy is expected to be 79.5 years and 85 .7  years for men and women, respectively.2 Gastric cancer is caused  by environmental factors and the accumulation of specific ge-netic alterations.",Non-OADS,/arxiv_data1/oa_pdf/ec/44/jgc-16-254.PMC5206316.pdf
Available from: http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B42&conn_path=I2.,OADS,/arxiv_data1/oa_pdf/ec/44/jgc-16-254.PMC5206316.pdf
Available from: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040202000000.,Non-OADS,/arxiv_data1/oa_pdf/ec/44/jgc-16-254.PMC5206316.pdf
Available from: http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1YL0201&conn_path=I2.,OADS,/arxiv_data1/oa_pdf/ec/44/jgc-16-254.PMC5206316.pdf
"Original Article J Gastric Cancer 2016;16(4):260-265  https://doi.org/10.5230/jgc.2016.16.4.260 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Most cancers are primarily a disease of aged people.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/jgc-16-260.PMC5206317.pdf
Avail-able from: http://kosis.kr/stati sticsList/statisticsList_01List.,OADS,/arxiv_data1/oa_pdf/01/bd/jgc-16-260.PMC5206317.pdf
"Case Report J Gastric Cancer 2016;16(4):266-270  https://doi.org/10.5230/jgc.2016.16.4.266 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Gastric cancer is one of the most frequently reported ma- lignant tumors in Korea.1 Cases of multiple synchronous or  metachronous gastric cancers have been increasing in number during the last few decades, due to both the development of mor e  sophisticated diagnostic tools and an increase in the number of   elderly patients.",Non-OADS,/arxiv_data1/oa_pdf/48/a6/jgc-16-266.PMC5206318.pdf
"Case Report J Gastric Cancer 2016;16(4):271-276  https://doi.org/10.5230/jgc.2016.16.4.271 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Pregnancy-associated gastric cancer is rare, occurring in only  0.025% to 0.1% of all pregnancies.1 Gastric cancer diagnosed  during pregnancy can be a devastating situation for the mother and the fetus, and patients with gastric cancer diagnosed durin g  pregnancy have a dismal prognosis.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/jgc-16-271.PMC5206319.pdf
"Correction J Gastric Cancer 2016;16(4):277  https://doi.org/10.5230/jgc.2016.16.4.277 Copyrights © 2016 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.The affiliation of this article should be deleted.",Non-OADS,/arxiv_data1/oa_pdf/78/f1/jgc-16-277.PMC5206320.pdf
"pISSN : 2093-582X, eISSN : 2093-5641 Correspondence to: Young-Woo Kim Gastric Cancer Branch, Division of Translational & Clinical Res earch, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goya ng 10408, Korea Tel: +82-31-920-1635, Fax: +82-31-920-0696E-mail: gskim@ncc.re.krCorrigendum: Korean Gastric Cancer Association  Nationwide Survey on Gastric Cancer in 2014 The Information Committee of Korean Gastric Cancer Association This paper contains an error correction of affiliation in the ‘Korean Gastric Cancer Association Nationwide Survey on Gastric Cancer in  2014, ’ J Gastric Cancer 2016;16(3):131-140 (https://doi.org/10.5230/jgc.2016.16.3.131).",Non-OADS,/arxiv_data1/oa_pdf/78/f1/jgc-16-277.PMC5206320.pdf
"Wessa P. Free Statistics Software, Office for Research Development and Education,  version 1.1.23-r7, 2014; URL http://www.wessa.net/.",OADS,/arxiv_data1/oa_pdf/17/42/AMS-13-27133.PMC5206358.pdf
References 1. http://www.idf.org/diabetesatlas (Available at: 11.09.2014).Table II.,Non-OADS,/arxiv_data1/oa_pdf/73/b4/AMS-13-28828.PMC5206366.pdf
"9. http://stat.gov.pl/obszary-tematyczne/ludnosc/trwan-ie-zycia/trwanie-zycia-w-2013-r-,2,8.html (Available at: 27.09.2014).",Non-OADS,/arxiv_data1/oa_pdf/73/b4/AMS-13-28828.PMC5206366.pdf
http://www.ey.com/Publication/vwLUAssets/Spra-   wne_Panstwo_Optymalizacja_POZ/$FILE/ Sprawne-Panstwo-Optymalizacja-POZ-05092012.pdf  24.,Non-OADS,/arxiv_data1/oa_pdf/34/f1/AMS-13-28931.PMC5206369.pdf
http://www.r3i.org/definition.php 40.,Non-OADS,/arxiv_data1/oa_pdf/34/f1/AMS-13-28931.PMC5206369.pdf
Medycyna Praktyczna 2016; http://www.mp.pl/artykuly/26863 (30 czerwca 2016).,Non-OADS,/arxiv_data1/oa_pdf/34/f1/AMS-13-28931.PMC5206369.pdf
E. http://www.cdc.gov/nchs/ nhanes/ (accessed October 2015).,OADS,/arxiv_data1/oa_pdf/fb/b2/AMS-13-28933.PMC5206371.pdf
11. http://www.tuik.gov.tr/PreHaberBultenleri.do?id=15974 ad- r esinden 14.04.2015 tarihinde erişilmiştir.,Non-OADS,/arxiv_data1/oa_pdf/a8/de/NCI-3-118.PMC5206461.pdf
Available at:  http://www.cdc.gov/tb/statis- tics/reports/surv2005/default.htm.,OADS,/arxiv_data1/oa_pdf/1e/9c/NCI-3-150.PMC5206468.pdf
"“http://medicaldictionary.thefreedictionary.com/ chromatography”>chromatography.prepared column, detector, and recorder.",Non-OADS,/arxiv_data1/oa_pdf/81/aa/NCI-3-156.PMC5206469.pdf
"1  227–244 https://doi.org/10.1084/jem.20141461227Introduct Ion Microbial detection receptors sample different subcellular  compartments (Akira et al., 2006), and the sites of microbial  detection by innate immune receptors are thought to be spa - tially separated from the sites of receptor signal transduction  (Kagan, 2012).",OADS,/arxiv_data1/oa_pdf/9b/69/JEM_20141461.PMC5206490.pdf
1  165–181 https://doi.org/10.1084/jem.20151414165Introduct Ion Hematopoietic stem cells (HSCs) are defined by their ability  to repopulate the blood cell system in steady-state and trans - plantation settings.,Non-OADS,/arxiv_data1/oa_pdf/c0/02/JEM_20151414.PMC5206491.pdf
1  245–267 https://doi.org/10.1084/jem.20151673245Introduct Ion Glioblastoma multiforme (GBM) is the most common and  malignant primary brain tumor with an extremely poor  prognosis.,Non-OADS,/arxiv_data1/oa_pdf/ee/ec/JEM_20151673.PMC5206492.pdf
"1  209–226 https://doi.org/10.1084/jem.20160068209Introduct Ion Multiple sclerosis (MS) is considered a T cell–mediated in - flammatory and demyelinating disease of the CNS with a  complex genetic background (McFarland and Martin, 2007).",Non-OADS,/arxiv_data1/oa_pdf/79/0a/JEM_20160068.PMC5206493.pdf
1  17–25 https://doi.org/10.1084/jem.2016044717Introduct Ion Neurofibromatosis type 1 (NF1) is a monogenic cancer  predisposition syndrome that results from germline mu - tations in the NF1 tumor suppressor gene and predisposes  affected individuals to develop benign and malignant tu - mors.,Non-OADS,/arxiv_data1/oa_pdf/2d/26/JEM_20160447.PMC5206494.pdf
1  125–142 https://doi.org/10.1084/jem.20160470125Introduct Ion DCs are a specialized population of innate immune cells that  play a pivotal role in the initiation of adaptive T cell immunity.,Non-OADS,/arxiv_data1/oa_pdf/cf/73/JEM_20160470.PMC5206495.pdf
"1  143–163 https://doi.org/10.1084/jem.20160675143Introduct Ion Chronic obstructive pulmonary disease (COPD) is one of  the leading causes of morbidity and mortality in the world,  resulting in a growing social and economic burden (Mathers  and Loncar, 2006; Vestbo et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/19/23/JEM_20160675.PMC5206496.pdf
1  73–89 https://doi.org/10.1084/jem.2016078473Introduct Ion EBV is a γ-herpes virus that infects most humans and has  a marked tropism for B lymphocytes.,Non-OADS,/arxiv_data1/oa_pdf/57/a8/JEM_20160784.PMC5206497.pdf
1  197–208 https://doi.org/10.1084/jem.20160789197Introduct Ion Antigen receptor gene assembly in the BM via V(D)J recom - bination endows B lymphocytes with a remarkable repertoire  of specificities against a vast array of pathogens.,Non-OADS,/arxiv_data1/oa_pdf/cc/c2/JEM_20160789.PMC5206498.pdf
"1  91–106 https://doi.org/10.1084/jem.2016084991In this study, we describe four patients from two unrelated families of different ethnicities with a primary immunodeficiency,  predominantly manifesting as susceptibility to Epstein-Barr virus (EBV)–related diseases.",Non-OADS,/arxiv_data1/oa_pdf/cc/2a/JEM_20160849.PMC5206499.pdf
1  107–123 https://doi.org/10.1084/jem.20160961107Introduct Ion Regulatory T (T reg) cells maintain immune homeostasis  and play a pivotal role in immune tolerance.,Non-OADS,/arxiv_data1/oa_pdf/57/26/JEM_20160961.PMC5206500.pdf
"1  183–196 https://doi.org/10.1084/jem.20161056183Introduct Ion Heterogeneity of allele activation in single cells is emerging as  a general property of transcriptional programs (Trapnell et al.,  2014).",Non-OADS,/arxiv_data1/oa_pdf/83/97/JEM_20161056.PMC5206502.pdf
"1  59–71 https://doi.org/10.1084/jem.2016122859Introduct Ion The actin cytoskeleton is crucial for normal immune func - tion, and a growing number of primary immunodeficiencies  are caused by mutations in actin-regulating genes (Moulding  et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/2e/45/JEM_20161228.PMC5206503.pdf
"1  27–37 https://doi.org/10.1084/jem.2016127427Introduct Ion T ype 2, or allergic, inflammation in the lung requires the  cytokines IL-5, IL-13, and IL-9, which collectively elicit  eosinophilia, alternative activation of macrophages, gob - let cell hyperplasia, smooth muscle hypercontractility, and  tissue remodeling, and may contribute to wound healing   (Licona-Limón et al., 2013; Gour and Wills-Karp, 2015).",Non-OADS,/arxiv_data1/oa_pdf/aa/27/JEM_20161274.PMC5206504.pdf
"1  49–58 https://doi.org/10.1084/jem.2016164949B lymphocytes are rapidly dividing cells that suffer genome  damage as a result of replication stress (Gaillard et al., 2015)  and errors in chromosome segregation (Santaguida and  Amon, 2015).",Non-OADS,/arxiv_data1/oa_pdf/54/46/JEM_20161649.PMC5206505.pdf
1  3–16 https://doi.org/10.1084/jem.201617653Introduction The HIV-1 virus expresses a trimeric envelope glycoprotein  (Env) on its surface.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/JEM_20161765.PMC5206506.pdf
1  1–2 https://doi.org/10.1084/jem.201621161Changes in the JEM Editorial Board JEM has a unique editorial process that combines the exper - tise of research-active academic editors and full-time profes - sional editors who have a strong scientific background.,Non-OADS,/arxiv_data1/oa_pdf/8b/61/JEM_20162116.PMC5206507.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.MICROBIAL DRUG RESISTANCE Volume 23, Number 1, 2017Mary Ann Liebert, Inc.DOI: 10.1089/mdr.2016.0160 44",Non-OADS,/arxiv_data1/oa_pdf/1d/7d/mdr.2016.0160.PMC5206683.pdf
Preparation and examination of S. aureus cells by transmission electron microscopy (TEM) were performed as described previously.15Ultrathin sections of the samples were examined using a Zeiss 10C elec-tron microscope and images analyzed with Image J 1.46r software (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/1d/7d/mdr.2016.0160.PMC5206683.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ENVIRONMENTAL ENGINEERING SCIENCE Volume 34, Number 1, 2017Mary Ann Liebert, Inc.DOI: 10.1089/ees.2016.0223 51",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://curve.carleton.ca/ b945d1f1-64d4-40eb-92d2-1a29effe0f76 (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://web.stanford .edu/dept/pres-provost/president/speeches/961206gcfallow.html (accessed September 16, 2016).PERVERSE INCENTIVES IN ACADEMIC RESEARCH 57",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://chroniclevitae.com/news/ 215-what-we-talk-about-when-we -talk-about-quitting?cid =vem (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://chroniclevitae.com/news/tags/Quit%20Lit (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://theconversation.com/how-cyclings-dark-history-continues- to-haunt-the-tour-de-france-44 312 (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://oversight.house.gov/wp-content/uploads/2016/02/Edwards- VA-Tech-Statement-2-3-Flint-Wa ter.pdf (accessed September 16, 2016).",OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://phylogenomics.blogspot.com/p/blog-page .html (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://theweek.com/articles/618141/big-science- broken (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
Available at: http://rr.liglab.,Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://dc.mit.edu/sites/ default/ﬁles/Future%20Postponed.pdf (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://jasonya.com/wp/gaming-the-system- how-to-get-an-astronomical-h-i ndex-with-little-scientiﬁc-impact (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://report.nih.gov/ NIH_Investment/PDF_sectionw ise/NIH_Extramural_DataBook_ PDF/NEDB_SPECIAL_TOPIC-AVERAGE_AGE.pdf (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://report.nih.gov/ success_rates/Success_ByIC.cfm (accessed September 16, 2016).",OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://dellweb.bfa.nsf.gov/awdfr3/default.asp (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://retractionwatch.com/2015/11/ 05/got-the-blues-you-can-still- see-blue-after-all-paper-on- sadness-and-color-perception-retracted (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Harvard Business Review , Case Study # 314015-PDF-ENG, Available at: https://hbr.org/product/ following-lance-armstrong-ex cellence-corrupted/an/314015- PDF-ENG (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: http://sites.nationalacademies .org/cs/groups/pgasite/documents/webpage/pga_087667.pdf (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://arxiv.org/abs/1605.09511 (ac- cessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available at: https://oversight.house.gov/hearing/examining- federal-administration-of-the-safe-drinking-water-act-in-ﬂint- michigan (accessed September 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/73/66/ees.2016.0223.PMC5206685.pdf
"Available from: http://www.who.int/emergencies/mers-cov/en/ (accessed on October 29, 2015).",OADS,/arxiv_data1/oa_pdf/58/14/jphr-2016-3-733.PMC5206772.pdf
Available from: http://www.canadiancriticalcare.org/website/Guidelines/CCCS%20 SARI%20guidance%20January%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/14/jphr-2016-3-733.PMC5206772.pdf
Available from: http://www.diabetesatlas.org.,Non-OADS,/arxiv_data1/oa_pdf/58/14/jphr-2016-3-733.PMC5206772.pdf
Available from: http://www.qualitative- research.net/index.php/fqs/article/view/1801/3334 26.,Non-OADS,/arxiv_data1/oa_pdf/ad/bc/jphr-2016-3-744.PMC5206773.pdf
The link to fill in the questionnaire (http://igiene.unibs.it/indagini/index.php/621542?lang=it) has been shared on Facebook in order to invite as many people as possible to par- ticipate.,Non-OADS,/arxiv_data1/oa_pdf/83/e2/jphr-2016-3-768.PMC5206777.pdf
"In 2012, a global stockpile of two million doses of  OCV was created by the WHO primarily for epidemic  response ( http://www.who.int/cholera/vaccines/ ocv_stockpile_2013/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/db/26/IJMR-144-149.PMC5206864.pdf
The Delivering Oral Vaccine Effectively  (DOVE) project funded by the Bill and Melinda  Gates Foundation and based at the Johns Hopkins  Bloomberg School of Public Health was also created  in 2012 ( http://www.stopcholera.org ).,Non-OADS,/arxiv_data1/oa_pdf/db/26/IJMR-144-149.PMC5206864.pdf
"Latest position documents of the international and selected national agencies monitoring the human papillomavirus vaccine  safety in the national immunization programmes Monitoring agency Latest published report on HPV vaccine safety Conclusion regarding safety GACVS, WHO Report of GACVS meeting of December  2-3, 2015 was published in the WHO Weekly  Epidemiological Record of 22 January 2016 Available from: http://www.who.int/vaccine_ safety/committee/topics/hpv/Dec_2015/en/“The GACVS has systematically investigated  safety concerns raised about HPV vaccines and has  issued several reports in this regard to date, GACVS  has not found any safety issue that would alter its  recommendations for the use of the vaccine”.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
EMA; Pharmaco-vigilance  Risk Assessment CommitteeReport date: November 2015 Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Therapeutic Goods  Administration, Australia  (HPV vaccine was introduced  in Australia in 2007)Report date: May 2015 Available from: http://www.tga.gov.au/alert/ gardasil-quadrivalent-human-papillomavirus- vaccine-update-2  “No safety concerns either in males and females  identified”.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"MEDRA, United Kingdom  (HPV vaccine was  introduced in UK in 2008)Report date: November 2012 (Modification was  not felt necessary since then; Last reviewed on  September 24, 2014) Available from: https://www.gov.uk/drug-safety- update/human-papillomavirus-vaccine-cervarix- balance-of-risks-and-benefits-remains-clearly- positive“Balance of risks and benefits remains clearly  positive after 6 million doses in 4 years”.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"ACIP, Centers for Disease  Control and Prevention, USA  (Quadrivalent vaccine was  licensed in USA in 2006 and  the bivalent vaccine in 2009)Report date: August 2014 Available from: http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr6305a1.htm“HPV vaccines are very safe.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://www.hpvcentre.net/ statistics/reports/XWX.pdf,  accessed on September 21, 2016.",OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://www.who.int/immunization/ diseases/hpv/en,  accessed on September 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://www.afro.who.int/en/uganda/press- materials/item/8186-uganda-launches-human-papillomavirus  -	vaccine.html,  accessed on September 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://adva.asia/ads/day2/ Rohani-Jahis+Saidatul-Norbaya-Buang.pdf,  accessed on  September 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
Available from: http://www.tga.,Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://www.thehindu.com/opinion/op-ed/ need-for-an-hpv-vaccine/article9040754.ece,  accessed on  September 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from: http://indianexpress.com/article/cities/delhi/	 delhi- first-state-to-launch-hpv-vaccine-as-public-health-programme-in- schools,  accessed on September 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/IJMR-144-169.PMC5206867.pdf
"Available from:  http://www.cancer.org/cancer/cancercauses/sunanduvexposure/ skin-cancer-facts , accessed on June 05, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a1/8a/IJMR-144-181.PMC5206868.pdf
"Read mapping and variant analysis : The human  reference genome was obtained from the UCSC  database ( http://www.genome.ucsc.edu/ ), version hg19  (build 37.1).",OADS,/arxiv_data1/oa_pdf/46/30/IJMR-144-200.PMC5206870.pdf
"All candidate mutations were filtered  against the Single-nucleotide Polymorphism database  (dbSNP137, http://www.ncbi.nlm.nih.gov/projects/ SNP/snp_summary.cgi ), 1000 genomes data (1000  genomes release_20100804), HapMap project (2010- 08_phase II + III) and YanHuang1 (YH1) project1,12.",OADS,/arxiv_data1/oa_pdf/46/30/IJMR-144-200.PMC5206870.pdf
SIFT prediction ( http://sift.jcvi.org ) was performed  to predict whether an amino acid substitution affects  the function of the protein17.,OADS,/arxiv_data1/oa_pdf/46/30/IJMR-144-200.PMC5206870.pdf
"Available from: http://www.diabetesatlas.org/ , accessed on  May 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/92/1a/IJMR-144-220.PMC5206873.pdf
Available  from: http://www.phac-aspc.gc.ca/publicat/lbg-ldmbl-04/ch8- eng.php.,Non-OADS,/arxiv_data1/oa_pdf/56/e1/IJMR-144-245.PMC5206876.pdf
"Available from: http://www.cdc.gov/od/ohs/biosfty/ bmbl4/bmbl4toc.htm , accessed on August 15, 2015.",OADS,/arxiv_data1/oa_pdf/56/e1/IJMR-144-245.PMC5206876.pdf
"Available	from:	 http://www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm , accessed on  August 15, 2015.",OADS,/arxiv_data1/oa_pdf/56/e1/IJMR-144-245.PMC5206876.pdf
Available  from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.,Non-OADS,/arxiv_data1/oa_pdf/9d/d6/IJMR-144-250.PMC5206877.pdf
"Available  from: http://www.ginasthma.org , accessed on August 20,  2012.",Non-OADS,/arxiv_data1/oa_pdf/9d/d6/IJMR-144-250.PMC5206877.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2017:8 11–29Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  11 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S94170Burkitt lymphoma in adolescents and young  adults: management challenges Massimo Dozzo1 Francesca Carobolante1 Pietro Maria Donisi2 Annamaria Scattolin1 elena Maino1 Rosaria Sancetta1 Piera viero1 Renato Bassan1 1Complex Operative Unit of  Hematology, Ospedale dell’Angelo,   2Simple Departmental Operative Unit  of Anatomic Pathology, Ospedale Ss.",Non-OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
"The aim of Correspondence: Renato Bassan Complex Operative Unit of Hematology, Ospedale dell’Angelo, via Paccagnella 11, 30174 Mestre-venice, italyTel +39 41 965 7362Fax +39 41 965 7361email renato.bassan@ulss12.ve.itJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Dozzo et alRunning head recto: Burkitt lymphoma in younger adults and adolescentsDOI: http://dx.doi.org/10.2147/AHMT.S94170",Non-OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
"Adolescent Health, Medicine and Therapeutics 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/27/ahmt-8-011.PMC5207020.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 37–41Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 37 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S120525 communication pitfalls of traditional history and  physical write-up documentation Jeffrey l Brown1,2 1Department of Pediatrics, new  Y ork Medical college, 2Departments  of Pediatrics and Psychiatry, Weill  cornell Medical college, nY, UsABackground: An unofficial standardized “write-up” outline is commonly used for documenting  history and physical examinations, giving oral presentations, and teaching clinical skills.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Despite decades of use and general acceptance, there is an apparent discrepancy between the way patient encounters are conducted and how they are documented: Early observations about the patient’ s degree of illness and level of distress that guide correspondence: Jeffrey l Brown 10 Walnut court, White Plains, nY 10605, UsATel +1 914 552 5013Email jeffrey_brown@nymc.eduJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: BrownRunning head recto: Communication pitfalls of traditional write-up documentationDOI: http://dx.doi.org/10.2147/AMEP .S120525",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
Boston	University	College	of	Medicine	http://www.bumc.bu.edu/im-residency/files/2010/10/History-and-Physical-Exam-Guidelines.doc 2. case Western reserve University school of Medicine http://medicine.case.edu/medical-student-programs/clerkship-program/education/write-up3.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
louisiana state health sciences center http://www.medschool.lsuhsc.edu/medical_education/undergraduate/spm/sPM_100/documents/ historyandPhysical_000.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
Tulane University school of Medicine http://tulane.edu/counsel/upco/upload/Part-2-Doc-a-hx-revQuiz.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
University of california san Diego health https://meded.ucsd.edu/clinicalmed/write.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
University	of	Florida	College	of	Medicine	http://clerkship.medicine.ufl.edu/portfolio/patient-care/write-ups/instructions-for-write-ups/7.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Upstate Medical University, state University of new York http://www.upstate.edu/medicine/education/clerkship/objectives/sample-writeup.php 8.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
University of Tennessee health science center http://www.uthsc.edu/pediatrics/clerkship/docs/h&P%20cArD.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"University	of	Wisconsin	School	of	Medicine	and	Public	Health	http://www.fammed.wisc.edu/files/webfm-uploads/documents/med-student/pcc/pds- example-documentation-hx-pe.pdfTable 1  Examples of history and physical examination write-ups posted on medical school websites, accessed December 20, 2016 1. columbia University Physicians and surgeons http://www.columbia.edu/itc/hs/medical/physicalDiagnosis/06-07/sampleWriteUp.pdf2.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Drexel University college of Medicine https://webcampus.drexelmed.edu/skills/oral_presentation/assets/sample_written_h_and_P.pdf 3. loyola University, stritch school of Medicine http://www.meddean.luc.edu/lumen/meded/elective/pulmonary/copd/120699/c1_f.htm 4.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Michigan state University, college of human Medicine http://learn.chm.msu.edu/clinicalhpcases/content/pediatrics/Pediatrics_hP.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
University of north carolina school of Medicine http://www.med.unc.edu/medselect/resources/sample-notes/sample-write-up-1\ 6.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
University of Texas houston Medical school http://www.utmb.edu/psychiatry/Education/Undergraduate/sampleh&P.pdf,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
Avail- able from: http://medical-dictionary.thefreedictionary.com/well-developed%2c+well-nourished.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Available from:  http://www.ncbi.nlm.nih.gov/books/NBK330/ Accessed November 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK20487/.,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 41 communication pitfalls of traditional write-up documentation,Non-OADS,/arxiv_data1/oa_pdf/44/50/amep-8-037.PMC5207202.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 25–29Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 25 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S122312 Balancing standardized testing with personalized  training in surgery Aadil Ahmed Muhammad Abbas Abid Nasir I Bhatti Department of Otolaryngology-Head  and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore,  MD, USAAbstract:  Students pursuing a medical career in the US are subject to standardized testing at  regular intervals.",Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
"4 Correspondence: Nasir I Bhatti Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins School of Medicine, 6 th floor, 601 N Caroline  Street, Baltimore, MD 21287, USATel +1 410 955 7137Email Nbhatti1@jhmi.eduJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Ahmed et alRunning head recto: Balancing standardized testing with personalized training in surgeryDOI: http://dx.doi.org/10.2147/AMEP .S122312",Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 29 Balancing standardized testing with personalized training in surgery  2.,Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
Available from: https://psychsocialissues.com/2011/07/20/sat-the-validity-and-reliability-and-its-effect-on-cultural-and-racial-minorities/.,Non-OADS,/arxiv_data1/oa_pdf/d9/51/amep-8-025.PMC5207203.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 31–32Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 31 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S127999 Simulation-based medical education to improve  intrinsic motivation in medical students Helen-Cara Y ounan Faculty of Medicine, Imperial College  London, London, UKDear editor I read with great interest the results of the study by Deane and Murphy1 regarding learn- ing strategies of medical students in a clinical rotation of obstetrics and gynecology.",Non-OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
"Reflecting on this session increased my intrinsic drive by motivating me to increase  my clinical skills and knowledge so that I could be helpful if I ever found myself in any of these situations.Correspondence: Helen-Cara Younan   Faculty of Medicine, Imperial College  London, Sir Alexander Fleming Building, Prince Consort Road, Kensington SW7 2BB, London, UK   Tel +44 77 7859 0724   Email helen-cara.younan12@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2017V olume: 8Running head verso: Y ounanRunning head recto: SBME to improve intrinsic motivationDOI: http://dx.doi.org/10.2147/AMEP .S127999",Non-OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 32 Y ounan Additionally, working with other students to deal with  these situations also gave me an opportunity to practice  important communication skills and teamwork.",Non-OADS,/arxiv_data1/oa_pdf/f2/6b/amep-8-031.PMC5207204.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 33–36Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 33 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S119440 Evaluating medical students’ proficiency with a  handheld ophthalmoscope: a pilot study Gregory Gilmour1 James McKivigan2 1Physical Medicine and Rehabilitation,   Michigan State University, Lansing,   MI, 2School of Physical Therapy, T ouro  University, Henderson, NV, USAIntroduction: Historically, testing medical students’ skills using a handheld ophthalmoscope  has been difficult to do objectively.",Non-OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
"7 Other authors have incorporated fundus photographs in a kind of match-correspondence: James McKivigan School of Physical Therapy, Touro University, 874 American Pacific Drive, Henderson, NV 89014, USATel +1 702 777 3055Fax +1 702 777 3096Email james.mckivigan@tun.touro.eduJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: Gilmour and McKiviganRunning head recto: Medical students’ proficiency with handheld ophthalmoscopeDOI: http://dx.doi.org/10.2147/AMEP .S119440",Non-OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 36 gilmour and McKivigan eye drops.,Non-OADS,/arxiv_data1/oa_pdf/d4/ee/amep-8-033.PMC5207205.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS We are grateful to the families who participated in this study.,Non-OADS,/arxiv_data1/oa_pdf/43/fe/gim2016126a.PMC5207316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) GeNeTICs in MeDICINe  |   Volume 19  |  Number 4  |  April 2017",Non-OADS,/arxiv_data1/oa_pdf/43/fe/gim2016126a.PMC5207316.pdf
"Raw sequencing reads in FASTQ format and coverage files normalized by DESeq2 size factors are availablevia Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo) under accession number GSE74425.",OADS,/arxiv_data1/oa_pdf/f3/1d/EMBJ-35-991.PMC5207318.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 95–104International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  95OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11887 1 gender differences in partners of patients with  COPD and their perceptions about the patients nienke nakken1 Daisy Ja Janssen1,2 Monique van Vliet3 geeuwke J de Vries4 giny al Clappers-gielen5 arent Jan Michels6 Jean WM Muris7 Jan h Vercoulen8 emiel FM Wouters1,9 Martijn a spruit1 1Department of research and  education, CIr O, horn, 2Centre  of expertise for Palliative Care,   Maastricht University Medical  Centre+ (MUMC +), Maastricht,   3Department of respiratory Medicine,   Zuyderland, heerlen, 4Department  of respiratory Medicine, Zuyderland,   sittard-geleen, 5Department of  respiratory Medicine, elkerliek  hospital, helmond, 6Department  of respiratory Medicine, st anna  hospital, geldrop, 7Department of  Family Medicine, C aPhrI school  of Public health and Primary Care,   Maastricht University, Maastricht,   8Department of Medical Psychology  and Department of Pulmonary  Diseases, radboud University  nijmegen Medical Centre, nijmegen,   9Department of respiratory Medicine,   Maastricht University Medical  Centre+ (MUMC +), Maastricht,   the netherlandsBackground/objectives:  Chronic obstructive pulmonary disease (COPD) not only affects patients  but also their partners.",Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
"For instance, women with COPD report more  symptoms such as dyspnea, fatigue, chronic cough, anxiety, and depression, but they  also report a lower health-related quality of life compared to their male peers.3–6 Patients’ symptom burden can result into problems with activities of daily life,  which, in turn can result in care dependence on family members and in particular  partners.7 Y et, research regarding possible gender differences in partners of patients  with COPD has been conducted to a lesser extent, and most research focused on female  partners.8,9 Indeed, compared to male family caregivers, female family caregivers Correspondence: nienke nakken Department of research and education,  CIrO, hornerheide 1, 6085 nM horn,  the netherlands Tel +31 475 587 602 email nienkenakken@ciro-horn.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Nakken et al Running head recto: Gender differences in partners of COPD patients DOI: http://dx.doi.org/10.2147/COPD.S118871",Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/b9/copd-12-095.PMC5207329.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/71/bctt-9-001.PMC5207330.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Breast Cancer: Targets and Therapy 2017:9 1–7Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S7950 6Gastric and colon metastasis from breast cancer:  case report, review of the literature, and possible  underlying mechanisms J Carlos Villa Guzmán1 J Espinosa1 R Cervera1 M Delgado2 R Patón3 JM Cordero García4 1Department of Medical Oncology,   2Department of Pathology,   3Department of Gastroenterology,   4Department of Nuclear Medicine,   University Ciudad Real General  Hospital, Ciudad Real, Spain Correspondence: J Carlos Villa Guzmán   Department of Medical Oncology,  University Ciudad Real General Hospital,  Obispo Rafael Torjia St, 13002 Ciudad  Real, Spain   Tel +34 1 696 658 482   Fax +34 926 27 85 79   Email jvillaguzman1@yahoo.e sAbstract:  Gastrointestinal metastases from breast cancer are not common.",Non-OADS,/arxiv_data1/oa_pdf/e8/71/bctt-9-001.PMC5207330.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast­cancer ­­­targets­and­therapy­journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e8/71/bctt-9-001.PMC5207330.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/8d/dddt-11-083.PMC5207331.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 83–89Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  83Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11272 3 analysis of pramipexole dose–response  relationships in Parkinson’s disease Ying Wang1 sheng-gang sun2 sui-Qiang Zhu3 chun-Feng liu4 Yi-Ming liu5 Qing Di6 hui-Fang shang7 Yan ren8 Wei Xiang9 sheng-Di chen1 1Department of neurology, ruijin  hospital affiliated to shanghai Jiao  T ong University school of Medicine,   shanghai, 2Department of n eurology,   Union hospital affiliated to Tongji  Medical college of huazhong  University of science and T echnology,   Wuhan, 3Department of neurology,   Tongji hospital affiliated to Tongji  Medical college of huazhong  University of science and T echnology,   Wuhan, 4Department of neurology,   The second affiliated hospital  of soochow University, suzhou,   5Department of neurology, Qilu  hospital affiliated to shandong  University, Jinan, 6Department of  neurology, nanjing Brain hospital,   nanjing, 7Department of neurology,   West china hospital affiliated  to sichuan University, chengdu,   8Department of neurology, First  affiliated hospital of china Medical  University, shenyang, 9Medical  Department, Boehringer ingelheim  (china) investment co., ltd., shanghai,   People’s republic of chinaBackground:  Pramipexole (PPX), a non-ergot dopamine receptor agonist, is a first-line  treatment for Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/44/8d/dddt-11-083.PMC5207331.pdf
"Sustained-release (SR) formulations of PPX, the same formulation with extended- release PPX, showed similar pharmacokinetics and tolerability as equivalent dose correspondence: sheng-Di chen Department of neurology, ruijin  Hospital affiliated to Shanghai Jiao Tong  University school of Medicine, no 197,  ruijin second road, shanghai 200025,  People’s republic of china email chen_sd@medmail.com.c nJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Wang et al Running head recto: Analysis of pramipexole dose–response relationships DOI: http://dx.doi.org/10.2147/DDDT.S112723",Non-OADS,/arxiv_data1/oa_pdf/44/8d/dddt-11-083.PMC5207331.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/44/8d/dddt-11-083.PMC5207331.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/8d/dddt-11-083.PMC5207331.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 37–44Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  37OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12246 4 Pressure ulcers in palliative ward patients:  hyponatremia and low blood pressure as  indicators of risk Danuta sternal1 Krzysztof Wilczyński2 Jan szewieczek2 1Department of nursing and  Paramedical sciences, Faculty  of health sciences, University  of Bielsko-Biala, Bielsko-Biala,   2Department of geriatrics, school of  health sciences in Katowice, Medical  University of silesia, Katowice, PolandBackground:  Prevention strategies for pressure ulcer formation remain critical in patients with  an advanced illness.",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
"Keywords:  pressure ulcers, palliative care, advanced illness, Waterlow score, hyponatremia,  blood pressure Introduction Pressure ulcers represent a frequent and significant challenge for medical, nursing, and  social care systems among the elderly, disabled, and other patient populations.1–6 Dete - rioration of physical, psychological, and social health due to pressure ulcers within sus - ceptible patients is often devastating7,8 and increases the risk of death.9 While prolonged  skin pressure, shear stress, and/or friction are primary causal factors leading to ulcer  formation, variability of pressure ulcer risk factors, prevalence, incidence, and prognosis  have been observed in different patient populations.1–3 Advanced chronic illness, defined Correspondence: Jan szewieczek Department of geriatrics, school of  health sciences in Katowice, Medical  University of silesia, gCM, ulica Ziolowa  45/47, 40-635 Katowice, Poland Tel +48 32 359 8239 Fax +48 32 205 9483 email jszewieczek@sum.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sternal et al Running head recto: Pressure ulcers in palliative ward patients DOI: http://dx.doi.org/10.2147/CIA.S122464",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
Available from: https://www.nice.org.uk/guidance/ cg17 9.,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/cia-12-037.PMC5207332.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 91–102Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  91Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7987 0 Vitamin D deficiency and the risk of tuberculosis:  a meta-analysis shao-Jun huang1 Xian-hua Wang2 Zhi-Dong liu1 Wen-li cao3 Yi han1 ai-guo Ma2 shao-Fa Xu1 1Department of Thoracic Surgery,   Beijing chest hospital, capital  Medical University, Beijing, People’s  Republic of China; 2Department  of Nutrition and Food Hygiene,   Institute of Human Nutrition, Medical  College of Qingdao University,   Qingdao, People’s Republic of China;   3Department of Pulmonary Medicine,   Beijing geriatric hospital, Beijing,   People’s Republic of ChinaBackground and aim:  To conduct meta-analyses of all published studies on various aspects  of association between vitamin D and tuberculosis (TB).",Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
"It was estimated  that there were 8.7 million reported new TB cases and that 1.4 million people died from  TB in 2011.1 Various factors that could possibly affect the incidence and progression  of TB have been reported, one of them is vitamin D deficiency (VDD).1–6 Exposure  to sunlight is the main source of vitamin D for human and induces the conversion of  7-dehydrocholesterol to vitamin D3 via previtamin D3 in the skin.7 Vitamin D3 is then  converted to 25-hydroxyvitamin D (25(OH)D) in the liver and is further converted  to the bioactive form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in the  kidney.7 Studies have found that 1,25(OH)2D3 binds to vitamin D receptor (VDR),  activates VDR signaling, and induces a series of antimicrobial responses such as  induction of autophagy, phagolysosomal fusion, release and activation of the antimi - crobial peptide cathelicidin, and killing of intracellular Mycobacterium tuberculosis .7–9 correspondence: shao-Fa Xu Department of Thoracic Surgery,  Beijing chest hospital, capital  Medical University, no 97 Machang,  Tongzhou District, Beijing,  People’s Republic of China Tel +86 10 8950 9326 email shaofaxu@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Huang et al Running head recto: Vitamin D and tuberculosis: a meta-analysis DOI: http://dx.doi.org/10.2147/DDDT.S79870",Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
Available from: http://handbook.cochrane.org /  16.,OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
Avail - able from: http://handbook.cochrane.org /  18.,Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/86/dddt-11-091.PMC5207333.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 55–63Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  55OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12576 2 Predictors of outcomes following reablement in  community-dwelling older adults hanne T untland1,2 Ingvild Kjeken3,4 eva langeland2,5 Bjarte Folkestad2,6 Birgitte espehaug7 Oddvar Førland2,8 Mona Kristin Aaslund1 1Department of global Public health  and Primary Care, Faculty of Medicine  and Dentistry, University of Bergen,   2Centre for Care research Western  norway, Bergen University College,   Bergen, 3national Advisory Unit  on rehabilitation in rheumatology,   Diakonhjemmet hospital,   4Department of Occupational  Therapy, Prosthetics and Orthotics,   Faculty of health sciences, Oslo  and Akershus University College of  Applied sciences, Oslo, 5Department  of nursing, Faculty of health and  social sciences, Bergen University  College, 6Uni research rokkan  Centre, 7Centre for evidence- Based Practice, Bergen University  College, 8Faculty of health studies,   VID specialized University, Campus  Bergen, Bergen, norwayBackground:  Reablement is a rehabilitation intervention for community-dwelling older adults,  which has recently been implemented in several countries.",Non-OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
"It has been seen as a solution to a number of long-standing challenges in health  care, including the cost pressures associated with a rapidly aging population, and is  therefore being implemented in a growing number of countries.1 There is limited  evidence, although not conclusive, that reablement leads to improved function in  daily occupations, physical function and health-related quality of life for home- dwelling older adults2–5 and to reduced costs and decreased demand for public health  care services.4–6Correspondence: hanne Tuntland Centre for Care research Western  norway, Bergen University College,  PO Box 7030, 5020 Bergen, norway Tel +47 5558 7839 email hanne.kristin.tuntland@hib.n o Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Tuntland et al Running head recto: Predictors of reablement DOI: http://dx.doi.org/10.2147/CIA.S125762",Non-OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
"Available from: https://brage.bibsys.no/xmlui/bitstream/ handle/11250/2389813/1/Rapport6_16_web.pd f. Accessed November  10, 2016.",OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/19/af/cia-12-055.PMC5207334.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 9–19Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 9 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S124860 Luteolin inhibits lung metastasis, cell migration,  and viability of triple-negative breast cancer cells Matthew T Cook1,2  Yayun Liang1,2  Cynthia Besch-Williford3  Salman M Hyder1,2 1Department of Biomedical Sciences,   2Dalton Cardiovascular Research  Center, University of Missouri,   3IDEXX BioResearch, Columbia, MO,   USAAbstract: Most breast cancer-related deaths from triple-negative breast cancer (TNBC) occur  following metastasis of cancer cells and development of tumors at secondary sites.",Non-OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
"6 TNBC represents a cancer phenotype  that is difficult to treat, and cancers of this type that escape adjuvant treatment and Correspondence: Salman M Hyder Dalton Cardiovascular Research Center, University of Missouri, 134 Research Park Drive, Columbia, MO 65211, USA Tel +1 573 882 1266   Fax +1 573 884 4232   Email hyders@missouri.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Cook et alRunning head recto: LU suppresses metastasis of TNBC cellsDOI: http://dx.doi.org/10.2147/BCTT.S124860",Non-OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 19 LU suppresses metastasis of TNBC cells 11.,Non-OADS,/arxiv_data1/oa_pdf/bf/36/bctt-9-009.PMC5207335.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/e3/dddt-11-103.PMC5207336.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 103–121Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  103Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11513 5 Anticancer and anti-inflammatory activities  of girinimbine isolated from Murraya  koenigii Venoos iman1 syam Mohan2 siddig ibrahim abdelwahab2 hamed Karimian1 noraziah nordin1 Mehran Fadaeinasab3 Mohamad ibrahim noordin1 suzita Mohd noor4 1Department of Pharmacy, Faculty of  Medicine, University of Malaya, Kuala  lumpur, Malaysia; 2Medical research  center, Jazan University, Jazan, saudi  arabia; 3Department of chemistry,   4Department of Biomedical science,   Faculty of Medicine, University of  Malaya, Kuala lumpur, MalaysiaAbstract:  Therapy that directly targets apoptosis and/or inflammation could be highly effective  for the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/f3/e3/dddt-11-103.PMC5207336.pdf
"Despite advances in cancer therapy, it remains the fourth most common cause  of cancer mortality worldwide.1 Among colorectal cancer patients, only ~20% have  a familial basis; environmental factors, food-borne mutagens, intestinal commensals, correspondence: suzita Mohd noor Department of Biomedical science,  Faculty of Medicine, University of Malaya,  50603 Kuala lumpur, Malaysia Tel +60 3 7967 4901 Fax +60 3 7967 6600 email suzita@um.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Iman et al Running head recto: Anticancer and anti-inflammatory activities of girinimbine DOI: http://dx.doi.org/10.2147/DDDT.S115135",Non-OADS,/arxiv_data1/oa_pdf/f3/e3/dddt-11-103.PMC5207336.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f3/e3/dddt-11-103.PMC5207336.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/e3/dddt-11-103.PMC5207336.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fb/05/dddt-11-133.PMC5207337.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy Drug Design, Development and Therapy 2017:11 133Dove press submit your manuscript | www.dovepress.co m Dove press  Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fb/05/dddt-11-133.PMC5207337.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 133CorrigenDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S12907 1 A triazole derivative elicits autophagic clearance of polyglutamine  aggregation in neuronal cells [Corrigendum] Hsieh CH, Lee LC, Leong WY, Y ang TC, Y ao CF, Fang K.  Drug Des Devel Ther .",Non-OADS,/arxiv_data1/oa_pdf/fb/05/dddt-11-133.PMC5207337.pdf
"2016;10:2947–2957.On page 2950, Figure 1, part B should have been the  following:Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2017 Volume: 11 Running head verso: Hsieh et al Running head recto: A triazole derivative elicits autophagic clearance of polyglutamine DOI: http://dx.doi.org/10.2147/DDDT.S129071 1 1 11 11 1 12 22 2 2 2",Non-OADS,/arxiv_data1/oa_pdf/fb/05/dddt-11-133.PMC5207337.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/23/dddt-11-123.PMC5207338.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 123–131Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12039 9 effects of multiple-dose ponesimod, a selective  s1P1 receptor modulator, on lymphocyte subsets  in healthy humans stipo Jurcevic1 Pierre-eric Juif2 colleen hamid3 roseanna greenlaw3 Daniele D’ambrosio2 Jasper Dingemanse2 1Department of Biomedical  sciences, University of Westminster,   london, UK; 2Department of  clinical Pharmacology, actelion  Pharmaceuticals ltd, allschwil,   switzerland; 3Division of  Transplantation immunology &  Mucosal Biology, King’s college  london, london, UKAbstract:  This study investigated the effects of ponesimod, a selective S1P1 receptor modulator,  on T lymphocyte subsets in 16 healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/29/23/dddt-11-123.PMC5207338.pdf
"Lymphocytes return to the blood and lymphatic correspondence: Pierre-eric Juif Department of clinical Pharmacology,  actelion Pharmaceuticals ltd,  gewerbestrasse 16, ch-4123  allschwil, switzerland Tel +41 61 565 8890 Fax +41 61 565 6200 email pierre-eric.juif@actelion.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Jurcevic et al Running head recto: Ponesimod-triggered changes in lymphocyte subsets DOI: http://dx.doi.org/10.2147/DDDT.S120399",Non-OADS,/arxiv_data1/oa_pdf/29/23/dddt-11-123.PMC5207338.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/29/23/dddt-11-123.PMC5207338.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/23/dddt-11-123.PMC5207338.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 1–11Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S113874 Coaching and barriers to weight loss: an  integrative review Karen Fernanda Muñoz  Obino1 Caroline Aguiar Pereira1 Rafaela Siviero Caron-Lienert 2 1Nutrology/Clinical Nutrition  Unit, Ernesto Dornelles Hospital,   2Nutrition of the Educational and  Research Institute of Moinhos de  Vento Hospital, Porto Alegre, BrazilIntroduction: Coaching is proposed to raise a patient’ s awareness and responsibility for their  health behaviour change by transforming the professional–patient relationship.",Non-OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
"However, Correspondence: Karen Fernanda Muñoz  ObinoNutrology/Clinical Nutrition Unit, Ernesto Dornelles Hospital, Avenida Ipiranga, 1801 - Porto Alegre - RS, 90160-092, BrazilEmail karenfmunoz@gmail.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Muñoz Obino et alRunning head recto: Coaching and weight loss: reviewDOI: http://dx.doi.org/10.2147/DMSO.S113874",Non-OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 11 Coaching and weight loss: review Supplementary material Identification Title of the article: Main author:Country: Language: Publication year: Institution HospitalUniversityResearch center Single-center study Multicenter studyOther institutionsNot identifies local Characters of the study methodology • Publication type Quantitative approach Qualitative approachLiterature reviewCase reportOthers Purpose of study issueSample Size:Age:Sex:Diagnosis: Inclusion/exclusion criteria of subjects Intervention performed • Methods employed for intervention of measurement ResultsImplications • What are the recommendations of the authors Figure S1 Instrument for data collection based on study by Ursi.1 Note: Copyright © 2001–2014.,Non-OADS,/arxiv_data1/oa_pdf/2d/44/dmso-10-001.PMC5207339.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201771Practical and illustrated summary of  updated BI-RADS for ultrasonography Jiyon Lee Department of Radiology, NYU School of Medicine, NYU Cancer Institute, Breast Imaging  Center, New York, NY , USA https://doi.org/10.14366/usg.16034 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:71-81The American College of Radiology released the fifth edition of the Breast Imaging-Reporting and  Data System (BI-RADS) in 2014 (copyright 2013), which includes the expanded second edition of the ultrasound BI-RADS lexicon.",Non-OADS,/arxiv_data1/oa_pdf/40/2a/usg-16034.PMC5207351.pdf
"+1-212-731-5554     E-mail: Jiyon.Lee@nyumc.orgPICTORIAL ESSAY This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/40/2a/usg-16034.PMC5207351.pdf
ORCID: Jiyon Lee: http://orcid.org/0000-0003-0036-8828 Conflict of Interest Conflict of interest relevant to this article was not reported.,Non-OADS,/arxiv_data1/oa_pdf/40/2a/usg-16034.PMC5207351.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201733Ultrasonographic features of traumatic  neuromas in breast cancer patients after mastectomy Hwa Sung Sung, Young-Seon Kim Department of Radiology, Yeungnam University College of Medicine, Daegu, Korea https://doi.org/10.14366/usg.16029 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:33-38 Purpose: The purpose of this study was to evaluate the ultrasonographic (US) features of  traumatic neuromas in breast cancer patients after mastectomy.",Non-OADS,/arxiv_data1/oa_pdf/78/06/usg-16029.PMC5207352.pdf
"+82-53-653-5484 E-mail: ing29@hanmail.netORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/78/06/usg-16029.PMC5207352.pdf
ORCID: Hwa Sung Sung: http://orcid.org/0000-0003-4646-9528; Young-Seon Kim:  http://orcid.org/0000-0002-9168-8204 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/78/06/usg-16029.PMC5207352.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 20173Clinical application of S-Detect to breast  masses on ultrasonography: a study evaluating the diagnostic performance and agreement with a dedicated breast radiologist Kiwook Kim1, Mi Kyung Song2, Eun-Kyung Kim1, Jung Hyun Yoon1 1Department of Radiology, Severance Hospital, Research Institute of Radiological Science,  2Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College  of Medicine, Seoul, Koreahttps://doi.org/10.14366/usg.16012 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:3-9 Purpose: The purpose of this study was to evaluate the diagnostic performance of S-Detect when  applied to breast ultrasonography (US), and the agreement with an experienced radiologist  specializing in breast imaging.Methods: From June to August 2015, 192 breast masses in 175 women were included.",Non-OADS,/arxiv_data1/oa_pdf/51/01/usg-16012.PMC5207353.pdf
"+82-2-393-3035 E-mail: lvjenny@yuhs.acORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/51/01/usg-16012.PMC5207353.pdf
ORCID: Kiwook Kim: http://orcid.org/0000-0002-8798-5038; Mi Kyung Song: http:// orcid.org/0000-0003-3799-0426; Eun-Kyung Kim: http://orcid.org/0000-0002-3368-5013; Jung Hyun Yoon: http://orcid.org/0000-0002-2100-3513 Conflict of Interest This study has been supported by the research fund of Samsung  Medison.,Non-OADS,/arxiv_data1/oa_pdf/51/01/usg-16012.PMC5207353.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 20171ULTRASONOGRAPHY: how to raise  the impact factor This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/11/18/usg-13047.PMC5207354.pdf
"All of the e-published articles in the “ahead-of-print” status as well as all officially issued articles are searchable in PubMed (https://www.ncbi.nlm.nih.gov/ pubmed?term=Ultrasonography[jour]), and the early indexing in PubMed has contributed to  maximizing the span of time our articles appear to global readers.",Non-OADS,/arxiv_data1/oa_pdf/11/18/usg-13047.PMC5207354.pdf
"Toward this goal, a large number of Editor-in-Chief  Ultrasonography  https://doi.org/10.14366/usg.13047 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:1-2 Received: November 23, 2016 Revised: November 26, 2016Accepted: November 30, 2016Editorial",Non-OADS,/arxiv_data1/oa_pdf/11/18/usg-13047.PMC5207354.pdf
ORCID: Jeong-Sik Yu: http://orcid.org/0000-0002-8171-5838 References  1.,Non-OADS,/arxiv_data1/oa_pdf/11/18/usg-13047.PMC5207354.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201725Shear wave elastography using  ultrasound: effects of anisotropy and stretch stress on a tissue phantom and  in vivo  reactive lymph nodes in the neck Ha Young Lee1, Jeong Hyun Lee2, Ji Hoon Shin2, So Yeon Kim2, Hee Jung Shin2,  Jeong Seon Park3, Young Jun Choi2, Jung Hwan Baek2 1Department of Radiology, University of Inha College of Medicine, Incheon; 2Department  of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul; 3Department of Radiology, Hanyang University College of  Medicine, Seoul, Koreahttps://doi.org/10.14366/usg.16003 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:25-32 Purpose: The purpose of this study was to evaluate how the anisotropy and the static stretch  stress of the cervical musculature influence the measured shear modulus in a tissue-mimicking  phantom and in cervical lymph nodes in vivo  by using shear wave elastography (SWE).",Non-OADS,/arxiv_data1/oa_pdf/d3/c9/usg-16003.PMC5207355.pdf
"+82-2-476-0090 E-mail: jeonghlee@amc.seoul.krORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/c9/usg-16003.PMC5207355.pdf
ORCID: Ha Young Lee: http://orcid.org/0000-0003-2343-3434; Jeong Hyun Lee:  http://orcid.org/0000-0002-0021-4477; Ji Hoon Shin: http://orcid.org/0000-0001-6598-9049; So Yeon Kim: http://orcid.org/0000-0001-6245-8867; Hee Jung Shin: http://orcid.org/0000-0002-3398-1074; Jeong Seon Park: http://orcid.org/0000-0002-5550-6645; Young Jun Choi: http://orcid.org/0000-0001-7098-5042; Jung Hwan Baek: http://orcid.org/0000-0003-0480-4754  Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/usg-16003.PMC5207355.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201717Assessing the accuracy and reliability  of ultrasonographic three-dimensional parathyroid volume measurement in a patient with secondary hyperparathyroidism: a comparison with the two-dimensional conventional method Sung-Hye You1, Sang-il Suh2, In-Seon Ryoo2, Gyu-Ri Son1, Young-Hen Lee3,  Hyung Suk Seo3, Nam Joon Lee1, Hae Young Seol2 1Department of Radiology, Korea University Anam Hospital, Seoul; 2Department of Radiology,  Korea University Guro Hospital, Seoul; 3Department of Radiology, Korea University Ansan  Hospital, Ansan, Koreahttps://doi.org/10.14366/usg.16022 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:17-24 Purpose: The purpose of this study was to investigate the accuracy and reliability of the semi- automated ultrasonographic volume measurement tool, virtual organ computer-aided analysis  (VOCAL), for measuring the volume of parathyroid glands.Methods: Volume measurements for 40 parathyroid glands were performed in patients with  secondary hyperparathyroidism caused by chronic renal failure.",Non-OADS,/arxiv_data1/oa_pdf/e7/e0/usg-16022.PMC5207356.pdf
"+82-2-6280-9076 E-mail: sangil.suh@gmail.com or  ssickh@korea.ac.krORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/e0/usg-16022.PMC5207356.pdf
ORCID: Sung-Hye You: http://orcid.org/0000-0001-5005-9383; Sang-il Suh:   http://orcid.org/0000-0001-8933-0492; In-Seon Ryoo: http://orcid.org/0000-0001- 6866-7926; Gyu-Ri Son: http://orcid.org/0000-0003-0614-071X; Young-Hen Lee: http://orcid.org/0000-0001-7739-4173; Hyung Suk Seo: http://orcid.org/0000-0003-2303-7415; Nam Joon Lee: http://orcid.org/0000-0002-4538-092X; Hae Young Seol: http://orcid.org/0000-0003-4231-5409 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/e7/e0/usg-16022.PMC5207356.pdf
"Junwoo Kim1, Sung Il Hwang1, Hak Jong Lee1, Sung Kyu Hong2, Seok-Soo Byun2,  Sangchul Lee2, Gheeyoung Choe3 Departments of 1Radiology, 2Urology, and 3Pathology, Seoul National University Bundang  Hospital, Seongnam, Koreahttps://doi.org/10.14366/usg.16014 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:10-16 Purpose: The purpose of this study was to analyze the detection rate of prostate cancers from  targeted biopsy specimens of midline focal lesions and to investigate the ultrasonographic  findings to reduce unnecessary additional targeted biopsies.Methods: Ninety-eight men with midline focal lesions detected on transrectal ultrasonography  were enrolled.",Non-OADS,/arxiv_data1/oa_pdf/44/46/usg-16014.PMC5207357.pdf
"+82-31-787-4011 E-mail: hwangsi49@gmail.comORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/44/46/usg-16014.PMC5207357.pdf
ORCID: Junwoo Kim: http://orcid.org/0000-0001-8680-658X; Sung Il Hwang: http:// orcid.org/0000-0001-7516-5369; Hak Jong Lee: http://orcid.org/0000-0003-0858-7873; Sung Kyu Hong: http://orcid.org/0000-0002-8344-6774; Seok-Soo Byun: http://orcid.org/0000-0001-7979-9035; Sangchul Lee: http://orcid.org/0000-0003-0844-6843; Gheeyoung Choe: http://orcid.org/0000-0001-6547-5603Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/44/46/usg-16014.PMC5207357.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201753Value of sagittal color Doppler  ultrasonography as a supplementary tool in the differential diagnosis of fetal cleft lip and palate Myoung Seok Lee1, Jeong Yeon Cho2,3, Sang Youn Kim2, Seung Hyup Kim2,3,  Joong Shin Park3,4, Jong Kwan Jun3,4 1Department of Radiology, Seoul Metropolitan Government-Seoul National University  Boramae Medical Center, Seoul; 2Department of Radiology, Seoul National University  Hospital, Seoul; 3College of Medicine, Seoul National University, Seoul; 4Department of  Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Koreahttps://doi.org/10.14366/usg.16025 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:53-59 Purpose: The purpose of this study was to evaluate the feasibility and usefulness of sagittal color  Doppler ultrasonography (CDUS) for the diagnosis of fetal cleft lip (CL) and cleft palate (CP).",Non-OADS,/arxiv_data1/oa_pdf/4c/a2/usg-16025.PMC5207358.pdf
"+82-2-747-7418 E-mail: radjycho@snu.ac.krORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/a2/usg-16025.PMC5207358.pdf
ORCID: Myoung Seok Lee: http://orcid.org/0000-0001-5285-4874; Jeong Yeon Cho:  http://orcid.org/0000-0001-8659-0918; Sang Youn Kim: http://orcid.org/0000-0003-4038-7345; Seung Hyup Kim: http://orcid.org/0000-0002-9339-5907; Joong Shin Park: http://orcid.org/0000-0002-5246-0477; Jong Kwan Jun: http://orcid.org/0000-0002-0242-1736 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/4c/a2/usg-16025.PMC5207358.pdf
"60  Ultrasonography 36(1), January 2017 e-ultrasonography.orgThe value of intraoperative ultrasonography  during the resection of relapsed irradiated malignant gliomas in the brain Kay Mursch1, Martin Scholz2, Wolfgang Brück3, Julianne Behnke-Mursch1 1Department of Neurosurgery, Zentralklinik, Bad Berka; 2Department of Neurosurgery,  Klinikum Duisburg, Duisburg; 3Department of Neuropathology, Georg August Universität,  Göttingen, Germanyhttps://doi.org/10.14366/usg.16015 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:60-65 Purpose: The aim of this study was to investigate whether intraoperative ultrasonography (IOUS)  helped the surgeon navigate towards the tumor as seen in preoperative magnetic resonance  imaging and whether IOUS was able to distinguish between tumor margins and the surrounding tissue.",Non-OADS,/arxiv_data1/oa_pdf/f5/53/usg-16015.PMC5207359.pdf
"+49-36458-53512 E-mail: kay.mursch@zentralklinik.deORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/53/usg-16015.PMC5207359.pdf
ORCID: Kay Mursch: http://orcid.org/0000-0001-9818-292X Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/f5/53/usg-16015.PMC5207359.pdf
"e-ultrasonography.org Ultrasonography 36(1), January 201739Evaluation of factors influencing arterial  Doppler waveforms in an in vitro  flow  phantom Chang Kyu Sung1, Kyoung Ho Lee2, Seung Hyup Kim3 1Department of Radiology, SMG-SNU Boramae Medical Center, Seoul National University  College of Medicine, Seoul; 2Department of Radiology, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, Seongnam; 3Department of  Radiology and the Institute of Radiation Medicine, Seoul National University Hospital, Seoul  National University College of Medicine, Seoul, Koreahttps://doi.org/10.14366/usg.15055 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:39-52 Purpose: The aim of this study was to investigate factors that influence arterial Doppler  waveforms in an in vitro  phantom to provide a more accurate and comprehensive explanation of  the Doppler signal.",Non-OADS,/arxiv_data1/oa_pdf/4a/d4/usg-15055.PMC5207360.pdf
"+82-2-743-6385 E-mail: kimsh@radcom.snu.ac.krORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/d4/usg-15055.PMC5207360.pdf
ORCID: Chang Kyu Sung: http://orcid.org/0000-0003-4922-5107; Kyoung Ho Lee:  http://orcid.org/0000-0001-6045-765X; Seung Hyup Kim: http://orcid.org/0000-0002-9339-5907 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/4a/d4/usg-15055.PMC5207360.pdf
Summary of Doppler examinations for  various combinations of compliance and tube length (https://doi.org/10.14366/usg.15055).,Non-OADS,/arxiv_data1/oa_pdf/4a/d4/usg-15055.PMC5207360.pdf
"66  Ultrasonography 36(1), January 2017 e-ultrasonography.orgUltrasonographic findings of Kikuchi  cervical lymphadenopathy in children Ji Young Kim1, Hyunju Lee2, Bo La Yun1 Departments of 1Radiology and 2Pediatrics, Seoul National University Bundang Hospital,  Seongnam, Korea https://doi.org/10.14366/usg.16047 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:66-70 Received: September 29, 2016 Revised: December 1, 2016Accepted: December 2, 2016 Correspondence to: Ji Young Kim, MD, Department of Radiology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/usg-16047.PMC5207361.pdf
"+82-31-787-4011 E-mail: poohahe@gmail.comORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/86/e8/usg-16047.PMC5207361.pdf
ORCID: Ji Young Kim: http://orcid.org/0000-0003-1466-2112; Hyunju Lee:  http://orcid.org/0000-0003-0107-0724; Bo La Yun: http://orcid.org/0000-0002-5457-7847 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/86/e8/usg-16047.PMC5207361.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
"Tel: +82-2-3410-2600, Fax: +82-2-3410-2619,  E-mail: dh8lim@skku.eduRadiat Oncol J 2016;34(4):290-296 https://doi.org/10.3857/roj.2016.01795pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Radiotherapy (RT) is considered a mainstay of treatment in parameningeal rhabdomyosarcoma (PM-RMS).",Non-OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
RT for parameningeal rhabdomyosarcoma291 www.e-roj.org https://doi.org/10.3857/roj.2016.01795of treatment in PM-RMS.,Non-OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
"Yunseon Choi, et al292 www.e-roj.org https://doi.org/10.3857/roj.2016.01795regional, and distant failure or death).",OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
RT for parameningeal rhabdomyosarcoma293 www.e-roj.org https://doi.org/10.3857/roj.2016.01795in patients without distant metastases and 0% in patients  with distant metastases (p < 0.001).,Non-OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
"Yunseon Choi, et al294 www.e-roj.org https://doi.org/10.3857/roj.2016.01795(p = 0.071) (Table 2).",OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
RT for parameningeal rhabdomyosarcoma295 www.e-roj.org https://doi.org/10.3857/roj.2016.01795was distant metastasis.,Non-OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
"Yunseon Choi, et al296 www.e-roj.org https://doi.org/10.3857/roj.2016.01795 2.",OADS,/arxiv_data1/oa_pdf/24/5c/roj-2016-01795.PMC5207364.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
305Original Article Radiat Oncol J 2016;34(4):305-312 https://doi.org/10.3857/roj.2016.01914pISSN 2234-1900 · eISSN 2234-3156   Purpose:  The objective of this prospective study was to evaluate the relationship between the circulating lymphocyte  subpopulation counts during preoperative chemoradiotherapy (CRT) and tumor response in locally advanced rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
"Jaesung Heo, et al306 www.e-roj.org https://doi.org/10.3857/roj.2016.01914In previous studies, researchers attempted to identify the  predictive factors that influence tumor response to CRT for  rectal cancer.",OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
Tumor response to host immunity307 www.e-roj.org https://doi.org/10.3857/roj.2016.01914on diffusion-weighted MRI with conventional MRI and CT. We  used the sustaining ratio (SR) as a method of estimating CRT sensitivity of the lymphocyte subset.,Non-OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
"Jaesung Heo, et al308 www.e-roj.org https://doi.org/10.3857/roj.2016.01914which was the lowest compared to the other subpopulation  values (Fig.",OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
Tumor response to host immunity309 www.e-roj.org https://doi.org/10.3857/roj.2016.01914Fig.,Non-OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
"Jaesung Heo, et al310 www.e-roj.org https://doi.org/10.3857/roj.2016.01914change between before and after CRT showed a trend for  the association with nodal response (p = 0.052 by repeated measure analysis) (Fig.",OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
Tumor response to host immunity311 www.e-roj.org https://doi.org/10.3857/roj.2016.01914NK cells was the lowest in the lymphocyte subset (mSR =  0.55).,OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
"Jaesung Heo, et al312 www.e-roj.org https://doi.org/10.3857/roj.2016.01914cancer.",OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
Available from: https://cran.r-project.org/ web/packages/npIntFactRep/npIntFactRep.pdf.,OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
Available  from: https://cran.r-project.org/doc/manuals/r-release/ fullrefman.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/39/roj-2016-01914.PMC5207365.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"297Original Article Radiat Oncol J 2016;34(4):297-304 https://doi.org/10.3857/roj.2016.01879pISSN 2234-1900 · eISSN 2234-3156   Purpose:  To investigate the outcomes of postoperative radiotherapy (RT), in patients with extrahepatic bile duct (EHBD) cancer  by comparing the survival rate between patients undergoing surgery alone or surgery plus postoperative RT, and to identify the  prognostic factors affecting survival.",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Mi Young Kim, et al298 www.e-roj.org https://doi.org/10.3857/roj.2016.01879postoperative radiotherapy (RT) with or without chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Radiotherapy for the EHBD cancer299 www.e-roj.org https://doi.org/10.3857/roj.2016.01879(range, 3 to 105 months).",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Mi Young Kim, et al300 www.e-roj.org https://doi.org/10.3857/roj.2016.01879Table 2.",OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Radiotherapy for the EHBD cancer301 www.e-roj.org https://doi.org/10.3857/roj.2016.01879resection without RT (p = 0.032 for DFS, p = 0.001 for LRFS) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Mi Young Kim, et al302 www.e-roj.org https://doi.org/10.3857/roj.2016.01879patients.",OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Radiotherapy for the EHBD cancer303 www.e-roj.org https://doi.org/10.3857/roj.2016.01879In the present study, the predominant pattern of failure  was distant metastasis in patients who received postoperative  RT, primarily as a result of increased loco-regional control.",Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"Mi Young Kim, et al304 www.e-roj.org https://doi.org/10.3857/roj.2016.018792000;7:115-21.",OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
Available from: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/7d/roj-2016-01879.PMC5207366.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"Tel: +82-2-2650-5331, Fax: +82-2-2654-0363, E-mail: jihae.leee@gmail.comRadiat Oncol J 2016;34(4):265-272 https://doi.org/10.3857/roj.2016.01648pISSN 2234-1900 · eISSN 2234-3156   Purpose:  The purpose of this study is to evaluate the treatment outcomes of adjuvant radiotherapy using vaginal brachytherapy  (VB) with a lower dose per fraction and/or external beam radiotherapy (EBRT) following surgery for patients with stage I  endometrial carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"Jiyoung Kim, et al266 www.e-roj.org https://doi.org/10.3857/roj.2016.01648cancer is generally hysterectomy and bilateral salpingo- oophorectomy with or without lymph node dissection.",Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
Adjuvant radiotherapy for stage I endometrial cancer267 www.e-roj.org https://doi.org/10.3857/roj.2016.01648Details of the radiotherapy regimens are presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"Jiyoung Kim, et al268 www.e-roj.org https://doi.org/10.3857/roj.2016.01648tomography (PET-CT).",OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
Adjuvant radiotherapy for stage I endometrial cancer269 www.e-roj.org https://doi.org/10.3857/roj.2016.01648surgery followed by palliative radiotherapy to the bone.,Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"Jiyoung Kim, et al270 www.e-roj.org https://doi.org/10.3857/roj.2016.01648 Table 4.",OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
Adjuvant radiotherapy for stage I endometrial cancer271 www.e-roj.org https://doi.org/10.3857/roj.2016.01648patients in our EBRT group reported severe late complications  (small bowel obstruction and pelvic bone insufficiency fracture).,Non-OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"Jiyoung Kim, et al272 www.e-roj.org https://doi.org/10.3857/roj.2016.01648Cochrane systematic review and meta-analysis.",OADS,/arxiv_data1/oa_pdf/29/7c/roj-2016-01648.PMC5207367.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"239Review Article Radiat Oncol J 2016;34(4):239-249 https://doi.org/10.3857/roj.2016.02012pISSN 2234-1900 · eISSN 2234-3156   Tumor hypoxia, a common feature occurring in nearly all human solid tumors is a major contributing factor for failures of  anticancer therapies.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Beom-Ju Hong, et al240 www.e-roj.org https://doi.org/10.3857/roj.2016.02012study in human colorectal adenocarcinoma xenografts has  reported that small tumors of less than 1 mm in diameter are already being extensively hypoxic and poorly perfused [5].",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Tumor hypoxia–past, present, and future241 www.e-roj.org https://doi.org/10.3857/roj.2016.02012were given [21].",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Beom-Ju Hong, et al242 www.e-roj.org https://doi.org/10.3857/roj.2016.02012hours up to days [37].",OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Tumor hypoxia–past, present, and future243 www.e-roj.org https://doi.org/10.3857/roj.2016.02012regions of tumors.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Beom-Ju Hong, et al244 www.e-roj.org https://doi.org/10.3857/roj.2016.02012this high dose hypofractionated regimen [43] (‘B’ in Fig.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Tumor hypoxia–past, present, and future245 www.e-roj.org https://doi.org/10.3857/roj.2016.02012pancreatic cancer patients when it was combined with 25 Gy  intraoperative radiotherapy [32].",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Beom-Ju Hong, et al246 www.e-roj.org https://doi.org/10.3857/roj.2016.02012to a significantly increased radiotherapy efficacy in breast  cancer models in mice.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Tumor hypoxia–past, present, and future247 www.e-roj.org https://doi.org/10.3857/roj.2016.02012Kim JW (NRF-2016H1A2A1908006), and Kim YE (NRF- 2012H1A2A1002871) are Global PhD fellowship recipients supported by Ministry of Science, ICT, and Future Planning, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Beom-Ju Hong, et al248 www.e-roj.org https://doi.org/10.3857/roj.2016.02012review and meta-analysis.",OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
http://dx.doi.org/10.1016/j.ijrobp.2016.09.018.,OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"Tumor hypoxia–past, present, and future249 www.e-roj.org https://doi.org/10.3857/roj.2016.02012rate FLASH irradiation increases the differential response  between normal and tumor tissue in mice.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/roj-2016-02012.PMC5207368.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
313Original Article Radiat Oncol J 2016;34(4):313-321 https://doi.org/10.3857/roj.2016.01935pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Total scalp irradiation (TSI) is a rare but challenging indication.,Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
"Christian Ostheimer, et al314 www.e-roj.org https://doi.org/10.3857/roj.2016.01935of the tumor on the one side (multifocal spread, irregular  borders) and the complex geometry of the scalp on the other side (convex surface, close proximity of visual organs and face).",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
IMRT and VMAT in total scalp irradiation315 www.e-roj.org https://doi.org/10.3857/roj.2016.01935OAR contours were deleted.,OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
"Christian Ostheimer, et al316 www.e-roj.org https://doi.org/10.3857/roj.2016.01935per mm.",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
IMRT and VMAT in total scalp irradiation317 www.e-roj.org https://doi.org/10.3857/roj.2016.01935Table 1.,OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
"Christian Ostheimer, et al318 www.e-roj.org https://doi.org/10.3857/roj.2016.01935compared to non-coplanar (range, 18.7 to 24 Gy) and coplanar  IMRT plans (range, 19.7 to 25.8 Gy).",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
IMRT and VMAT in total scalp irradiation319 www.e-roj.org https://doi.org/10.3857/roj.2016.01935coplanar IMRT and VMAT.,OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
"Christian Ostheimer, et al320 www.e-roj.org https://doi.org/10.3857/roj.2016.01935target coverage and brain protection where IMRT significantly  deceased doses to the brain compared to 3D-CRT.",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
IMRT and VMAT in total scalp irradiation321 www.e-roj.org https://doi.org/10.3857/roj.2016.01935head.,OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
http://doi.org/10.1093/ jicru/ndq001.,Non-OADS,/arxiv_data1/oa_pdf/b7/1d/roj-2016-01935.PMC5207369.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"280Original Article Radiat Oncol J 2016;34(4):280-289 https://doi.org/10.3857/roj.2016.01711pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Early hypopharyngeal squamous cell carcinoma (HPSCC) is a rarely diagnosed disease, for which the optimal treatment  has not been defined yet.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Pattern of treatment failures of early hypopharyngeal cancer281 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1definitive RT or partial laryngopharyngectomy with ipsilateral  or bilateral neck dissection for early-stage HPSCC.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"Nalee Kim, et al282 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1= 7), 6 patients underwent partial pharyngectomy and one  patient underwent mass excision.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Pattern of treatment failures of early hypopharyngeal cancer283 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1(84.2%) and laser or trans-oral surgery (TORS) in 3 patients  (15.8%).,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"Nalee Kim, et al284 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1group were treated with elective irradiation to bilateral neck  nodes.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Pattern of treatment failures of early hypopharyngeal cancer285 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"Nalee Kim, et al286 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1and PORT 66.7%, 51.9%, and 100%; p = 0.17) (Fig.",OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Pattern of treatment failures of early hypopharyngeal cancer287 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1with PS apex extension was 37.6% compared to 75.6% in  tumors without apex extension (p = 0.09).,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"Nalee Kim, et al288 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1research will be necessary to identify the prognostic factor(s)  related to regional control in terms of optimal neck treatment.",Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
Pattern of treatment failures of early hypopharyngeal cancer289 www.e-roj.org https://doi.org/10.3857/roj.2016.0171 1to conservation surgery.,Non-OADS,/arxiv_data1/oa_pdf/f7/98/roj-2016-01711.PMC5207370.pdf
"Tel: +82-32-890-3070, Fax: +82-32-890-3082, E-mail:  cancerovercome@gmail.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2016;34(4):260-264 https://doi.org/10.3857/roj.2015.01571pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
"261 CyberKnife in localized prostate cancer www.e-roj.org https://doi.org/10.3857/roj.2015.01571intermediate risk prostate cancer, recent published literature  support use of hypofractionated SBRT using CyberKnife with excellent 5-year biochemical control rates and correspondingly acceptable rates of toxicity [2,9].",Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
"Toxicity was documented at follow-up visits  Hun Jung Kim, et al 2 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1intermediate risk prostate cancer, recent published literature  support use of hypofractionated SBRT using CyberKnife with excellent 5-year biochemical control rates and correspondingly acceptable rates of toxicity [2,9].",Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
"Hun Jung Kim, et al262 www.e-roj.org https://doi.org/10.3857/roj.2015.01571using the Radiation Therapy Oncology Groups.",Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
3CyberKnife in localized prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2016.34.1.1using the Radiation Therapy Oncology Groups.,Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
263 CyberKnife in localized prostate cancer www.e-roj.org https://doi.org/10.3857/roj.2015.01571bleeding at 3–6 months after treatment.,Non-OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
"Hun Jung Kim, et al264 www.e-roj.org https://doi.org/10.3857/roj.2015.01571reported.",OADS,/arxiv_data1/oa_pdf/aa/f4/roj-2015-01571.PMC5207371.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"250Review Article Radiat Oncol J 2016;34(4):250-259 https://doi.org/10.3857/roj.2016.02033pISSN 2234-1900 · eISSN 2234-3156   Immune checkpoint blockades including monoclonal antibodies (mAbs) of cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed  death-1 (PD-1), and programmed death-ligand 1 (PD-L1) have been emerged as a promising anticancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Immune checkpoint blockade combined with radiotherapy251 www.e-roj.org https://doi.org/10.3857/roj.2016.02033Immune Checkpoint Blockades Immune checkpoint blockades have been showing remarkable  progress in the field of immunotherapy, regulating key immunosuppressive pathways of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Taeryool Koo, In Ah Kim252 www.e-roj.org https://doi.org/10.3857/roj.2016.02033shown to have crucial role, while CD4+ T cell did not.",OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Immune checkpoint blockade combined with radiotherapy253 www.e-roj.org https://doi.org/10.3857/roj.2016.02033immunotherapy trials without RT, hence we can expect the  combination of RT and checkpoint blockades could be a useful treatment modality.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Taeryool Koo, In Ah Kim254 www.e-roj.org https://doi.org/10.3857/roj.2016.02033 Table 2.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
Immune checkpoint blockade combined with radiotherapy255 www.e-roj.org https://doi.org/10.3857/roj.2016.02033Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Taeryool Koo, In Ah Kim256 www.e-roj.org https://doi.org/10.3857/roj.2016.02033 Table 2.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
Immune checkpoint blockade combined with radiotherapy257 www.e-roj.org https://doi.org/10.3857/roj.2016.02033combination with RT or not.,Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"Taeryool Koo, In Ah Kim258 www.e-roj.org https://doi.org/10.3857/roj.2016.02033Cancer Lett 2015;356:82-90.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
Immune checkpoint blockade combined with radiotherapy259 www.e-roj.org https://doi.org/10.3857/roj.2016.0203337.,Non-OADS,/arxiv_data1/oa_pdf/2b/47/roj-2016-02033.PMC5207372.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"273Original Article Radiat Oncol J 2016;34(4):273-279 https://doi.org/10.3857/roj.2016.01781pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Although each Waldeyer’s ring sub-site is considered an independent prognostic factor, few studies have assessed the  prognosis and treatment of tonsillar lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"Yun Hee Lee, et al274 www.e-roj.org https://doi.org/10.3857/roj.2016.01781primary extranodal lymphomas [3].",OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"Primary tonsillar lymphoma275 www.e-roj.org https://doi.org/10.3857/roj.2016.01781dose of 36 Gy (range, 30 to 55.8 Gy) per 1.8–2 Gy fraction size,  and to neck lymph nodes with a median of 30.6 Gy (range, 26 to 50.4 Gy) per 1.5–2 Gy fraction size.",Non-OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"Yun Hee Lee, et al276 www.e-roj.org https://doi.org/10.3857/roj.2016.01781because of the small number of cases of locoregional  recurrences.",OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
Primary tonsillar lymphoma277 www.e-roj.org https://doi.org/10.3857/roj.2016.01781was observed in 1 patient in the CHOP + RT group at 29  months after RT.,Non-OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"Yun Hee Lee, et al278 www.e-roj.org https://doi.org/10.3857/roj.2016.01781with NHL [7-9,11].",OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
Primary tonsillar lymphoma279 www.e-roj.org https://doi.org/10.3857/roj.2016.01781patients with early-stage diffuse large B-cell lymphoma of  Waldeyer’s ring in remission after anthracycline-containing  chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/bb/fb/roj-2016-01781.PMC5207373.pdf
"33The terminal loops of H/ACA scaRNA hairpins carry CONTACT Be/C19ata E. J /C19ady jady@ibcg.biotoul.fr ; Tam /C19as Kiss tamas@ibcg.biotoul.fr Published with license by Taylor & Francis Group, LLC © CNRS and INSERM This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"12, 1274 –1285 http://dx.doi.org/10.1080/15476286.2016.1239689",Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
computer folding of experimentally validated human H/ACA RNA sequences available in the LBME SnoRNA Database(https://www-snorna.biotoul.fr ) con ﬁrmed that H/ACA RNAs carry fairly uniformly sized 5 0- and 30-terminal hairpins.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Human H/ACA RNA sequences were collected from the LBME snoRNA database ( https://www-snorna.biotoul.fr ) and they were folded by the mfold web server ( http://unafold.rna.albany.edu/?q Dmfold/ download-mfold ).,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"Cold Spring Harbor, New York: Cold SpringHarbor Laboratory Press, 1999; 37:487-524; http://dx.doi.org/10.1101/ 087969589.37.487 2.",Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell 2010; 37:597-606; PMID:20227365; http://dx.doi.org10.1016/j.molcel.2010.01.032 3.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Wiley Interdiscip Rev RNA 2012; 3:397-414;PMID:22065625; http://dx.doi.org10.1002/wrna.117 4.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
RNA Biol 2014; 11:1483-94; PMID: 25590339; http://dx.doi.org10.4161/15476286.2014.972855 5.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
89:799-809; PMID:9182768; http://dx.doi.org10.1016/S0092-8674(00) 80263-9 6.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 1999; 19:567-76; PMID:9858580; http://dx.doi.org10.1128/MCB.19.1.567 8.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 2012; 26:1897-910; PMID:22892240; http://dx.doi.org10.1101/gad.197467.112 9.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Cell 1997; 89:565-73; PMID:9160748; http://dx.doi.org10.1016/S0092-8674(00)80238-X 10.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 1997; 11:941-56; PMID:9106664; http://dx.doi.org10.1101/gad.11.7.941 11.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Cell 1996; 86:823-34; PMID:8797828; http://dx.doi.org10.1016/S0092-8674(00)80156-7 12.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 1996; 16:1391-400; PMID:8657112; http://dx.doi.org10.1128/MCB.16.4.1391 13.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
MolCell Biol 2010; 30:2775-86; PMID:20351177; http://dx.doi.org10.1128/ MCB.00151-10 14.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 2011; 25:2409-21; PMID:22085967; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
EMBO J 2011; 30:5010-20; PMID:22117216; http://dx.doi.org10.1038/emboj.2011.427 16.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell 2007; 26:205-15; PMID:17466623; http://dx.doi.org10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nature 2006; 443:302-7; PMID:16943774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nat Struct Mol Biol 2009; 16:740-6; PMID:19478803; http://dx.doi.org10.1038/nsmb.1624 20.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"Manival X, Charron C, Fourmann JB, Godard F, Charpentier B, Bran- lant C. Crystal structure determination and site-directed mutagenesis of the Pyrococcus abyssi aCBF5-aNOP10 complex reveal crucial roles of the C-terminal domains of both proteins in H/ACA sRNP activity.Nucleic Acids Res 2006; 34:826-39; PMID:16456033; http://dx.doi.org10.1093/nar/gkj482 21.",OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell 2006; 21:249-60; PMID:16427014; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"Duan J, Li L, Lu J, Wang W, Ye K. Structural mechanism of substrate RNA recruitment in H/ACA RNA-guided pseudouridine synthase.Mol Cell 2009; 34:427-39; PMID:19481523; http://dx.doi.org10.1016/j.",OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nucleic Acids Res 2003; 31:869-77;PMID:12560482; http://dx.doi.org10.1093/nar/gkg175 24.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
RNA 2013; 19:357-64; PMID:23325110; http://dx.doi.org10.1261/rna.036657.112 25.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nat StructMol Biol 2007; 14:1189-95; PMID:18059286; http://dx.doi.org10.1038/nsmb1336 26.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
EMBO J 2004;23:1857-67; PMID:15044956; http://dx.doi.org10.1038/sj.emboj.7600181 27.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"RNA New York, NY 2004; 10:1704-12; PMID:15388873; http://dx.doi.org/10.1261/rna.7770604 28.",OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nucleic Acids Res 2001; 29:2733-46; PMID:11433018; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 2005; 19:1238-48; PMID:15870259; http://dx.doi.org10.1101/gad.1309605 30.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
EMBO J 1997; 16:4770-6;PMID:9303321; http://dx.doi.org10.1093/emboj/16.15.4770 31.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nucleic Acids Res 2005; 33:3133-44; PMID:15933208; http://dx.doi.org10.1093/nar/gki630 32.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nucleic Acids Res 2015; 43:7207-16; PMID:26206671; http://dx.doi.org10.1093/nar/gkv757 33.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
EMBO J 2002; 21:2746-56;PMID:12032087; http://dx.doi.org10.1093/emboj/21.11.2746 34.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
J Cell Biol 2004; 164:647-52; PMID:14981093; http://dx.doi.org10.1083/jcb.200310138 35.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
EMBO J 2003; 22:4283-93;PMID:12912925; http://dx.doi.org10.1093/emboj/cdg394 36.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
MolCell 2009; 34:47-57; PMID:19285445; http://dx.doi.org10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Science 2009; 323:644-8; PMID:19179534; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 1995; 9:1411-24; PMID:7797080; http://dx.doi.org10.1101/gad.9.11.1411 39.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 2006; 26:630-42; PMID:16382153; http://dx.doi.org10.1128/MCB.26.7.2540-2549.2006 40.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
J Cell Biol 2006; 173:207-18; PMID:16618814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 2005; 25:3295-304; PMID:15798213; http://dx.doi.org10.1128/MCB.25.8.3295-3304.2005 42.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 2005; 25:5396-403;PMID:15964797; http://dx.doi.org10.1128/MCB.25.13.5396-5403.2005 43.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Genes Dev 2015; 29:1095-105; PMID:26063571; http://dx.doi.org10.1101/gad.263863.115 44.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Curr Opin Genet Dev 2013; 23:526-33; PMID:23993228; http://dx.doi.org10.1016/j.gde.2013.07.006 47.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
CellRep 2015; 13:2232-43; PMID:26628367; http://dx.doi.org10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Cell Rep 2015; 13:2244-57; PMID:26628368; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell 2007; 27:869- 81; PMID:17889661; http://dx.doi.org10.1016/j.molcel.2007.07.017 50.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell 2003; 11:1361-72; PMID:12769858; http://dx.doi.org10.1016/S1097-2765(03)00196-5 51.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 2012; 32:2428-39;PMID:22527283; http://dx.doi.org10.1128/MCB.00286-12 52.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
J Biol Chem 2001; 276:5856-65;PMID:11056167; http://dx.doi.org10.1074/jbc.M008419200 53.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Mol Cell Biol 2000; 20:3037-48; PMID:10757788; http://dx.doi.org10.1128/MCB.20.9.3037-3048.2000 54.,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
J Mol Biol 2011; 411:927-42; PMID:21708174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
Nucleic Acids Res 1995; 23:4530-1; PMID:7501483; http://dx.doi.org10.1093/nar/23.21.4530RNA BIOLOGY 1285,Non-OADS,/arxiv_data1/oa_pdf/08/30/krnb-13-12-1239689.PMC5207380.pdf
"Published with license by Taylor & Francis Group, LLC © Farhana Lipi, Suxiang Chen, Madhuri Chakravarthy, Shilpa Rakesh, and Rakesh N. Veedu This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"12, 1232 –1245 http://dx.doi.org/10.1080/15476286.2016.1236173",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
ORCID Farhana Lipi http://orcid.org/0000-0002-0467-6409References 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Rev Drug Discov 2010; 9:537-50; PMID:20592747; http://dx.doi.org/ 10.1038/nrd3141 2.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Annu Rev Med 2005; 56:555-83; PMID:15660527; http://dx.doi.org/10.1146/annurev.med.56.062904.144915 3.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Rev 2007;107:3715-43; PMID:17715981; http://dx.doi.org/10.1021/cr0306743 4.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Curr Top Med Chem 2015; 15:1065; PMID:25866280;http://dx.doi.org/10.2174/1568026615666150413161707 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Biomol Eng 2007; 24:381-403; PMID:17627883; http://dx.doi.org/10.1016/j.bioeng.2007.06.001 7.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Anal Bioanal Chem 2007; 387:171-82; PMID:17072603; http://dx.doi.org/10.1007/ s00216-006-0826-2 8.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Rev Drug Discov 2006; 5:123-32; PMID:16518379; http://dx.doi.org/10.1038/nrd1955 10.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Ophthalmology 2005; 112:1747-57; PMID:16154196; http://dx.doi.org/10.1016/j.ophtha.2005.06.007 11.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Curr Med Chem 2015; 22:2539-57; PMID:25723512; http://dx.doi.org/10.2174/0929867322666150227144909 12.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2003; 31:3406-15; PMID:12824337; http://dx.doi.org/10.1093/nar/gkg595 13.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2003; 31:3429-31; PMID:12824340; http://dx.doi.org/10.1093/ nar/gkg599 14.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Molecules 2015; 20:16643-71; PMID:26389865;http://dx.doi.org/10.3390/molecules200916643 15.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Front Chem 2016;4:18; PMID:27200340; http://dx.doi.org/10.3389/fchem.2016.00018 16.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Mol Biotechnol 2016; 58:79-92; PMID:26607475; http://dx.doi.org/10.1007/s12033-015-9907-9 18.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Mol Ther Nucleic Acids 2014; 3:e201; PMID:25291143; http://dx.doi.org/ 10.1038/mtna.2014.49 19.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
ChemBioChem 2012; 13:19-25; PMID:22162282; http://dx.doi.org/10.1002/cbic.201100648 20.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Commun 2009:4619-31;PMID:19641798; http://dx.doi.org/10.1039/b903307f1242 F. LIPI ET AL.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2016; 44:3495-502; PMID:27016740; http://dx.doi.org/10.1093/nar/gkw200 22.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Mol Biosyst 2015; 11:1260-70; PMID:25720604; http://dx.doi.org/10.1039/ C5MB00045A 23.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Bioorg Med Chem Lett 2013; 23:1288-92; PMID:23374873; http://dx.doi.org/10.1016/j.bmcl.2012.12.093 24.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
PLoS One 2012; 7:e41702; PMID:22860007; http://dx.doi.org/10.1371/journal.pone.0041702 25.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
BMC Bio- technol 2007; 7(1):48; PMID:17199888; http://dx.doi.org/10.1186/ 1472-6750-7-48 26.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Microsc Res Tech 2007; 70:372-81; PMID:17262788; http://dx.doi.org/10.1002/jemt.20421 27.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 1994; 22:5229-34;PMID:7529404; http://dx.doi.org/10.1093/nar/22.24.5229 29.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Biol 1995; 2:683-95; PMID:9383475; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Biol 2000; 7:323-34; PMID:10801472; http://dx.doi.org/10.1016/S1074-5521(00)00110-1 31.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Biochemistry 1995; 34:11363-72; PMID:7547864; http://dx.doi.org/ 10.1021/bi00036a009 32.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"Bugaut A, Toulm /C19e J-J, Rayner B. SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers.Org Biomol Chem 2006; 4:4082-8; PMID:17312962; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Biol Chem 1998; 273:20556-67; PMID:9685413; http://dx.doi.org/10.1074/jbc.273.32.20556 34.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Cancer Res 2002; 62:4029-33; PMID:12124337; http://dx.doi.org/10.1158/ 0008-5472.can-12-2152 35.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Biotechnol 2006; 24:1005-15; PMID:16823371; http://dx.doi.org/10.1038/nbt122336.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Immunopharmacol-ogy 1999; 42:219-30; PMID:10408383; http://dx.doi.org/10.1016/S0162-3109(99)00020-X 37.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Oligonu- cleotides 2007; 17:1-11; PMID:17461758; http://dx.doi.org/10.1089/ oli.2006.0059 38.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nature 2002; 419:90-4; PMID:12214238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Methods 2016; 97:58-68;PMID:26542762; http://dx.doi.org/10.1016/j.ymeth.2015.10.022 40.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Biotechnol 1997;15:68-73; PMID:9035109; http://dx.doi.org/10.1038/nbt0197-68 42.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Biol 2005; 12:25-33; PMID:15664512; http://dx.doi.org/ 10.1016/j.chembiol.2004.10.017 43.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Oligonucleotides 2006; 16:337-51;PMID:17155909; http://dx.doi.org/10.1089/oli.2006.16.337 44.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Blood 2011; 117:5514-22; PMID:21389323; http://dx.doi.org/10.1182/blood-2010-10-311936 45.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Biotechnol 2004; 22:1155-60; PMID:15300257; http://dx.doi.org/10.1038/nbt1001 46.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J AmChem Soc 2004; 126:1748-54; PMID:14871106; http://dx.doi.org/10.1021/ja038525p 47.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Commun 2012; 48:9870-2; PMID:22932771; http://dx.doi.org/10.1039/c2cc35028a 48.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2002; 30:e138-e; PMID:12490729; http://dx.doi.org/10.1093/nar/gnf138 49.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Proc Natl Acad Sci 2010; 107:5-10; PMID:20080797; http://dx.doi.org/10.1073/ pnas.0909611107 50.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2005; 33:2942-51; PMID:15914669; http://dx.doi.org/10.1093/nar/gki578 51.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2015; 43:9587-99; PMID:26476448; http://dx.doi.org/10.1093/ nar/gkv1057RNA BIOLOGY 1243,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"Pinheiro VB, Taylor AI, Cozens C, Abramov M, Renders M, Zhang S, Chaput JC, Wengel J, Peak-Chew S-Y, McLaughlin SH.Synthetic genetic polymers capable of heredity and evolution.Science 2012; 336:341-4; PMID:22517858; http://dx.doi.org/ 10.1126/science.1217622 53.",OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Chem 2012; 4:183-7; PMID:22354431; http://dx.doi.org/10.1038/ nchem.1241 54.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2013; 135:3583-91; PMID:23432469; http://dx.doi.org/10.1021/ ja3118703 55.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleosides Nucleotides Nucleic Acids 2007; 26:1207- 10; PMID:18058567; http://dx.doi.org/10.1080/15257770701527844 57.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"Nucleic Acids Symp Ser: Oxford Univ Press, 2007; 51(1):29- 30; PMID:18029570; http://dx.doi.org/10.1093/nass/nrm015 58.",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
ChemBioChem 2007; 8:490-2;PMID:17315250; http://dx.doi.org/10.1002/cbic.200600501 59.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J AmChem Soc 2008; 130:8124-5; PMID:18533656; http://dx.doi.org/10.1021/ja801389n 60.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Org Biomol Chem 2009; 7:1404-9; PMID:19300826; http://dx.doi.org/10.1039/ b819946a 61.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers.Mol Biosyst 2009; 5:787-92; PMID:19603111; http://dx.doi.org/ 10.1039/b905513b 62.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Biodivers 2010; 7:536-42;PMID:20232325; http://dx.doi.org/10.1002/cbdv.200900343 63.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
RNA Biol 2009; 6:321-3; PMID:19458498; http://dx.doi.org/10.4161/rna.6.3.8807 64.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
PLoSOne 2012; 7:e35990; PMID:22558297; http://dx.doi.org/10.1371/ journal.pone.0035990 65.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Artif DNA PNA XNA 2012; 3:14-21; PMID:22679529; http://dx.doi.org/10.4161/adna.19272 66.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Bioorg Med Chem Lett 2012; 22:3522-6; PMID:22503454; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
New J Chem 2010; 34:877-9; http://dx.doi.org/10.1039/b9nj00628a 68.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Commun 2012; 48:11020-2; PMID:23042489; http://dx.doi.org/10.1039/c2cc36464f 69.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2008; 36:4257-65; PMID:18583360; http://dx.doi.org/10.1093/nar/gkn404 70.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Anal Chem 2013; 85:4961-7; PMID:23662585; http://dx.doi.org/10.1021/ac400058z 71.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Biotechnol 1996; 14:1112-5; PMID:9631061; http://dx.doi.org/10.1038/nbt0996-1112 72.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Bio-technol 1996; 14:1116-9; PMID:9631062; http://dx.doi.org/10.1038/nbt0996-1116 73.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"Purschke WG, Radtke F, Kleinjung F, Klussmann S. A DNA Spie- gelmer to staphylococcal enterotoxin B. Nucleic Acids Res 2003;31:3027-32; PMID:12799428; http://dx.doi.org/10.1093/nar/gkg413 75.",OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2003; 31:e130-e; PMID:14576330; http://dx.doi.org/ 10.1093/nar/gng130 76.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
RNA 2004; 10:516-27; PMID:14970396; http://dx.doi.org/10.1261/rna.5186504 78.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Biol2002; 9:351-9; PMID:11927260; http://dx.doi.org/10.1016/S1074-5521(02)00111-4 79.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2006;34:e86-e; PMID:16855281; http://dx.doi.org/10.1093/nar/gkl463 80.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Proc Natl AcadSci U S A 2004; 101:13174-9; PMID:15329412; http://dx.doi.org/ 10.1073/pnas.0404175101 81.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Eur J Pharm Sci 2013; 48:259-71;PMID:23142634; http://dx.doi.org/10.1016/j.ejps.2012.10.014 82.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Commun 2015; 6:6481; PMID:25901944; http://dx.doi.org/10.1038/ncomms7481 84.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Chem 2016; 8:698-704; PMID:27325097; http://dx.doi.org/10.1038/nchem.2517 85.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2006; 34:5383-94; PMID:17012278; http://dx.doi.org/10.1093/nar/gkl637 86.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Angew Chem Int Ed 2011; 50:11238-42; PMID:22191092; http://dx.doi.org/10.1002/anie.201105555 87.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2014; 136:1726-9; PMID:24446826; http://dx.doi.org/10.1021/ja411212q 88.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Angew Chem Int Ed 2015; 54:10971-4; PMID:26224087; http://dx.doi.org/10.1002/anie.201503652 89.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Chem Biol 2014; 10:990-9;PMID:25393493; http://dx.doi.org/10.1038/nchembio.1685 90.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Chem Eur J 2013; 19:17291-5; PMID:24227340; http://dx.doi.org/10.1002/chem.201303848 91.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Bioorg Med Chem Lett 2010; 20:6565-8; PMID:20932755; http://dx.doi.org/10.1016/j.bmcl.2010.09.044 9 2 .,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nature 2014; 509:291-2; PMID:24805244; http://dx.doi.org/10.1038/nature13335 94.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 1994; 22:2817-22; PMID:7519769; http://dx.doi.org/10.1093/nar/22.14.2817 97.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Proc Natl Acad Sci 1995; 92:12220-4; PMID:8618873; http://dx.doi.org/ 10.1073/pnas.92.26.12220 98.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J AmChem Soc 1999; 121:9781-9; PMID:11543572; http://dx.doi.org/10.1021/ja9816436 99.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Biochemistry2003; 42:8842-51; PMID:12873145; http://dx.doi.org/10.1021/ bi027354i100.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2007; 129:1456-64; PMID:17263432;http://dx.doi.org/10.1021/ja067098n 101.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2013; 135:9412-9; PMID:23734784; http://dx.doi.org/10.1021/ ja4012222 102.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2008; 130:12636-8; PMID:18763762; http://dx.doi.org/10.1021/ja801510d 103.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2010; 132:4141-51; PMID:20201573; http://dx.doi.org/10.1021/ja908035g 104.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
J Am Chem Soc 2000; 122:2433-9; PMID:11543272; http://dx.doi.org/ 10.1021/ja993688s 105.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nat Biotechnol 2013; 31:453-7; PMID:23563318; http://dx.doi.org/10.1038/nbt.2556 106.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
ACS Comb Sci 2013;15:174-82; PMID:23485334; http://dx.doi.org/10.1021/co3001378 107.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
PLoS One 2010; 5:e15004;PMID:21165148; http://dx.doi.org/10.1371/journal.pone.0015004 108.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Bioorg Med Chem Lett 1998; 8:2285-90; PMID:9873529; http://dx.doi.org/10.1016/S0960-894X(98)00414-4 111.,OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Biochemistry 2002; 41:9696-706; PMID:12135392; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Bio- chemistry 1998; 37:16489-93; PMID:9843415; http://dx.doi.org/ 10.1021/bi981780f 113.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
Nucleic Acids Res 2002; 30:1401-7; PMID:11884639; http://dx.doi.org/10.1093/nar/30.6.1401RNA BIOLOGY 1245,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/krnb-13-12-1236173.PMC5207382.pdf
"12, 1212 –1217 http://dx.doi.org/10.1080/15476286.2016.1229732",Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Science 2000; 287:2494-7; PMID:10741970;http://dx.doi.org/10.1126/science.287.5462.2494 2.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2016; 165:88-99; PMID:27015309; http://dx.doi.org/ 10.1016/j.cell.2016.02.057 3.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Philos Trans R Soc Lond B Biol Sci2011; 366:2266-73; PMID:21727132; http://dx.doi.org/10.1098/ rstb.2011.0042 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2014; 157:95-109; PMID:24679529;http://dx.doi.org/10.1016/j.cell.2014.02.045 5.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Trends Genet 2012; 28:164-174;PMID:22386917; http://dx.doi.org/10.1016/j.tig.2012.01.005 6.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nat Struct Mol Biol 2010; 17:679-87; PMID:20473313; http://dx.doi.org/10.1038/nsmb.1821 7.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature 2009; 460:473-8; PMID:19525931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Prog Biophys Mol Biol 2013; 111:99-107; PMID:22975443;http://dx.doi.org/10.1016/j.pbiomolbio.2012.08.014 9.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature 2008; 452:877-81; PMID:18354397; http://dx.doi.org/10.1038/nature06714 10.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Dev Biol 2005; 280:225-236; PMID:15766761; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nat Genet 2008; 40:1016-1022; PMID:18622394; http://dx.doi.org/10.1038/ng.186 12.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2015; 161:868-878; PMID:25936839; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature 2011; 479:365- 71; PMID:22012258; http://dx.doi.org/10.1038/nature10572 15.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Science 2014; 345:1515-8; PMID:25237104; http://dx.doi.org/ 10.1126/science.1255023 16.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
2015; 25:2398-2403; PMID:26365259; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Proc Natl Acad Sci U S A 2011; 108:19683-8; PMID:22106253; http://dx.doi.org/10.1073/ pnas.1113310108 18.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Science 2008; 321:537-41; PMID:18653886;http://dx.doi.org/10.1126/science.1157647 19.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature 1998; 391:806-11; PMID:9486653;http://dx.doi.org/10.1126/science.1157647 20.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Gene 2001; 263:103-112; PMID:11223248; http://dx.doi.org/10.1016/S0378-1119(00)00579-5 22.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Genetics 2008; 180:1275-88; PMID:18757930; http://dx.doi.org/10.1534/genetics.108.089433 23.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2009; 139:123-34; PMID:19804758;http://dx.doi.org/10.1016/j.cell.2009.09.014 24.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature 2012; 489:447-51; PMID:22810588; http://dx.doi.org/10.1038/nature11352 25.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Mol Cell 2009; 36:231-44; PMID:19800275; http://dx.doi.org/10.1016/j.molcel.2009.09.020 26.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2012; 151:885- 99; PMID:23141544; http://dx.doi.org/10.1016/j.cell.2012.10.022 27.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Science 2007; 315:241-4; PMID:17124291; http://dx.doi.org/10.1126/science.1132839 28.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2010; 37:679-89; PMID:20116306; http://dx.doi.org/10.1016/j.molcel.2010.01.012 29.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
EMBO J 2007; 26:5007-19; PMID:18007599; http://dx.doi.org/10.1038/sj.emboj.7601910 30.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
WormBook 2014; 1-49; PMID:24816713; http://dx.doi.org/10.1895/wormbook.1.170.1 31.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Trends Ecol Evol 2008; 23:578-87; PMID:18715673;http://dx.doi.org/10.1016/j.tree.2008.06.005 32.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
PhilosTrans R Soc Lond B Biol Sci 2009; 364:99-115; PMID:18926973;http://dx.doi.org/10.1098/rstb.2008.0168 33.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Science 2013; 341:467-8; PMID:23908213; http://dx.doi.org/10.1126/science.1243175 34.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2006; 124:343-54; PMID:16439208; http://dx.doi.org/10.1016/j.cell.2005.11.036 35.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Genes Dev 2001; 15:2654-9; PMID:11641272; http://dx.doi.org/10.1101/gad.927801 36.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Gene expression: long-term gene silencing by RNAi.Nature 2006; 442:882; PMID:16929289; http://dx.doi.org/10.1038/442882a 37.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
PLoS Genet 2015; 11:e1005078;PMID:25811365; http://dx.doi.org/10.1371/journal.pgen.1005078 38.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2012; 150:65-77; PMID:22738726; http://dx.doi.org/10.1016/j.cell.2012.06.015 39.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
"Buckley BA, Burkhart KB, Gu SG, Spracklin G, Kershner A, Fritz H, Kimble J, Fire A, Kennedy S. A nuclear Argonaute promotes multigenerational epigenetic inheritance and germline immortality.Nature 2012; 489:447-51; PMID:22810588; http://dx.doi.org/10.1038/ nature11352 40.",OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Genes Dev 2014; 28:637-51;PMID:24637117; http://dx.doi.org/10.1101/gad.235770.113 42.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2016; 165:396-409; PMID:27020753; http://dx.doi.org/10.1016/j.cell.2016.02.040 43.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2012;149:452-66; PMID:22500807; http://dx.doi.org/10.1016/j.cell.2012.02.050 44.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
NatGenet 2012; 44:157-64; PMID:22231482; http://dx.doi.org/10.1038/ ng.1039 45.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Genes (Basel) 2013; 3; PMID:23483754; http://dx.doi.org/10.3390/genes3040671 46.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Nature2004; 427:645-9; PMID:14961122; http://dx.doi.org/10.1038/ nature02302 47.,Non-OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell Res 2014; 24:680-700; PMID:24787618; http://dx.doi.org/10.1038/cr.2014.41 48.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2014; 158:277-87; PMID:25018105; http://dx.doi.org/10.1016/j.cell.2014.06.020 50.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Cell 2011; 147:1248-1256; PMID:22119442; http://dx.doi.org/10.1016/j.cell.2011.10.042 51.,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
Sci Rep 2014; 4:7387; PMID:25552271; http://dx.doi.org/10.1038/srep07387RNA BIOLOGY 1217,OADS,/arxiv_data1/oa_pdf/b3/fa/krnb-13-12-1229732.PMC5207387.pdf
"Published with license by Taylor & Francis Group, LLC © Rya Ero, Veerendra Kumar, Yun Chen, and Yong-Gui Gao This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
"12, 1258 –1273 http://dx.doi.org/10.1080/15476286.2016.1201627",Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell 2005; 121:991-1004; PMID:15989950; http://dx.doi.org/ 10.1016/j.cell.2005.04.015 2.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nature 2000; 406:319-22;PMID:10917535; http://dx.doi.org/10.1038/35018597 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nature 1989; 342:142-8; PMID:2682263;http://dx.doi.org/10.1038/342142a0 4.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2007; 370:530-40;PMID:17512008; http://dx.doi.org/10.1016/j.jmb.2007.04.042 5.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
RNA 2009;15:772-80; PMID:19324963; http://dx.doi.org/10.1261/rna.1592509 6.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochem Soc Trans 2011; 39:658-62; PMID:21428957; http://dx.doi.org/10.1042/BST0390658 7.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nature 2010; 466:329-33; PMID:20631791; http://dx.doi.org/10.1038/nature09206 8.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Bioessays 2014; 36:908- 18; PMID:25118068; http://dx.doi.org/10.1002/bies.201400076 9.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Cell 2007; 25:751-64;PMID:17349960; http://dx.doi.org/10.1016/j.molcel.2007.01.027 10.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nature 1997; 385:37-41; PMID:8985244; http://dx.doi.org/10.1038/385037a0 11.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochemistry 2002; 41:12806-12; PMID:12379123; http://dx.doi.org/10.1021/bi0264871 12.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell 2002; 108:557-72; PMID:11909526; http://dx.doi.org/10.1016/S0092-8674(02)00619-0 13.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
BMC Genomics 2007; 8:15; PMID:17214893; http://dx.doi.org/10.1186/1471-2164-8-15 1 4 .,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2002; 317:41- 72; PMID:11916378; http://dx.doi.org/10.1006/jmbi.2001.5378 15.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Curr Opin Microbiol 2003; 6:135-9; PMID:12732302; http://dx.doi.org/10.1016/S1369-5274(03)00037-7 16.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Protein Cell 2014; 5:563-7; PMID:24706296; http://dx.do i.org/10.1007/s13238-014-0050-3 17.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell 2006; 127:721-33; PMID:17110332; http://dx.doi.org/10.1016/j.cell.2006.09.037 19.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochimie 2010; 92:157-63; PMID:19925844; http://dx.doi.org/10.1016/j.biochi.2009.11.002 20.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 2003; 278:21972-9; PMID:12690106; http://dx.doi.org/10.1074/jbc.M302109200 22.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
FEMS Microbiol Lett 2010; 311:147-51; PMID:20735483; http://dx.doi.org/10.1111/j.1574-6968.2010.02083.x 23.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2008; 15(9):910-5; PMID:19172743; http://dx.doi.org/10.1038/nsmb.1469 24.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2010; 396:1043-52;PMID:20045415; http://dx.doi.org/10.1016/j.jmb.2009.12.043 25.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nucleic Acids Res 2014; 42:13370-83;PMID:25378333; http://dx.doi.org/10.1093/nar/gku109827.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat StructMol Biol 2016; 23(2):125-31; PMID:26809121; http://dx.doi.org/ 10.1038/nsmb.3160 28.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Rev Microbiol 2014; 12:89-100; PMID:24362468; http://dx.doi.org/10.1038/nrmicro3176 29.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
MBio 2014; 5:e01708; PMID:25491353; http://dx.doi.org/ 10.1128/mBio.01708-14 30.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
"Cell 2008; 135:679-90; PMID:19013277; http://dx.doi.org/10.1016/j.cell.2008.09.038 31. deLivron MA, Robinson VL.",OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Bacteriol 2008; 190:5944-52; PMID:18621905; http://dx.doi.org/10.1128/JB.00763-08 32.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Plant Microbe Interact 2004; 17:235-44; PMID:15000390; http://dx.doi.org/10.1094/MPMI.2004.17.3.235 33.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Microbiol 1995; 17:523-31; PMID:8559071; http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_17030523.x 34.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Micro-biol 1998; 28:265-79; PMID:9622352; http://dx.doi.org/10.1046/ j.1365-2958.1998.00793.x 35.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Microbiol 2003; 48:507-21; PMID:12675808; http://dx.doi.org/ 10.1046/j.1365-2958.2003.t01-1-03447.x 36.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Bacteriol 2007; 189:2164- 9; PMID:17158671; http://dx.doi.org/10.1128/JB.01623-06 37.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Bacteriol 2000; 182:2741-5;PMID:10781541; http://dx.doi.or g/10.1128/JB.182.10.2741-2745.2000 38.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
BMC Microbiol 2013; 13:77; PMID:23570569; http://dx.doi.org/ 10.1186/1471-2180-13-77 39.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Genet Genomics 2001; 266:313-7;PMID:11683274; http://dx.doi.org/10.1007/s004380100559 40.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Appl Microbiol Biotechnol 2008;81:731-41; PMID:18807027; http://dx.doi.org/10.1007/s00253-008- 1709-6 41.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Bacteriol 2002; 184:2500-20; PMID:11948165; http://dx.doi.org/10.1128/JB.184.9.2500-2520.2002 42.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
"J Bacteriol 2008; 190:7675-83; PMID:18820021; http://dx.doi.org/10.1128/JB.00835-08 43. deLivron MA, Makanji HS, Lane MC, Robinson VL.",Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochemistry 2009; 48:10533-41; PMID:19803466; http://dx.doi.org/10.1021/bi901026z 44.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Chem Biol 2011; 18:589-600; PMID:21609840; http://dx.doi.org/10.1016/j.chembiol.2011.03.010 45.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Bacteriol2015; 197(10):1819-27; PMID:25777676; http://dx.doi.org/10.1128/JB.00023-15 46.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 2015; 290(34):20856-64;PMID:26163516; http://dx.doi.org/10.1074/jbc.M115.659136 50.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
"FEBS Lett 2005; 579:4492-7; PMID:16083884; http://dx.doi.org/10.1016/j.febslet.2005.07.016 52. al-Karadaghi S, Aevarsson A, Garber M, Zheltonosova J, Liljas A.",OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Structure 1996; 4:555-65; PMID:8736554; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Proc Natl Acad Sci U SA 2008; 105:15678-83; PMID:18836081; http://dx.doi.org/10.1073/ pnas.0807912105 54.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2009; 326:694-9; PMID:19833919; http://dx.doi.org/10.1126/science.1179709 55.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Acta Crystallogr D Biol Crystallogr 2012; 68:578-83; PMID:22525755; http://dx.doi.org/10.1107/S0907444912006348 56.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell 2015; 160:219-27; PMID:25594181; http://dx.doi.org/10.1016/j.cell.2014.11.049 57.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2013; 20:1077-84; PMID:23912278; http://dx.doi.org/10.1038/nsmb.2645 58.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Control of ribosomal subunit rotation by elongation factor G. Science 2013; 340:1235970; PMID:23812721; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2013; 340:1235490; PMID:23812720; http://dx.doi.org/ 10.1126/science.1235490 60.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2013; 340:1236086; PMID:23812722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
EMBO J 2009; 28:2053-65; PMID:19536129; http://dx.doi.org/10.1038/emboj.2009.169 64.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochemistry1997; 36:10327-34; PMID:9254632; http://dx.doi.org/10.1021/bi970610k 65.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nature 2010; 468:713-6; PMID:2112 4459; http://dx.doi.org/10.1038/nature09547 66.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2009; 325:1014-7; PMID:19696352; http://dx.doi.org/10.1126/science.1175275 67.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 2016; 291:12943-50; PMID:27137929;http://dx.doi.org/10.1074/jbc.M116.725945 6 9 .,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
JMol Biol 2007; 368:1412-25; PMID:17395204; http://dx.doi.org/10.1016/j.jmb.2007.03.009 71.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 2000; 275:890-4;PMID:10625623; http://dx.doi.org/10.1074/jbc.275.2.890 72.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Sci Rep 2015; 5:8573; PMID:25712150; http://dx.doi.org/10.1038/srep08573 74.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Sci-ence 2010; 330:835-8; PMID:21051640; http://dx.doi.org/10.1126/ science.1194460 75.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2014; 345:1188-91; PMID:25190797; http://dx.doi.org/ 10.1126/science.1255030 76.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2004; 337:15-30; PMID:15001349; http://dx.doi.org/10.1016/j.jmb.2004.01.013 78.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
100:301-9; PMID:10676812; http://dx.doi.org/10.1016/S0092-8674 (00)80666-2 79.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
RNA 2007; 13:1473-82; PMID:17630323; http://dx.doi.org/10.1261/rna.601507 80.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2011; 18:457-62; PMID:21399643; http://dx.doi.org/10.1038/nsmb.2011 81.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2011; 332:981-4; PMID:21596992; http://dx.doi.org/10.1126/ science.1202692 84.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2005; 310:827-34; PMID:16272117; http://dx.doi.org/10.1126/science.1117230 85.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Cell 2003; 11:1517-23;PMID:12820965; http://dx.doi.org/10.1016/S1097-2765(03)00230-2 86.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Cell 2007; 25:519-29; PMID:17317625; http://dx.doi.org/10.1016/j.molcel.2007.01.014 87.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2001; 294:1299-304; PMID:11701921; http://dx.doi.org/10.1126/science.1062023 88.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2000; 300:951-61; PMID:10891280; http://dx.doi.org/ 10.1006/jmbi.2000.3886 90.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 1998; 273:18562-6; PMID:9660827; http://dx.doi.org/10.1074/jbc.273.29.18562 92.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
RNA 2010; 16:2023-32; PMID:20719918; http://dx.doi.org/ 10.1261/rna.2160010 93.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell 2009; 139:1084-95; PMID:20005802;http://dx.doi.org/10.1016/j.cell.2009.11.015 94.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nucleic Acids Res 2013; 41:9549-56; PMID:23945936; http://dx.doi.org/10.1093/nar/gkt742 95.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2007; 14:493- 7; PMID:17515906; http://dx.doi.org/10.1038/nsmb1243 96.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Mol Biol 2004; 343:1183-94; PMID:15491605; http://dx.doi.org/10.1016/j.jmb.2004.08.097 97.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2010; 17:289-93; PMID:20154709; http://dx.doi.org/10.1038/nsmb.1755 98.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Mol Cell 2006; 24:931-42; PMID:17189194; http://dx.doi.org/10.1016/j.molcel.2006.11.025 99.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2007; 14:318-24;PMID:17369838; http://dx.doi.org/10.1038/nsmb1221 100.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Science 2009; 326:688-94;PMID:19833920; http://dx.doi.org/10.1126/science.1179700 101.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
PLoS One 2013; 8:e58829; http://dx.doi.org/10.1371/journal.pone.0058829 102.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Biochemistry 2006; 45:2504-14;PMID:16489743; http://dx.doi.org/10.1021/bi0516677 103.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Biol Chem 2007; 282:657-66; PMID:17082187; http://dx.doi.org/10.1074/jbc.M607830200 104.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Biol 2003; 10:379-85; PMID:12692531; http://dx.doi.org/10.1038/nsb923 105.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
EMBO J 2004; 23:1008-19; PMID:14976550; http://dx.doi.org/10.1038/sj.emboj.7600102 106.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
J Comput Aided Mol Des 2013; 27:173-84; PMID:23397219; http://dx.doi.org/10.1007/s10822-013-9636-8 107.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
FEBS Lett 2012; 586:3373-8; PMID:22841550; http://dx.doi.org/10.1016/j.febslet.2012.07.040 108.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Cell Rep 2014; 6:357-65;PMID:24412368; http://dx.do i.org/10.1016/j.celrep.2013.12.024 109.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Annu Rev Biochem 2010;79:381-412; PMID:20235828; http://dx.doi.org/10.1146/annurev- biochem-060408-173330 110.,Non-OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2007; 14:727-32; PMID:17660832; http://dx.doi.org/10.1038/nsmb1271 111.,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
Nat Struct Mol Biol 2012; 19:957-63; PMID:22902368; http://dx.doi.org/10.1038/nsmb.2360RNA BIOLOGY 1273,OADS,/arxiv_data1/oa_pdf/cf/d8/krnb-13-12-1201627.PMC5207388.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 7–9International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 7 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S102524Extreme leukocytosis and leukemoid reaction  associated with the lung sarcomatoid carcinoma:  an unusual case report Danyang Wang Haiyan Zhang Fengkuan Yu Baijun Fang Department of Hematopathy,   The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou,  People’s Republic of ChinaPurpose: To report a rare case of extreme leukocytosis and leukemoid reaction associated with  lung sarcomatoid carcinoma (LSC) and increase people’ s awareness of the disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"Correspondence: Baijun Fang Department of Hematopathy, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, People’s Republic of ChinaEmail fdation@126.com.cnJournal name: International Journal of General Medicine Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Wang et alRunning head recto: Leukocytosis and leukemoid reaction associated with LSCDOI: http://dx.doi.org/10.2147/IJGM.S102524",Non-OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 9 Leukocytosis and leukemoid reaction associated with LSC  Leukemoid reaction is defined as a WBC count > 50×109/L  without evidence of leukemia or infection.5 Leukemoid reaction  is a potential cause for leukocytosis, especially in the presence  of predominately mature granulocytic leukocytosis.",Non-OADS,/arxiv_data1/oa_pdf/6a/22/ijgm-10-007.PMC5207432.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7c/c2/tcrm-13-033.PMC5207433.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 33–40Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  33ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12248 0 a Phase ii single-arm trial of palonosetron for the  prevention of acute and delayed chemotherapy- induced nausea and vomiting in malignant glioma  patients receiving multidose irinotecan in  combination with bevacizumab Mary lou affronti1–3 sarah Woodring1,2 Katherine B Peters1,4 James e herndon ii5 Frances Mcsherry5 Patrick n healy5 annick Desjardins1,4 James J Vredenburgh6 henry s Friedman1,2 1The Preston Robert Tisch Brain  T umor Center at Duke, south  hospital, Duke University Medical  Center, 2Department of neurosurgery,  Duke University health system,  3Duke University school of nursing,  4Department of neurology,  5Department of Biostatistics and  Bioinformatics, Duke University  health system, Durham, nC, 6saint  Francis Cancer Center, hartford,  CT, UsaPurpose:  Given that the prognosis of recurrent malignant glioma (MG) remains poor, improving  quality of life (QoL) through symptom management is important.",Non-OADS,/arxiv_data1/oa_pdf/7c/c2/tcrm-13-033.PMC5207433.pdf
"Keywords:  chemotherapy, nausea, chemotherapy-induced nausea and vomiting, antiemetic  guidelines, evidence-based practice, glioma Introduction Chemotherapy-induced nausea and vomiting (CINV) continues to be one of the most  debilitating side effects of cancer therapy, despite dramatic advances in antiemetics.1,2 Correspondence: Mary lou affronti Preston Robert Tisch Brain Tumor  Center at Duke, Room 047, Baker  house, south hospital, Trent Drive,  Duke University Medical Center,  Durham, nC 27710, Usa Tel +1 919 684 5301 Fax +1 919 681 1697 email affro002@mc.duke.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Affronti et al Running head recto: CINV in malignant glioma DOI: http://dx.doi.org/10.2147/TCRM.S122480",Non-OADS,/arxiv_data1/oa_pdf/7c/c2/tcrm-13-033.PMC5207433.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7c/c2/tcrm-13-033.PMC5207433.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/c2/tcrm-13-033.PMC5207433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/19/ijn-12-251.PMC5207434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 251–261International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  251OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11989 5 lung-targeting drug delivery system of baicalin- loaded nanoliposomes: development, biodistribution  in rabbits, and pharmacodynamics in nude mice  bearing orthotopic human lung cancer Yumeng Wei1 Jing liang1 Xiaoli Zheng2 chao Pi1 hao liu1 hongru Yang3 Y onggen Zou4 Yun Ye1,5 ling Zhao1 1Department of Pharmaceutics,   school of Pharmacy, southwest  Medical University, 2Department  of Biochemistry, The Institute of  Basic Medical sciences, southwest  Medical University, Jiangyang District,    3Department of Oncology, The  affiliated hospital of southwest  Medical University, 4Department of  Orthopedics, The affiliated hospital  of Traditional chinese Medicine  of southwest Medical University,   longma Tan District, 5Department of  Pharmacy, The affiliated hospital of  southwest Medical University, luzhou  city, sichuan Province, People’s  republic of chinaAbstract:  The present study aims to develop a kind of novel nanoliposomes for the lung-targeting  delivery system of baicalin as a Chinese medicine monomer.",Non-OADS,/arxiv_data1/oa_pdf/f3/19/ijn-12-251.PMC5207434.pdf
"However, because most of drugs in conventional dosage forms are distributed correspondence: ling Zhao Department of Pharmaceutics, school of  Pharmacy, southwest Medical University,  No 3-319, Zhongshan road, Jiangyang  District, luzhou city, sichuan Province  646000, People’s republic of china Tel/fax +86 830 316 2291 email zhaoling-998@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wei et al Running head recto: Lung-targeting drug delivery system of baicalin-loaded nanoliposomes DOI: http://dx.doi.org/10.2147/IJN.S119895",Non-OADS,/arxiv_data1/oa_pdf/f3/19/ijn-12-251.PMC5207434.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f3/19/ijn-12-251.PMC5207434.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/19/ijn-12-251.PMC5207434.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/opth-11-087.PMC5207435.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 87–93Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  87Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12254 2 effects of 3% diquafosol sodium ophthalmic  solution on higher-order aberrations in patients  diagnosed with dry eye after cataract surgery Yasushi inoue shintarou Ochi inoue eye Clinic, Tamano,   Okayama, JapanPurpose:  To evaluate the effects of diquafosol sodium ophthalmic solution 3% (DQS)  and artificial tears (AT) on higher-order aberrations (HOAs) in patients with dry eye after  cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/opth-11-087.PMC5207435.pdf
"Tear film instability in dry eye is considered to cause subjective Correspondence: Yasushi inoue inoue eye Clinic, 1-14-31 Uno,  Tamanoshi, Okayama, Japan Tel +81 863 31 1030 Fax +81 893 31 1114 email inoue@oka.urban.ne.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Inoue and Ochi Running head recto: Effect of diquafosol ophthalmic solution on HOAs in dry eyes DOI: http://dx.doi.org/10.2147/OPTH.S122542",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/opth-11-087.PMC5207435.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f7/2c/opth-11-087.PMC5207435.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/2c/opth-11-087.PMC5207435.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/97/opth-11-115.PMC5207437.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 115–125Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  115Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12130 7 reversibility of retinal ischemia due to central  retinal artery occlusion by hyperbaric oxygen amir hadanny1,2 amit Maliar1 gregory Fishlev1 Yair Bechor1 Jacob Bergan1 Mony Friedman1 isaac avni2,3 shai efrati1,2,4,5 1sagol Center for hyperbaric Medicine  and research, assaf harofeh Medical  Center, Zerifin, israel; 2sackler school  of Medicine, T el-a viv University,   T el-a viv, israel; 3Opthalmology  Department, assaf harofeh Medical  Center, Zeirifin, israel; 4research and  Development Unit, assaf harofeh  Medical Center, Zerifin, israel; 5sagol  school of neuroscience, Tel- aviv  University, T el-a viv, israelPurpose:  Ischemic retinal damage can be reversed by hyperbaric oxygen therapy (HBOT) as  long as irreversible infarction damage has not developed.",Non-OADS,/arxiv_data1/oa_pdf/25/97/opth-11-115.PMC5207437.pdf
"Some  authors suggest elapsed time of around 6–6.5 hours6 but due to the large variability  between patients, types of occlusion, and residual perfusion, this time frame is not  reliable and thus another biologically based marker is needed.Correspondence: amir hadanny sagol Center for hyperbaric Medicine  and research, assaf harofeh Medical  Center, Zerifin 70300, Israel Tel +972 54470 7381 Fax +972 8977 9748 email amir.had@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Hadanny et al Running head recto: Reversibility of CRAO by HBOT DOI: http://dx.doi.org/10.2147/OPTH.S121307",Non-OADS,/arxiv_data1/oa_pdf/25/97/opth-11-115.PMC5207437.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/25/97/opth-11-115.PMC5207437.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/97/opth-11-115.PMC5207437.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ott-10-165.PMC5207438.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 165–175OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  165Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10051 2 Pediatric papillary thyroid cancer: current  management challenges Frederik A verburg1 Hanneke M van Santen2 Markus Luster1 1University Hospital Gießen and  Marburg, Department of Nuclear  Medicine, Marburg, Germany;   2University Medical Center Utrecht,   wilhelmina Children’s Hospital,   Utrecht, the NetherlandsAbstract:  Although with a standardized incidence of 0.54 cases per 100,000 persons, differentiated  thyroid cancer (DTC) is a rare disease in children and adolescents, it nonetheless concerns ~1.4% of  all pediatric malignancies.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ott-10-165.PMC5207438.pdf
"The rarity  of pediatric PTC as well as on the whole very good prognosis, combined with the ethical Correspondence: Frederik A verburg University Hospital Marburg, Department  of Nuclear Medicine, Baldingerstraße,  35043 Marburg, Germany Tel +49 6421 5862 815 email frederik.verburg@staff.uni-   marburg.d e Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Verburg et al Running head recto: Pediatric papillary thyroid cancer DOI: http://dx.doi.org/10.2147/OTT.S100512",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ott-10-165.PMC5207438.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ott-10-165.PMC5207438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/8f/ott-10-165.PMC5207438.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/21/ott-10-129.PMC5207439.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 129–135OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  129Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11430 3 Decreased mir-503 expression in gastric  cancer is inversely correlated with serum  carcinoembryonic antigen and acts as a potential  prognostic and diagnostic biomarker Daoyi Wu gaojian cao Zhenfeng huang Kai Jin haowei hu Jie Yu Yu Zeng Department of gastrointestinal  surgery, The Third affiliated hospital  of Wenzhou Medical University,   ruian,  People’s republic of chinaBackground:  Altered expression of miR-503 has been linked to human carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/e6/21/ott-10-129.PMC5207439.pdf
"MicroRNAs (miRNAs), a class of small regulatory ( ~25–28 nucleotides),  noncoding RNAs, have emerged as important regulators by involving in various correspondence: Yu Zeng Department of gastrointestinal  Surgery, The Third Affiliated Hospital  of Wenzhou Medical University,  108 Wansong road, ruian, Zhejiang  325200, People’s republic of china email 562988116@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wu et al Running head recto: MiR-503 as a biomarker in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S114303",Non-OADS,/arxiv_data1/oa_pdf/e6/21/ott-10-129.PMC5207439.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/21/ott-10-129.PMC5207439.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/21/ott-10-129.PMC5207439.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/91/opth-11-097.PMC5207442.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 97–103Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  97Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11554 7 applicability of automatic spectral domain optical  coherence tomography for glaucoma mass  screening Tadashi nakano1 Takeshi hayashi2 T oru nakagawa2 T oru honda2 satoshi Owada3 hitoshi endo3 Masayuki Tatemichi3 1Department of Ophthalmology, The  Jikei University school of Medicine,   T okyo, 2hitachi health Care Center,   ibaraki, 3Department of Preventive  Medicine, T okai University, school of  Medicine, Kanagawa, JapanPurpose:  To perform a preliminary evaluation of the applicability of automatic spectral domain  optical coherence tomography (ASD-OCT) for glaucoma mass screening in a population-based  setting.",Non-OADS,/arxiv_data1/oa_pdf/e0/91/opth-11-097.PMC5207442.pdf
"Glaucoma is  asymptomatic until its end stage,1 resulting in .75% patients not receiving medical  treatment in Japan.3 Thus, the development of an ideal mass screening program is a  very important challenge for the maintenance of public health.Correspondence: Masayuki Tatemichi Department of Preventive Medicine,  Tokai University school of Medicine,  143 shimokasuya, isehara, Kanagawa  259-1193, Japan Tel +81 4 6393 1121 ext 2621 Fax +81 4 6392 3549 email tatemichi@tokai-u.j pJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Nakano et al Running head recto: Automatic SD-OCT for glaucoma mass screening DOI: http://dx.doi.org/10.2147/OPTH.S115547",Non-OADS,/arxiv_data1/oa_pdf/e0/91/opth-11-097.PMC5207442.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e0/91/opth-11-097.PMC5207442.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/91/opth-11-097.PMC5207442.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 1–11Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S122385The relatives’ voice: how do relatives experience  participation in reablement?",Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"In Norway, rehabilitation is defined as time-limited, planned processes with clear goals and measures, where several providers collaborate in assisting the person’ s own efforts in achieving the optimal level of Correspondence: Kari Margrete Hjelle Department of Occupational Therapy, Physiotherapy, and Radiography, Faculty of Health and Social Sciences, Bergen University College, Post Box 7030, Bergen 5020, NorwayTel +47 5 9771 1341Email Kari.Hjelle@hib.noJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Hjelle et alRunning head recto: The relative’ s voiceDOI: http://dx.doi.org/10.2147/JMDH.S122385",Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
Creative Commons license and disclaimer available from: http://creativecommons.org/licenses/ by/4.0/legalcode.23 Abbreviation:  COPM; Canadian Occupational Performance Measurement.,OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 11 The relative’s voice  3.,Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
Available from: https://www.unece.org/fileadmin/DAM/pau/age/Policy_briefs/ECE-WG.1-21-PB15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"Available from: https://www.google.co.nz/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwiT9au-te3QAhUEFJQKHdzgAh8QFggdMAA&url=https%3A%2F%2Fwww.unece.org%2Ffileadmin%2FDAM%2Fpau%2Fage%2FPolicy_briefs%2FECE-WG.1-23.pdf&usg=AFQjCNGNHZPWKCux6ag55C3jfIQEPufXpQ&sig2=1Y eikeaqVStjb-OyT8p2Lg&bvm=bv.141320020,d.dGc.",OADS,/arxiv_data1/oa_pdf/35/0f/jmdh-10-001.PMC5207447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/fb/ndt-13-101.PMC5207448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 101–107Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  101OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12084 3 risperidone improves interpersonal perception  and executive function in patients with  schizophrenia Zhenhe Zhou Yuanyuan Zhu Jun Wang hongmei Zhu Department of Psychiatry, Wuxi  Mental health center of Nanjing  Medical University, Jiangsu Province,   People’s republic of chinaObjective:  To investigate whether risperidone improves social cognitive impairments and  executive dysfunction in people with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/13/fb/ndt-13-101.PMC5207448.pdf
"Furthermore,  cognitive deficits should be recognized as a major element in the social and professional correspondence: Zhenhe Zhou Department of Psychiatry, Wuxi Mental  health center of Nanjing Medical  University, 156 Qianrong road, Wuxi  214151, Jiangsu Province, People’s  republic of china Tel +86 133 5811 8986 Fax +86 510 8301 2201 email zhouzh@njmu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Zhou et al Running head recto: Risperidone improves interpersonal perception and executive function DOI: http://dx.doi.org/10.2147/NDT.S120843",Non-OADS,/arxiv_data1/oa_pdf/13/fb/ndt-13-101.PMC5207448.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/fb/ndt-13-101.PMC5207448.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/fb/ndt-13-101.PMC5207448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 69–76Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  69OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12366 9 alterations of white matter fractional anisotropy  in unmedicated obsessive–compulsive disorder Jiong Tao1,2 Xianglan Wang2 Zhiyong Zhong1,2 hongying han2 sha liu3 shenglin Wen4 Nianhong guan2 lingjiang li1 1Mental health institute of the second  Xiangya hospital, central south  University, changsha, 2Department  of Psychiatry, The Third affiliated  hospital of sun Yat-sen University,   3Department of radiology, guangzhou  huiai hospital, guangzhou,   4Department of Psychiatry, The  Fifth affiliated hospital of sun Yat- sen University, Zhuhai, People’s  republic of chinaBackground:  Abnormalities in white matter (WM) have previously been reported in patients  with obsessive–compulsive disorder (OCD).",Non-OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"It  is directionally dependent on water molecule diffusivity, quite sensitive to some of the  tissue properties such as fiber density, axonal diameter, thickness of the myelin sheaths, correspondence: lingjiang li Mental health institute of the second  Xiangya hospital, National T echnology  institute of Psychiatry, Key laboratory of  Psychiatry and Mental health of hunan  Province, central south University,  No 139 renmin Middle road, changsha  410011, People’s republic of china email llj2920@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Tao et al Running head recto: Alterations of white matter fractional anisotropy in OCD DOI: http://dx.doi.org/10.2147/NDT.S123669",Non-OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"Mri data processing All the data were processed by using Statistical Parametric  Mapping (SPM8; http://www.fil.ion.ucl.ac.uk/spm /) and soft - ware tools from the Functional MRI of the Brain (FMRIB)  software library FSL (FSL, http://www.fmrib.ox.ac.uk/fsl /).",OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
A WM mask made while processing was used  to restrict the region for analysis.8 The statistical result was corrected for multiple com - parisons by using the “AlphaSim” implementation in the  Resting-State fMRI Data Analysis Toolkit (REST).21 This function is based on the Monte Carlo simulation in Analysis  of Functional NeuroImages (AFNI) (see the AlphaSim com - mand description at http://afni.nimh.nih.gov/afni/doc/manual/ AlphaSi m).,OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"Then, the corresponding two  samples t-test in SPM8 results were superimposed onto the  averaged maps, by using xjview ( http://www.alivelearn.net/ xjview 8).",OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/f2/ndt-13-069.PMC5207449.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/26/opth-11-095.PMC5207450.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ec/26/opth-11-095.PMC5207450.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres sClinical Ophthalmology Clinical Ophthalmology 2017:11 95Dove press submit your manuscript | www.dovepress.co m Dove press  95COrrigendumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S13074 9 Macular morphology and response to ranibizumab treatment in patients  with wet age-related macular degeneration [Corrigendum]Journal name: Clinical Ophthalmology Article Designation: Corrigendum Y ear: 2017 Volume: 11 Running head verso: Dervenis and Y ounis Running head recto: Macular morphology and response to ranibizumab treatment in patients DOI: http://dx.doi.org/10.2147/OPTH.S130749 Dervenis N, Y ounis S. Clin Opthalmol .",Non-OADS,/arxiv_data1/oa_pdf/ec/26/opth-11-095.PMC5207450.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nanotechnology, Science and Applications 2017:10 11–21Nanotechnology, Science and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress 11 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S117018 Synthetic nanoparticles of bovine serum albumin  with entrapped salicylic acid ES Bronze-Uhle1 BC Costa1 VF Ximenes2 PN Lisboa-Filho1 1Department of Physics, São Paulo  State University (Unesp), School of  Sciences, Bauru, São Paulo, Brazil;   2Department of Chemistry, São Paulo  State University (Unesp), School of Sciences, Bauru, São Paulo, BrazilAbstract: Bovine serum albumin (BSA) is highly water soluble and binds drugs or inorganic  substances noncovalently for their effective delivery to various affected areas of the body.",Non-OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
"Luiz Edmundo Carrijo Coube 14-01, 17033-360 Bauru, São Paulo, BrazilTel +55 14 3103 6000Email eriuhle@fc.unesp.brJournal name: Nanotechnology, Science and Applications Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Bronze-Uhle et alRunning head recto: Synthetic nanoparticles of BSA with entrapped salicylic acidDOI: http://dx.doi.org/10.2147/NSA.S117018",Non-OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
"Nanotechnology, Science and Applications 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nanotechnology-science-and-applications-journalNanotechnology, Science and Applications is an international, peer-reviewed, open  access journal that focuses on the science of nanotechnology in a wide range of industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 21 Synthetic nanoparticles of BSA with entrapped salicylic acid  41.,Non-OADS,/arxiv_data1/oa_pdf/5f/5a/nsa-10-011.PMC5207451.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 105–114Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  105Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12244 2 Comparison of Visian toric collamer lens and  toric acrylic intraocular lens implantation for the  treatment of myopia with astigmatism hatem ammar Mohamed anbar Marwa M abdellah Department of Ophthalmology,   Faculty of Medicine, sohag University,   sohag, egyptPurpose:  To compare the efficacy and outcome of phakic toric implantable collamer lens (TICL)  and refractive clear lens extraction with AcrySof Toric intraocular lens (TIOL) implantation  for the treatment of myopic astigmatism.",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
"Keywords:  myopic astigmatism, intraocular lens implantation, Visian toric, AcrySof toric Introduction Astigmatic correction has become a longstanding topic of debate, from the traditional  use of spectacles and contact lenses to the era of keratotomy and laser-assisted  in situ keratomileusis (LASIK).1 Although LASIK is widely accepted among  ophthalmologists, its effects on the clear, central, corneal zone are associated with a  number of intraoperative and postoperative complications such as regression, haze,  dry eyes, diffuse lamellar keratitis, undercorrection, and overcorrection, which have  been reported to increase with increased ablation depth.2–5 Simultaneously, changes in  corneal shape, especially in high laser ablation, may result in poor visual quality.6 Techniques for surgical correction of myopic astigmatism with the implantation of  toric intraocular lens (TIOL; phakic or aphakic) have advanced in the past few years.7  Phacoemulsification with TIOL implantation is used not only for cataract surgery8,9 but  also for refractive surgery.10,11 TIOLs may provide greater reversibility or adjustability  than some keratorefractive procedures.10,12–14 However, this procedure is associated Correspondence: hatem ammar Department of Ophthalmology,  Faculty of Medicine, sohag University,  sohag 82516, egypt Tel +20 11 4000 0324 Fax +20 93 457 0262 email htmammar@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ammar et al Running head recto: Lens implant comparison for astigmatism treatment DOI: http://dx.doi.org/10.2147/OPTH.S122442",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
"TiOl power calculation Intraocular lens cylinder power and alignment axis were  calculated using a web-based TIOL calculator program  (http://www.acrysoftoriccalculator.co m), which considers  the IOLMaster biometry and keratometry data as well as the  surgically induced astigmatism.",OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
The poster’s abstract was  published in “Poster Abstracts” at the XXXIV Congress of  the ESCRS in Copenhagen Journal with the link below to the  abstract http://www.escrs.org/Copenhagen2016/programme/ poster-village-details.asp?id =26842&day =0.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/c5/opth-11-105.PMC5207452.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/5f/ndt-13-091.PMC5207453.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 91–100Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  91OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12463 0 long-term bicycle riding ameliorates the depression  of the patients undergoing hemodialysis by   affecting the levels of interleukin-6 and   interleukin-18 chunhui Zhao hui Ma lei Yang Y ong Xiao Blood Purification center, The First  affiliated hospital of Dalian Medical  University, Dalian, People’s republic  of chinaPurpose:  Hemodialysis patients with depression have a higher risk of death and hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/4e/5f/ndt-13-091.PMC5207453.pdf
"More seriously, depression is  closely associated with suicidal events.10,11 There are some diagnostic features according  to the international Beck Depression Inventory-II (BDI-II) with 21 questions about correspondence: Yong Xiao Blood Purification Center, The First  Affiliated Hospital of Dalian Medical  University, No 222 Zhongshan road,  Xigang District, Dalian, liaoning Province,  People’s republic of china Tel/fax +86 411 8363 5963 email xyong2016@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Zhao et al Running head recto: Effects of bicycle riding on interleukin levels DOI: http://dx.doi.org/10.2147/NDT.S124630",Non-OADS,/arxiv_data1/oa_pdf/4e/5f/ndt-13-091.PMC5207453.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4e/5f/ndt-13-091.PMC5207453.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/5f/ndt-13-091.PMC5207453.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/7c/ott-10-153.PMC5207454.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 153–163OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  153Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12105 9 clinicopathological and immunohistochemical  features of lung invasive mucinous adenocarcinoma  based on computed tomography findings Katsuhiko shimizu riki Okita shinsuke saisho ai Maeda Yuji nojima Masao nakata Department of general Thoracic  surgery, Kawasaki Medical school,   Kurashiki, Okayama, JapanBackground:  We performed an analysis to clarify differences in clinicopathological and  molecular features of lung invasive mucinous adenocarcinoma (IMA) based on computed  tomography (CT) findings and their impact on prognosis.",Non-OADS,/arxiv_data1/oa_pdf/84/7c/ott-10-153.PMC5207454.pdf
"A new classification for lung adenocarcinoma was  proposed by an international multidisciplinary expert panel of the International Associa - tion for the Study of Lung Cancer/American Thoracic Society/European Respiratory  Society (IASLC/ATS/ERS) in 2011.3 Invasive mucinous adenocarcinoma (IMA) was correspondence: Katsuhiko shimizu Department of general Thoracic  surgery, Kawasaki Medical school,  577 Matsushima, Kurashiki, Okayama  701-0192, Japan Tel +81 86 464 1124 Fax +81 86 464 1124 email kshimizu@med.kawasaki-m.ac.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Shimizu et al Running head recto: Lung invasive mucinous adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S121059",Non-OADS,/arxiv_data1/oa_pdf/84/7c/ott-10-153.PMC5207454.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/84/7c/ott-10-153.PMC5207454.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/7c/ott-10-153.PMC5207454.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 47–53Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  47OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11757 2 Patient knowledge on reporting adverse drug  reactions in Poland Anna staniszewska1 Marta Dąbrowska-Bender2 Dominik Olejniczak2 Aneta Duda-Zalewska2 Magdalena Bujalska- Zadrożny3 1Department of experimental and  Clinical Pharmacology, 2Department  of Public Health, 3Department of  Pharmacodynamics, Medical University  of Warsaw, Warsaw, PolandAim:  The aim of the study was to assess patient knowledge on reporting of adverse drug  reactions.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"The process of collecting and analyzing data on safety of drugs after  registration is referred to as pharmacovigilance.3 The global program for collecting information on adverse drug reactions (ADRs)  (Program for International Drug Monitoring)  of WHO was launched in 1968 in Uppsala,  Sweden.4 Poland joined the program in 1972.5 The aim of the program is to identify  unknown risks associated with the use of a given drug.4 In Poland, all suspected adverse reactions of medicinal products intended for human  use are supposed to be reported to the Department for Monitoring Adverse Reactions  of Medicinal Products at the Office for Registration of Medicinal Products, Medical correspondence: Anna staniszewska Department of experimental and clinical  Pharmacology, Medical University in  Warsaw, Banacha 1b Street, 02-067  Warsaw, Poland Tel/fax +48 22 116 61 60 email anna.staniszewska@wum.edu.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Staniszewska et al Running head recto: Patient knowledge on reporting adverse drug reactions in Poland DOI: http://dx.doi.org/10.2147/PPA.S117572",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"According to the statement of the Ethi - cal Committee of the Medical University of Warsaw: “The  Committee does not provide opinions on surveys, retro - spective studies, or other non-invasive research” (Detailed  information and templates of documents of Ethics Com - mittee of Medical University of Warsaw (Accessed 2016- 10-01): http://komisjabioetyczna.wum.edu.pl/content/ szczeg%C3%B3%C5%82owe-informacje-orazwzory- dokument%C3%B3w .",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"The WHO Programme for International Drug Monitoring, Available  from: http://www.who.int/medicines/areas/quality_safety/safety_effi - cacy/National_PV_Centres_Map/en /.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"Countries participating in the WHO  Programme for International Drug Monitoring, with year of join - ing, Available from: http://www.who-umc.org/DynPage.aspx?id=1 00653&mn1=7347&mn2=7252&mn3=7322&mn4=744 2.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
Available  from: http://www.urpl.gov.pl/pl/produkty-lecznicze/monitorowanie- bezpiecze%C5%84stwa-lek%C3%B3w/zg%C5%82o%C5%9B- dzia%C5%82anie-niepo%C5%BC%C4%85dane- 0.,Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"Drug safety monitoring, Available from: http://www.urpl.gov.pl/ pl/produkty-lecznicze/monitorowanie-bezpiecze%C5%84stwa- lek%C3%B3 w. Accessed June 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"To mo że się zmienić, Available from: http://www.rynekaptek.",Non-OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"Adverse Reaction and Medical Device Problem  Reporting, Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/ report-declaration/index-eng.php.",OADS,/arxiv_data1/oa_pdf/fb/2d/ppa-11-047.PMC5207455.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ndt-13-077.PMC5207456.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 77–85Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  77OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12049 6 The role of heme oxygenase-1 (hO-1) in the  regulation of inflammatory reaction, neuronal  cell proliferation and apoptosis in rats after  intracerebral hemorrhage (ich) Xuezheng Fan1 linshen Mu2 1Department of Neurosurgery,   People’s hospital of guangming  New District, Shenzhen, Guangdong,   People’s republic of china;   2Department of Neurosurgery,   guangzhou Medical University  Affiliated Brain Hospital, Guangzhou,   Guangdong, People’s Republic of  chinaObjective:  To investigate the role of heme oxygenase-1 (HO-1) in the regulation of inflammatory  reaction, neuronal cell proliferation and apoptosis in rats after intracerebral hemorrhage (ICH).",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ndt-13-077.PMC5207456.pdf
"However, correspondence: Xuezheng Fan Department of Neurosurgery,  People’s hospital of guangming  New District, 4253 Songbai Road,  Gongming Street, Guangming New  District, Shenzhen 518106, Guangdong,  People’s republic of china Tel +86 151 0771 3812 email fan_xuezheng@163.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Fan and Mu Running head recto: The role of heme oxygenase-1 after intracerebral hemorrhage DOI: http://dx.doi.org/10.2147/NDT.S120496",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ndt-13-077.PMC5207456.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ndt-13-077.PMC5207456.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ndt-13-077.PMC5207456.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/ndt-13-061.PMC5207457.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 61–67Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  61OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12333 8 apathy and intrinsic functional connectivity  networks in amnestic mild cognitive impairment soo hyun Joo1 chang Uk lee1 hyun Kook lim2 1Department of Psychiatry,   seoul st Mary’s hospital, seoul,   2Department of Psychiatry, saint  Vincent hospital, college of Medicine,   The catholic University of Korea,   suwon, republic of KoreaBackground:  Although several prior works reported that apathy is associated with conversion to  Alzheimer’s disease in individuals with amnestic mild cognitive impairment (aMCI), effects of  apathy on the functional connectivity (FC) of the brain remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/ndt-13-061.PMC5207457.pdf
"Studies using different modalities including structural magnetic resonance imaging (MRI),  positron emission tomography (PET) and single photon emission computed tomography  (SPECT) have shown associations among apathy and cortical thinning, white matter integ - rity change, hypometabolism and hypoperfusion in the orbitofrontal, anterior cingulate  and inferior temporal areas in the brains of AD patients.9–15 Additionally, several studies  showed that the presence of white matter lesions was associated with apathy in aMCI  patients.16,17 Although strong evidence indicates that apathy is correlated with these specific  brain damages that might affect disconnection of the cortico-subcortical network, the direct  effects of apathy on the functional connectivity (FC) of the brain remain unclear.correspondence: hyun Kook lim Department of Psychiatry, saint Vincent  hospital, college of Medicine, The  catholic University of Korea, Jungbu- daero 93, Paldal-gu, suwon, gyeonggi-do  16247, republic of Korea Tel +82 31 249 8167 Fax +82 31 248 6758 email drblues@catholic.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Joo et al Running head recto: Association between apathy and DMN, SN and CEN DOI: http://dx.doi.org/10.2147/NDT.S123338",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/ndt-13-061.PMC5207457.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ca/cd/ndt-13-061.PMC5207457.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/cd/ndt-13-061.PMC5207457.pdf
"In connection with complet- 1Conceptual Progress for the Improvements in the Selectivity and  Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview Kyeong-Man Kim * College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of KoreaOverview Biomol  Ther 25(1), 1-3 (2017) *Corresponding Author E-mail: kmkim@jnu.ac.kr  Tel: +82-62-530-2936, Fax: +82-62-530-2949Received  Nov 24, 2016  Revised  Dec 9, 2016  Accepted  Dec 12, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.262 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/9f/bt-25-001.PMC5207458.pdf
"2 https://doi.org/10.4062/biomolther.2016.262ed human genome projects, a genomic approach will be im- portant to understand the link between GPCR polymorphism  and heterogeneity of drug efficacy in the population.",Non-OADS,/arxiv_data1/oa_pdf/cb/9f/bt-25-001.PMC5207458.pdf
"Key Words:  G protein, G protein-coupled receptor, Structure, DynamicsAbstractInvited Review Biomol  Ther 25(1), 4-11 (2017) *Corresponding Author E-mail: kychung2@skku.edu Tel: +82-31-290-7787, Fax: +82-31-292-8800Received  Aug 2, 2016  Revised  Aug 26, 2016  Accepted  Sep 1, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.169 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/95/bt-25-004.PMC5207459.pdf
"6 https://doi.org/10.4062/biomolther.2016.169Gabγ heterotrimer (Noel et al., 1993; Coleman et al., 1994;  Lambright et al., 1994; Sondek et al., 1994; Mixon et al.,  1995; Wall et al., 1995; Lambright et al., 1996; Lutz et al.,  2007; Nishimura et al., 2010).",OADS,/arxiv_data1/oa_pdf/fd/95/bt-25-004.PMC5207459.pdf
8 https://doi.org/10.4062/biomolther.2016.169receptors (Fig.,OADS,/arxiv_data1/oa_pdf/fd/95/bt-25-004.PMC5207459.pdf
10 https://doi.org/10.4062/biomolther.2016.169these problems in the near future.,Non-OADS,/arxiv_data1/oa_pdf/fd/95/bt-25-004.PMC5207459.pdf
"Key Words:  b-arrestin, biased signaling, G protein-coupled receptor , G protein AbstractInvited Review Biomol  Ther 25(1), 12-25 (2017) *Corresponding Author E-mail: ILKIM@augusta.edu Tel: +1-706-721-9414, Fax: +1-706-721-9799Received  Jul 30, 2016  Revised  Aug 19, 2016  Accepted  Aug 23, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.165 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
"14 https://doi.org/10.4062/biomolther.2016.165tein 2 (AP2) complex, b-arrestins also target the GPCRs for  clathrin-mediated endocytosis and internalization (Lefkowitz,  1998; Ferguson, 2001).",Non-OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
16 https://doi.org/10.4062/biomolther.2016.165high level of receptor internalization.,OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
"18 https://doi.org/10.4062/biomolther.2016.165preserving renal functions (Boerrigter et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
20 https://doi.org/10.4062/biomolther.2016.165such therapeutic agents are yet to be developed.,Non-OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
22 https://doi.org/10.4062/biomolther.2016.165diates endocytosis of CCR7 following ligation of CCL19 but not  CCL21.,Non-OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
"24 https://doi.org/10.4062/biomolther.2016.165Perrino, C. and Rockman, H. A.",OADS,/arxiv_data1/oa_pdf/68/71/bt-25-012.PMC5207460.pdf
"Key Words:  G protein-coupled receptor, Endocytosis, Ral, ARF6, Glycosylation, PalmitoylationAbstractBiomol  Ther 25(1), 26-43 (2017) *Corresponding Author E-mail: kmkim@jnu.ac.kr  Tel: +82-62-530-2936, Fax: +82-62-530-2949Received  Aug 18, 2016  Revised  Nov 21, 2016  Accepted  Nov 30, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.186 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
28 https://doi.org/10.4062/biomolther.2016.186in heterologous regulatory processes remains elusive.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
30 https://doi.org/10.4062/biomolther.2016.186are commonly used to directly label receptors on the cell sur- face (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
32 https://doi.org/10.4062/biomolther.2016.186intracellular trafficking and to completely remove the agonist  bound to the receptors.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
"34 https://doi.org/10.4062/biomolther.2016.186al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
"36 https://doi.org/10.4062/biomolther.2016.186nalization, whereas N-linked glycosylation within the second  extracellular loop is exclusively responsible for internalization  (Min et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
38 https://doi.org/10.4062/biomolther.2016.186in permanently transfected BHK cells.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
"40 https://doi.org/10.4062/biomolther.2016.186Ivanov, A. I.",OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
"42 https://doi.org/10.4062/biomolther.2016.186Pierce, K. L., Maudsley, S., Daaka, Y., Luttrell, L. M. and Lefkowitz, R.  J.",OADS,/arxiv_data1/oa_pdf/d8/8c/bt-25-026.PMC5207461.pdf
"Key Words:  b-adrenergic receptor, b-blockers, G protein-coupled receptor  kinase, Heart diseases, Insulin resistance, Protein  kinase AAbstractInvited Review Biomol  Ther 25(1), 44-56 (2017) *Corresponding Author E-mail: hikurose@phar.kyushu-u.ac.jp Tel: +81-92-642-6884, Fax: +81-92-642-6884Received  Jun 16, 2016  Revised  Jul 26, 2016  Accepted  Aug 2, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.128 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
"46 https://doi.org/10.4062/biomolther.2016.128pressed on many cell types, implicating the broad array of bio- logical responses to insulin (Fig.",OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
"48 https://doi.org/10.4062/biomolther.2016.128(Jellinger, 2007).",Non-OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
50 https://doi.org/10.4062/biomolther.2016.128responses induced by cAMP and their compartmentalization  remain to be defined.,Non-OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
52 https://doi.org/10.4062/biomolther.2016.128dent signaling.,OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
54 https://doi.org/10.4062/biomolther.2016.128coupled receptor kinase 2 plays an essential role in b-adrenergic  receptor-induced insulin resistance.,Non-OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
56 https://doi.org/10.4062/biomolther.2016.128rat heart.,Non-OADS,/arxiv_data1/oa_pdf/25/97/bt-25-044.PMC5207462.pdf
"Key Words:  Neuropeptide, 7TMR, G protein-coupled receptor, Coevolution, Gene duplication, Whole genome duplication, Evolutionary  historyAbstractInvited Review Biomol  Ther 25(1), 57-68 (2017) *Corresponding Author E-mail: jyseong@korea.ac.kr Tel: +82-2-2286-1090, Fax: +82-2-921-4355Received  Sep 6, 2016  Revised  Nov 3, 2016  Accepted  Nov 15, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.199 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
"58 https://doi.org/10.4062/biomolther.2016.199ence a number of physiological and psychological processes  including reproduction, growth, homeostasis, metabolism, food  intake, sleep, and social and sexual behaviours (Cho et al.,  2007; Mirabeau and Joly, 2013; Vaudry and Seong, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
"60 https://doi.org/10.4062/biomolther.2016.199Biomol  Ther 25(1), 57-68 (2017)  3 Neuromedin-B/Bombesin subtype 3/ Gastrin-releasing peptideNMBR/BRS3/GRPR NMBR BRS3GRPRGRPNMBGRP/NMB Endothelian EDNR A/B/B2 EDNRAEDNRBEDNRB2EDN1EDN2EDN3EDN4EDN Orphan 37 GPR37 /L1 GPR37GPR37L1Unknown Unknown 4 Neuromedin-U NMUR 1/2/3 NMUR1NMUR2NMUR3NMUNMSNMU/NMS Growth hormone secretagogue/Motilin GHSR 1/2/3 MLNR GHSRGHSR2GHSR3MLNRGHSMLNGHS/MLN Orphan 39 GPR39-1/2 GPR39GPR39-2Unknown Unknown Neurotensin NTSR 1/2 NTSR1NTSR2NTSNTS2NTS Thyrotropin-releasing hormone TRHR 1/2/3 TRHR1TRHR2TRHR3TRH1/2* TRH NMUR4 NMUR4 NMUR4 Unknown Unknown Orphan 139/142 GPR 139/142 GPR139GPR142Unknown Unknown NMOGPR** Unclear Unclear Unknown Unknown Orphan 139-like** Unclear Unclear Unknown UnknownTable 1.",Non-OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
"62 https://doi.org/10.4062/biomolther.2016.199Salaneck, 2004; Hwang et al., 2013, 2014; Kim et al., 2014a;  Sefideh et al., 2014).",OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
64 https://doi.org/10.4062/biomolther.2016.199ditional two KISS genes on GAC_D0 and D3.,Non-OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
66 https://doi.org/10.4062/biomolther.2016.199esting therapeutic possibilities as each subtype of GALRs has  been found to exhibit largely divergent physiological function.,Non-OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
"68 https://doi.org/10.4062/biomolther.2016.199Mehta, T. K., Ravi, V., Yamasaki, S., Lee, A. P., Lian, M. M., Tay, B.  H., Tohari, S., Yanai, S., Tay, A., Brenner, S. and Venkatesh, B.",OADS,/arxiv_data1/oa_pdf/ae/cd/bt-25-057.PMC5207463.pdf
"Key Words:  G protein-coupled receptor, Human cytomegalovirus, US28, Virally-encoded G protein-coupled receptor, Chemokine  receptor, Antiviral targetAbstractInvited Review Biomol  Ther 25(1), 69-79 (2017) *Corresponding Author E-mail: choongholee@dongguk.edu Tel: +82-31-961-5223, Fax: +82-31-961-5206 †The first two authors contributed equally to this work.Received  Sep 20, 2016  Revised  Nov 19, 2016  Accepted  Nov 22, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.208 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
70 https://doi.org/10.4062/biomolther.2016.208cAMP affect the enzymatic activity of protein kinase A (PKA).,Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
"72 https://doi.org/10.4062/biomolther.2016.208US28, AN HCMV vGPCR Among six CCR homologues encoded by herpesviruses,  US28 is by far the best characterized CCR homologue identi - fied so far.",Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
74 https://doi.org/10.4062/biomolther.2016.208associated kinases (GRKs) turned out to be required for con- sistent internalization of US28.,Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
"76 https://doi.org/10.4062/biomolther.2016.208(STAT3) signaling axis to promote cell proliferation in both an  autocrine and paracrine fashion (Slinger et al., 2010) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
"78 https://doi.org/10.4062/biomolther.2016.2085-(benzyloxy)-2-(5-bromo-2-methoxyphenyl)-4H-chromen-4- one (11b) acted on the US28 receptor as a nontoxic, inverse  agonist with the potency (EC 50=3.5 µM) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/4b/d4/bt-25-069.PMC5207464.pdf
"Key Words:  Sphingosine 1-phosphate, G protein-coupled receptor, Fingolimod, FTY720, Drug discovery, S1P agonist AbstractInvited Review Biomol  Ther 25(1), 80-90 (2017) *Corresponding Author E-mail: imds@pusan.ac.kr Tel: +82-51-510-2817, Fax: +82-51-513-6754Received  Jul 22, 2016  Revised  Oct 6, 2016  Accepted  Oct 27, 2016 Published Online  Jan 1, 2017 Copyright © 2017 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.160 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"82 https://doi.org/10.4062/biomolther.2016.160(LDL) receptor-deficient mice, fingolimod significantly attenu- ated atherosclerotic lesion formation, necrotic core formation,  and lymphocyte function (Nofer et al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"Summary of S1P receptor modulators currently undergoing or completed in clinical trials (based on data at http://www.clinicaltrials.gov/ in July  2016) Chemical Target Condition Stage Status NLM ID Fingolimod   (FTY-720)S1P1/3/4/5 Relapsing remitting multiple   sclerosis (RRMS) Neurodegeneration SchizophreniaRett SyndromeAcute StrokeAmyotrophic lateral sclerosisPrimary progressive multiple   sclerosis Renal insufficiencyModerate asthmaRenal/Kidney transplantationPhase IVPhase IIPhase IIPhase IIPhase IIPhase III Phase I Phase IIPhase IIIApproved (2010) Active ActiveActiveActiveCompleted (2015)Completed (2014) Completed (2011) Completed (2009)Completed (2006)NCT02575365NCT01779700NCT02061137NCT02002390NCT01786174NCT00731692 NCT00731523 NCT00785083NCT00099801 KRP-203 S1P 1 Subacute cutaneous lupus   erythematosus  Hematological malignanciesPhase II Phase IActiveActiveNCT01294774NCT01830010 Siponimod  (BAF312)S1P 1/5 Secondary progressive multiple  sclerosis RRMS - (Extension) -PolymyositisActive dermatomyositisHepatic impairmentRenal impairmentPhase III Phase IIPhase II Phase IIPhase IPhase IActive Completed (2012) - Active -ActiveCompleted (2016)Completed (2014)Completed (2014)NCT01665144 NCT00879658 NCT01185821NCT01801917NCT02029274NCT01565902NCT01904214 CS-0777 S1P 1 Multiple sclerosis Phase I Completed (2010) NCT00616733 Ponesimod   (ACT-128800)S1P1 RRMSPonesimod vs teriflunomide   in RRMS Chronic GVHDPsoriasisPhase IIPhase III Phase II Phase IIActiveActive Active Completed (2012)NCT01093326NCT02425644 NCT02461134 NCT01208090 Ozanimod  (RPC1063)S1P 1/5 Multiple sclerosisUlcerative colitisCrohn's diseasePhase IIIPhase IIIPhase IIActiveActiveActiveNCT02047734NCT02435992NCT02531113 Ceralifimod   (ONO-4641)S1P 1/5 RRMS- (Extension) -Phase IIPhase IICompleted (2011)Terminated(2015)NCT01081782NCT01226745 GSK2018682 S1P 1/5 RRMS Phase I Completed (2011) NCT01466322 MT-1303 S1P1 Crohn's diseaseSystemic lupus erythematosusRRMSPlaque psoriasisInflammatory bowel diseasePhase IIPhase IPhase IIPhase IIPhase IActiveActiveCompleted (2014)Completed (2014)Completed (2014)NCT02378688NCT02307643NCT01742052NCT01987843NCT01666327 RRMS, relapsing remitting multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"84 https://doi.org/10.4062/biomolther.2016.160lagen aI and aIII, and total hydroxyproline contents (Liu et al.,  2011).",OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"86 https://doi.org/10.4062/biomolther.2016.160responses in endothelial cells, such as, cytoskeletal re-struc- turing and cell-extracellular/intracellular matrix interactions.",OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
88 https://doi.org/10.4062/biomolther.2016.160Sci.,Non-OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"90 https://doi.org/10.4062/biomolther.2016.160man, M. S., Stuve, O., Rieckmann, P., Montalban, X., Ziemssen,  T., Auberson, L. Z., Pohlmann, H., Mercier, F., Dahlke, F. and Wall-strom, E. (2013) Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.",Non-OADS,/arxiv_data1/oa_pdf/54/21/bt-25-080.PMC5207465.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/be/ott-10-185.PMC5207466.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 185–194OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  185Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11661 9 The role of microrna-21 in predicting brain  metastases from non-small cell lung cancer Jing Dong1 Zhi Zhang2 Tao gu3 shu-Feng Xu4 li-Xin Dong3 Xin li5 Bao-hong Fu3 Zhan-Zhao Fu3 1Basic research for Oncology, north  china University of science and  T echnology, 2Department of Oncology,   Workers’ hospital of Tangshan city,   Tangshan, 3Department of Oncology,   4Department of respiratory Medicine,   The First hospital of Qinhuangdao  city, Qinhuangdao, 5Department of  Oncology, chengde Medical college,   chengde, People’s republic of chinaObjective:  This study aimed at exploring the role of microRNA-21 (miR-21) in predicting  brain metastases (BM) from non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/89/be/ott-10-185.PMC5207466.pdf
"Keywords:  non-small cell lung cancer, microRNA-21, brain metastases, angiogenesis Introduction Non-small cell lung cancer (NSCLC) is a type of epithelial lung cancer other than small  cell lung carcinoma and accounts for approximately 85%–90% of all lung cancers.1,2  The incidence rates of NSCLC vary from 22 to 63 per 100,000 men and from 5 to 33 per  100,000 women per year.3 It has been reported that the 5-year survival rate of NSCLC  patients ranges from 25% to 73% on the basis of different pathological stages.4 Despite  advances in NSCLC treatments, the prognosis for NSCLC patients remains poor, with  the majority of NSCLC patients dying of pulmonary infection, respiratory failure, brain  metastases (BM), and so on.5,6 BM is the most common neurologic complication related  to systemic cancer, which is up to 10 times more common than primary malignant  brain tumors and is a significant burden in the management of patients with advanced  cancer.7 In addition, among patients with NSCLC, approximately 20%–40% suffer  from BM, a major concern in the NSCLC treatment, during the course of the disease,  which may significantly influence the survival and quality of life of patients.8,9 The  prognosis of BM in NSCLC patients has been reported to be very poor, and the median  survival of BM patients from lung cancer was less than 1 year.9,10 In this regard, it is correspondence: Zhan-Zhao Fu Department of Oncology, The  First hospital of Qinhuangdao city,  no 258 Wenhua road, haigang, 066099  Qinhuangdao, People’s republic of china Tel/fax +86 335 590 8238 email zhanzhaofufu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Dong et al Running head recto: Role of miR-21 in predicting BM from NSCLC DOI: http://dx.doi.org/10.2147/OTT.S116619",Non-OADS,/arxiv_data1/oa_pdf/89/be/ott-10-185.PMC5207466.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/89/be/ott-10-185.PMC5207466.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/be/ott-10-185.PMC5207466.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/89/ndt-13-041.PMC5207467.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 41–49Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  41OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12350 1 local mild hypothermia therapy as an  augmentation strategy for minimally invasive  surgery of hypertensive intracerebral hemorrhage:  a meta-analysis of randomized clinical trials Yu han1 Ke sheng1 Meilan su1 Nan Yang1 Dong Wan2 1Department of Neurology,   2Department of emergency, The First  affiliated hospital of chongqing  Medical University, chongqing,   People’s republic of chinaBackground:  Previous studies reported that the mild hypothermia therapy (MHT) could  significantly improve the clinical outcomes for patients with hypertensive intracerebral hemor - rhage (HICH).",Non-OADS,/arxiv_data1/oa_pdf/ea/89/ndt-13-041.PMC5207467.pdf
"To date, there are  still no effective drug therapies for HICH.6 Moreover, HICH is characterized by high  incidence, high mortality and high morbidity, which seriously endangers the health of correspondence: Dong Wan Department of emergency, The First  Affiliated Hospital of Chongqing Medical  University, 1 Yixueyuan road, Yuzhong  District, chongqing 400016, People’s  republic of china Tel/fax +86 23 6881 1360 email dongwdf@yeah.ne t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Han et al Running head recto: Mild hypothermia therapy for hypertensive intracerebral hemorrhage DOI: http://dx.doi.org/10.2147/NDT.S123501",Non-OADS,/arxiv_data1/oa_pdf/ea/89/ndt-13-041.PMC5207467.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ea/89/ndt-13-041.PMC5207467.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/89/ndt-13-041.PMC5207467.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance 2017:10 1–17Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIg Inal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S118877Peptide consensus sequence determination for  the enhancement of the antimicrobial activity  and selectivity of antimicrobial peptides ammar almaaytah1 Ya’u ajingi2 ahmad abualhaijaa2 shadi Tarazi2 nizar alshar’i3 Qosay al-Balas3 1Department of Pharmaceutical  T echnology, Faculty of Pharmacy,   Jordan University of science and  T echnology, Irbid, Jordan; 2Department  of applied Biological sciences, Faculty  of science and arts, Jordan University  of science and T echnology, Irbid,   Jordan; 3Department of Medicinal  chemistry, Faculty of Pharmacy,  Jordan University of science and  T echnology, Irbid, JordanAbstract:  The rise of multidrug-resistant bacteria is causing a serious threat to the world’ s  human population.",Non-OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"2 The broad spectrum activity and diverse  mechanism of action associated with AMPs have qualified them to be considered as correspondence: ammar almaaytah Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of science and Technology, PO Box 3030, 22110 Irbid, JordanTel +962 7 9555 0234Fax +962 2 720 1075email amalmaaytah@just.edu.jo Journal name: Infection and Drug Resistance  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Almaaytah et alRunning head recto: Pepcon, a consensus peptide with potent antibacterial activityDOI: http://dx.doi.org/10.2147/IDR.S118877",Non-OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"Infection and Drug Resistance 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 17 Pepcon, a consensus peptide with potent antibacterial activity",Non-OADS,/arxiv_data1/oa_pdf/c5/54/idr-10-001.PMC5207468.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/ff/ndt-13-087.PMC5207469.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 87–90Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  87Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12231 6 aripiprazole augmentation in managing comorbid  obsessive–compulsive disorder and bipolar  disorder: a case with suicidal attempts Jianbo Lai1,2 Qiaoqiao Lu1 peng Zhang2,3 Tingting Xu2,3 Yi Xu1,2 shaohua Hu1,2 1Department of psychiatry, the  First affiliated Hospital, Zhejiang  University school of Medicine, 2The  Key Laboratory of Mental Disorder’s  Management in Zhejiang province,   3Department of psychiatry, Mental  Health Centre, Xiaoshan Hospital  of Zhejiang province, Hangzhou,   Zhejiang, people’s republic of ChinaAbstract:  Comorbid obsessive–compulsive disorder (OCD) and bipolar disorder (BD) have  long been an intractable problem in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/37/ff/ndt-13-087.PMC5207469.pdf
"This patient reported repetitive suicidal Correspondence: shaohua Hu; Yi Xu Department of psychiatry, the  First Affiliated Hospital, Zhejiang  University school of Medicine, 79  Qingchun road, Hangzhou 310003,  people’s republic of China Tel +86 571 5672 3002;   +86 138 0574 6579 Fax +86 571 5672 3001 email dorhushaohua@zju.edu.c n;  xuyizju61@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2017 Volume: 13 Running head verso: Lai et al Running head recto: Aripiprazole augmentation in managing comorbid OCD and BD DOI: http://dx.doi.org/10.2147/NDT.S122316",Non-OADS,/arxiv_data1/oa_pdf/37/ff/ndt-13-087.PMC5207469.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/37/ff/ndt-13-087.PMC5207469.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/ff/ndt-13-087.PMC5207469.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 37–46Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  37 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121315Influence of exercise on visceral pain: an  explorative study in healthy volunteers Laura JGM van  Weerdenburg1  Christina Brock2,3  Asbjørn Mohr Drewes2  Harry van Goor1  Marjan de Vries1  Oliver HG Wilder-Smith4 1Department of Surgery, Radboud  University Medical Centre, Nijmegen,   the Netherlands; 2Mech-Sense,   Department of Gastroenterology,  Aalborg University Hospital, Aalborg,   3Department of Drug Design  and Pharmacology, University of Copenhagen, Copenhagen, Denmark;   4Department of Anesthesiology, Pain  and Palliative Medicine, Radboud University Nijmegen Medical Centre,  Nijmegen, the NetherlandsBackground and objectives: Contradictory results have been found about the effect of dif- ferent exercise modalities on pain.",Non-OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
"1 This effect is seen with several types of exercise,  including aerobic exercise,2–4 isometric exercise5–10 and dynamic resistance exercise.11,12  EIH has been shown in healthy individuals, as well as in patients with chronic low back pain, 13,14 shoulder myalgia,15 fibromyalgia16–18 and chronic musculoskeletal pain,19 Correspondence: Laura JGM van  Weerdenburg   Department of Surgery (route 618), Radboud University Medical Centre,   PO Box 9101, 6500 HB Nijmegen,   the Netherlands   Tel +31 6 5790 7591   Email laura.van.weerdenburg@student.ru.nlJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: van Weerdenburg et alRunning head recto: Exercise and visceral painDOI: http://dx.doi.org/10.2147/JPR.S121315",Non-OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
The randomization list was gener - ated from http://www.randomisation.com.,OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 46 van Weerdenburg et al  29.,Non-OADS,/arxiv_data1/oa_pdf/80/78/jpr-10-037.PMC5207470.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 51–60Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  51Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11881 8 A biopsychological review of gambling disorder Gabriel C Quintero Florida State University – Republic  of Panama, Panama City, PanamaAbstract:  The present review is an overview of previous experimental work on biopsychological  aspects of gambling disorder.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
"As an illustration, different  researchers have evaluated relationships between gambling disorder and psychiatric  disorders across different ethnic groups.5,6 Specifically, Barry et al5 studied a sample  of 31,830 adult subjects (87% white and 13% Hispanic), and concluded that dif - ferent degrees of gambling-disorder seriousness were related to the comorbidities Correspondence: Gabriel C Quintero Florida State University – Republic  of Panama, 227 City of Knowledge,  Clayton, Panama City, Panama Tel +507 317 0367 Fax +507 317 0366 email gquintero@fsu.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Quintero Running head recto: Biopsychology of gambling disorder DOI: http://dx.doi.org/10.2147/NDT.S118818",Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
"Available from: http://www.norc.org/pdfs/publications/ gibsfinalreportapril1999.pd f. Accessed November 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric­disease­and­treatment­journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/59/ndt-13-051.PMC5207471.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/opth-11-081.PMC5207472.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 81–86Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  81Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12026 7 refractive and visual outcomes after Keraring  intrastromal corneal ring segment implantation  for keratoconus assisted by femtosecond laser  at 6 months follow-up Mohamed a heikal Marwa abdelshafy Tarek T soliman abdelmonem M hamed Department of Ophthalmology, Benha  University, Banha, egyptPurpose:  We attempted to evaluate the efficacy of femtosecond laser-assisted intrastromal  corneal ring segment implantation in patients with keratoconus (KC).",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/opth-11-081.PMC5207472.pdf
"Keywords:  femtosecond laser, K astigmatism Keraring, spherical error Introduction Keratoconus (KC) is a noninflammatory ectatic corneal disease characterized by  progressive paracentral corneal thinning and inferior corneal steepening that causes  irregular astigmatism, protrusion and decreased visual acuity.1,2 It usually starts in early  adulthood and progresses until the third decade of life and then becomes stable.3,4 Dif- ferent methods of increasing visual acuity in KC, including spectacles, contact lenses  and corneal grafting, have been introduced.3,5Correspondence: Mohamed a heikal Department of Ophthalmology, Benha  University, 17 Fareed nada street,  Banha 13518, egypt email mohammedheikel@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Heikal et al Running head recto: Refractive and visual outcomes after Keraring implantation DOI: http://dx.doi.org/10.2147/OPTH.S120267",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/opth-11-081.PMC5207472.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/opth-11-081.PMC5207472.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/bd/opth-11-081.PMC5207472.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/1c/ijn-12-239.PMC5207473.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 239–249International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  239OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9902 0 Nanocoating with plant-derived pectins activates  osteoblast response in vitro J Folkert1 a Meresta1 T gaber2 K Miksch1 F Buttgereit2 J Detert2 N Pischon3,* K gurzawska3,4,* 1environmental Biotechnology  Department, Faculty of Power and  environmental, silesian University  of T echnology, gliwice, Poland;   2Department of rheumatology and  clinical Immunology, 3Department  of Periodontology, charité- Universitätsmedizin, Berlin, germany;   4Department of Oral surgery, The  school of Dentistry, University of  Birmingham, Birmingham, UK *These authors contributed equally  to this workAbstract:  A new strategy to improve osseointegration of implants is to stimulate adhesion of  bone cells, bone matrix formation, and mineralization at the implant surface by modifying surface  coating on the nanoscale level.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/ijn-12-239.PMC5207473.pdf
"Nanocoating with organic molecules and human-, animal-, and plant-derived poly - saccharides demonstrated that complementary lectins to cell-surface carbohydrates  have the ability to bind polysaccharide present at the surface and mediate cell response  (Figure 1).4 Plant-derived pectins have been proposed as potential candidates for surface  nanocoating of medical devices due to their effect on bone cells and the possibility of  controlling their structure.13–15 The effect on bone cells has been explained by a direct correspondence: K gurzawska Department of Oral surgery,  The school of Dentistry, University  of Birmingham, st chad’s Queensway,  B4 6NN Birmingham, UK Tel +44 121 466 5496 Fax +44 121 466 5493 email k.a.gurzawska@bham.ac.u k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Folkert et al Running head recto: Nanocoating with plant-derived pectins DOI: http://dx.doi.org/10.2147/IJN.S99020",Non-OADS,/arxiv_data1/oa_pdf/11/1c/ijn-12-239.PMC5207473.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/1c/ijn-12-239.PMC5207473.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/1c/ijn-12-239.PMC5207473.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 1–9Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S96085 Surgical resection of localized hepatocellular  carcinoma: patient selection and special  consideration Ka Wing Ma Tan T o Cheung Department of Surgery, Queen Mary  Hospital, The University of Hong Kong, Pok Fu Lam, Hong KongAbstract: Localized hepatocellular carcinoma (HCC) refers to a solitary or few tumors located  within either the left or right hemiliver without evidence of bilobar or extrahepatic spread.",Non-OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
comJournal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEWY ear: 2017V olume: 4Running head verso: Ma and CheungRunning head recto: Surgical resection of localized hepatocellular carcinomaDOI: http://dx.doi.org/10.2147/JHC.S96085,Non-OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 9 Surgical resection of localized hepatocellular carcinoma 131.,Non-OADS,/arxiv_data1/oa_pdf/2e/68/jhc-4-001.PMC5207474.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 23–32International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  23RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S12371 0 Hysterosalpingo-foam sonography: patient  selection and perspectives Hemashree Rajesh Serene Liqing Lim Su Ling Yu Centre of Assisted Reproduction,   Department of Obstetrics and  Gynecology, Singapore General  Hospital, SingaporeAbstract:  We present an overview of the common types of tubal patency tests, with a focus  on hysterosalpingo-foam sonography (HyFoSy).",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
com.s g Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Rajesh et al Running head recto: Hysterosalpingo-foam sonography: patient selection and perspectives DOI: http://dx.doi.org/10.2147/IJWH.S123710,Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
"Available  from: http://www.exemfoamkit.co.uk/faq.ph p. Accessed July 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/24/ijwh-9-023.PMC5207475.pdf
"Building Trust and Relationships Between Patients and  Providers: An Essential Complement to Health Literacy in HIV  Care Carol Dawson-Rose, PhD, RN, FAAN*, Professor, University of California, San Francisco (UCSF) School of Nursing, San Francisco,  California, USA Yvette P. Cuca, PhD, MPH, MIA , Specialist, UCSF School of Nursing, San Francisco, California, USA Allison R. Webel, PhD, RN , Assistant Professor, Case Western Reserve University, Cleveland, Ohio, USA Solymar S. Solís Báez, BA , Coordinator, University of Puerto Rico, San Juan, Puerto Rico William L. Holzemer, RN, PhD, FAAN , Dean and Professor, Rutgers College of Nursing, Newark, New Jersey, USA Marta Rivero-Méndez, RN, DNS , Professor, University of Puerto Rico, San Juan, Puerto Rico Lucille Sanzero Eller, PhD, RN , Professor, Rutgers College of Nursing, Cedar Grove, New Jersey, USA Paula Reid, PhD, RNC, WHNP , Assistant Professor, University of North Carolina at Wilmington, Wilmington, North Carolina, USA Mallory O. Johnson, PhD , Professor, UCSF , San Francisco, California, USA Jeanne Kemppainen, PhD, RN , Professor and Assistant Department Chair, University of North Carolina Wilmington, Wilmington,  North Carolina, USA Darcel Reyes, PhD, RN, ANP-BC, MS , Adult Nurse Practitioner, HELP/PSI, Y onkers, New Y ork, USA Kathleen Nokes, PhD, RN, FAAN , Professor Emerita, Hunter College and Graduate Center, City University of New Y ork, Stone  Ridge, New Y ork, USA This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1016/S1055-3290(06)60132-5 .,OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1177/1049732304266795 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1080/09540120600774263 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1016/0022-3956(75)90026-6 .,OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1016/S1473-3099(1370272-X) .,OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.2105/ AJPH.2014.302284 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
"Retrieved from https://iom.nationalacademies.org/Reports/2004/Health-Literacy-A- Prescription-to-End-Confusion.aspx Kitahata MM, Van Rompaey SE, Dillingham PW, Koepsell TD, Deyo RA, Dodge W, Wagner EH.",Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/ 10.1046/j.1525-1497.2003.11049.x .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
"Retrieved from http://nces.ed.gov/naal/pdf/2006470_1.pdf Lanier L, DeMarco R. A synthesis of the theory of silencing the self and the social ecological model:  Understanding gender, race, and depression in African American women living with HIV  infection.",Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1089/apc.,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/ 10.1089/apc.2012.0294 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
2008; 67(12):2072– 2078. http://dx.doi.org/10.1016/j.socscimed.2008.09.050 .,OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.5555/ajhb.,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/ 10.1016/0738-3991(95)00787-3 .,OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1093/heapro/ dan001 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.1345/aph.1P477 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/ 10.1007/s11904-013-0178-4 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
2012; 15(1):10. http://dx.doi.org/ 10.1186/1758-2652-15-10 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
http://dx.doi.org/10.2105/AJPH.2005.063255 .,Non-OADS,/arxiv_data1/oa_pdf/07/0f/nihms837565.PMC5207494.pdf
Medicine (2016) 95:52(e4778)Received: 16 November 2015 / Received in ﬁnal form: 30 July 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004778Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"The standardized data collection form for the 4 scores are shown inAppendices 1 –4, http://links.lww.com/MD/B288.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"To achieve adequate power to address the objectivesby using 2-tailed alpha of 0.05 and a power of 80%.Thecalculation formula for sample size is shown in Appendix 9, http://links.lww.com/MD/B288.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"[12] The de ﬁnitions for the individual risk scores are in Appendices 1–4, http://links.lww.com/MD/B288.Chen et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"The distributions of patients in each score are shown in Appendices 5 –8, http://links.lww.com/MD/B288.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"available online, http://www.who.int/mediacentre/factsheets/fs317/en/index.html.Accessed February 25, 2013.",OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
"availableonline, http://www.chp.gov.hk/en/content/9/25/57.html.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/medi-95-e4778.PMC5207539.pdf
Medicine (2016) 95:52(e5353)Received: 8 August 2016 / Received in ﬁnal form: 16 October 2016 / Accepted: 18 October 2016 http://dx.doi.org/10.1097/MD.0000000000005353Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c9/8e/medi-95-e5353.PMC5207540.pdf
"Exclusion criteria were intake of vitamin D preparations during 8 weeks prior to study enrollment, pregnancy or lactation, hypersensitivity to vitamin D, any known cardiovascular, pulmonary, renal, or hepatic disease, anemia, hyper- andhypocalcemia (corrected serum calcium levels >2.54mmol/L or<2.09mmol/L, respectively, the normal range given by the local laboratory), presence of muscle or bone disease, severeinfection, in ﬂammation, malignancy, known mental disorders, sleep disorders, chronic intake of concurrent medication, except oral contraceptives, known chronic kidney disease with glomer- ular ﬁltration rate (CKD-EPI-estimated) <60mL/min/1.73m 2, medication affecting physical or mental performance, participa- tion in any other therapeutic trial within the previous month, inability to follow the procedures of the study, for example, dueto language problems, psychological disorders, dementia etc., enrollment of the investigator, his/her family members, employ- ees, and other dependent persons (Supplemental Table, http://links.lww.com/MD/B463).",Non-OADS,/arxiv_data1/oa_pdf/c9/8e/medi-95-e5353.PMC5207540.pdf
"Procedures The schedule of study visits is shown in Supplemental Figure, http://links.lww.com/MD/B463.",Non-OADS,/arxiv_data1/oa_pdf/c9/8e/medi-95-e5353.PMC5207540.pdf
"[11,12]TheCYP2C9 gene (10q24) encompasses 9 exons and it is highly polymorphic, as more than 60 variant alleles have been identi ﬁed (http://www.cypalleles.ki.se, last access February 2016).",Non-OADS,/arxiv_data1/oa_pdf/c4/8e/medi-95-e5451.PMC5207541.pdf
Medicine (2016) 95:52(e5451)Received: 24 May 2016 / Received in ﬁnal form: 31 August 2016 / Accepted: 28 October 2016 http://dx.doi.org/10.1097/MD.0000000000005451Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c4/8e/medi-95-e5451.PMC5207541.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2010/009218s108lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/8e/medi-95-e5451.PMC5207541.pdf
Medicine (2016) 95:52(e5517)Received: 29 August 2016 / Received in ﬁnal form: 3 November 2016 / Accepted: 8 November 2016 http://dx.doi.org/10.1097/MD.0000000000005517Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/61/20/medi-95-e5517.PMC5207542.pdf
"Common terminology criteria for adverse events, version 3.0. http://ctep.cancer.gov/reporting/ctc.html.",Non-OADS,/arxiv_data1/oa_pdf/61/20/medi-95-e5517.PMC5207542.pdf
Medicine (2016) 95:52(e5522)Received: 27 February 2016 / Received in ﬁnal form: 10 October 2016 / Accepted: 10 November 2016 http://dx.doi.org/10.1097/MD.0000000000005522Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/83/2b/medi-95-e5522.PMC5207543.pdf
"According to the results of the log-rank test, the Pvalues of an age >60 years, an operative time >570 minutes, and mucinous-type tumors were0.795, 0.235, and 0.683, respectively (Supplemental Figures 1 –3, http://links.lww.com/MD/B476).",Non-OADS,/arxiv_data1/oa_pdf/83/2b/medi-95-e5522.PMC5207543.pdf
Medicine (2016) 95:52(e5539)Received: 1 August 2016 / Received in ﬁnal form: 13 October 2016 / Accepted: 10 November 2016 http://dx.doi.org/10.1097/MD.0000000000005539Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/36/f6/medi-95-e5539.PMC5207545.pdf
Medicine (2016) 95:52(e5543)Received: 24 July 2016 / Received in ﬁnal form: 13 November 2016 / Accepted: 14 November 2016 http://dx.doi.org/10.1097/MD.0000000000005543Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5d/11/medi-95-e5543.PMC5207546.pdf
Medicine (2016) 95:52(e5548)Received: 18 August 2016 / Received in ﬁnal form: 12 October 2016 / Accepted: 13 November 2016 http://dx.doi.org/10.1097/MD.0000000000005548Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c7/3c/medi-95-e5548.PMC5207547.pdf
Medicine (2016) 95:52(e5579)Received: 9 September 2016 / Received in ﬁnal form: 14 November 2016 / Accepted: 15 November 2016 http://dx.doi.org/10.1097/MD.0000000000005579Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e3/53/medi-95-e5579.PMC5207548.pdf
Medicine (2016) 95:52(e5635)Received: 26 August 2016 / Received in ﬁnal form: 11 November 2016 / Accepted: 19 November 2016 http://dx.doi.org/10.1097/MD.0000000000005635Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4d/ce/medi-95-e5635.PMC5207549.pdf
"This trial was registered at Korean Clinical Trials Registry (http://cris.nih.go.kr, number KCT0001044).",Non-OADS,/arxiv_data1/oa_pdf/4d/ce/medi-95-e5635.PMC5207549.pdf
Medicine (2016) 95:52(e5638)Received: 5 April 2016 / Received in ﬁnal form: 14 August 2016 / Accepted: 21 November 2016 http://dx.doi.org/10.1097/MD.0000000000005638Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/97/f6/medi-95-e5638.PMC5207550.pdf
Medicine (2016) 95:52(e5645)Received: 27 June 2016 / Received in ﬁnal form: 20 November 2016 / Accepted: 20 November 2016 http://dx.doi.org/10.1097/MD.0000000000005645Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7a/5e/medi-95-e5645.PMC5207551.pdf
Medicine (2016) 95:52(e5669)Received: 5 May 2016 / Received in ﬁnal form: 21 November 2016 / Accepted: 23 November 2016 http://dx.doi.org/10.1097/MD.0000000000005669Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2d/bf/medi-95-e5669.PMC5207552.pdf
"Third, the environmental response genes (ERGs) in KBD were identi ﬁed according to the Comparative Toxicogenomics Database (http://ctdbase.org/),and combined the identi ﬁed ERFs and DEGs.",OADS,/arxiv_data1/oa_pdf/2d/bf/medi-95-e5669.PMC5207552.pdf
Identi ﬁed environmental response genes The ERGs list was accessed from the environmentally related genomic database named Comparative Toxicogenomics Database (http://ctdbase.org/).,OADS,/arxiv_data1/oa_pdf/2d/bf/medi-95-e5669.PMC5207552.pdf
"The interaction between ERFs and DEGs is shown in Appendix S1, http://links.lww.com/MD/B482.",Non-OADS,/arxiv_data1/oa_pdf/2d/bf/medi-95-e5669.PMC5207552.pdf
Medicine (2016) 95:52(e5674)Received: 10 November 2016 / Received in ﬁnal form: 21 November 2016 / Accepted: 22 November 2016 http://dx.doi.org/10.1097/MD.0000000000005674Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/84/e8/medi-95-e5674.PMC5207553.pdf
Medicine (2016) 95:52(e5681)Received: 3 May 2016 / Received in ﬁnal form: 20 November 2016 / Accepted: 25 November 2016 http://dx.doi.org/10.1097/MD.0000000000005681Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/67/7e/medi-95-e5681.PMC5207554.pdf
Medicine (2016) 95:52(e5685)Received: 18 September 2016 / Received in ﬁnal form: 17 November 2016 / Accepted: 24 November 2016 http://dx.doi.org/10.1097/MD.0000000000005685Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/20/d6/medi-95-e5685.PMC5207555.pdf
Medicine (2016) 95:52(e5689)Received: 3 October 2016 / Received in ﬁnal form: 22 November 2016 / Accepted: 23 November 2016 http://dx.doi.org/10.1097/MD.0000000000005689Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e5/a4/medi-95-e5689.PMC5207557.pdf
Medicine (2016) 95:52(e5693)Received: 29 August 2016 / Received in ﬁnal form: 15 November 2016 / Accepted: 29 November 2016 http://dx.doi.org/10.1097/MD.0000000000005693Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1f/b1/medi-95-e5693.PMC5207558.pdf
Medicine (2016) 95:52(e5698)Received: 20 July 2016 / Received in ﬁnal form: 12 November 2016 / Accepted: 28 November 2016 http://dx.doi.org/10.1097/MD.0000000000005698Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a4/c2/medi-95-e5698.PMC5207559.pdf
Medicine (2016) 95:52(e5699)Received: 13 July 2016 / Received in ﬁnal form: 23 November 2016 / Accepted: 28 November 2016 http://dx.doi.org/10.1097/MD.0000000000005699Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/33/41/medi-95-e5699.PMC5207560.pdf
Medicine (2016) 95:52(e5701)Received: 12 September 2016 / Received in ﬁnal form: 18 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005701Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/60/9f/medi-95-e5701.PMC5207562.pdf
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta- analyses; 2013 http://www.ohri.ca/Programs/clinical epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/medi-95-e5701.PMC5207562.pdf
Medicine (2016) 95:52(e5703)Received: 22 April 2016 / Received in ﬁnal form: 24 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005703Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9f/d3/medi-95-e5703.PMC5207563.pdf
"studies provided HRs adjusted for at least 6 conventional cardiovascular risk factors, described in the Methods section.Quality assessment scores and additional adjustments made by the individual studies are presented in Supplemental Table S1, http://links.lww.com/MD/B481.",Non-OADS,/arxiv_data1/oa_pdf/9f/d3/medi-95-e5703.PMC5207563.pdf
Medicine (2016) 95:52(e5704)Received: 12 August 2016 / Received in ﬁnal form: 27 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005704Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/medi-95-e5704.PMC5207564.pdf
Medicine (2016) 95:52(e5705)Received: 29 March 2016 / Received in ﬁnal form: 21 June 2016 / Accepted: 29 November 2016 http://dx.doi.org/10.1097/MD.0000000000005705Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/44/df/medi-95-e5705.PMC5207565.pdf
Medicine (2016) 95:52(e5706)Received: 17 May 2016 / Received in ﬁnal form: 26 August 2016 / Accepted: 29 November 2016 http://dx.doi.org/10.1097/MD.0000000000005706Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/24/4c/medi-95-e5706.PMC5207566.pdf
Medicine (2016) 95:52(e5714)Received: 12 June 2016 / Received in ﬁnal form: 10 November 2016 / Accepted: 25 November 2016 http://dx.doi.org/10.1097/MD.0000000000005714Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/6f/medi-95-e5714.PMC5207569.pdf
Ethical approval This was an observational cross-sectional and clinical pilot cohort study (protocol identi ﬁcation number NCT02564913 at http://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/ae/6f/medi-95-e5714.PMC5207569.pdf
Medicine (2016) 95:52(e5715)Received: 30 July 2016 / Received in ﬁnal form: 26 October 2016 / Accepted: 29 November 2016 http://dx.doi.org/10.1097/MD.0000000000005715Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/03/01/medi-95-e5715.PMC5207570.pdf
Medicine (2016) 95:52(e5717)Received: 22 April 2016 / Received in ﬁnal form: 11 October 2016 / Accepted: 25 November 2016 http://dx.doi.org/10.1097/MD.0000000000005717Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/41/2b/medi-95-e5717.PMC5207571.pdf
Medicine (2016) 95:52(e5721)Received: 16 June 2016 / Received in ﬁnal form: 28 November 2016 / Accepted: 28 November 2016 http://dx.doi.org/10.1097/MD.0000000000005721Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/08/0d/medi-95-e5721.PMC5207572.pdf
Medicine (2016) 95:52(e5723)Received: 8 August 2016 / Received in ﬁnal form: 14 November 2016 / Accepted: 27 November 2016 http://dx.doi.org/10.1097/MD.0000000000005723Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d0/b5/medi-95-e5723.PMC5207573.pdf
Medicine (2016) 95:52(e5725)Received: 29 June 2016 / Received in ﬁnal form: 7 November 2016 / Accepted: 29 November 2016 http://dx.doi.org/10.1097/MD.0000000000005725Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/26/5c/medi-95-e5725.PMC5207574.pdf
Medicine (2016) 95:52(e5729)Received: 17 September 2016 / Received in ﬁnal form: 18 November 2016 / Accepted: 23 November 2016 http://dx.doi.org/10.1097/MD.0000000000005729Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ad/a8/medi-95-e5729.PMC5207576.pdf
Medicine (2016) 95:52(e5738)Received: 27 June 2016 / Received in ﬁnal form: 29 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005738Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9d/85/medi-95-e5738.PMC5207578.pdf
Medicine (2016) 95:52(e5743)Received: 29 August 2016 / Received in ﬁnal form: 6 November 2016 / Accepted: 4 December 2016 http://dx.doi.org/10.1097/MD.0000000000005743Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/04/a8/medi-95-e5743.PMC5207580.pdf
Medicine (2016) 95:52(e5744)Received: 31 August 2016 / Received in ﬁnal form: 1 December 2016 / Accepted: 5 December 2016 http://dx.doi.org/10.1097/MD.0000000000005744Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7f/f2/medi-95-e5744.PMC5207581.pdf
Medicine (2016) 95:52(e5745)Received: 31 January 2016 / Received in ﬁnal form: 3 December 2016 / Accepted: 5 December 2016 http://dx.doi.org/10.1097/MD.0000000000005745Economic Evaluation Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/64/medi-95-e5745.PMC5207582.pdf
Available at: http://www.ibge.gov.br/home/estatistica/populacao/tabuadevida/2013/default.shtm.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/medi-95-e5745.PMC5207582.pdf
Available at: http://www.conass.org.br/notas%20tecnicas/NT%2064_2011%20-%20Tratamento%20Glaucoma%20dez.2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/medi-95-e5745.PMC5207582.pdf
Available at: http://www.who.int/choice/costs/CER_levels/en/.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/medi-95-e5745.PMC5207582.pdf
Available at: http://brasilemsintese.ibge.gov.br/contas-nacionais/pib-per- capita.html.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/medi-95-e5745.PMC5207582.pdf
Medicine (2016) 95:52(e5749)Received: 2 June 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 2 December 2016 http://dx.doi.org/10.1097/MD.0000000000005749Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/eb/b0/medi-95-e5749.PMC5207584.pdf
Medicine (2016) 95:52(e5756)Received: 15 August 2016 / Received in ﬁnal form: 29 November 2016 / Accepted: 2 December 2016 http://dx.doi.org/10.1097/MD.0000000000005756Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c7/b8/medi-95-e5756.PMC5207585.pdf
Medicine (2016) 95:52(e5757)Received: 2 November 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 1 December 2016 http://dx.doi.org/10.1097/MD.0000000000005757Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c7/8d/medi-95-e5757.PMC5207586.pdf
Medicine (2016) 95:52(e5758)Received: 8 November 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 1 December 2016 http://dx.doi.org/10.1097/MD.0000000000005758Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/64/3b/medi-95-e5758.PMC5207587.pdf
"The study design was also prospectively registered (http://cris.nih.go.kr, kct0001624/).",Non-OADS,/arxiv_data1/oa_pdf/64/3b/medi-95-e5758.PMC5207587.pdf
Medicine (2016) 95:52(e5760)Received: 3 October 2016 / Received in ﬁnal form: 24 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005760Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b2/f7/medi-95-e5760.PMC5207588.pdf
Medicine (2016) 95:52(e5762)Received: 19 August 2016 / Received in ﬁnal form: 22 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005762Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5b/99/medi-95-e5762.PMC5207589.pdf
Medicine (2016) 95:52(e5763)Received: 26 August 2016 / Received in ﬁnal form: 12 November 2016 / Accepted: 30 November 2016 http://dx.doi.org/10.1097/MD.0000000000005763Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/51/23/medi-95-e5763.PMC5207590.pdf
Medicine (2016) 95:52(e5764)Received: 9 August 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 1 December 2016 http://dx.doi.org/10.1097/MD.0000000000005764Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/37/aa/medi-95-e5764.PMC5207591.pdf
Medicine (2016) 95:52(e5775)Received: 8 April 2016 / Received in ﬁnal form: 4 December 2016 / Accepted: 6 December 2016 http://dx.doi.org/10.1097/MD.0000000000005775Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/81/8e/medi-95-e5775.PMC5207594.pdf
Medicine (2016) 95:52(e5776)Received: 30 May 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 7 December 2016 http://dx.doi.org/10.1097/MD.0000000000005776Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/medi-95-e5776.PMC5207595.pdf
Medicine (2016) 95:52(e5785)Received: 31 August 2016 / Received in ﬁnal form: 30 November 2016 / Accepted: 1 December 2016 http://dx.doi.org/10.1097/MD.0000000000005785Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/94/8a/medi-95-e5785.PMC5207597.pdf
"GCIPLT in RP patients are shown in Supplementary material, http://links.lww.com/MD/B487.",Non-OADS,/arxiv_data1/oa_pdf/94/8a/medi-95-e5785.PMC5207597.pdf
"The original data of EZ length in RP patients are shown inSupplementary material, http://links.lww.com/MD/B487.",Non-OADS,/arxiv_data1/oa_pdf/94/8a/medi-95-e5785.PMC5207597.pdf
Medicine (2016) 95:52(e5791)Received: 22 July 2016 / Received in ﬁnal form: 29 October 2016 / Accepted: 6 December 2016 http://dx.doi.org/10.1097/MD.0000000000005791Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/68/bc/medi-95-e5791.PMC5207598.pdf
"Health Organization, 2013:4. http://www.who.int/cardiovascular_di seases/publications/global_brief_hypertension/en/.",Non-OADS,/arxiv_data1/oa_pdf/68/bc/medi-95-e5791.PMC5207598.pdf
Medicine (2016) 95:52(e5819)Received: 17 October 2016 / Received in ﬁnal form: 12 December 2016 / Accepted: 14 December 2016 http://dx.doi.org/10.1097/MD.0000000000005819Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) reporting recommendations statement forreporting systematic reviews and meta-analyses of RCTs [12]was applied (see Supplemental Digital Table 1, http://links.lww.com/ MD/B492).",OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"1.A-I, http://links.lww.com/MD/B492).",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"2.A-I, http://links.lww.com/MD/B492).",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"3.A-I,http://links.lww.com/MD/B492).",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"4, http://links.lww.com/MD/B492.",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"5, http://links.lww.com/MD/B492.",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"6, http://links.lww.com/MD/B492.",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"7.A-I for each individual outcome, http://links.lww.com/MD/B492).",Non-OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"Individual study quality appraisal and risk ofbias for the included RCTs are summarized in Supplemental Digital Table 2, http://links.lww.com/MD/B492.4.",OADS,/arxiv_data1/oa_pdf/39/70/medi-95-e5819.PMC5207602.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.209 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.209&domain=pdf&date_stamp=2016-12-30 Targeting Lipid Metabo lic Reprogramming as  Anticancer TherapeuticsReview Ji-Young Cha, Ho-Jae Lee Department of Biochemistry, Gachon University College of Medicine, Incheon, Korea Cancer cells rewire their metabolism to satisfy the demands of growth and survival, and this metabolic reprogramming has been r ecognized  as an emerging hallmark of cancer.",Non-OADS,/arxiv_data1/oa_pdf/81/5d/jcp-21-209.PMC5207604.pdf
"(J Cancer Prev 2016;21:209-215) Key Words: Lipid metabolism, Lipogenesis, Cancer, Therapeutics Received  November 15, 2016, Revised  November 25, 2016, Accepted  November 26, 2016 Correspondence to: Ho-Jae Lee Department of Biochemistry, Gachon Un iversity College of Medicine, 155 Gaetbe ol-ro, Yeonsu-gu, Incheon 21999, Korea Tel: +82-32-899-6054, Fax: +82-32-899-6039, E-mail: hojlee@gachon.a c.kr, ORCID: Ho-Jae Lee, http://orcid.org/0000-0003-2170-355 X Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/5d/jcp-21-209.PMC5207604.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.216 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.216&domain=pdf&date_stamp=2016-12-30 Role of Apigenin in Ca ncer Prevention via the  Induction of Apoptosis and AutophagyReview Bokyung Sung, Hae Young Chung, Nam Deuk Kim Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National Univ ersity, Busan,  Korea Apigenin (4’,5,7-trihydroxyflavone) is a flavonoid commonly found in  m a n y  f r u i t s  a n d  v e g e t a b l e s  s u c h  a s  p a r s l e y ,  c h a m o m i l e ,  c e l ery,  and kumquats.",Non-OADS,/arxiv_data1/oa_pdf/e0/85/jcp-21-216.PMC5207605.pdf
"(J Cancer Prev 2016;21:216-226) Key Words: Apigenin, Chemoprevention, Apoptosis, Autophagy Received  November 16, 2016, Revised  November 28, 2016, Accepted  November 29, 2016 Correspondence to: Nam Deuk Kim Department of Pharmacy, College of Phar macy, Pusan National University, 2 Busanda ehak-ro 63beon-gil, Geumjeong-gu, Busan 46241,  Korea Tel: ＋82-51-510-2801, Fax: ＋82-51-513-6754, E-mail: nadkim@pusan.ac.kr, ORCID:  Nam Deuk Kim, http://orcid.org/0000-0001-9033-9865 Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/85/jcp-21-216.PMC5207605.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.227 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.22 7&domain=pdf&date_stamp=2016-12-30 Aberrant DNA Double-strand Break Repair Threads  in Breast Carcinoma: Orchestrating Genomic Insult  SurvivalReview Azad Kumar, Shruti Purohit, Nilesh Kumar Sharma Cancer and Translational Research Lab, Dr. D. Y. Patil Biotechnology & Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pu ne, Maharashtra, India Breast carcinoma is a heterogeneous disease that has exhibited rapid resistance to treatment in the last decade.",Non-OADS,/arxiv_data1/oa_pdf/34/f6/jcp-21-227.PMC5207606.pdf
"in, ORCID: Nilesh Kumar Sharma, http://orcid.org/0000 -0002-8774-3020 Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/f6/jcp-21-227.PMC5207606.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.235 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.235&domain=pdf&date_stamp=2016-12-30 Identification of Biomarkers  for Breast Cancer Using  DatabasesReview Eunhye Lee, Aree Moon Duksung Innovative Drug Center, College of Pharmacy, Duksung Women’s University, Seoul, Korea Breast cancer is one of the major causes of cancer death in women.",Non-OADS,/arxiv_data1/oa_pdf/35/13/jcp-21-235.PMC5207607.pdf
"(J Cancer Prev 2016;21:235-242) Key Words: Biomarkers, Breast cancer, Database Received  December 12, 2016, Revised  December 15, 2016, Accepted  December 15, 2016 Correspondence to: Aree Moon Duksung Innovative Drug Center, College of  Pharmacy, Duksung Women’s University, 33 Samyang-ro 144-gil, Dobong-gu, Seoul 01369,  Korea Tel: ＋82-2-901-8394, Fax: ＋82-2-901-8386, E-mail: armoon@duksung.ac.kr, OR CID: Aree Moon, http://orcid.org/0000-0001-5044-8813  Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/13/jcp-21-235.PMC5207607.pdf
https://cancergenome.nih.gov/abouttcga/overview .,Non-OADS,/arxiv_data1/oa_pdf/35/13/jcp-21-235.PMC5207607.pdf
https://www.ncbi.nlm.nih.gov/books/NBK159736/.,Non-OADS,/arxiv_data1/oa_pdf/35/13/jcp-21-235.PMC5207607.pdf
https://seer.cancer.gov/about/ overview .html.,Non-OADS,/arxiv_data1/oa_pdf/35/13/jcp-21-235.PMC5207607.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.243 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.243&domain=pdf&date_stamp=2016-12-30 Inducible Mouse Models for Cancer Drug Target  ValidationReview Joseph H. Jeong Department of Developmental Biology and Genomics, College of Veterinary Medicine, Seoul National University and Korea Mouse Phe notyping  Center, Seoul, Korea Genetically-engineered mouse (GEM) models have provided significant contributions to our understanding of cancer biology and  developing anticancer therapeutic strategies.",Non-OADS,/arxiv_data1/oa_pdf/69/a3/jcp-21-243.PMC5207608.pdf
"ac.kr, ORCID: Joseph H. Jeong, http://orcid.org/0000-0001-694 5-8157 Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/a3/jcp-21-243.PMC5207608.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.249 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.249&domain=pdf&date_stamp=2016-12-30 Sorbus rufopilosa  Extract Exhibits  Antioxidant and  Anticancer Activities by Inducing Cell Cycle Arrest  and Apoptosis in Human Colon Adenocarcinoma  HT29 CellsOriginal  Ar ticle You Na Oh1, Soojung Jin1,2, Hyun-Jin Park1, Hyun Ju Kwon1,2, Byung Woo Kim1,2 1Blue-Bio Industry Regional Innovation Center and 2Department of Life Science and Biotechnology, College of Natural Sciences and Human Ecology,  Dong-Eui University, Busan, Korea Background:  Sorbus rufopilosa , a tsema rowan, is a species of the small ornamental trees in the genus Sorbus and the family Rosaceae  found in East Asia.",Non-OADS,/arxiv_data1/oa_pdf/f6/f2/jcp-21-249.PMC5207609.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.257 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.25 7&domain=pdf&date_stamp=2016-12-30 Protective Effect of an Isoflavone, Tectorigenin,  Against Oxidative Stress-induced Cell Death via  Catalase ActivationOriginal  Ar ticle Rui Zhang1,2,*, Mei Jing Piao1,*, Min Chang Oh1, Jeong Eon Park1, Kristina Shilnikova1, Yu Jin Moon1, Dong Hyun Kim3,  Uhee Jung4, In Gyu Kim5,6, Jin Won Hyun1 1Department of Biochemistry, Jeju National University School of Medicine, Jeju, Korea, 2School of Medical Science and Laboratory Medicine, Jiangsu  University, Jiangsu, China, 3Department of Microbial Chemistry, College of Pharmacy, Kyung Hee University, Seoul, 4Radiation Biotechnology  Research Division, Korea Atomic Energy Research Institute, Jeongeup, 5Department of Radiation Biology, Environmental Radiation Research Group,  Korea Atomic Energy Research Institute, Daejeon, 6Department of Radiation Biotechnology and Applied Radioisotope, Korea University of Science  and Technology, Daejeon, Korea Background:  Isoflavones are biologically active compounds that occur naturally in a variety of plants, with relatively high levels in soyb ean.",Non-OADS,/arxiv_data1/oa_pdf/6e/94/jcp-21-257.PMC5207610.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.264 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.264&domain=pdf&date_stamp=2016-12-30 Iron Supplementation Reve rses the Reduction of  Hydroxymethylcytosine in Hepatic DNA Associated  With Chronic Alcohol Consumption in RatsOriginal  Ar ticle Stephanie A. Tammen1, Jung Eun Park2, Phil Kyung Shin2,3, Simonetta Friso4, Jayong Chung2,*, Sang-Woon Choi1,3,* 1Friedman School of Nutrition Science and Policy Tufts University, Boston, MA, USA, 2Department of Food and Nutrition, College of Human  Ecology, Kyung Hee University, Seoul, 3Chaum Life Center, CHA University School of Medicine, Seoul, Korea, 4University of Verona School of  Medicine, Verona, Italy  Background:  Alcohol is known to affect two epigenetic phenomena, DNA methylation and DNA hydroxymethylation, and iron is a cofactor  of ten-eleven translocation (TET) enzymes that catalyze the conversion from methylcytosine to hydroxymethylcytosine.",Non-OADS,/arxiv_data1/oa_pdf/52/a5/jcp-21-264.PMC5207611.pdf
"(J Cancer Prev 2016;21:264-270) Key Words: Alcohols, Iron, DNA hydroxymethylation, DNA methylation, Epigenetics Received  October 24, 2016, Revised  November 10, 2016, Accepted  November 13, 2016 Correspondence to: Sang-Woon Choi Chaum Life Center, CHA University, 442 Do san-daero, Gangnam-gu, Seoul 06062, Korea Tel: ＋82-31-881-7176, Fax: ＋82-31-881-7185, E-mail: sang.choi@cha.ac.kr, ORCID:  Sang-Woon Choi, http://orcid.org/0000-0003-0713-379X Correspondence to: Jayong Chung Department of Food and Nutrition, College  of Human Ecology, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 0244 7, Korea Tel: ＋82-2-961-0977, Fax: ＋82-2-961-0261, E-mail: jchung@khu.ac.kr *These authors contributed equally to this work as co-correspondence authors.",Non-OADS,/arxiv_data1/oa_pdf/52/a5/jcp-21-264.PMC5207611.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.271 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.271&domain=pdf&date_stamp=2016-12-30 The Effect of Sex on th e Azoxymethane/Dextran  Sulfate Sodium-treated Mice Model of Colon CancerOriginal  Ar ticle Sun Min Lee1, Nayoung Kim1,2, Hee Jin Son3, Ji Hyun Park2, Ryoung Hee Nam1, Min Hee Ham1, Daeun Choi1,  Sung Hwa Sohn1, Eun Shin4, Young-Jae Hwang1, Jihee Sung1, Dong Ho Lee1, Ha-Na Lee5 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine and Liver Research  Institute, Seoul National University College of Medicine, 3Seoul National University College of Medicine, Seoul, 4Department of Pathology, Seoul National  University Bundang Hospital, Seongnam, Korea, 5Receptor Cell Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious  Diseases, NIH, Rockville, MD 20852, USA Background:  The colitis-associated cancer exhibits di fferent characteristics according to sex in the initiation and progression of the tum ors.",Non-OADS,/arxiv_data1/oa_pdf/74/59/jcp-21-271.PMC5207612.pdf
"(J Cancer Prev 2016;21:271-278) Key Words: Sex, Disease models, animal, Colitis, Colonic neoplasms Received  October 25, 2016, Accepted  November 26, 2016 Correspondence to: Nayoung Kim Department of Internal Medicine , Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620 , Korea Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-ma il: nayoungkim49@empas.com, ORCID: Nayoung Kim, http://orcid.org/0000-0002-9397 -0406 Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/59/jcp-21-271.PMC5207612.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.279 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.279&domain=pdf&date_stamp=2016-12-30 Expression of Leucine-rich Repeat-containing  G-protein Coupled Receptor 5 and CD44: Potential  Implications for Gastric Cancer Stem Cell MarkerOriginal  Ar ticle Yoon Jin Choi1, Nayoung Kim1,2, Hye Seung Lee3, Seon Mee Park4, Ji Hyun Park2, Hyuk Yoon1, Cheol Min Shin1,  Young Soo Park1, Jin-Wook Kim1, Dong Ho Lee1 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine and Liver Research  Institute, Seoul National University College of Medicine, Seoul, 3Department of Pathology, Seoul National University Bundang Hospital, Seongnam,  4Department of Internal Medicine, Chungbuk National University College of Medicine and Medical Research Institute, Cheongju, Kor ea Background:  The human leucine-rich repeat-containing G-protein coupled receptor (LGR) 5 and CD44 are one of the candidates for  the marker of gastric cancer stem cells.",OADS,/arxiv_data1/oa_pdf/00/d3/jcp-21-279.PMC5207613.pdf
"(J Cancer Prev 2016;21:279-287) Key Words: LGR5 protein, Gastric cancer, Stem cell Received  October 24, 2016, Revised  November 14, 2016, Accepted  November 15, 2016 Correspondence to: Nayoung Kim Department of Internal Medicine , Seoul National University Bundang Hospital, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 1362 0, Korea Tel: ＋82-31-787-7008, Fax: ＋82-31-787-4051, E-mail: nayoungkim49@empas.com, ORCID:  Nayoung Kim, http://orcid.org/0000-0002-9397-0406 Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/d3/jcp-21-279.PMC5207613.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.288 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.288&domain=pdf&date_stamp=2016-12-30 The Evaluation of p53 Polymorphism at Codon 72  and Association With Breast Cancer in Iran:  A Systematic Review and Meta-analysisOriginal  Ar ticle Abozar Soleimani1, Yousef Rahmani2, Negin Farshchian3, Ali Delpisheh1, Kivan Khassi4, Afshar Shahmohammadi2,  Nasrin Amirifard3 1Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, 2Clinical Research Development Center, Imam Ali and  Taleghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, 3Cancer Research Center, Imam Reza Hospital, Kermanshah University  of Medical Sciences, Kermanshah, 4Province Health Center, Kermanshah University of Medical Sciences, Kermanshah, Iran Background:  Breast cancer is the most common cancer among women in Iran and the world.",Non-OADS,/arxiv_data1/oa_pdf/a6/74/jcp-21-288.PMC5207614.pdf
http://www.pezeshk.us/?p=  23319.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/jcp-21-288.PMC5207614.pdf
"4, December 2016https://doi.org/10.15430/JCP.2016.21.4.294 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.294&domain=pdf&date_stamp=2016-12-30 The Role of Oral Contracep tive Pills on Increased  Risk of Breast Cancer in Iranian Populations:  A Meta-analysisOriginal  Ar ticle Ali Soroush1, Negin Farshchian2, Saeid Komasi3, Neda Izadi4, Nasrin Amirifard2, Afshar Shahmohammadi3 1Lifestyle Modification Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, 2Cancer Research Center, Imam Reza  Hospital, Kermanshah University of Medical Sciences, 3Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical  Sciences, 4HSR unit of Treatment Deputy, Kermanshah University of Medical Sciences, Kermanshah, Iran Background:  Cancer is one of the main public health issues in the world.",Non-OADS,/arxiv_data1/oa_pdf/39/83/jcp-21-294.PMC5207615.pdf
"4, December 2016http://dx.doi.org/10.15430/JCP.2016.21.4.302 pISSN 2288-3649ㆍeISSN 2288-3657 www.jcpjournal.orghttp://crossmark.crossref.org/dialog/?doi=10.15430/JCP.2016.21.4.302&domain=pdf&date_stamp=2016-12-30 Diagnostic Value of Combining Tumor and  Inflammatory Markers in Lung CancerCorrigendum Ho Il Yoon1, Oh-Ran Kwon2, Kyung Nam Kang2, Yong Sung Shin2, Ho Sang Shin2, Eun Hee Yeon2, Keon Young Kwon3,  Ilseon Hwang3, Yun Kyung Jeon4, Yongdai Kim5, Chul Woo Kim2,4 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seo ngnam, 2BioInfra,  Inc., Seoul, 3Department of Pathology, Korea Regional Bank, Keimyung University School of Medicine, Daegu, 4Department of Pathology, Seoul  National University College of Medicine, 5Department of Statistics, College of Natural Science, Seoul National University, Seoul, Korea Correspondence to: Chul Woo Kim Department of Pathology, Seoul National University Colle ge of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-3668-7449, Fax: +82-2-6499-1941, E-ma il: cwkim@snu.ac.kr, ORCID: Chul Woo Kim, http://orcid.org/0000-0002-1229-198X Copyright © 2016 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Table 2.",Non-OADS,/arxiv_data1/oa_pdf/08/8a/jcp-21-302.PMC5207616.pdf
"Comparison of AUC values of training data set for single/combined marker(s) using logistic regression Marker AUC Probability Sensitivity at 94% specificity (%) Cutoff at 94% specificity HE4 0.821 5.04E-51 51.43 0.1094199  CEA 0.753 1.78E-32 33.21 0.6434527 RANTES 0.858 1.02E-62 61.79 4.67369 ApoA2 0.867 4.98E-66 61.07 5.350998 TTR 0.83 1.20E-53 46.07 5.374748 Svcam-1 0.552 0.0074418 13.93 2.881887 CEA, HE4 0.855 6.12E-62 55.00 0.5850375 RANTES, ApoA2, TTR, Svcam-1 0.964 2.88E-104 84.29 0.4779614CEA, HE4, RANTES, ApoA2, TTR, Svcam-1 0.983 2.03E-112 92.50 0.357278CEA, HE4, RANTES, ApoA2, TTR, Svcam-1, age 0.986 3.68E-114 93.21 0.3700928 AUC, the area under the curve; HE4, human epididymis secretory protein 4; CEA, carcin oembryonic antigen; RANTES, regulated on a ctivation,  normal T cell expressed and secreted; ApoA2, apolipoprotein A2; TT R, transthyretin; sVCAM-1, secretory vascular cell adhesion m olecule-1.J Cancer Prev 2016;21:187-193 https://doi.org/10.15430/JCP.2016.21.3.187 In Table 2 and 3, cutoff values of RANTES, ApoA2, TTR, Svcam-1 (and sensitivity and specificity values accordingly) were wrongl y  marked.",OADS,/arxiv_data1/oa_pdf/08/8a/jcp-21-302.PMC5207616.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/18/2f/40273_2016_Article_451.PMC5209408.pdf
2012. http://globocan.iarc.fr/ Pages/fact_sheets_cancer.aspx .,Non-OADS,/arxiv_data1/oa_pdf/18/2f/40273_2016_Article_451.PMC5209408.pdf
2015. http://data.worldbank.org/about/country-and-lending- groups .,Non-OADS,/arxiv_data1/oa_pdf/18/2f/40273_2016_Article_451.PMC5209408.pdf
2014. http://www.gavi.org/support/nvs/human-papillo-mavirus-vaccine-support/#.,Non-OADS,/arxiv_data1/oa_pdf/18/2f/40273_2016_Article_451.PMC5209408.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2016. http://www.meteos.co.uk/wp-content/uploads/ PHARMADIPLOMACY-REPORT-low-res.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2012. https://www.nice.org.uk/process/pmg4/chapter/introduction .,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2016. http://www.eunethta.eu/hta- core-model .,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2016. http://www.ispor.org/opensourceindex/index.aspx .,OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2006. http://www.inahta.org/wp-content/ themes/inahta/img/AboutHTA_Guidelines_for_the_Economic_Evaluation_of_Health_Technologies.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2016. https://icer-review.org/methodology/icers-methods/ icer-value-assessment-framework/ Accessed 12 Oct 2016.,OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
1999. http://www.oreilly.,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
2007. http://eprints.soton.ac.uk/265753/1/greenroad.html .,Non-OADS,/arxiv_data1/oa_pdf/a6/6c/40273_2016_Article_479.PMC5209409.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/02/fb/40273_2016_Article_448.PMC5209411.pdf
Available from: http://www.goldcopd.org/ .,Non-OADS,/arxiv_data1/oa_pdf/02/fb/40273_2016_Article_448.PMC5209411.pdf
Available at: http://www.ispor.org/PEguidelines/ index.asp .,Non-OADS,/arxiv_data1/oa_pdf/02/fb/40273_2016_Article_448.PMC5209411.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a1/95/40261_2016_Article_456.PMC5209413.pdf
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/95/40261_2016_Article_456.PMC5209413.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), whichpermits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Available at: http://ecdc.europa.eu/en/ publications/Publications/20120905_GUI_HPV_vaccine_update.,Non-OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Available at: http://databankws.lareb.nl/ Downloads/Lareb_rapport_HPV_dec15_03.pdf .,OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Available at: http://www.ssi.dk/ Smitteberedskab/Sygdomsovervaagning/VaccinationSurveillance.,Non-OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Available at: http://sanevax.org/open-letter-ema-hpv-vaccine- safety/ .,Non-OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Availableat:http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_Products/ Guidelines/Efﬁcacy/E2B/Step4/E2B_R2__Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
Available at: http://www.dysautonomiainternational.org/pdf/ Vernino_Muscarinic_Abstract.pdf .,OADS,/arxiv_data1/oa_pdf/5f/45/40264_2016_Article_456.PMC5209415.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2012. http://www.nydailynews.com/life- style/health/eu-tighten-medical-controls-pip-breast-implant- scandal-article-1.1169444 .,Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2016. http://www.fda.gov/AboutFDA/ Transparency/Basics/ucm194932.htm .,Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2011. http://www.fda.gov/downloads/AboutFDA/CentersOfﬁces/ OfﬁceofMedicalProductsandTobacco/CDRH/CDRHInnovation/UCM242528.pdf .,OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2013. http://www.meddra.org/sites/ default/ﬁles/page/documents/meddra2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2014. http://www.fda.gov/MedicalDevices/DeviceRegula tionandGuidance/PostmarketRequirements/ReportingAdverse Events/EventProblemCodes/ucm134751.htm .,OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2016. http://ihtsdo.org/snomed-ct/ .,OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2016. http://www.who.int/classiﬁcations/icd/en/ .,OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
https://kce.fgov.be/publication/report/towards-a-guided- and-phased-introduction-of-high-risk-medical-devices-in-belgium .,Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
2016. http://www.fda.gov/AboutFDA/CentersOfﬁces/Ofﬁceof MedicalProductsandTobacco/CDRH/CDRHPatientEngagement/ucm462830.htm .,Non-OADS,/arxiv_data1/oa_pdf/05/16/40264_2016_Article_474.PMC5209416.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
2015. https://www.cms.gov/apps/physician-fee- schedule/search/search-criteria.aspx .,Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
http://info.kaiserpermanente.org/ …/endocrinology_fee_ list.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
http://www.hcupnet.ahrq.gov .,Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
http://www.bluecrossma.com/blue-iq/ pdfs/TypicalCosts_89717_042709.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
http://www.micromedexsolutions.com .,Non-OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
2015. http://www.fda.gov/ downloads/AboutFDA/ReportsManualsForms/Reports/UCM472777.pdf .,OADS,/arxiv_data1/oa_pdf/5e/70/40261_2016_Article_462.PMC5209418.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/aa/e5/40261_2016_Article_455.PMC5209422.pdf
Available at: http://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultData SetPDF/400256_2329030F1020_1_04 .,OADS,/arxiv_data1/oa_pdf/aa/e5/40261_2016_Article_455.PMC5209422.pdf
2016. http://www.nihs.go.jp/drug/be-guide(e)/ be2006e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/e5/40261_2016_Article_455.PMC5209422.pdf
Available at http://www.kenes.com/easl2010/posters/Abstract78.htm.,Non-OADS,/arxiv_data1/oa_pdf/bc/ce/PG-11-26992.PMC5209462.pdf
Cited  on 14th January 2014 available at: http://reference.medscape.com/calculator/qt-interval-correction-ekg22.,Non-OADS,/arxiv_data1/oa_pdf/bc/ce/PG-11-26992.PMC5209462.pdf
(Available at:) http://www.asahq.org/publicationsAndServices/standards/14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/0a/PG-11-28070.PMC5209467.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/4c/omw094.PMC5209553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/omw095.PMC5209554.pdf
"With the exceptions of life-style modification and revascularization procedures, these pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 155-164 https://doi.org/10.5534/wjmh.2016.34.3.155",Non-OADS,/arxiv_data1/oa_pdf/5b/f6/wjmh-34-155.PMC5209555.pdf
Aziz et al [4] reported a pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 165-172 https://doi.org/10.5534/wjmh.2016.34.3.165,Non-OADS,/arxiv_data1/oa_pdf/dc/01/wjmh-34-165.PMC5209556.pdf
"Of these options, non-medical therapy is both safe and effective [6].pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 173-178  https://doi.org/10.5534/wjmh.2016.34.3.173",Non-OADS,/arxiv_data1/oa_pdf/de/b3/wjmh-34-173.PMC5209557.pdf
Key Words:  Herbals; Prostatitis; RatspISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 179-185 https://doi.org/10.5534/wjmh.2016.34.3.179,Non-OADS,/arxiv_data1/oa_pdf/39/aa/wjmh-34-179.PMC5209558.pdf
It is a relatively common medical problem and is estimated to affect 322 pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 186-193 https://doi.org/10.5534/wjmh.2016.34.3.186,Non-OADS,/arxiv_data1/oa_pdf/7a/a2/wjmh-34-186.PMC5209559.pdf
Key Words:  Cognition; Depression; TestosteronepISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 194-199 https://doi.org/10.5534/wjmh.2016.34.3.194,Non-OADS,/arxiv_data1/oa_pdf/00/d5/wjmh-34-194.PMC5209560.pdf
The processes in-volved in seeking healthcare are complex and affected by pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 200-208 https://doi.org/10.5534/wjmh.2016.34.3.200,Non-OADS,/arxiv_data1/oa_pdf/60/ea/wjmh-34-200.PMC5209561.pdf
"This disease can induce long-term damage and dysfunction in various organs, in-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 209-216 https://doi.org/10.5534/wjmh.2016.34.3.209",Non-OADS,/arxiv_data1/oa_pdf/e4/fc/wjmh-34-209.PMC5209562.pdf
Key Words:  Dapoxetine; Diagnosis; Premature ejaculation; TherapypISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 217-223 https://doi.org/10.5534/wjmh.2016.34.3.217,Non-OADS,/arxiv_data1/oa_pdf/af/3e/wjmh-34-217.PMC5209563.pdf
"As a result, we should seek to provide the explicit sys- tematically developed answers for hypogonadal men with erectile dysfunction using methodologically rigorous and pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2016 December 34(3): 224-225 https://doi.org/10.5534/wjmh.2016.34.3.224",Non-OADS,/arxiv_data1/oa_pdf/d0/fe/wjmh-34-224.PMC5209564.pdf
Available  from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/D rugs/ReproductiveHealthDru gsAdvisoryCommittee/UCM418144.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/fe/wjmh-34-224.PMC5209564.pdf
"•  Conflict of Interest:  No potential conflict of interest relevant to  this article was reported.Editorial https://doi.org/10.5213/inj.1620edi009 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Basic Research as the Top Priority for INJ  Tack Lee       http://orcid.org/0000-0001-8508-9099 Editor-in-Chief Department of Urology, Inha University Hospital, Incheon, Korea E-mail: lee.tack33@gmail.com Int Neurourol J 2016;20:273-273",Non-OADS,/arxiv_data1/oa_pdf/0c/75/inj-1620edi009.PMC5209565.pdf
"Consequently, comprehensive information on adult neuro -Editorial https://doi.org/10.5213/inj.1620edi010 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Neurourological Application of Neurogenesis and Inflammation  and Pain Mechanisms of Rocuronium Bromide Khae Hawn Kim      http://orcid.org/0000-0002-7045-8004 Department of Urology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea E-mail: kimcho99@gilhospital.com Int Neurourol J 2016;20:274-275",Non-OADS,/arxiv_data1/oa_pdf/8a/99/inj-1620edi010.PMC5209566.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Erratum: Fund and Grant Support correction https://doi.org/10.5213/inj.1620err.002 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNALInt Neurourol J 2016;20:374-374 Increased Expression of Herpes Virus-Encoded hsv1-miR-H18  and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue  Compared to That in Benign Prostate Hyperplasia Tissue Seok Joong Yun1,*, Pildu Jeong1,*, Ho Won Kang1, Helen Ki Shinn2, Y e-Hwan Kim1, Chunri Y an1, Y oung-Ki Choi3, Dongho Kim4,  Dong Hee Ryu5, Yun-Sok Ha6, Tae-Hwan Kim6, Tae Gyun Kwon6, Jung Min Kim7, Sang Heon Suh8, Seon-Kyu Kim9,   Seon-Y oung Kim9, Sang Tae Kim10, Won Tae Kim1, Ok-Jun Lee11, Sung-Kwon Moon12, Nam-Hyung Kim13, Isaac Yi Kim14,  Jayoung Kim15,16,17, Hee-Jae Cha18, Yung-Hyun Choi19, Eun-Jong Cha20, Wun-Jae Kim1  1Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea 2Department of Anesthesiology and Pain Medicine, Inha University College of Medicine, Incheon, Korea 3Department of Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea 4Bio Medical Laboratories, Daejeon, Korea 5Department of Surgery, Chungbuk National University, College of Medicine and Medical Research Institute, Cheongju, Korea 6Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea 7NAR Center Inc., Daejeon Oriental Hospital of Daejeon University, Daejeon, Korea 8 The Laboratory of Vascular Biology and Stem Cells, BioMedical Research Center, Graduate School of Medical Science and Engineering, Korea Advanced  Institute of Science and Technology (KAIST), Daejeon, Korea 9 Medical Genomics Research Center, Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Department of Functional  Genomics, University of Science and Technology, Daejeon, Korea 10 Biomedical Research Institute, Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seoul, Korea 11Department of Pathology, Chungbuk National University College of Medicine, Cheongju, Korea 12School of Food Science and Technology, Chung-Ang University, Anseong, Korea 13Department of Animal Sciences, Chungbuk National University, Cheongju, Korea 14 The Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson  Medical School, New Brunswick, NJ, USA 15Department of Surgery, Harvard Medical School, Boston, MA, USA 16 Division of Cancer Biology and Therapeutics, Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars- Sinai Medical Center, Los Angeles, CA, USA 17Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA 18Department of Parasitology and Genetics, Kosin University College of Medicine, Busan, Korea 19Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan, Korea 20Department of Biomedical Engineering, Chungbuk National University, Cheongju, Korea Int Neurourol J 2016;20(2):122-130. https://doi.org/10.5213/inj.1632552.276 In this article, a part of fund and grant supports was omitted unintentionally.",Non-OADS,/arxiv_data1/oa_pdf/c0/29/inj-1620err-002.PMC5209567.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Erratum: First Author’s Affiliation Change  https://doi.org/10.5213/inj.1620err.003 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNALInt Neurourol J 2016;20:375-375 Application of Virtual, Augmented, and Mixed Reality to Urology Alaric Hamacher1,4, Su Jin Kim2, Sung Tae Cho3, Sunil Pardeshi4, Seung Hyun Lee4, Sung-Jong Eun1, Taeg Keun Whangbo1  1Department of Computer Science, Gachon University, Seongnam, Korea 2Department of Urology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea 3Department of Urology, Hallym University College of Medicine, Seoul, Korea 4Graduate School of Information Contents, Kwangwoon University, Seoul, Korea Int Neurourol J 2016;20(3):172-181 https://doi.org/10.5213/inj.1632714.357 As per first author’s request, in this article, the first author’s affiliation should be changed from “1” to “1 and 4” as to indicate two affiliations.",Non-OADS,/arxiv_data1/oa_pdf/74/f7/inj-1620err-003.PMC5209568.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Hong Sang Moon     http://orcid.org/0000-0003-2101-1019 Department of Urology, Hanyang University Guri Hospital, 153 Gyeongchun-ro,  Guri 11923, Korea E-mail: moonuro@hanyang.ac.kr / Tel: +82-31-560-2374 / Fax: +82-31-560-2377 Submitted:  July 3, 2016 / Accepted: August 12, 2016INTRODUCTION According to the definition of the International Continence So - ciety, overactive bladder (OAB) includes symptoms of urinary urgency with or without incontinence, often combined with  urinary frequency and/or nocturia without any underlying dis - ease, infection, or condition [1].",Non-OADS,/arxiv_data1/oa_pdf/c2/23/inj-1624678-339.PMC5209569.pdf
"OAB is diagnosed in every age  group, with similar prevalence in men and women, and its Original Article https://doi.org/10.5213/inj.1624678.339 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  We investigated improvements in overactive bladder symptoms and depressive symptoms after solifenacin treat - ment in overactive bladder patients with or without depressive symptoms.",Non-OADS,/arxiv_data1/oa_pdf/c2/23/inj-1624678-339.PMC5209569.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Jang Hwan Kim     http://orcid.org/0000-0002-9056-7072 Department of Urology, Y onsei University College of Medicine, 50-1 Y onsei-ro,  Seodaemun-gu, Seoul 03722, Korea  E-mail: JKIM@yuhs.ac / Tel: +82-2-2228-2310/ Fax: +82-2-312-2538 Submitted:  February 19, 2016 / Accepted after revision:  April 21, 2016INTRODUCTION Spinal cord injury (SCI) is roughly estimated to afflict a total of  74,000 patients in the South Korea, and that number is increas - ing by 2,000 each year [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/ea/inj-1630540-270.PMC5209570.pdf
"However, in addition to physical disabilities, com -Original Article https://doi.org/10.5213/inj.1630540.270 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Complaints from spinal cord injury (SCI) patients are typically related to physical disability affecting activities of  daily life.",Non-OADS,/arxiv_data1/oa_pdf/ee/ea/inj-1630540-270.PMC5209570.pdf
SUPPLEMENTARY MATERIAL Supplementary material — Questionnaire for spinal cord injury pa - tients — can be found via https://doi.org/10.5213/inj.1630540.270.,Non-OADS,/arxiv_data1/oa_pdf/ee/ea/inj-1630540-270.PMC5209570.pdf
Available from: https://www.nscisc.uab.edu/ PublicDocuments/fact_figures_docs/Facts%202013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ee/ea/inj-1630540-270.PMC5209570.pdf
Available from: https://www.nscisc.uab.edu/definition_eligibility.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ee/ea/inj-1630540-270.PMC5209570.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Hann-Chorng Kuo     http://orcid.org/0000-0001-7165-4771 Department of Urology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung  Y ang Road, Hualien, Taiwan E-mail: hck@tzuchi.com.tw / Tel: +886-3-8561825 (ext.",Non-OADS,/arxiv_data1/oa_pdf/ea/bb/inj-1632526-263.PMC5209571.pdf
Treat -Original Article https://doi.org/10.5213/inj.1632526.263 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To investigate long-term therapeutic effects and patient adherence to a combination therapy of a 5α-reductase in - hibitor and an α-blocker and to identify causes of withdrawal from medication in patients with clinical benign prostatic hy - perplasia (BPH).,Non-OADS,/arxiv_data1/oa_pdf/ea/bb/inj-1632526-263.PMC5209571.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Joo-Ho Chung     http://orcid.org/0000-0003-3517-7175 Kohwang Medical Research Institute, Kyung Hee University School of Medicine,  26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea E-mail: jhchung@khu.ac.kr / Tel: +82-2-961-0281 / Fax: +82-2-968-0560 * These authors contributed equally to this study and should be considered co-first  authors.",Non-OADS,/arxiv_data1/oa_pdf/4a/74/inj-1632538-269.PMC5209572.pdf
Epithelial cell  proliferation in prostate tissue is a major pathologic feature of Original Article https://doi.org/10.5213/inj.1632538.269 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Recent studies have suggested that specific single-nucleotide polymorphisms (SNPs) contribute to the clinical fea - tures of benign prostatic hyperplasia (BPH).,Non-OADS,/arxiv_data1/oa_pdf/4a/74/inj-1632538-269.PMC5209572.pdf
"SNP Selection and Genotyping The National Center for Biotechnology Information SNP data - base was searched to select SNPs of the EGF and EGFR  genes  for study (http://www.ncbi.nlm.nih.gov/SNP , BUILD 141).",OADS,/arxiv_data1/oa_pdf/4a/74/inj-1632538-269.PMC5209572.pdf
Statistical Analysis The derivation of tested SNPs in Hardy-Weinberg equilibrium  was evaluated using SNPstats (http://bioinfo.iconcologia.net/ snpstats/start.htm).,OADS,/arxiv_data1/oa_pdf/4a/74/inj-1632538-269.PMC5209572.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Stephen S. Y ang     http://orcid.org/0000-0003-3814-6980 Division of Urology, Taipei Tzu Chi Hospital, No.289, Jianguo Rd., Xindian  Dist., New Taipei, Taiwan E-mail: urolyang@tzuchi.com.tw / Tel: +886-66286336 / Fax: +886-66283039 Submitted:  February 22, 2016 / Accepted after revision:  April 7, 2016INTRODUCTION Ketamine, a dissociative anesthetic agent, is an N-methyl-D-as - partate receptor antagonist.",Non-OADS,/arxiv_data1/oa_pdf/83/79/inj-1632542-271.PMC5209573.pdf
A urine culture performed at Case Report https://doi.org/10.5213/inj.1632542.271 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL A 28-year-old female with a 1-year history of ketamine abuse developed ketamine-associated urinary symptoms that were re - fractory to conservative treatment after the complete cessation of ketamine use.,Non-OADS,/arxiv_data1/oa_pdf/83/79/inj-1632542-271.PMC5209573.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Ali Ersin Zumrutbas     http://orcid.org/0000-0001-5933-402X Department of Urology, Pamukkale University School of Medicine, Denizli,  Turkey E-mail: alizumrut@yahoo.com / Tel: +90-532-789-8961 / Fax: +90-258-296-6001 Submitted:  March 3, 2016 / Accepted after revision:  April 4, 2016INTRODUCTION Nocturia is one of the most prevalent and bothersome lower  urinary tract symptoms (LUTS) [1].",Non-OADS,/arxiv_data1/oa_pdf/31/72/inj-1632558-279.PMC5209574.pdf
"According to the 2002 International Continence Society  (ICS) definition, nocturia is defined as waking at night to void, Original Article https://doi.org/10.5213/inj.1632558.279 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The aims of this study were to assess the prevalence of nocturia and nocturnal polyuria (NP) and to define new cut - off values according to age and sex for both conditions.",Non-OADS,/arxiv_data1/oa_pdf/31/72/inj-1632558-279.PMC5209574.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Pietro Ferrara     http://orcid.org/0000-0001-9449-3464 Institute of Pediatrics, Catholic University Medical School, L.go Francesco Vito,  1, 00168, Rome, Italy E-mail pferrara@rm.unicatt.it, p.ferrara@unicampus.it / Tel: +39-06-30154348 /  Fax: +39-06-3383211 Submitted:  March 9, 2016 / Accepted after revision:  March 30, 2016INTRODUCTION Headache is a common complaint among children that occurs  in 75% of adolescents and 25% of young children; it is also the most common neurological disease observed in clinical practice  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/3f/38/inj-1632566-283.PMC5209575.pdf
"In particular, migraine without aura and tension-type head -Original Article https://doi.org/10.5213/inj.1632566.283 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  This study aims to evaluate the prevalence of headaches and migraine in children with nocturnal enuresis (NE) and  to improve knowledge on these conditions.",Non-OADS,/arxiv_data1/oa_pdf/3f/38/inj-1632566-283.PMC5209575.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Sang-Baek Koh     http://orcid.org/0000-0001-5609-6521  Department of Preventive Medicine, Y onsei University Wonju College of  Medicine, 20 Ilsan-ro, Wonju 26426, Korea E-mail: kohhj@yonsei.ac.kr / Tel: +82-33-741-0345 / Fax: +82-33-741-0409 Submitted:  March 24, 2016 / Accepted:  April 25, 2016Original Article https://doi.org/10.5213/inj.1632584.292 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  We aimed to evaluate obesity, a risk factor of metabolic syndrome, and its association with prostatic enlargement in  a retrospective cohort in Korea.",Non-OADS,/arxiv_data1/oa_pdf/2a/ea/inj-1632584-292.PMC5209576.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Woo Suk Choi     http://orcid.org/0000-0002-8352-578X Department of Urology, Konkuk University School of Medicine, 120  Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea E-mail: 20140123@kuh.ac.kr / Tel: +82-2-2030-7676 / Fax: +82-2-2030-5319  Submitted:  May 5, 2016 / Accepted:  July 25, 2016INTRODUCTION Nocturia is common lower urinary tract symptoms (LUTS).",Non-OADS,/arxiv_data1/oa_pdf/4a/7c/inj-1632624-312.PMC5209577.pdf
Except in the Original Article https://doi.org/10.5213/inj.1632624.312 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To evaluate changes in nocturia after surgical correction of obstructive sleep apnea (OSA).,Non-OADS,/arxiv_data1/oa_pdf/4a/7c/inj-1632624-312.PMC5209577.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Jae Hyun Bae     http://orcid.org/0000-0001-9862-3545 Department of Urology, Korea University Hospital, Korea University College of  Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea  E-mail: doc71377@hanmail.net / Tel: +82-31-412-5190 / Fax: +82-31-412-5194 Submitted:  May 9, 2016 / Accepted after revision:  July 18, 2016INTRODUCTION Prostate cancer is hormone sensitive and can be treated with  androgen deprivation by blocking the androgen receptor (AR)  or by reducing the production of testosterone.",Non-OADS,/arxiv_data1/oa_pdf/7f/e1/inj-1632628-314.PMC5209578.pdf
"Without a doubt, pa - tients with symptomatic benign prostatic hyperplasia (BPH)  who receive dutasteride or finasteride experience a significant Original Article https://doi.org/10.5213/inj.1632628.314 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  The goal of this study is to investigate the effects of androgen deprivation therapy (ADT) on total prostate volume  and lower urinary tract symptoms (LUTS).",Non-OADS,/arxiv_data1/oa_pdf/7f/e1/inj-1632628-314.PMC5209578.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Alexander Kretschmer     http://orcid.org/0000-0002-6511-4354 Department of Urology, Ludwig-Maximilians-University, Marchioninistrasse 15  81377 Munich, Germany E-mail: Alexander.kretschmer@med.uni-muenchen.de / Tel: +49-89-4400-0 /   Fax: +49-89-4400-5444 Submitted:  May 28, 2016 / Accepted after revision:  June 18, 2016INTRODUCTION When conservative management of male stress urinary incon -tinence (SUI) fails, a surgical approach is recommended [1].",Non-OADS,/arxiv_data1/oa_pdf/81/e5/inj-1632648-324.PMC5209579.pdf
While there is strong evidence for the Original Article https://doi.org/10.5213/inj.1632648.324 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  To evaluate long-term outcomes of AdVance and AdVanceXP male slings in patients with persistent stress urinary  incontinence (SUI) after transurethral resection of the prostate (TURP).,Non-OADS,/arxiv_data1/oa_pdf/81/e5/inj-1632648-324.PMC5209579.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Xing-Ming Zhong     http://orcid.org/0000-0002-7906-7843 Department of Neurosurgery, the First Affiliated Hospital of Huzhou Teachers  College, No.",Non-OADS,/arxiv_data1/oa_pdf/f1/5b/inj-1632692-346.PMC5209580.pdf
The disruption of the structural integrity of  the blood-brain barrier (BBB) plays an essential role in EBI and  has been found within hours after aneurysmal SAH; it causes a Original Article https://doi.org/10.5213/inj.1632692.346 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Microvascular endothelial integrity is important for maintaining the blood-brain barrier (BBB).,Non-OADS,/arxiv_data1/oa_pdf/f1/5b/inj-1632692-346.PMC5209580.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Seong-Ho Koh     http://orcid.org/0000-0001-5419-5761 Department of Neurology, Hanyang University Guri Hospital, Hanyang  University College of Medicine, 153 Gyeongchun-ro, Guri 11923, Korea E-mail: ksh213@hanyang.ac.kr / Tel: +82-31-560-2267 / Fax: +82-31-560-2267 Submitted:  November 16, 2016 / Accepted after revision:  December 12, 2016INTRODUCTION As the aging population increases, common neurological disor - ders including Alzheimer disease (AD), Parkinson disease  (PD), and ischemic stroke (IS) have increased and become im - portant health issues with increasing socioeconomic burdens  throughout the world [1].",Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
"The motor symptoms and mechanisms of PD are well  known, including age-dependent uncontrollable tremors, pos - tural imbalance, and slowness of movement and rigidity which  are caused by the degeneration of dopaminergic neurons in the  substantia nigra pars compacta (SNc) located in the midbrain Review Article https://doi.org/10.5213/inj.1632776.388 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Neurological diseases such as Alzheimer, Parkinson, and ischemic stroke have increased in occurrence and become important  health issues throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
https://doi.org/10.1007/s12975- 016-0460-z.,Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
https://doi.org/10.1002/hipo.22669.,Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
https://doi.org/10.1111/jnc.13413.,Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
https://doi.org/10.1101/cshperspect.a019034.,Non-OADS,/arxiv_data1/oa_pdf/f7/ba/inj-1632776-388.PMC5209581.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Jun Y oung Chung     http://orcid.org/0000-0002-3517-249X Department of Anesthesiology and Pain Medicine, Kyung Hee University Hospital  at Gangdong, College of Medicine, Kyung Hee University, 892 Dongnam-ro,  Gangdong-gu, Seoul 05278, Korea Tel: +82-2-440-7809 , Fax: +82-2-440-7808, E-mail: madsleep@gmail.com   Submitted:  November 12, 2016 / Accpted : December 12, 2016INTRODUCTION Rocuronium bromide is a nondepolarizing neuromuscular  blocking drug, and it has been used as an adjunct for relaxation or paralysis of skeletal muscles, facilitation of endotracheal in - tubation, and improving surgical conditions during general an - esthesia [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b0/4a/inj-1632796-398.PMC5209582.pdf
"The introduction of rocuronium bromide to the  anesthetic field replaced succinylcholine for rapid sequence in -Original Article https://doi.org/10.5213/inj.1632796.398 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Rocuronium bromide is a nondepolarizing neuromuscular blocking drug and has been used as an adjunct for relax - ation or paralysis of the skeletal muscles, facilitation of endotracheal intubation, and improving surgical conditions during  general anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/b0/4a/inj-1632796-398.PMC5209582.pdf
https://doi.org/10.1016/j.accpm.2016.03.010.,OADS,/arxiv_data1/oa_pdf/b0/4a/inj-1632796-398.PMC5209582.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/0c/94/JCIS-6-51.PMC5209857.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/6f/a9/JCIS-6-52.PMC5209858.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/df/cf/JCIS-6-50.PMC5209859.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/dd/78/JCIS-6-49.PMC5209860.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs339/en/.,Non-OADS,/arxiv_data1/oa_pdf/db/ed/IJPVM-7-131.PMC5209861.pdf
"International Journal of Preventive Medicine 2016, 7:131 http://www.ijpvmjournal.net/content/7/1/131for Plain Packaging; 2016.",Non-OADS,/arxiv_data1/oa_pdf/db/ed/IJPVM-7-131.PMC5209861.pdf
Available from: http://www.who.int/campaigns/ no‑tobacco‑day/2016/event/en/.,Non-OADS,/arxiv_data1/oa_pdf/db/ed/IJPVM-7-131.PMC5209861.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/db/a2/JCIS-6-48.PMC5209862.pdf
"International Journal of Preventive Medicine 2016, 7:132 http://www.ijpvmjournal.net/content/7/1/132INTRODUCTION Keratoconus is an ectasia of the cornea causing progressive  thinning, bulging, and distortion.",Non-OADS,/arxiv_data1/oa_pdf/58/72/IJPVM-7-132.PMC5209947.pdf
"International Journal of Preventive Medicine 2016, 7:132 http://www.ijpvmjournal.net/content/7/1/132the tip of the front lens (Achroplan 40×/0.75 W ∞/0),  confocal scanning was done using ConfoScan 3 (Nidek  Technologies, Padova, Italy).",Non-OADS,/arxiv_data1/oa_pdf/58/72/IJPVM-7-132.PMC5209947.pdf
"International Journal of Preventive Medicine 2016, 7:132 http://www.ijpvmjournal.net/content/7/1/132endothelial cell density before CXL and after 1 and  6 months of procedure were 3005.8 ± 304.4 cell/ mm², 2922.3 ± 316.4 cell/mm², and 2911.3 ± 279.4  cell/mm², respectively.",Non-OADS,/arxiv_data1/oa_pdf/58/72/IJPVM-7-132.PMC5209947.pdf
"International Journal of Preventive Medicine 2016, 7:132 http://www.ijpvmjournal.net/content/7/1/132303.52 ± 12.92 mOsm/L[20,21] is known to be normal,  and mean of all of these parameters were within normal  ranges in our patients before CXL and 1 and 6 months  thereafter.",Non-OADS,/arxiv_data1/oa_pdf/58/72/IJPVM-7-132.PMC5209947.pdf
"International Journal of Preventive Medicine 2016, 7:132 http://www.ijpvmjournal.net/content/7/1/1326.",Non-OADS,/arxiv_data1/oa_pdf/58/72/IJPVM-7-132.PMC5209947.pdf
"Impacts and shortcomings of genetic clustering methods for infectious disease outbreaks Art F. Y. Poon1,*,‡ 1Department of Pathology and Laboratory Medicine, Western University, London, Canada *Corresponding author: E-mail: apoon42@uwo.ca ‡http://orcid.org/0000-0003-3779-154X Abstract For infectious diseases, a genetic cluster is a group of closely related infections that is usually interpreted as representing a recent outbreak of transmission.",Non-OADS,/arxiv_data1/oa_pdf/1e/b5/vew031.PMC5210024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/b5/vew031.PMC5210024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/ba/vew033.PMC5210029.pdf
"The generated sRNA sequencing data (FASTQ files) were then analyzed using a pipeline established in our laboratory.Using the pipeline, FASTQ files were trimmed of the 3 0adapter using FASTX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/),size selected (initially all 19–32 nt reads; then 19–23 nt, and24–32 nt) and aligned to the POWV consensus sequence of therespective individual samples using Bowtie 0.12.8 ( Langmead et al.",OADS,/arxiv_data1/oa_pdf/af/ba/vew033.PMC5210029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/ae/vew032.PMC5210030.pdf
available from http://beast.bio.ed.ac.uk/Tracer.,OADS,/arxiv_data1/oa_pdf/6b/ae/vew032.PMC5210030.pdf
"Available from: http://www.repeatmasker.org Suttle, C. A.",Non-OADS,/arxiv_data1/oa_pdf/6b/ae/vew032.PMC5210030.pdf
Available from: http://www.alzheirs.org.uk/site/ scripts/documents_info.php?documentID=138.,Non-OADS,/arxiv_data1/oa_pdf/67/37/JFDS-8-173a.PMC5210107.pdf
Available from: https://www3.applied biosystems.com.,OADS,/arxiv_data1/oa_pdf/4c/74/JFDS-8-175a.PMC5210110.pdf
Available from: http://www.jiaomr.in/article.asp?,Non-OADS,/arxiv_data1/oa_pdf/e1/fe/JFDS-8-177a.PMC5210113.pdf
Available  from: http://lifeloom.com//II2Aggrawal.htm.,Non-OADS,/arxiv_data1/oa_pdf/cb/08/JFDS-8-177b.PMC5210114.pdf
Available  from: http://lifeloom.com//II2Aggarwal.htm.,Non-OADS,/arxiv_data1/oa_pdf/cc/68/JFDS-8-178a.PMC5210115.pdf
: The reliability of QR code dentureor website (https://www.the‑qrcode‑generator.com/).,Non-OADS,/arxiv_data1/oa_pdf/1c/35/JFDS-8-179.PMC5210117.pdf
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repositorydatabase (http://www.ebi.ac.uk/pride) with the data set identifierPXD004966.,OADS,/arxiv_data1/oa_pdf/b6/46/EMBJ-36-79.PMC5210157.pdf
"Cigarette smoke and calcium conspire to impair CFTR function   in airway epithelia Andrew P Braun* University of Calgary; Calgary, AB Canada Keywords:  airways, epithelium, calcium,  lysosome *Correspondence to: Andrew P Braun;   Email: abraun@ucalgary.ca Submitted: 04/15/21014; Accepted: 04/15/2014Published Online: 05/14/2014http://dx.doi.org/10.4161/chan.28970 Rasmussen  JE, Sheridan  JT, Polk W, Davies  CM,  Tarran  R. Cigarette smoke-induced Ca2+ release lead  to cystic fibrosis transmembrane conductance regulator  (CFTR) dysfunction .",Non-OADS,/arxiv_data1/oa_pdf/c7/49/kchl-08-03-10928970.PMC5210164.pdf
J Biol Chem  2014 ; 289:7671 - 81; PMID:24448802 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c7/49/kchl-08-03-10928970.PMC5210164.pdf
"Matthew E Pamenter1,* and Gabriel G Haddad2,3,4 1Department of Zoology; University of British Columbia; Vancouver, BC Canada; 2Department of Pediatrics; Section of Respiratory Medicine;   University of California San Diego; La Jolla, CA USA; 3Department of Neuroscience; University of California San Diego; La Jolla, CA USA;   4The Rady Children’s Hospital–San Diego; San Diego, CA USA Keywords:  tumor, calcium, LN229, IP3,  cancer *Correspondence to: Matthew E Pamenter; Email:  pamenter@zoology.ubc.ca Submitted: 03/05/2014Accepted: 03/09/2014Published Online: 05/09/2014http://dx.doi.org/10.4161/chan.28994 Commentary to: Gu XQ, Pamenter ME, Siemen  D, Sun X, Haddad GG.",Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Glia 2014; 64:504-13; PMID: 24446243; http://dx.doi.org/10.1002/glia.22620,Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
J Clin Invest 1999;  104:577-88;  PMID:10487772 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Cell Physiol Biochem 2008; 22:127-36;  PMID:18769039 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Sontheimer H. Exp Biol Med (Maywood) 2008; 233:779-91;  PMID:18445774 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Glia 2014; 62:504-13; PMID:24446243 ;  http://dx.doi.org/10.1002/glia.22620 6.,Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Am J Physiol Cell Physiol 2012;  303:C1070-8;  PMID:22992678 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
Glia 2002; 38:281-91;  PMID:12007141 ; http://dx.doi.org/10.1002/ glia.10064 8.,OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
J Biol Chem 2007; 282:31558-68; PMID:17711864 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/77/ec/kchl-08-03-10928994.PMC5210165.pdf
"Archana Jha1, Eugen Brailoiu2,*, and Shmuel Muallem1,* 1Epithelial Signaling and Transport Section; Molecular Physiology and Therapeutics Branch; NIDCR; NIH; Bethesda, MD USA; 2The Department of  Pharmacology; Temple University School of Medicine; Philadelphia, PA USA *Correspondence to: Eugen Brailoiu;   Email: ebrailoiu@temple.edu;  Shmuel Muallem; Email: shmuel.muallem@nih.gov Submitted: 03/08/2014Accepted: 03/12/2014 Published Online: 05/08/2014http://dx.doi.org/10.4161/chan.28995 Commentary to: Jha  A, Ahuja  M, Patel  S, Brailoiu   E, Muallem  S. Convergent regulation of the lyso - somal two-pore channel-2 by Mg²+, NAADP, PI(3,5) P₂ and multiple protein kinases.",Non-OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
EMBO J  2014;  33:501–11; PMID:24502975 ; http://dx.doi.org/10.1002/ embj.201387035,Non-OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
Channels (Austin) 2012; 6:344- 51; PMID:22907062; http://dx.doi.org/10.4161/ chan.21723 2.,Non-OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
EMBO J 2014; 33:501-11;  PMID:24502975; http://dx.doi.org/10.1002/ embj.201387035 3.,Non-OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
Cell 2012; 151:372-83;  PMID:23063126; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
Nat Commun 2010; 1:38; PMID:20802798; http://dx.doi.org/10.1038/ ncomms1037 5.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
J Biol Chem 2010; 285:16513-20; PMID:20378547; http://dx.doi.org/10.1074/jbc.M109.078204 6.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
Cell 2013; 152:778-90;  PMID:23394946; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
J Biol Chem 2011; 286:22934- 42; PMID:21540176; http://dx.doi.org/10.1074/ jbc.M110.210930 8.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
Bioessays 2014; 36:173-83; PMID:24277557; http://dx.doi.org/10.1002/ bies.201300118 Figure 1.  the major endolysosomal ion transporters.,OADS,/arxiv_data1/oa_pdf/8a/37/kchl-08-03-10928995.PMC5210166.pdf
"Channels 2014; 8; PMID:24394769;   http://dx.doi.org/10.4161/chan.27470 Paul Albert Fuchs The Center for Hearing and Balance; Department of Otolaryngology-Head and Neck Surgery; the Center for Sensory Biology in the Institute for Basic Biomedical  Science; Johns Hopkins University School of Medicine; Baltimore, MD USA Email: pfuchs1@jhmi.edu; http://dx.doi.org/10.4161/chan.28999Channels News & Views These observations gain additional signifi - cance from the unusual ultrastructure of effer - ent synapses on hair cells.2,3 These are cisternal  synapses like the cholinergic inputs to cranial  motor neurons,4 in which a near-membrane  reticulum aligns with the presynaptic con - tact.",Non-OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
Saito K. J Ultrastruct r es 1980; 71:222-32;  PMID:7381992; http://dx.doi.org/10.1016/ S0022-5320(80)90108-2 3.,OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
Synapse 1993; 15:17-32; PMID:8310422;  http://dx.doi.org/10.1002/syn.890150103 5.,OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
"J Comp Neurol 2014; 522:717- 29; PMID:24122766; http://dx.doi.org/10.1002/ cne.23478 6. r oux I, et al.",OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
J Neurosci 2011; 31:15092-101;  PMID:22016543; http://dx.doi.org/10.1523/ JNeUrOSCI.,Non-OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
"Murthy V, et al.. Mol Cell Neurosci 2009; 40:39- 49; PMID:18848895; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
J Physiol 2008; 586:5471-85;  PMID:18818242; http://dx.doi.org/10.1113/ jphysiol.2008.160077 www.landesbioscience.com Journal  1,Non-OADS,/arxiv_data1/oa_pdf/39/28/kchl-08-03-10928999.PMC5210167.pdf
s ci s ignal 2010; 3:pe10;  PMID:20332425; http://dx.doi.org/10.1126/ scisignal.3114pe10 2.,OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
J Neurosci 2012; 32:11820-34; PMID:22915123; http://dx.doi.org/10.1523/ JNeUrOsCI.0875-12.2012 3.,Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
Neurosci Lett 2012; 516:274-9; PMID:22516463; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
PLos One 2012; 7:e52056;  PMID:23284867; http://dx.doi.org/10.1371/journal.pone.0052056 6.,Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
Channels ( austin) 2014; 8; Forthcoming;  http://dx.doi.org/10.4161/chan.27471.,Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
J Neurosci 2010; 30:8566-80;  PMID:20573903; http://dx.doi.org/10.1523/ JNeUrOsCI.1554-10.2010 8.,Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
Neuroscience 1999; 92:499- 513; PMID:10408600; http://dx.doi.org/10.1016/ s0306-4522(99)00042-1Ryanodine receptors: Dual contribution to Alzheimer disease?,Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
"Channels 2014; 8; PMID:24476841;   http://dx.doi.org/10.4161/chan.27471 Mounia Chami1,2,* and Frédéric Checler1,2 1University of Nice Sophia Antipolis; IPMC; Sophia Antipolis, France; 2CNRS; IPMC; Sophia Antipolis, France *Email: mchami@pmc.cnrs.fr; http://dx.doi.org/10.4161/chan.29000Channels News & Views",Non-OADS,/arxiv_data1/oa_pdf/31/26/kchl-08-03-10929000.PMC5210168.pdf
"The findings presented in the work illustrate the significance of TRPV4 in choroid plexus epithelial cells and emphasize the importance of the interaction between Ca 2+-permeable  channels and Ca2+-activated proteins Interaction between TRP and Ca2+-activated chloride channels Ma koto Tominaga1,2,*, and Yasunori Takayama1 1Division of Cell Signaling; Okazaki Institute for Integrative Bioscience (National Institute for Physiological Sciences); National Institutes of Natural Sciences;  Okazaki, Japan; 2Department of Physiological Sciences; Graduate University for Advanced Studies; Okazaki, Japan Keywords:  TRP channels, Ca2+, Ca2+- activated chloride channels, TMEM16A (anoctamin 1), choroid plexus *Correspondence to: Makoto Tominaga; Email:  tominaga@nips.ac.jp Submitted 04/03/2014Accepted 04/05/2014Published Online: 04/25/2014http://dx.doi.org/10.4161/chan.29001 Commentary to: Takayama Y, Shibasaki K, Suzuki  Y, Yamanaka A, Tominaga M. Modulation of water efflux through functional interaction between TRPV4 and TMEM16A/anoctamin 1.",OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
FASEB J 2014;  PMID:24509911 ; http://dx.doi.org/10.1096/ fj.13-243436,OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
ACS Chem Neurosci 2013 ; 4:238- 47; PMID:23421674 ; http://dx.doi.org/10.1021/ cn300193h 3.,OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
Nature  2013 ; 504:107-12;  PMID:24305160 ; http://dx.doi.org/10.1038/ nature12822 4.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
Cell 2000 ; 103:525- 35; PMID:11081638 ; http://dx.doi.org/10.1016/ S0092-8674(00)00143-4 5.,OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
Nature  2008 ; 455:1210 - 5; PMID:18724360 ; http://dx.doi.org/10.1038/ nature07313 6.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
FASEB J  2014 ;  PMID:24509911 ; http://dx.doi.org/10.1096/ fj.13-243436 7.,OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
Nature   2003 ; 424:938-42; PMID:12931188 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/46/kchl-08-03-10929001.PMC5210169.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/dd/19/JAH3-5-e003751.PMC5210318.pdf
"To account for relatedness in the Old Order Amish participants, the Mixed Models Analysis for Populations and Pedigrees(MMAP) program was used (http://edn.som.umaryland.edu/ mmap/index.php).",Non-OADS,/arxiv_data1/oa_pdf/dd/19/JAH3-5-e003751.PMC5210318.pdf
Available at: http://www.ashg.org/2008meeting/abstracts/ fulltext/f22593.htm.,Non-OADS,/arxiv_data1/oa_pdf/dd/19/JAH3-5-e003751.PMC5210318.pdf
Accompanying Figures S1 through S5 are available at http://jaha.ahajournals.org/content/5/11/e003896/DC1/embed/inline-supplementary-mat erial-1.pdf *Dr Wei and Dr Gu contributed equally to this study and are co- ﬁrst authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
Available at: http://formu-laryjournal.modernmedicine.com/formulary-journal/news/clinical/clinical- pharmacology/p ﬁzer-voluntarily-withdraws- sitaxsentan-marke?page=full.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
Available at: https://www.clinicaltrials.gov/ct2/show/results/NCT01474109.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ucm245852.htm.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
Available at: http://www.gilead.com/~/media/Files/pdfs/medicines/cardiovascular/le- tairis/letairis_pi.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
https://www.clinicaltrials.gov/ct2/show/results/NCT00879229.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
https://www.clinicaltrials.gov/ct2/s how/results/NCT01474109.,Non-OADS,/arxiv_data1/oa_pdf/f6/cf/JAH3-5-e003896.PMC5210319.pdf
"Accompanying Videos S1 through S3, Data S1, Tables S1 through S7 and Figures S1 through S5 are available at http://jaha.ahajournals.org/content/5/ 11/ e004095.full#sec-20 *Dr Rudic and Dr Chaykovskaya contributed equally to this article.Correspondence to: Boris Rudic, MD, Department of Medicine –Cardiology, University Medical Centre Mannheim –I, Theodor-Kutzer-Ufer 1-3, Mannheim D-68167, Germany.",Non-OADS,/arxiv_data1/oa_pdf/56/7d/JAH3-5-e004095.PMC5210320.pdf
"Accompanying Tables S1 through S4 and Figures S1, S2 are available at http://jaha.ahajournals.org/content/5/11/e003348/DC1/embed/inline-sup plementary- material-1.pdf Correspondence to: M a m a sA .M a m a s ,B M B C h ,P h D ,K e e l eC a r d i o v a s c u l a rR e s e a r c hG r o u p ,I n s t itutes of Science and Technology in Medicine and Primary Care and Health Sciences, Keele University, Guy Hilton Research Centre, Thornburrow Drive, Hartshill, Stoke-on-Trent ST4 7QB, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/68/78/JAH3-5-e003348.PMC5210321.pdf
25 Data Collection The MINAP data set collects standardized data on prehospital and in-hospital care for all ACS admissions from all 230 NHS trusts in England and Wales and is part of the NHSdata dictionary (http://www.hqip.org.uk/minap-2013-report/).,OADS,/arxiv_data1/oa_pdf/68/78/JAH3-5-e003348.PMC5210321.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/16/6c/JAH3-5-e003833.PMC5210325.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/d1/d8/JAH3-5-e003977.PMC5210327.pdf
"Accompanying Figure S1 and Tables S1 through S4 are available at http://jaha.ahajournals.org/content/5/11/e003977/DC1/embed/inline-supplem entary- material-1.pdf Correspondence to: Matthew T. Roe, MD, MHS, 2400 Pratt St, Room 7035, Durham, NC 27705.",Non-OADS,/arxiv_data1/oa_pdf/d1/d8/JAH3-5-e003977.PMC5210327.pdf
All conﬂicts of interest are listed at https://www.dcri.org/ about-us/con ﬂict-of-interest.,Non-OADS,/arxiv_data1/oa_pdf/d1/d8/JAH3-5-e003977.PMC5210327.pdf
"Accompanying Figures S1 through S3 are available at http://jaha.ahajournals.org/content/5/11/e004401/DC1/embed/inline-supplementary-mat erial-1.pdf Correspondence to: Mary G. Sorci-Thomas, PhD, Division of Endocrinology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226.",Non-OADS,/arxiv_data1/oa_pdf/45/8e/JAH3-5-e004401.PMC5210328.pdf
Available at: http://circ.ahajournals.org/content/early/2016/10/27/CIRCU LATIONAHA.116.024143.,Non-OADS,/arxiv_data1/oa_pdf/af/87/JAH3-5-e004905.PMC5210330.pdf
Available at: https://www.fhi.no/en/op/public-health-report-2014/ risk–protective-factors/overweight-and-obesity-in-norway —/#about-overweight- and-obesity.,Non-OADS,/arxiv_data1/oa_pdf/65/16/JAH3-5-e004311.PMC5210332.pdf
Available at: http://www.medpac.gov/documents/reports/ Mar11_EntireReport.pdf?sfvrsn=0.,OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
"Available at: http://www.imshealth.com/ en/thought-leadership/ims-institute/reports/use-of-medicines-in-the-us-2013.Accessed June 03, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: https://aspe.hhs.gov/basic-report/expanding-use-generic-drugs.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: http://www.cms.gov/Outreach-and- Education/Training/CMSNationalTrainingProgram/Downloads/Part-D-Bene ﬁts- Parameters.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: http://kff.org/medicare/report/the-medicare-part-d-cov- erage-gap-costs-and-consequences-in-2007/.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at:https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrug- CovGenIn/Downloads/2016-Technical-Notes-Preview-1-v2015_08_05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: http://www.medpac.gov/documents/march-2016-meeting-pre- sentation-improving-medicare-part-d.pdf?sfvrsn=0.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: http://www.rand.org/content/dam/rand/pubs/technical_re- ports/2009/RAND_TR765.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
Available at: http://memoryworks.org/PUBS/NIA/Talking%20With%20Your% 20Older%20Patient-A%20Clinician ’s%20Handbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/01/JAH3-5-e003377.PMC5210334.pdf
"Administrative Healthcare Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in Congenital Heart Defects Public Health Investigations Name Brief Description Sponsoring Organization Data Years URL (Accessed as of June 1, 2016) Administrative —Heathcare Cost and Utilization Project (HCUP) Databases Kids ’Inpatient Database (KID)Weighted sample of the SID data (see below) used to identify, track, & analyze national trends in pediatric inpatient healthcare; sampling weights help provide national estimatesAgency for Healthcare Research and Quality (AHRQ)Every 3 years; 1997 –present http://www.hcup-us.ahrq.gov/ kidoverview.jsp Nationwide Emergency Department Sample (NEDS)Sampled from the SID and SEDD data (see below), is the largest all-payer emergency department (ED) database in the US usedto create estimates of ED careAgency for Healthcare Research and Quality (AHRQ)2006 –2013 http://www.hcup-us.ahrq.gov/ nedsoverview.jsp Nationwide/National Inpatient Sample (NIS)Weighted sample of discharges from US community hospitals, which is the largest publicly available all-payer inpatient healthcare database in the US; sampling weights help provide national estimatesAgency for Healthcare Research and Quality (AHRQ)1988 –present http://www.hcup-us.ahrq.gov/ nisoverview.jsp Nationwide Readmission Database (NRD)Sampled from the SID data (see below), used to create estimates of national readmission rates for all payers and the uninsuredAgency for Healthcare Research and Quality (AHRQ)2013 http://www.hcup-us.ahrq.gov/ nrdoverview.jsp State Ambulatory Surgical and Service Databases (SASD)Encounter data for ambulatory surgery & other outpatient services from hospital- owned facilities; capture of hospital-based outpatient diagnostic and/or pediatric cardiac catheterization is variable, as are data content & years; some states have nonhospital outpatient dataAgency for Healthcare Research and Quality (AHRQ)1997 –present http://www.hcup-us.ahrq.gov/ sasdoverview.jsp State Emergency Department Databases (SEDD)Discharge data on all ED visits in a given state that do not result in an admission; ED visits resulting in admissions are captured in the SIDAgency for Healthcare Research and Quality (AHRQ)1999 –present http://www.hcup-us.ahrq.gov/ seddoverview.jsp State Inpatient Databases (SID)Inpatient discharge data from participating states used to identify, track, & analyze state trends in healthcare utilization, access, charges, quality, and outcomesAgency for Healthcare Research and Quality (AHRQ)1990 –present http://www.hcup-us.ahrq.gov/ sidoverview.jsp Continued DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 3Databases for Congenital Heart Defects Riehle-Colarusso et alCONTEMPORARY REVIEW",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Continued Name Brief Description Sponsoring Organization Data Years URL (Accessed as of June 1, 2016) Administrative —Others Healthcare Cost Institute (HCCI) DatabaseCollection of claims data by nonpartisan, nonprofit organization on over 50 million people with employer-sponsored insurance; annual reports published and data available to researchers to better understand determinants of US health care costs and utilizationHealthcare Cost Institute (HCCI)2007 –present http://www.healthcostinstitute.org/ MarketScan/C226Research DatabasesDatabase system linking healthcare usage through commercial insurance, Medicaid, and Medicare to analyze a variety of outcomesTruven Health Analytics 1995 –present http://truvenhealth.com/your- healthcare-focus/analytic- research/marketscan-research- databases Medicaid Analytic Extracts (MAX)Contains enrollment information and paid claims at the state level for all Medicaid beneficiaries for inpatient and outpatient care, prescription medicationsCenters for Medicare and Medicaid Services (CMS)1999 –2012 http://www.resdac.org/cms-data/ file-family/Medicaid-Analytic- Extracts-MAX National Association of Children ’s Hospitals (NACH) Case Mix Comparative Data ProgramDatabase of 95 children ’s hospitals in the US with data to analyze inpatient populations, target quality improvement, enhance hospital utilization, & support advocacy on behalf of children ’s hospitalsNational Children ’s Hospital Association2000 –2012 http://www.c hildrenshospitals.net/ Am/Template.cfm?Section=Home3 Pediatric Health Information System (PHIS)Database of clinical and financial data from 49 tertiary-care pediatric hospitals in the US affiliated with the Children ’s Hospital Association; data can be linked across encounters within the same hospitalChildren ’s Hospital Association1992 –present http://www.childrenshospitals.org/ Quebec Congenital Heart Disease Database*Database from 3 province-wide administrative databases, capturing demographics, diagnoses, procedures, and health services used throughout a patient ’s lifeMcGill Adult Unit Congenital Heart Disease Excellence1983 –present None *Denotes cardiac-speci ﬁc databases.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Copies of the HCUP databases can be purchased; aggregated data from select HCUP databases are freely available online atthe HCUPnet site (http://hcupnet.ahrq.gov).,OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Birth Defects Surveillance Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in Congenital Heart Defects Public Health Investigations Name Brief Description Sponsoring Organization Data Years URL (Accessed as of June 1, 2016) Florida Birth Defects Registry (FBDR)Statewide population-based birth defects surveillance program for live-born infants ≤age 1 year; multiple data sources & linkages, including hospital & ambulatory discharge data, Children ’s Medical Services Florida, vital records, other administrative and clinical dataFlorida Department of Health 1999 –present http://fbdr.org/ Metropolitan Atlanta Congenital Defects Program (MACDP)Population-based birth defects surveillance program for live-born & stillborn infants, fetuses, and children diagnosed up to 6 years of age born to residents of metropolitan Atlanta, Georgia; multiple clinical data sources with linkage to vital records; active case finding, review and classification of CHDsCenters for Disease Control and Prevention —National Center on Birth Defects and Developmental Disabilities1967 –present http://www.cdc.gov/ncbddd/ birthdefects/macdp.html National Birth Defects Prevention Network (NBDPN) Data RepositoryData registry from 12 birth defect surveillance systems (including FBDR and MACDP) collaborating on birth defects surveillance, research, and prevention projectsNational Birth Defects Prevention Network1998 –2007 http://www.nbdpn.org/ DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 5Databases for Congenital Heart Defects Riehle-Colarusso et alCONTEMPORARY REVIEW",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Clinical Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in Congenital Heart Defects Public Health Investigations Name Brief Description Sponsoring Organization Data Years URL (Accessed as of June 1, 2016) Congenital Cardiac Catheterization Outcomes Project(C3PO)*Database of patient and procedural characteristics on catheterization procedures performed for congenital & acquired heartdisease in infants, children, and adults at 15 pediatric heart centersBoston Children ’s Hospital Cardiovascular Program2007 –present https://c3po-qi.chboston.org Congenital Cardiac Interventional Study Consortium (CCISC)*Registry for demographic and procedural information on patients undergoing diagnostic & interventional cardiac catheterizations for congenital heart disease (CHD)Children ’s Hospital of Michigan Foundation2005 –2010 https://ccisc.med.wayne.edu/ Congenital Evaluation, Reporting, and Tracking Endeavor (CONGENERATE)*Database for providers of adults with CHD for multicenter collaboration, research, & quality metric initiativesMcGill University, University of Sherbrooke, University of Montreal2010 –present http://www.congenerate.org/ Congenital Heart Surgeons Society (CHSS) Database*Database for multi-institutional clinical studies evaluating surgical interventions for CHD.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Goals: increase, correlate, & disseminate knowledge of physiology, pathology and therapyCongenital Heart Surgeons ’ Society (CHSS)1985 –present http://www.chssdc.org/ IMproving Pediatric and Adult Congenital Treatments (IMPACT TM) Registry*Registry of demographics, management & outcomes of pediatric and adult patients with CHD undergoing diagnostic & intervention cardiac catheterizations and electrophysiology procedures at 55 sites; data for performance measurement, benchmarking, and quality improvement initiativesAmerican College of Cardiology/National Cardiovascular Data Registry2010 –present https://www.ncdr.com/webncdr/impact/ home Mid-Atlantic Group of Interventional Cardiology (MAGIC)*Registry of outcomes for specific cardiac interventional catheterizations for CHDs and pulmonary hypertension at 14 sitesJohns Hopkins University 2003 –2010 http://www.magicgroup.org/html/ news.html National Pediatric Cardiology Quality Improvement Collaborative*Providers & family network that collects data, conducts research, & uses quality improvement science to improve outcomes; multicenter database to identify care variations & best practices, and test hypothesesJoint Council on Congenital Heart Disease2006 –present https://jcchdqi.org/ Organ Procurement Transplant Network DatabaseDatabase containing secure data on all wait lists, organ donation & transplant events in the US; database can be queried online, and reports availableUnited Network for Organ Sharing (UNOS)1987 –present http://optn.transplant.hrsa.gov/ Continued DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 6Databases for Congenital Heart Defects Riehle-Colarusso et alCONTEMPORARY REVIEW",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Continued Name Brief Description Sponsoring Organization Data Years URL (Accessed as of June 1, 2016) Pediatric Cardiac Care Consortium (PCCC)*Registry of cardiac catheterizations, surgeries, & autopsies for infants, children, and adults with congenital or acquired heart disease from 57 pediatric cardiac centers; includes outcomes & longitudinal patient trackingUniversity of Minnesota 1982 –2011 http://www.pcccweb.com Pediatric Cardiac Critical Care Consortium (PC4)*Consortium of pediatric cardiac critical care, cardiac surgery, & cardiology that collects data on outcomes & practice, provides performance feedback, and promotes improvement based on empirical analysis and collaborative learningNational Institutes of Health/ University of Michigan/ Participating Sites2009 –present http://pc4quality.org/ Pediatric Heart Network (PHN)*Collaboration of clinical sites & a data coordinating center that conducts research to improve outcomes and quality of life of children with congenital and acquired heart disease.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Centers follow study protocol to collect identical data and treat patients in similar waysNational Heart, Lung, & Blood Institute2001 –present http://www.pediatricheartnetwork.com/ Pediatric Heart Transplant Study (PHTS) Database*International, prospective, event driven database for research in the field of pediatric heart transplantation.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"PHTS advances the science & treatment of children during listing for and following heart transplantationUniversity of Alabama Birmingham School of Medicine1993 –present http://www.uab.edu/medicine/phts/ Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD)*Database for quality improvement, patient safety, and research which contains data on >95% of pediatric cardiac operations in the US.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Represents120 United States pediatric cardiac surgery hospitals & 3 in CanadaSociety of Thoracic Surgeons1994 –present http://www.sts.org/sts-national-database/ database-managers/congenital-heart- surgery-database Virtual Pediatric Intensive Care Unit Systems, LLC (VPS)Collaboration of 115 hospitals to improve critical care quality& outcomes through actionable reports, data management, & researchNone 1998 –present http://www.myvps.org/about-vps.html Western Canadian Children ’s Heart Network Database (WCCHN)*Database containing data on all diagnosed pediatric heart disease and CHD cases for 5 Canadian sites and adult CHD cases in 1 siteWestern Canadian Children ’s Heart Network2006 –present http://www.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"However, a list of programs with links can be found at the National Birth Defect Prevention Network(NBDPN) website (http://www.nbdpn.org/state_programs_ and_related_lin.php).",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Survey Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in Congenital Heart Defects Public Health Investigations Name Brief Description Sponsoring Organization Data YearsURL (Accessed as of June 1, 2016) American Community Survey (ACS)Part of the Decennial Census Program, it is a nationwide continuous survey sent to a small percentage of US households to gather demographic, housing, social, and economic data and provide yearly reportsUnited States Decennial Census Program—Census Bureau2005 –present http://www.census.gov/ programs-surveys/acs/ Decennial Census Survey of all US households done every 10 years, consisting of short and long forms.",OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Data are used for numerous purposesUnited States Census Bureau 1790 –present https://www.census.gov/ Medical Expenditure Panel Survey (MEPS)Survey of households to estimate use of health services, cost, payment, & availability; surveys have 3 components: core household, insurance/employer, and the medical providerAgency for Healthcare Research and Quality (AHRQ)1996 –present http://meps.ahrq.gov/ mepsweb/ National Health Interview Survey(NHIS)Survey of households to estimate the amount, distribution, & effectsof illness & disability in the US across demographics and socioeconomic status; updated questions on select topics; main source of health information on the US populationCenters for Disease Control and Prevention —National Center for Health Statistics1957 –present http://www.cdc.gov/nchs/ nhis.htm National Survey on Children with Special Health Care Needs (NS-CSHCN)Random sample survey of households in all states to assess prevalence & impact of special healthcare needs among children in the US; survey has core & special topic areas such as CHDsCenters for Disease Control and Prevention —National Center for Health Statistics —Maternal Child Health Bureau2000, 2005, 2009 http://www.cdc.gov/nchs/ slaits/cshcn.htm DOI: 10.1161/JAHA.116.004148 Journal of the American Heart Association 8Databases for Congenital Heart Defects Riehle-Colarusso et alCONTEMPORARY REVIEW",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Combined Database Examples in the United States and Canada With Data From 1990 Onward for Potential Use in Congenital Heart Defects Public Health Investigations Name Brief Description Sponsoring Organization Data YearsURL (Accessed as of June 1, 2016) Administrative and Clinical Healthcare Systems Research Network (HCSRN)Collaboration of 18 integrated healthcare delivery systems implementing research findings in clinical practice; working over a broad scope of indicators, they aim to develop an extensive and usable databaseNone 2006 –present http://www.hcsrn.org/en/ Pediatric Health Information System Plus (PHIS +)Database augmenting the existing PHIS (see Table 1) database by linking electronic laboratory and radiology reports from 6 of the 49 Children ’s Hospital Association hospitals to conduct clinical comparative effectiveness research projectsAgency for Healthcare Research and Quality (AHRQ) and Children ’s Hospital Association2009 –2012 http://www.prisnetwork.org/ research/phis_plus.html Administrative and Survey National Ambulatory Medical Care Survey (NAMCS)National sample survey of nonfederal office- based physicians to provide data on ambulatory medical care services in the USCDC*—National Center for Health Statistics1973 –present http://www.cdc.gov/nchs/ ahcd/about_ahcd.htm National Hospital Ambulatory Medical Care Survey (NHAMCS)National sample survey of hospital emergency, outpatient, hospital-based, & nonhospital ambulatory surgery centers; provides data on care at hospital-based ambulatory services and ambulatory surgical centersCDC*—National Center for Health Statistics1992 –present http://www.cdc.gov/nchs/ ahcd/about_ahcd.htm National Hospital Discharge Survey (NHDS)Probability survey of inpatients discharged from nonfederal short-stay US hospitals; provides national estimates of hospital inpatient servicesCDC*—National Center for Health Statistics1965 –2010 http://www.cdc.gov/nchs/ nhds.htm National Hospital Care Survey (NHCS)Survey combining data from NHAMCS, NHDS, and drug abuse networkCDC*—National Center for Health Statistics2011 –present http://www.cdc.gov/nchs/ nhcs.htm Birth Defect Surveillance and Survey Birth Defects Study To Evaluate Pregnancy exposureS(BD-STEPS)Multisite population-based, case-control study of 17 birth defects, building on findings from the NBDPS (see below)Centers for Birth Defects Research and Prevention2014 –present http://bdsteps.org/ National Birth Defects Prevention Study (NBDPS)Multisite population-based, case-control study of 30 birth defects; includes maternal interview & cheek cell specimens from family members; excludes syndromes & chromosomal abnormalitiesCenters for Birth Defects Research and Prevention1997 –2011 http://www.nbdps.org/ Pregnancy Health Interview Study (Birth Defects Study)Multisite case-control study of birth defects & newborn health; focuses on environmental exposures (primarily medications) in pregnancy; includes maternal interview, medical record release; genetic specimens 1992 –2008Slone Epidemiology Center at Boston University1979 –present http://www.bu.edu/slone/ research/studies/phis/ *Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Variables for accurate linkage between data sets may not be adequate, although this could be assistedthrough the use of a global unique identi ﬁer, as has been endorsed by the National Institutes of Health for other groups (https://ndar.nih.gov/tools_guid_tool.html).",Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: https://www.apcdcouncil.org/manual.,Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: http://www.nbdpn.org/birth_ defects_surveillance_gui.php.,Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: http://www.census.gov/content/dam/Census/programs- surveys/acs/about/ACS_Information_Guide.pdf.,OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: http://www.childhealthdata.org/learn/ NS-CSHCN.,Non-OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: http://www.cdc.gov/nchs/nvss/index.htm.,OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
Available at: http://www.cdc.gov/nchs/data_access/VitalStatsOnline.htm.,OADS,/arxiv_data1/oa_pdf/60/0c/JAH3-5-e004148.PMC5210337.pdf
"Accompanying Data S1, Tables S1 through S5 and Figures S1 through S6 are available at http://jaha.ahajournals.org/content/5/11/e004035/DC1/em- bed/inline-supplementary-material-1.pdf Correspondence to: Ping Yan Chen, MS, Department of Biostatistics, School of Public Health, Southern Medical University, 1838 North GuangzhouAvenue, Guangzhou 510515, China.",Non-OADS,/arxiv_data1/oa_pdf/49/2f/JAH3-5-e004035.PMC5210339.pdf
Accompanying Table S1 and Appendix S1 are available at http://jaha.ahajournals.org/content/5/11/e004088/DC1/embed/inline-supplementary-m aterial-1.pdf A complete list of the Collaborators and Swiss Transcatheter Aortic Valve Implantation Registry Investigators can be found in the Supplemental Mate rial.,Non-OADS,/arxiv_data1/oa_pdf/57/38/JAH3-5-e004088.PMC5210340.pdf
"Avail- able at: http://linkinghub.elsevier.com/retrieve/pii/S0140673616300733.Accessed April 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/57/38/JAH3-5-e004088.PMC5210340.pdf
Available at: http://linkinghub.el- sevier.com/retrieve/pii/S000291491630296X.,Non-OADS,/arxiv_data1/oa_pdf/57/38/JAH3-5-e004088.PMC5210340.pdf
Available at: http://www.diabetes.org/advocacy/news- events/cost-of-diabetes.html?referrer=https://www.google.com/.,Non-OADS,/arxiv_data1/oa_pdf/27/17/JAH3-5-e004059.PMC5210341.pdf
Available at: http://www.cdc.- gov/obesity/downloads/CDCHealthEquityObesityToolkit508.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/17/JAH3-5-e004059.PMC5210341.pdf
Available at: http://www.cdc.- gov/nchs/nhis/quest_data_related_1997_forward.htm.,OADS,/arxiv_data1/oa_pdf/27/17/JAH3-5-e004059.PMC5210341.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/NBK2003/.,Non-OADS,/arxiv_data1/oa_pdf/27/17/JAH3-5-e004059.PMC5210341.pdf
Available at: http://www.cdc.gov/ nchs/data/nhis/2006var.pdf.,OADS,/arxiv_data1/oa_pdf/27/17/JAH3-5-e004059.PMC5210341.pdf
Available at: http://kff.org/infographic/ 10-essential-facts-about-medicare-and-prescription-drug-spending/.,Non-OADS,/arxiv_data1/oa_pdf/81/26/JAH3-5-e004466.PMC5210342.pdf
Available at: https://q1medicare.com/PartD-2006MedicarePartDSTPlanOverviews.,OADS,/arxiv_data1/oa_pdf/81/26/JAH3-5-e004466.PMC5210342.pdf
Available at: https://www.medi- care.gov/part-d/costs/coverage-gap/part-d-coverage-gap.html.,Non-OADS,/arxiv_data1/oa_pdf/81/26/JAH3-5-e004466.PMC5210342.pdf
Avail- able at: http://dashboard.healthit.gov/quickstats/pages/physician-ehr-adoption-trends.php.,Non-OADS,/arxiv_data1/oa_pdf/81/26/JAH3-5-e004466.PMC5210342.pdf
Available at: https://www.congress.gov/bill/114th-congress/house-bill/2/ text.,Non-OADS,/arxiv_data1/oa_pdf/81/26/JAH3-5-e004466.PMC5210342.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/62/d3/JAH3-5-e004255.PMC5210344.pdf
Clinical Trial Registration- —URL: http://www.anzctr.org.au.,Non-OADS,/arxiv_data1/oa_pdf/f3/ea/JAH3-5-e004203.PMC5210348.pdf
"Accompanying Figures S1 through S3 and Videos S1 through S3 are available at http://jaha.ahajournals.org/content/5/11/e003922/DC1/embed/in- line-supplementary-material-1.pdf Correspondence to: Todd K. Rosengart, MD, Michael E. De Bakey Department of Surgery, Baylor College of Medicine, 1 Baylor Plaza, MS 390,Houston, TX 77030.",Non-OADS,/arxiv_data1/oa_pdf/15/77/JAH3-5-e003922.PMC5210349.pdf
"The dual-luciferase reporter assay system (Promega Corp., Madison, WI) was used for analyses, and the data are shown as the ratio of luciferase activity normalized against that of Renilla.20The miRNA target prediction program, TargetScan, (http://www.targetscan.org)was used to identify putative targets.",OADS,/arxiv_data1/oa_pdf/15/77/JAH3-5-e003922.PMC5210349.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/11/e003836/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Anna Gundlund, MD, Herlev-Gentofte Hospital, Kildeg /C23ardsvej 28, 2900 Hellerup, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/b7/a2/JAH3-5-e003836.PMC5210350.pdf
"We matchedthe cases and the controls with a 1:1 match for age at AF diagnosis, year of AF diagnosis, and sex, using the Greedy Match method (http://www.mayo.edu/research/docu- ments/gmatchsas/doc-10027248).",OADS,/arxiv_data1/oa_pdf/b7/a2/JAH3-5-e003836.PMC5210350.pdf
Available at: http://www.Who.Int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/7e/af/JAH3-5-e004534.PMC5210351.pdf
"Accompanying Tables S1 through S4 and Figures S1, S2 are available at http://jaha.ahajournals.org/content/5/11/e004282/DC1/embed/inline-sup plementary- material-1.pdf This work was presented at the AcademyHealth Research Meeting, June 26 to 28, 2016, in Boston, MA.Correspondence to: Laura N. Medford-Davis, MD, Section of Emergency Medicine, Baylor College of Medicine, Ben Taub Emergency Center, 1504 Taub Loop, Houston, TX 77030.",Non-OADS,/arxiv_data1/oa_pdf/ba/78/JAH3-5-e004282.PMC5210352.pdf
Available at: http://kff.org/uninsured/fact-sheet/key-facts-about-the-unin- sured-population/.,Non-OADS,/arxiv_data1/oa_pdf/ba/78/JAH3-5-e004282.PMC5210352.pdf
"Available at: http://kff.org/state-category/health-cover-age-uninsured/health-insurance-status/Accessed September 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ba/78/JAH3-5-e004282.PMC5210352.pdf
"Accompanying Tables S1 through S9 and Figure S1 are available at http://jaha.ahajournals.org/content/5/11/e004065/DC1/embed/inline-supplem entary- material-1.pdf Presented during a moderated poster session at the European Society of Cardiology (ESC) congress, August 27 to 31, 2016, in Rome.Correspondence to: Kim Bouillon, MD, PhD, Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), 143-147 Blvd Anatole, F-93285 Saint-Denis Cedex, France.",Non-OADS,/arxiv_data1/oa_pdf/58/0d/JAH3-5-e004065.PMC5210354.pdf
Available at: https://www.nice.org.uk/guidance/ CG180.,Non-OADS,/arxiv_data1/oa_pdf/58/0d/JAH3-5-e004065.PMC5210354.pdf
Available at: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/58/0d/JAH3-5-e004065.PMC5210354.pdf
Available at: http://agence-prd.ansm.sante.fr/php/ecodex/rcp/R0192712.,Non-OADS,/arxiv_data1/oa_pdf/58/0d/JAH3-5-e004065.PMC5210354.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.org/content/5/11/e004413/DC1/embed/inline-supplementary-mate rial-1.pdf Correspondence to: Anders Grøntved, PhD, Research Unit for Exercise Epidemiology, Department of Sport Science and Clinical Biomechanics, Centre of Research in Childhood Health, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/a3/9b/JAH3-5-e004413.PMC5210355.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajour- nals.org/content/5/10/e004399/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Tobias Schmidt, MD, Department of Cardiology, Asklepios Klinik St. Georg, Lohm €uhlenstr.",Non-OADS,/arxiv_data1/oa_pdf/b8/46/JAH3-5-e004399.PMC5210356.pdf
Available at: http://www.sac.org.ar/wp-content/ uploads/2014/09/tct-2014-clean-tavi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/46/JAH3-5-e004399.PMC5210356.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/33/39/JAH3-5-e003554.PMC5210357.pdf
"Accompanying Table S1 and Figures S1 through S3 are avail- able athttp://jaha.ahajournals.org/content/5/11/e003990/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Zhengda Fan, BS, Department of Pharmacy, The Third People ’s Hospital of Changzhou, Changzhou, Jiangsu, China.",Non-OADS,/arxiv_data1/oa_pdf/cc/90/JAH3-5-e003990.PMC5210359.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/aa/9a/JAH3-5-e004323.PMC5210360.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/11/e003825/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Yook Chin Chia, MBBS, FRCP, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, 50603 KualaLumpur, Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/98/fe/JAH3-5-e003825.PMC5210361.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/content/ 5/11/e002946/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Dan M. Roden, MD, Vanderbilt University, 2215B Garland Ave, 1285 MRBIV Light Hall, Nashville, TN 37232.",Non-OADS,/arxiv_data1/oa_pdf/27/8a/JAH3-5-e002946.PMC5210363.pdf
The sequence ﬁles were then aligned to mouse assembly build mm10 using the Tophat2 splice junction mapper (http://ccb.jhu.edu/software/tophat/in- dex.shtml).,OADS,/arxiv_data1/oa_pdf/27/8a/JAH3-5-e002946.PMC5210363.pdf
Transcripts were assembled by and differential expression analysis was performed with Cuf ﬂinks (http://cole-trapnell-lab.github.io/cuf ﬂinks/) using the bias- correction (-u) and stranded-library (fr- ﬁrststrand) options.,OADS,/arxiv_data1/oa_pdf/27/8a/JAH3-5-e002946.PMC5210363.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/con tent/5/11/e004257/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Alka M. Kanaya, MD, Division of General Internal Medicine, University of California San Francisco, 1545 Divisadero St, Ste 311, San Francisco, CA 94115.",Non-OADS,/arxiv_data1/oa_pdf/c2/50/JAH3-5-e004257.PMC5210365.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/50/JAH3-5-e004257.PMC5210365.pdf
Available at: http://www.census.gov/prod/cen2010/pro ﬁletd.pdf.,OADS,/arxiv_data1/oa_pdf/c2/50/JAH3-5-e004257.PMC5210365.pdf
An accompanying Table S1 is available at http://jaha.ahajournals.org/con- tent/5/11/e004360/DC1/embed/inline-supplementary-material-1.pdf *Dr S /C19adaba and Dr Mart /C19ınez-Mart /C19ınez contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/9f/e1/JAH3-5-e004360.PMC5210369.pdf
A full list of participating MESA investigators can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/3c/46/JAH3-5-e004162.PMC5210393.pdf
"An accompanying Figure S1 is available at http://jaha.ahajournals.org/conte nt/5/12/e004700/DC1/embed/inline-supplementary-material-1.pdf *Dr Sun, Dr Yang and Dr Mao contributed equally to this study.Correspondence to: Rui Yan Zhang, MD, PhD, Department of Cardiology, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, 197 Ruijin Road II, Shanghai 200025, China.",Non-OADS,/arxiv_data1/oa_pdf/5e/e6/JAH3-5-e004700.PMC5210395.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/content/5/12/e004185/DC1/embed/inline-supplementary-material-1 .pdf Correspondence to: Carmine Pizzi, MD, FESC, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (Padiglione 11), Universit /C18a di Bologna, Via Giuseppe Massarenti 9, 40138 Bologna, Italy.",Non-OADS,/arxiv_data1/oa_pdf/50/be/JAH3-5-e004185.PMC5210396.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.org/content/5/12/e004362/DC1/embed/inline-supplementary-mate rial-1.pdf Correspondence to: Yong Ji, MD, PhD, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, 101 Longmian Rd, Nanjing 211166, China.",Non-OADS,/arxiv_data1/oa_pdf/e3/56/JAH3-5-e004362.PMC5210397.pdf
"Accompanying Data S1, Tables S1 through S4, and Figures S1 through S3 are available at http://jaha.ahajournals.org/content/5/12/e004496/DC1/em bed/ inline-supplementary-material-1.pdf Correspondence to: Zhe Zheng, MD, PhD, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.",Non-OADS,/arxiv_data1/oa_pdf/91/d0/JAH3-5-e004496.PMC5210398.pdf
Available from: http://arxiv.org/ftp/ arxiv/papers/1201/1201.6385.pdf).,Non-OADS,/arxiv_data1/oa_pdf/99/cc/JAH3-5-e004213.PMC5210400.pdf
Available at: http://www.resdac.org/.,Non-OADS,/arxiv_data1/oa_pdf/af/63/JAH3-5-e003928.PMC5210402.pdf
Available at: http://www.medscape.org/viewarticle/843974.,Non-OADS,/arxiv_data1/oa_pdf/af/63/JAH3-5-e003928.PMC5210402.pdf
An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/5/12/e004647/DC1/embed/inline-supplementary-material-1.pdf The views expressed in this article are those of the authors and do not necessarily re ﬂect those of Duke University.,Non-OADS,/arxiv_data1/oa_pdf/9b/64/JAH3-5-e004647.PMC5210404.pdf
Available at http://www.usinfla tioncalculator.com/.,Non-OADS,/arxiv_data1/oa_pdf/0e/8c/JAH3-5-e004509.PMC5210405.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/5/12/e003846/DC1/embed/inline-supplementary-mate- rial-1.pdf Correspondence to: Andrea Milde Øhrn, MD, Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, N-9037 Tromsø,Norway.",Non-OADS,/arxiv_data1/oa_pdf/e3/b2/JAH3-5-e003846.PMC5210406.pdf
"Accompanying Tables S1 through S3 and Figures S1 through S4 are available at http://jaha.ahajournals.org/content/5/12/e004076/DC1/embed/in line-supplementary-material-1.pdf Correspondence to: Olof Gidl €of, PhD, Department of Cardiology, BMC D12, S€olvegatan 19, 221 84 Lund, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JAH3-5-e004076.PMC5210409.pdf
Read quality was evaluated using FastQC using default run parameters (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/).,OADS,/arxiv_data1/oa_pdf/b6/d4/JAH3-5-e004076.PMC5210409.pdf
"18,19ChIP-Seq data are available through the Gene Omnibus Expression database (http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/b6/d4/JAH3-5-e004076.PMC5210409.pdf
Microarray data are available through the Gene Omnibus Expression database (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/b6/d4/JAH3-5-e004076.PMC5210409.pdf
"Accompanying Tables S1 through S8 and Figures S1, S2 are available at http://jaha.ahajournals.org/content/5/12/e004503/DC1/embed/in line-supplementary-material-1.pdf Correspondence to: C/C19eline Fernandez, PhD, Department of Clinical Sciences, Hypertension and Cardiovascular Disease, Jan Waldenstr €oms gata 35, Building 91, Floor 12, Sk /C23ane University Hospital, 20502 Malm €o, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/81/22/JAH3-5-e004503.PMC5210412.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/JAH3-5-e004438.PMC5210413.pdf
Available at: http://onlinelibrary.wiley.com/ doi/10.1002/ccd.26409/full.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/JAH3-5-e004438.PMC5210413.pdf
; 2015. https://www.census.gov/quickfacts/table/PST045215/ 00.,OADS,/arxiv_data1/oa_pdf/26/36/JAH3-5-e004245.PMC5210414.pdf
Available at: http://www.ohri.ca/programs/clinica l_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/JAH3-5-e004598.PMC5210416.pdf
Available at: http://acc.sagepub.com/content/early/ 2016/02/17/2048872616633882.,Non-OADS,/arxiv_data1/oa_pdf/98/a3/JAH3-5-e004202.PMC5210417.pdf
Available at: http://www.migrationpol- icy.org/article/limited-english-pro ﬁcient-population-united-states/.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.heart.org/HEARTORG/HealthcareResearch/GetWith TheGuidelines/GetWithTheGuidelines-Stroke/Get-With-The-Guidelines-Stroke-Overview_UCM_308021_Article.jsp.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www2.massgeneral.org /stopstroke/acuteStrokeService.aspx.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839563/.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://cis.org/record-one-in- ﬁve-us-residents-speaks-lan guage-other-than-english- at-home.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.lep.gov/demog_data/demog_data.html.,OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.mass.gov/eohhs/docs/dph/health- equity/appendix-f-language-audience-guides.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.pewhispanic.org/ ﬁles/reports/ 85.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2014/rwjf414189.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: https://www2.massgeneral.org/stopstroke/pdfs/ Protocol%20%28IV%20tPA%20in%20the%203-4.5hrs%29.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: https://www.thinkculturalhealth.hhs.gov/Content/clas.asp.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: https://www.census.gov/ prod/2012pubs/acs-19.pdf.,OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
Available at: http://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in- the-us/key-statistics-graphics.aspx#foodsecure.,Non-OADS,/arxiv_data1/oa_pdf/05/7e/JAH3-5-e003782.PMC5210419.pdf
"Clinical Trial Registration- —URL: http://www.ClinicalTrials.gov, www.ensaiosclinicos.gov.",Non-OADS,/arxiv_data1/oa_pdf/b6/83/JAH3-5-e004248.PMC5210423.pdf
"Accompanying Appendix S1 is available at http://jaha.ahajournals.org/content/5/12/e004248/DC1/embed/inline-supplementary-material-1.p df Correspondence to: Sandra Costa Fuchs, MD, PhD, Clinical Research Center, Hospital de Cl /C19ınicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 5th Floor, Ramiro Barcelos 2350, Porto Alegre, Rio Grande do Sul, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/b6/83/JAH3-5-e004248.PMC5210423.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/af/68/JAH3-5-e003905.PMC5210425.pdf
"Accompanying Tables S1 through S5, Figures S1 through S9 and Appendix S1 are available at http://jaha.ahajournals.org/content/5/11/e003905/DC1 /embed/ inline-supplementary-material-1.pdf A complete list of the Episode Review Committee, the Adverse Event Advisory Committee and Participating Investigators can be found in the Supplement al Material.",Non-OADS,/arxiv_data1/oa_pdf/af/68/JAH3-5-e003905.PMC5210425.pdf
Available at: http://onlinelibrary.wiley.com/wol1/doi/ 10.1002/ccd.26596/full.,Non-OADS,/arxiv_data1/oa_pdf/8b/b8/JAH3-5-e004400.PMC5210426.pdf
"Accompanying Figures S1, S2 and Tables S1 through S3 are available at http://jaha.ahajournals.org/content/5/12/e004629/DC1/embed/inline-sup plementary- material-1.pdf *Dr Afzal and Dr Luong contributed equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/6c/bb/JAH3-5-e004629.PMC5210428.pdf
"Importantly, by utilizing several computational algorithmic databases, such as RNA22 (https://cm.jefferson.edu/rna22/), DIANA-microT- CDS (http://diana.imis.athena-innovation.gr/DianaTools/inde x.php?r=MicroT_CDS/index), TargetScan7.1 (http://www.ta rgetscan.org/mmu_71/), miRanda-rel2010 (http://www.microrna.org/microrna/getGeneForm.do), and miRDB4.0 (http:// mirdb.org/cgi-bin/search.cgi), we identi ﬁed≥1 miR-214 binding site within the 3 0UTR of 39 (of 59) genes with protein expression levels that were decreased by miR-214 overexpression.",OADS,/arxiv_data1/oa_pdf/6c/bb/JAH3-5-e004629.PMC5210428.pdf
"Moreover, a favorable minimum loop-free energy (dH: /C0136.5, /C0143.1 and /C0150.2 kcal/ mol for binding site 1, 2 and 3, respectively) in the formation of the miR-214: NCKAP1 30UTR duplex stem loop for all 3 binding sites was observed by using mFold software (http://mfold.rna.albany.edu/?q=DINAMelt/Two-state-melting) (Fig- ure S1B).",OADS,/arxiv_data1/oa_pdf/6c/bb/JAH3-5-e004629.PMC5210428.pdf
JAHA/2016/004629- T1R1    3 loop (binding site) were calculated by and extracted  from  mFold  software   (http://mfold.rna.albany.edu/?q=DINAMelt/Two -state-melting ).,OADS,/arxiv_data1/oa_pdf/6c/bb/JAH3-5-e004629.PMC5210428.pdf
"Accompanying Data S1, Tables S1 through S3 and Figure S1 are available at http://jaha.ahajournals.org/content/5/12/e004703/DC1/embed/inline-supplementary-material-1.pdf *Dr Li and Dr Hu contributed equally to this work.Correspondence to: Zhenyu Tang, MD, PhD, Department of Neurology, The Second Af ﬁliated Hospital of Nanchang University; No.",Non-OADS,/arxiv_data1/oa_pdf/e7/ca/JAH3-5-e004703.PMC5210429.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9a/5e/JAH3-5-e003957.PMC5210434.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/conte nt/5/12/e003957/DC1/embed/inline-supplementary-material-1.pdf Correspondence to: Emmanouil Charitakis, MD, Department of Cardiology, Link€oping University Hospital, Garnisonsv €agen 10, 581 85 Link €oping, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/JAH3-5-e003957.PMC5210434.pdf
Accompanying Tables S1 through S4 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/JAH3-5-e004067.PMC5210435.pdf
Available at: http://www.who.int/nmh/countries/cri_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/JAH3-5-e004067.PMC5210435.pdf
Available at: http://www.paho.org/cor/index.php?option= com_docman&view=download&category_slug=alimentacion-y-nutricion&alias= 67-encuesta-nacional-de-nutricion-costa-rica-2008-2009&Itemid=222&lang=en.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/JAH3-5-e004067.PMC5210435.pdf
Available at:http://apps.who.int/iris/bitstream/10665/42665/1/WHO_TRS_916.pdf.,OADS,/arxiv_data1/oa_pdf/8b/7b/JAH3-5-e004067.PMC5210435.pdf
Availableat: http://files.kff.org/attachment/Issue-Brief-The-Coverage-Gap-Uninsured- Poor-Adults-in-States-that-Do-Not-Expand-Medicaid.,Non-OADS,/arxiv_data1/oa_pdf/03/65/JAH3-5-e005130.PMC5210437.pdf
An accompanying Table S1 is available at http://jaha.ahajournals.org/content/5/12/e002965/DC1/embed/inline-supplementary-material-1.pd f *Dr Jones and Ms Magid contributed equally to this work and share co- ﬁrst authorship.,Non-OADS,/arxiv_data1/oa_pdf/95/75/JAH3-5-e002965.PMC5210438.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/95/75/JAH3-5-e002965.PMC5210438.pdf
"Available at: http://www.who.int/mediacentre/factsheets/fs317/en/.Accesed September, 2016.",Non-OADS,/arxiv_data1/oa_pdf/79/05/JAH3-5-e003998.PMC5210439.pdf
Available at: http://www.cdc.gov/injury/ wisqars/index.html.,OADS,/arxiv_data1/oa_pdf/79/05/JAH3-5-e003998.PMC5210439.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajour- nals.org/content/5/12/e004555/DC1/embed/inline-supplementary-mate-rial-1.pdf Correspondence to: Kristian Engeseth, MD, Department of Cardiology, Oslo University Hospital, Ullevaal, PB 4956 Nydalen, 0424 Oslo, Norway.",Non-OADS,/arxiv_data1/oa_pdf/37/91/JAH3-5-e004555.PMC5210440.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/a9/d1/JAH3-5-e004287.PMC5210442.pdf
"Assignment of de novo sequenced peptides to complement determining regions (CDR) and framework regions were based on Uniprot information and by using the VBASE sequence directory (Tomlinson et al, MRCCentre for Protein Engineering, http://www2.mrc-lmb.cam.ac.",OADS,/arxiv_data1/oa_pdf/d0/d3/JAH3-5-e004415.PMC5210446.pdf
Available at: http://www.hcup-us.a hrq.gov/nedsoverview.jsp.,Non-OADS,/arxiv_data1/oa_pdf/b2/b9/JAH3-5-e004511.PMC5210448.pdf
Available at: http://www.ahrq.gov/research/ ﬁndings/nhqrdr/nhqr13/index.,OADS,/arxiv_data1/oa_pdf/6f/27/JAH3-5-e004313.PMC5210449.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/fa/18/JAH3-5-e004234.PMC5210451.pdf
"Channels (Austin) 2014; 8:8; PMID:24457979;   http://dx.doi.org/10.4161/chan.27662 Nathalie Strutz-Seebohm, Eva Wrobel, Eric Schulze-Bahr, and Guiscard Seebohm* Institute for Genetics of Heart Diseases (IfGH); Department of Cardiovascular Medicine; University Hospital Muenster; Muenster , Germany *Email: guiscard.seeboh@gmx.de; http:// dx.doi.org/10.4161/chan.29659 The Klotho gene codes for a type- i mem - brane protein that exists in two forms—as a  transmembrane protein and as a secreted pro - tein.",Non-OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
Rejuvenation Res 2014; 17:212- 6; PM iD:24164579; http://dx.doi.org/10.1089/ rej.2013.1523 2.,Non-OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
Channels 2014; 8:8; PM iD:24457979;  http://dx.doi.org/10.4161/chan.27662 4.,Non-OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
Pflugers Arch 2010; 460:277- 88; PM iD:20401729; http://dx.doi.org/10.1007/ s00424-010-0831-3 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
"Nature 1996; 384:78-80;  PMiD:8900282; http://dx.doi.org/10.1038/384078a0 6. s anguinetti MC, et al.",OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
"Nature 1996; 384:80-3;  PMiD:8900283; http://dx.doi.org/10.1038/384080a0 7. s eebohm G, et al.",OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
Circ Res 2007; 100:686-92;  PMiD:17293474; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
J Biol Chem 2013; 288:36841-54; PM iD:24214981; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f3/4b/kchl-08-04-10929659.PMC5210506.pdf
"5 This observation  was in good agreement with the confocal A xona l Kv7.2 /7.3 cha nnels Caught in the act Maarten HP Kole1,2,* and Edward C Cooper3 1Netherlands Institute for Neuroscience; Royal Netherlands Academy of Arts and Sciences; Amsterdam, The Netherlands; 2Cell Biology; Faculty of Science;  Utrecht University; Utrecht, The Netherlands 3Neurology, Neuroscience, and Molecular and Human Genetics; Baylor College of Medicine; Houston, TX USA Keywords:  KCNQ2, KCNQ3, action  potential, M-current, axon initial segment, node of Ranvier, epileptic encephalopathy *Correspondence to: Maarten HP Kole;   Email: m.kole@nin.knaw.nl Submitted: 05/26/2014Accepted: 05/30/2014Published Online: 07/23/2014http://dx.doi.org/10.4161/chan.29965 Battefeld A, Tran BT, Gavrilis J, Cooper EC, Kole  MH.",Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
J Neurosci 2014; 34:3719-32; PMID:24599470; http://dx.doi.org/10.1523/JNEUROSCI.4206-13.2014,Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
Science 1998; 282:1890-3; PMID:9836639 ; http://dx.doi.org/10.1126/ science.282.5395.1890 2.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
Br J Pharmacol 2009; 156 :1185-95;  PMID:19298256 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
J Neurosci  2014; 34:3719-32; PMID:24599470; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
"J Neurosci 2006; 26:2599- 613; PMID:16525039 ; http://dx.doi.org/10.1523/ JNEUROSCI.4314-05.2006 8 Schwarz JR, Glassmeier G, Cooper EC, Kao T-C,  Nodera H, Tabuena D, Kaji R, Bostock H. KCNQ channels mediate IKs, a slow K+ current regulat - ing excitability in the rat node of Ranvier.",OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
J Physiol 2006; 573:17-34;  PMID:16527853 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
Ann Neurol 2014; 75:382-94; PMID:24318194 ;  http://dx.doi.org/10.1002/ana.24080Figure  1.,OADS,/arxiv_data1/oa_pdf/b0/34/kchl-08-04-10929965.PMC5210507.pdf
"An initial inhibition of TASK1/3 was quickly followed by Oxygen sensing with ion channels Donghee Kim * Department of Physiology and Biophysics; Chicago Medical School; Rosalind Franklin University of Medicine and Science; North Chicago, IL USA Keywords:  Oxygen sensing, hypoxia,  carotid body, chemosensory reflex, non-selective cation channel, Ca2+, depolarization *Correspondence to: Donghee Kim;   Email: donghee.kim@rosalindfranklin.edu Submitted: 04/25/2014Accepted: 04/28/2014http://dx.doi.org/10.4161/chan.29966 Kang D, Wang J, Hogan JO, Vennekens R, Freichel  M, White C, Kim D. Increase in cytosolic Ca2+ produced by hypoxia and other depolarizing stimuli activates a non-selective cation channel in chemoreceptor cells of rat carotid body.",Non-OADS,/arxiv_data1/oa_pdf/b8/be/kchl-08-04-10929966.PMC5210508.pdf
Essays Biochem  2007 ; 43:43- 60; PMID:17705792 ; http://dx.doi.org/10.1042/ BSE0430043 3.,Non-OADS,/arxiv_data1/oa_pdf/b8/be/kchl-08-04-10929966.PMC5210508.pdf
Eur Respir  J 2008 ; 32:1386 -98; PMID:18978138 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/be/kchl-08-04-10929966.PMC5210508.pdf
"However, the  building of the model simulation also led Bridge between the channel and FRET of PtdIns(4,5) P2 sensor Masayuki X Mori * Department of Synthetic Chemistry and Biological Chemistry; Graduate School of Engineering; Kyoto University; Kyoto, Japan Keywords:  Ion channel regulation,  PIP2, TRPC channels, FRET, Model simulation *Correspondence to: Masayuki X Mori;   Email: mxmori@sbchem.kyoto-u.ac.jp Submitted: 03/11/2014; Accepted: 03/21/2014http://dx.doi.org/10.4161/chan.29967 Itsuki K, Imai Y, Hase H, Okamura Y, Inoue R, Mori  MX.",OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
J Gen Physiol 2014; 143:183-201; PMID:24470487; http://dx.doi.org/10.1085/jgp.201311033,Non-OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
Biochim Biophys Acta  1975; 415:81-47;  PMID:164246 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
Science 1996; 273:956-9; PMID:8688080 ;  http://dx.doi.org/10.1126/science.273.5277.956 4.,Non-OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
"J Physiol 2010; 588:3179- 85; PMID:20519312 ; http://dx.doi.org/10.1113/ jphysiol.2010.192153 5. van der Wal J, Habets  R, Várnai  P, Balla  T, Jalink   K. Monitoring agonist-induced phospholipase C  activation in live cells by fluorescence resonance energy transfer.",OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
J Biol Chem 2001 ; 276:15337 -44;  PMID:11152673 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
J Gen Physiol 2010; 135:99-114; PMID:20100891 ;  http://dx.doi.org/10.1085/jgp.200910345 7.,Non-OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
J  Gen Physiol 2014; 143:183-201; PMID:24470487 ;  http://dx.doi.org/10.1085/jgp.201311033Figure 1.,OADS,/arxiv_data1/oa_pdf/c4/79/kchl-08-04-10929967.PMC5210509.pdf
"carvelli@med.und.edu Submitted: 06/16/2014Accepted: 07/17/2014http://dx.doi.org/10.4161/chan.29968Safratowich BD, Lor C, Bianchi L, Carvelli L.  Amphetamine activates an amine-gated chloride channel to generate behavioral effects in Cae - norhabditis elegans.",Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
"J Biol Chem 2013; 288:21630-7; PMID:23775081; http://dx.doi.org/10.1074/jbc.M113.484139 Safratowich BD, Hossain M, Bianchi L, Carvelli L. Amphetamine potentiates the effects of β-phenylethylamine through activation of  an amine-gated chloride channel.",Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
J Neurosci 2014; 34:4686-91; PMID:24672014; http://dx.doi.org/10.1523/JNEUROSCI.3100-13.2014,Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
Prog Neurobiol 2005; 75:406-33; PMID:15955613 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
PLoS  Biol 2005; 3:e271; PMID:16050778 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
J Neurochem  2004; 91:362-73;  PMID:15447669 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
Mol Pharmacol 2010; 78:151-6; PMID:20410438 ; http://dx.doi.org/10.1124/ mol.109.0627035.,Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
J Biol Chem 2013; 288:21630-7;  PMID:23775081 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
J Neurosci 2014; 34:4686- 91; PMID:24672014 ; http://dx.doi.org/10.1523/ JNEUROSCI.3100-13.2014 7.,Non-OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
Neurochem Int 2014; 73:27-31; PMID:24161617 ;  http://dx.doi.org/10.1016/j.neuint.2013.10.010 8.,OADS,/arxiv_data1/oa_pdf/f6/f5/kchl-08-04-10929968.PMC5210510.pdf
"6 This loss of KIR channel Channeling stress Inwardly-rectifying K+ channels in stress and disease TA Longden1, SE Hammack2, and Mark T Nelson1,3,* 1Department of Pharmacology; University of Vermont; Burlington, VT USA; 2Department of Psychology; University of Vermont; Burlington, VT USA; 3Institute  of Cardiovascular Sciences; University of Manchester; Manchester, UK Keywords:  Kir channels, stress,  glucocorticoids, dementia *Correspondence to: Mark T Nelson;   Email: mark.nelson@uvm.edu Submitted: 06/11/2014Accepted: 06/16/2014http://dx.doi.org/10.4161/chan.29969 Longden TA, Dabertrand F, Hill-Eubanks DC,  Hammack SE, Nelson MT; Commentary To.",Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Arch Gen Psychiatry  1995; 52:1048-60;  PMID:7492257 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Annu Rev Public Health 1994; 15:381-411;  PMID:8054091 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Proc Natl Acad Sci U S  A 2014; 111:7462-7;  PMID:24808139 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Nat Neurosci 2006; 9:1397-403; PMID:17013381 ; http://dx.doi.org/10.1038/ nn1779 6.,Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Nat Rev Neurosci  2009; 10:423-33;  PMID:19469026 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Brain 2010; 133:2217-24;  PMID:20488887 ; http://dx.doi.org/10.1093/brain/ awq116 8.,Non-OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
Acta Psychiatr Scand  1964; 40:77-106;  PMID:14217631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/2f/kchl-08-04-10929969.PMC5210511.pdf
"Channels (Austin) 2014;  8:8; PMID:24476902; http://dx.doi.org/10.4161/chan.27686 Viktor Yarotskyy and Robert T Dirksen* Department of Pharmacology and Physiology; University of Rochester Medical Center; Rochester, NY USAKeywords: Calcium signaling, Excitation-contraction coupling, Excitation-coupled calcium entry, L-type calcium channel, RGK protein, skeletal muscle*Correspondence to: Robert T. Dirksen; Email: robert_dirksen@urmc.rochester.edu Members of the Ras superfamily of mono - meric GTP-binding proteins (RGK proteins:  Rad, Rem, Rem2, Gem/Kir) are potent inhibi - tors of multimeric, high voltage-activated Ca2+  channels (CaV1 and CaV2).1 specifically, RGK  proteins inhibit voltage-gated Ca2+ currents  mediated by cardiac CaV1.2, neuroendocrine/sinoatrial node CaV1.3, and neuronal CaV2.1  and CaV2.2 channels.",Non-OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
PLos One 2012; 7:e37079;  PMiD:22590648; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
s cience 1993; 262:1441-4; PM iD:8248782;  http://dx.doi.org/10.1126/science.8248782 3.,OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
Proc Natl Acad sci U s A  2003; 100:14469-74; PM iD:14623965; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
Biophys J 2008; 94:2631-8; PM iD:18192376; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
Biophys J 2014; 106:1950-7;  PMiD:24806927; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
"Nat Commun 2013; 4:1952; PM iD:23736855;  http://dx.doi.org/10.1038/ncomms2952 8. w ang ZM, Messi ML, Delbono O. L-Type Ca(2+)  channel charge movement and intracellular Ca(2+) in skeletal muscle fibers from aging mice.",OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
Biophys  J 2000; 78:1947-54; PM iD:10733973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/45/kchl-08-04-10929982.PMC5210512.pdf
"To en- couragefurtherresearchon E.coligeneproductsthathave no known function to date, the EcoCyc project has gener- atedasetofpublicSmartTablesthatcontain(i)innermem-braneproteinswithminimalornocharacterization,(ii)pre- dicted, but uncharacterized inner membrane transporters and(iii)predictedtranscriptionfactors.Thesetableswillbeupdated on an ongoing basis and are available under the ’SmartTables >Public SmartTables’ menu or by using the followinglinks: http://ecocyc.org/group?id=biocyc13-4655-3682893892 (uncharacterized inner membrane proteins) http://ecocyc.org/group?id=biocyc17-4655-3682299327 (predictedinner membrane transporters) http://ecocyc.org/group?id=biocyc17-1553-3682788185 (predictedtranscriptional regulators) StaticversionsofthesetablesareavailableasSupplemen- tary Tables S2–S4.",Non-OADS,/arxiv_data1/oa_pdf/00/c1/gkw1003.PMC5210515.pdf
Detailed instructions for running a metabolic model through the EcoCyc website are available by se- lecting the ’Getting Started Guide’ link ( http://ecocyc.org/ PToolsWebsiteHowto.shtml#metabolicmodels ).ECOCYC AVAILABILITY EcoCyc is freely and openly available to all.,Non-OADS,/arxiv_data1/oa_pdf/00/c1/gkw1003.PMC5210515.pdf
"DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, DeGroote School of Medicine, McMaster University, Hamilton, Ontario L8S 4K1, Canada,2Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, V5A 1S6, Canada,3Bacterial Epidemiology and Antimicrobial Resistance Research Unit, USDA-ARS U.S. National Poultry Research Center, U.S. Department of Agriculture, Athens, GA 30605, USA and4School of Medicine, Royal College of Surgeons in Ireland, Dublin 2, Republic of Ireland Received August 15, 2016; Revised September 30, 2016; Editorial Decision October 14, 2016; Accepted October 17, 2016 ABSTRACT The Comprehensive Antibiotic Resistance Database (CARD; http://arpcard.mcmaster.ca ) is a manually cu- rated resource containing high quality reference data on the molecular basis of antimicrobial resistance (AMR), with an emphasis on the genes, proteins andmutations involved in AMR.",Non-OADS,/arxiv_data1/oa_pdf/e4/fa/gkw1004.PMC5210516.pdf
"D572NucleicAcidsResearch,2017,Vol.45,Databaseissue ingthestructureoftheARO.ThepublicCARDwebinter- facecanbefoundonlineat http://arpcard.mcmaster.ca ,pro- viding tools for browsing and searching the Antibiotic Re- sistance Ontology knowledgebase, definition of AMR de-tection model types within the Model Ontology, and se- quences,mutationinformationandparametersforindivid- ualAMRdetectionmodels.Thisincludestoolsfortrackingchanges in CARD curation between releases.",OADS,/arxiv_data1/oa_pdf/e4/fa/gkw1004.PMC5210516.pdf
"The CARD website also contains an online version of the Resistance GeneIdentifier(RGI),includingvisualizationtoolsforon-lineorofflineRGIresults.Thedataandontologiescurated into the CARD are available for download at the CARD websiteinavarietyoffileformats,e.g.OBO,tab-delimited,FASTA,andJSON.Thewebsitealsoincludesadownload- able, stand-alone version of the RGI, plus CARD AMR detection model data and the command-line version of theRGIareadditionallyavailablewithintheBiocondaproject, https://bioconda.github.io , for use within the Conda open source package management system.",OADS,/arxiv_data1/oa_pdf/e4/fa/gkw1004.PMC5210516.pdf
"CARD users are en- couraged to join the CARD-L mailing list or follow the CARD twitter feed to receive information on monthly up-datesandsoftwarereleases,see http://arpcard.mcmaster.ca/ about.TheCARDcuratorsanddevelopersareavailablefor contactat card@mcmaster.ca.",Non-OADS,/arxiv_data1/oa_pdf/e4/fa/gkw1004.PMC5210516.pdf
TcoF-DB v2 can be accessed athttp://tcofdb.org/ .,OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"However, the recent release of the FARNA database (http://cbrc.kaust.edu.sa/farna ) utilised TcoFs ( 31 ) to infer functionsofover10000non-codingtranscriptsinhumans,showing the importance of TcoFs for the function of their target transcripts.",OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"We distinguish between experimental evidence (GO codes: EXP, IDA, IMP, IGI, IEP and IPI) and non- experimental evidence (all other codes; for more detailon the codes see http://geneontology.org/page/guide-go- evidence-codes ).",Non-OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"For example, in addition to general gene infor- mation from NCBI Gene ( https://www.ncbi.nlm.nih.gov/ gene/),wealsolinktopathwayinformationandexpression data through the FANTOM5 SSTAR and EBI expression atlas (45,46) and to ZENBU and UCSC genome browsers (47,48), to be able to study the genes genomic context.",OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"TcoF-DB v2 was build using the DJANGO framework (https://www.djangoproject.com/ ), with a MySQL ( https: //www.mysql.com/ ) database in the backend.",OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
TcoF-DB v2 can be accessed at http://tcofdb.org andhttp://www.cbrc.,OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"kaust.edu.sa/tcofdb2 , while the source-code is freely avail- able athttps://gitlab.com/s-schmeier/tcof .",OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"Finally, STAG1, PADI4 and PHF19 have been linked to rheumatoid arthritis phenotypes in a GWAS datasetsfrom the GWAS Catalog SNP-Phenotype Associations dataset ( http://amp.pharm.mssm.edu/Harmonizome/ gene set/Rheumatoid+arthritis/GWAS+Catalog+SNP- Phenotype+Associations ).",OADS,/arxiv_data1/oa_pdf/d5/4c/gkw1007.PMC5210517.pdf
"In order to overcome these limitations, we present MEGARes ( https://megares.meglab.org ), a hand-curated antimicrobial resistance database and annotation structure that provides a founda- tion for the development of high throughput acycli-cal classiﬁers and hierarchical statistical analysis of big data.",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
Each componentintheworkflowisconfiguredtousedefaultset- tingsbutcanbemodifiedbytheuserifdesired.Installationand documentation can be found in the pipeline documen- tation (http://megares.meglab.org/amrplusplus ).,OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"read metagenomic data can result in false positive AMR geneidentifications( 43),theAmrPlusPluspipelinecanfilter out genes with a gene fraction below a user-defined thresh- old using a custom C++ program called ResistomeAna-lyzer (source code available at https://github.com/cdeanj/ resistomeanalyzer ).Countsofalignedreadsarerecordedat thegene,group,mechanismandclasslevelsandprovidedasoutput to the user in tab-delimited format, which can then beused forstatistical analysis.",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"com/cdeanj/rarefactionanalyzer ); for more informa- tion, see the online documentation for AmrPlusPlus (http://megares.meglab.org/amrplusplus ).",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"In addition, while the traditionalgoals of SNP calling have been functional and population genetic analyses, the use of metagenomic data in surveil- lance efforts could portend a new use for SNPs; namely, as a type of DNA ‘fingerprint’ for tracking AMR genes overtimeandgeography.Therefore,weprovideatoolcalledSNPFinder that reports all possible SNPs and read pair haplotypesidentifiedwithinametagenomicsampleandal- lows the user to determine which SNPs and read-pair hap-lotypes are significant based on their knowledge of the re- search question and population under study (source code availableat https://github.com/cdeanj/snpfinder ).TheSNPs detectedbySNPFinderarenotintendedtopredictwhether geneticchangeswillaffecttheresistancephenotype,butin- steadwillallowgeneticcomparisonsforecologicaltracking,evolutionary studies, or other investigations of SNP pro- files.SNPFindertakeseachread(orreadpair)thataligned to the resistance database and compares the read sequencetothereferencesequenceonanucleotide-by-nucleotideba- sis.",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"https://www.whitehouse.gov/sites/default/files/docs/ national actionplanforcombating antibotic-resistant bacteria.pdf (25October2016,date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"FoodandAgriculturalOrganizationoftheUnitedNations(2016) TheFAO actionplanonantimicrobialresistance2016-2020:Rome,Italy.http://www.fao.org/3/a-i5996e.pdf (25October2016,datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"https://www.usda.gov/oig/webdocs/50601-0004-31.pdf (25October 2016,datelastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"http://ec.europa.eu/dgs/health food-safety/amr/docs/ amrevaluation 2011-16 evaluation-action-plan.pdf (25October 2016,datelastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"UnitedStatesFoodandDrugAdministration(2013)Report NationalAntimicrobialResistanceMonitoringSystem––Enteric Bacteria.NARMSIntegratedReport:2012-2013:SilverSpring,MD.http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/ NationalAntimicrobialResistanceMonitoringSystem/UCM453398.",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
http://healthycanadians.gc.ca/publications/drugs-products-medicaments-produits/antibiotic-resistance-antibiotique/alt/pub-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"EMBL-EBIMetagenomics(2016)Localsurveillanceofinfectious diseasesandantimicrobialresistancefromsewage:Project(ERP015410).https://www.ebi.ac.uk/metagenomics/projects/ERP015410 (25 October2016,date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"CentersforDiseaseControlandPrevention(2016)AMDProjects: CombattingHealthcare-associatedInfections:Washington,D.C.http://www.cdc.gov/amd/pdf/factsheets/amd-projects-hai-2016.pdf(25October2016,datelastaccessed).",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"InteragencyTaskForceonAntimicrobialResistance(2012)Updatea publichealthactionplantocombatantimicrobialresistance- 2012Update:Washington,D.C.http://www.cdc.gov/drugresistance/pdf/action-plan-2012.pdf (25 October2016,date lastaccessed).",OADS,/arxiv_data1/oa_pdf/ba/29/gkw1009.PMC5210519.pdf
"D264–D270 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline26October2016 doi:10.1093/nar/gkw1011 WERAM: a database of writers, erasers and readers of histone acetylation and methylation in eukaryotes Yang Xu†, Shuang Zhang†, Shaofeng Lin, Yaping Guo, Wankun Deng, Ying Zhang and Yu Xue* Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology and the Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China Received August 06, 2016; Revised September 28, 2016; Editorial Decision October 16, 2016; Accepted October 18, 2016 ABSTRACT In this work, we developed a database WERAM (http://weram.biocuckoo.org/ ) for histone acetyl- transferases, histone deacetylases, histone methyl- transferases, histone demethylases and acetyl- or methyl-binding proteins, which catalyze, remove and recognize histone acetylation and methyla-tion sites as ‘writers’, ‘erasers’ and ‘readers’, and synergistically determine the ‘histone code’.",OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
"Furthermore, we downloaded the complete proteome sets for 148 eukaryotes including 68 animals, 39 plants and 41 fungi, from Ensembl ( 31) (release version 84, http://www.ensembl.org/ , under the di- rectoryof‘ /pub /release-84 /fasta’),EnsemblPlants(release version 31, http://plants.ensembl.org/ ) and EnsemblFungi (release version 31, http://fungi.ensembl.org/ ), respectively.",OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
"Genome-wide identification of HATs, HDACs, HMTs, HDMs and reader proteins For families with ≥3 member genes, the catalytic do- main sequences of HATs, HDACs, HMTs and HDMs, or PTM-binding domain sequences of acetyl-readers andmethyl-readers were first aligned for each family sepa- ratelywithMUSCLE( http://www.drive5.com/muscle/ ,ver- sion 3.8.31), an extensively used tool for multiple se-quence alignment ( 34).",OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
HMM models of 569 known histone regulators were then constructedatthefamilylevelusingthehmmbuildprogramof the HMMER 3.1b2 package ( http://hmmer.org/ )(30).,OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
"For the four families without HMM profiles (Other of HATs, HD2 of HDACs, Other of HMTs and Other of methyl-readers), we further performed orthologoussearches to identify 260 HATs, 96 HDACs, 419 HMTs and 264methyl-readersfrom148eukaryoticorganisms, respec- tively.Aspreviouslydescribed( 35),thestrategyofRecipro- calBestHits(RBH)waschosen,andtheblastallprogramin theBLASTpackagewasutilized( 36).Allproteinsequences andHMMprofilesofhistoneregulatorscanbefreelydown-loaded at: http://weram.biocuckoo.org/download.php .",OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
"In total, we identified and integrated 20 033 histone reg- ulators, including 1337 HATs, 2504 HDACs, 3901 acetyl-readers, 4409 HMTs, 1610 HDMs, 10 949 methyl-readers from 148 eukaryotic species (Supplementary Table S3), whereas a heatmap of the results was visualized using theHemI program ( http://hemi.biocuckoo.org/ ) (Supplemen- tary Figure S3) ( 37).",OADS,/arxiv_data1/oa_pdf/15/e8/gkw1011.PMC5210520.pdf
"A term that generates a maximal MetaMap In-dexing ranking function score of 1000 (details available at http://skr.nlm.nih.gov/papers/references/ranking.pdf )t oa UMLSconceptisacceptedasalegitimatealiasforMalaC-ards.Intotal,13425uniqueUMLSconceptswereidentified and mapped onto 12 817 unique maladies in MalaCards.",OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
iii) A manually curated table for cancer and respiratory drugs from FDA labels ( http://labels.fda.gov/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
"Summaries are mapped in several ways, depending on the informa- tionsource.Forexample,theWikipediasummaryislinkedby searching for the MalaCards main name, using the MediaWiki search API ( https://www.mediawiki.org/wiki/ API:Search ), and the SwissProtKB summary ( http://www.",OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
A total of 73.6% of the gene disease associa-tions are supported by GeneCards through a text mining process in which the disease main name is mined from the cards of the genes in GeneCards by using a non-stemmedSolrindex( http://lucene.apache.org/solr/ )andElasticsearch queries(https://www.elastic.co/ ).Datafilteringheuristicsat this stage reduce the noise level while retaining support for75% of the elite associations.,OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
Data from UniProtKB /Swiss-Prot ( http://www.uniprot.,OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
"Current incoming links include: The UCSC genomebrowser ( 41), whereby relevant genes have disease track links to the appropriate MalaCards, based on the gene- disease matrix; Genetic Home Reference (GHR) ( https:// ghr.nlm.nih.gov/ ), and Diseasecard ( 42), both originating from their disease pages, employing MalaCards name uni- fication scheme; PubMed LinkOuts ( http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
"(2009)Acceleratingsearchesof researchgrantsand scientificliteraturewithnovo |seekSM.Nat.Methods ,6, http://www.nature.com/nmeth/journal/v6/n5/full/nmeth.f.250.html .",Non-OADS,/arxiv_data1/oa_pdf/56/bb/gkw1012.PMC5210521.pdf
An up-to-dateversion of this tablecan befoundat http://ogee.medgenius.info/cancer/ .,Non-OADS,/arxiv_data1/oa_pdf/6a/1c/gkw1013.PMC5210522.pdf
The 3DSNP database is available at http://biotech.bmi.ac.cn/3dsnp/ .,OADS,/arxiv_data1/oa_pdf/f2/79/gkw1022.PMC5210526.pdf
"3DSNP API enables different applications to access a set of functional cat- egories of request SNPs with programmable interfaces.The API is defined as a HTTP URL request message (http://biotech.bmi.ac.cn/3dsnp/api.do ), along with a set of parameters, including: request data type, responsemessage format and request functional category.",OADS,/arxiv_data1/oa_pdf/f2/79/gkw1022.PMC5210526.pdf
"Example API requests could be defined as: http://biotech.bmi.ac.cn/ 3dsnp/api.do?id=rs1000&format=json&type=3dgene or http://biotech.bmi.ac.cn/3dsnp/api.do?position=1000000- 1000100&chrom=chr1&format=xml&type=3dgene,eqtl .",OADS,/arxiv_data1/oa_pdf/f2/79/gkw1022.PMC5210526.pdf
"FUNDING National Basic Research Project (973 program) [2012CB518200] ( http://www.973.gov.cn/ ); General Pro- gram [31401141, 81573251] and Major Research plan[U1435222] of the Natural Science Foundation of China (www.nsfc.gov.cn ); State Key Laboratory of Proteomics of China[SKLP-Y201303,SKLP-O201104,SKLP-K201004](www.bprc.ac.cn ); Special Key Programs for Science and Technology of China [2012ZX09102301-016]; Program of International S&T Cooperation (2014DFB30020);National High Technology Research and Development Program of China (2015AA020108).",Non-OADS,/arxiv_data1/oa_pdf/f2/79/gkw1022.PMC5210526.pdf
"Publishedonline26October2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D397–D403 doi:10.1093/nar/gkw1028 CGDB: a database of circadian genes in eukaryotes Shujing Li1,2,†, Ke Shui1,†, Ying Zhang1,†, Yongqiang Lv1, Wankun Deng1, Shahid Ullah1, Luoying Zhang1,*and Yu Xue1,* 1Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology and the Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, Hubei430074, China and 2Department of Life Sciences, Bengbu Medical College, Bengbu, Anhui 233030, China Received August 08, 2016; Revised October 17, 2016; Editorial Decision October 17, 2016; Accepted October 18, 2016 ABSTRACT We report a database of circadian genes in eukary- otes (CGDB, http://cgdb.biocuckoo.org ), containing ∼73 000 circadian-related genes in 68 animals, 39 plants and 41 fungi.",OADS,/arxiv_data1/oa_pdf/31/4c/gkw1028.PMC5210527.pdf
"All the genes in the database were annotated with primary references, cycling information, post-translational modifications (PTMs) and annotations from UniProt andEnsembldatabases ( 34,37).Allcyclinginformationandse- quences of proteins in CGDB were available for download athttp://cgdb.biocuckoo.org/download.php .",OADS,/arxiv_data1/oa_pdf/31/4c/gkw1028.PMC5210527.pdf
"To further understand the function of circadian clocks and how they regulate physiological rhythms, we analyzed the functional distribution of human cycling (and poten-tial cycling) genes by mapping the non-redundant human proteome set to two databases of Gene Ontology Annota- tion (UniProt-GOA, http://www.ebi.ac.uk/GOA )(38)a n d KyotoEncyclopediaofGenesandGenomes(KEGG)( 39).",OADS,/arxiv_data1/oa_pdf/31/4c/gkw1028.PMC5210527.pdf
"Here we present IMG /VR ( https://img.jgi.doe.gov/vr/ ), the largest publicly available database of 3908 isolate ref-erence DNA viruses with 264 413 computationally identiﬁed viral contigs from >6000 ecologically di- verse metagenomic samples.",OADS,/arxiv_data1/oa_pdf/3f/79/gkw1030.PMC5210529.pdf
TFBSbank is freely accessible at http://tfbsbank.co.uk INTRODUCTION The regulation of gene expression is the cornerstone of or- ganism development.,Non-OADS,/arxiv_data1/oa_pdf/7d/a4/gkw1035.PMC5210532.pdf
http://bioconductor.org/packages/release/data/ annotation/html/TxDb.Dmelanogaster.UCSC.dm3.ensGene.html .,OADS,/arxiv_data1/oa_pdf/7d/a4/gkw1035.PMC5210532.pdf
We have developed XT ALKDB (http://www.xtalkdb.org ) to ﬁll this very important gap.,Non-OADS,/arxiv_data1/oa_pdf/09/f6/gkw1037.PMC5210533.pdf
"D902–D907 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline24November2016 doi:10.1093/nar/gkw1038 NSDNA: a manually curated database of experimentally supported ncRNAs associated withnervous system diseases Jianjian Wang1,†, Yuze Cao1,†, Huixue Zhang1,†, Tianfeng Wang1, Qinghua Tian1, Xiaoyu Lu1, Xiaoyan Lu1, Xiaotong Kong1, Zhaojun Liu1, Ning Wang1, Shuai Zhang1, Heping Ma2,*, Shangwei Ning3,*and Lihua Wang1,* 1Department of Neurology, The Second Afﬁliated Hospital of Harbin Medical University, Harbin 150081, China, 2Department of Physiology, Emory University School of Medicine, Atlanta, GA 30322, USA and3College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China Received August 09, 2016; Revised October 17, 2016; Editorial Decision October 18, 2016; Accepted October 20, 2016 ABSTRACT The Nervous System Disease NcRNAome Atlas (NS- DNA) ( http://www.bio-bigdata.net/nsdna/ )i sam a n u - ally curated database that provides comprehensive experimentally supported associations about ner- vous system diseases (NSDs) and noncoding RNAs(ncRNAs).",OADS,/arxiv_data1/oa_pdf/8b/2c/gkw1038.PMC5210534.pdf
The web service is running on an Apache Tomcat webserver.TheNSDNAdatabaseisfreelyavailableat http: //www.bio-bigdata.net/nsdna/ andhttp://www.bio-bigdata.,OADS,/arxiv_data1/oa_pdf/8b/2c/gkw1038.PMC5210534.pdf
"The Orphanet nomencla-ture of rare diseases, whose adoption has been recom- mendedbytheEuropeanCommissionexpertgroupofrare diseases for codification of rare-disease (RD) patients inhealth information systems (recommendation on ways to improve codification for rare diseases in health informa- tion systems: http://ec.europa.eu/health/rare diseases/docs/ recommendation codingcegrden.pdf), is being annotated with HPO terms in order to allow for deep phenotyping of RD in healthrecords and registries.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
This enables an easy process to map HPO-encoded data to standard health-careterminologiessuchasSNOMEDCT( 19).HPO has contributed to the establishment of the International ConsortiumofHumanPhenotypeTerminologies(ICHPT; http://www.ichpt.org ) to provide the community with stan- dards that achieve interoperability among databases incor- porating human phenotypic features.,OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
Requests for new terms or other amendments can be made using the GitHub issues tracker https://github.com/obophenotype/human- phenotype-ontology/issues .,Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
Further information on HPO- related publications and general announcements can be found on the HPO website at http://www.human- phenotype-ontology.org and on the HPO twitter feed @hp ontology.,Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
DECIPHER ( https://decipher.sanger.ac.uk )w a se s t a b - lishedin2004asaweb-basedsystemforinterpretationand sharing of genomic variants and their associated pheno- types.,OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
"Aselectionofpublic-facingclinicaldatabasesusingHPOtoannotatepatientdatafordisease-genediscoveryprojects Name URL Ref PhenomeCentral phenomecentral.org (16) DDD(DecipheringDevelopmentalDisorders) www.ddduk.org (61,62) DECIPHER(DatabasEof genomiCvarIationandPhenotypeinHumansusingEnsemblResources)decipher.sanger.ac.uk (63) ECARUCA(EuropeanCytogeneticistsAssociationRegisterof UnbalancedChromosomeAberrations)http://umcecaruca01.extern.umcn.nl: 8080/ecaruca/ecaruca.jsp(64) The100000GenomesProject https://www.genomicsengland.co.uk/ (65) Geno2MP(ExomesequencingdatalinkedtophenotypicinformationfromawidevarietyofMendeliangenediscoveryprojects)http://geno2mp.gs.washington.edu (21) NIHUDP(UndiagnosedDiseasesProgram) availablevia phenomecentral.org (66) NIHUDN(UndiagnosedDiseasesNetwork) availablevia phenomecentral.org (16) HDG(HumanDiseaseGeneWebsiteseries) www.humandiseasegenes.com Phenopolis(Anopenplatformforharmonizationandanalysisofsequencingandphenotypedata)https://phenopolis.github.io GenomeConnect(Patientportaldevelopedby ClinGen( 67) www.genomeconnect.org (68) FORGECanada&Care4RareConsortium availablevia phenomecentral.org (69) RD-Connect platform.rd-connect.eu (28) Genesis thegenesisprojectfoundation.org health service.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
An important goal of the HPO and the Monarch Initiative is to provide computational standards that will allow for exchange of detailed genotype and phe- notype data by means of the emerging PhenoPackets stan-dard (http://phenopackets.org ).,Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
"HPO: AN ASSESSMENT BY THE NIHR RARE DIS- EASE INITIATIVES HPO is used as the system to capture of phenotypic infor- mationfortheUK’sNationalInstituteforHealthResearch(NIHR)RareDiseaseinitiativesonprojectssuchasNIHR RD-TRC (Rare Disease––Translational Research Collabo- ration,http://rd.trc.nihr.ac.uk )andtheNIHRBioResource Rare Disease NIHR BR-RD.",OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
"(2014)Howgoodisyourphenotyping?Methodsforqualityassessment.PhenotypeDay @ISMB2014, http://phenoday2014.bio-lark.org/ .",Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
"Phenoday@ ISMB2014, http://phenoday2014.bio-lark.org/.",Non-OADS,/arxiv_data1/oa_pdf/eb/23/gkw1039.PMC5210535.pdf
MGD is the core component of the Mouse Genome In- formatics (MGI) consortium ( http://www.informatics.jax.,OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"New this year, human phenotype terms and disease-to- phenotype relationships from the Human Phenotype On- tology(HPO, http://human-phenotype-ontology.github.io ) Project are integrated into HMDC.",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
The Alliance was forged in response to changes in the funding model for biomedical resources at NIH which have been covered in several recent articles Na-ture ( http://www.nature.com/news/funding-for-model- organism-databases-in-trouble-1.20134 ) and Science( http: //science.sciencemag.org/content/351/6268/14.full ).,Non-OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
Bulk and programmatic data access MGD provides access to its data by a number of tools and includingwebservices(seelinkson http://www.informatics.,OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"In addition, bulk data sets are available as downloadable reports ( http://www.informatics.",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"jax.org/downloads/reports/index.html ) and via the MGD Batch Query tool ( http://www.informatics.jax.org/batch ), whichallows users tocustomize datasets.",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"All data sets are asso-ciated with their source, either a publication or an elec- tronicsubmissionreference.Detailsaboutdatasubmission procedurescanbefoundat http://www.informatics.jax.org/ submit.shtml .",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
•World wide web: http://www.informatics.jax.org/ mgihome/support/mgi inbox.shtml .,OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
•Facebook: https://www.facebook.com/mgi.informatics .,Non-OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
•Twitter:https://twitter.com/mgi mouse.,Non-OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
On-linetrainingmaterialsforMGDandotherMGIdata resourcesareavailableasFAQsandon-demandhelpdocu- ments.Other outreach MGI-LIST ( http://www.informatics.jax.org/mgihome/lists/ lists.shtml ) is a moderated and active email bulletin board for the scientific community supported by the MGD User Support group.,OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
Included in our outreach and training activities are summer and academic year research internships inwhich MGD staff members mentor high school and college students from diverse backgrounds to foster interest in biomedical informatics and data science(https://www.jax.org/education-and-learning/high-school- students-and-undergraduates/learn-earn-and-explore ).,Non-OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"Genome browsing is accomplished with our installation of JBrowse( http://jbrowse.org ),aJavaScript-basedinteractive genome browser with extensive features for navigation and track selection( 22).",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
The Batch Query tool ( http://www.informatics.jax.,OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"MGD also provides a large set of regularly up- dated database reports ( http://www.informatics.jax.org/ downloads/reports/index.html ),anddirectSQLaccesstoa read-only copy of the database (contact MGI user supportfor an account).",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"In addition, the following cita- tion format is suggested when referring to datasets spe-cific to the MGD component of MGI: mouse genome database(MGD),MGI,TheJacksonLaboratory,BarHar- bor,Maine(URL: http://www.informatics.jax.org ).",OADS,/arxiv_data1/oa_pdf/da/ac/gkw1040.PMC5210536.pdf
"D860–D864 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline24November2016 doi:10.1093/nar/gkw1050 IPD-MHC 2.0: an improved inter-species database for the study of the major histocompatibility complex Giuseppe Maccari1,2, James Robinson2,3, Keith Ballingall4, Lisbeth A. Guethlein5, Unni Grimholt6, Jim Kaufman7, Chak-Sum Ho8, Natasja G. de Groot9, Paul Flicek10, Ronald E. Bontrop9, John A. Hammond1,†and Steven G. E. Marsh2,3,*, † 1The Pirbright Institute, Pirbright, Woking, Surrey, GU24 0NF , UK,2Anthony Nolan Research Institute (ANRI), Royal Free Hospital, London, NW3 2QG, UK,3UCL Cancer Institute, Royal Free Campus, London, NW3 2QG, UK, 4Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK,5Stanford University, Stanford, CA, 94305, USA,6Norwegian Veterinary Institute, Oslo, 0454, Norway,7University of Cambridge, Cambridge, CB2 1QP , UK,8Gift of Life Michigan, Ann Arbor, MI, 48108, USA,9Biomedical Primate Research Centre, Rijswijk, 2288 GJ Rijswijk, Netherlands and10European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK Received September 15, 2016; Revised October 17, 2016; Editorial Decision October 18, 2016; Accepted: November 01, 2016 ABSTRACT The IPD-MHC Database project ( http://www.ebi.",Non-OADS,/arxiv_data1/oa_pdf/37/ef/gkw1050.PMC5210539.pdf
"These are plaintextfilesthatcompriseofaseriesofstrictlycontrolleddata entries, presented in a tabular manner and defined by EBI (http://www.ebi.ac.uk/ena/submit/data-formats ).",OADS,/arxiv_data1/oa_pdf/37/ef/gkw1050.PMC5210539.pdf
A list of changes and improvements to date is already available athttp://www.ebi.ac.uk/ipd/mhc/version .,Non-OADS,/arxiv_data1/oa_pdf/37/ef/gkw1050.PMC5210539.pdf
"In particular, the server side was built using silex ( http: //silex.sensiolabs.org/ ), the popular micro-framework, to- getherwithtwig( http://twig.sensiolabs.org/ ),atemplateen- gine for PHP.",OADS,/arxiv_data1/oa_pdf/37/ef/gkw1050.PMC5210539.pdf
"Because the comprehensive regulation of crosstalk be- tween diverse RNA and proteins still remains ambiguous, we updated the RAID database ( 5) to version 2.0 (RAID v2.0,http://www.rna-society.org/raid/ )byintegratingexper- imentalandcomputationalpredictioninteractionsthrough the manual curation of the literature and another 18 re- sourcesunderonecommonframework(Figure 1).Accord- ingly, RAID v2.0 will offer several distinctive advantages: (i) integration from numerous resources, including experi- mental and computational prediction databases as well asmanualcurationoftheliterature(recruitingmorethan5.27 millionRNA-associatedinteractionsandexceedingan850- foldincreaseoverthepreviousversion);(ii)provisionofanintegrative confidence score for each RNA-associated in- *Towhomcorrespondenceshouldbeaddressed.Tel: +8645186699584;Fax:+8645186699584;Email:wangdong@ems.hrbmu.edu.cn CorrespondencemayalsobeaddressedtoJiaYu.Tel:+861069156423;Fax:+861065240529;Email:j-yu@ibms.pumc.edu.cnCorrespondencemayalsobeaddressedtoXiaoboLi.Tel: +8645186699584;Fax:+8645186699584;Email:lixiaobo@ems.hrbmu.edu.cn †Theseauthors contributed equallyto this work asthe first authors.",Non-OADS,/arxiv_data1/oa_pdf/d9/b9/gkw1052.PMC5210540.pdf
"D236–D242 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline29November2016 doi:10.1093/nar/gkw1053 JET2 Viewer: a database of predicted multiple, possibly overlapping, protein–protein interaction sitesfor PDB structures Hugues Ripoche1,†, Elodie Laine1,†, Nicoletta Ceres2and Alessandra Carbone1,3,* 1Sorbonne Universit ´es, UPMC University Paris 06, CNRS, IBPS, UMR 7238, Laboratoire de Biologie Computationnelle et Quantitative (LCQB), 75005 Paris, France,2CNRS UMR 5086 /University Lyon I, Institut de Biologie et Chimie des Proteines, 69367 Lyon, France and3Institut Universitaire de France, 75005 Paris, France Received July 23, 2016; Revised October 18, 2016; Editorial Decision October 20, 2016; Accepted October 20, 2016 ABSTRACT The database JET2 Viewer, openly accessible at http://www.jet2viewer.upmc.fr/ , reports putative pro- tein binding sites for all three-dimensional (3D) struc- tures available in the Protein Data Bank (PDB).",OADS,/arxiv_data1/oa_pdf/0a/bf/gkw1053.PMC5210541.pdf
DETAILS ON THE INPUT DATA The non-redundant set of all chains in the PDB was as- sembledwiththePISCESserver( http://dunbrack.fccc.edu/ PISCES.php )(21) by imposing a filter of ≤40% sequence identity.,OADS,/arxiv_data1/oa_pdf/0a/bf/gkw1053.PMC5210541.pdf
"Version1.8, https://www.pymol.org/citing .",Non-OADS,/arxiv_data1/oa_pdf/0a/bf/gkw1053.PMC5210541.pdf
"Publishedonline29November2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D119–D127 doi:10.1093/nar/gkw1054 R-loopDB: a database for R-loop forming sequences (RLFS) and R-loops Piroon Jenjaroenpun1, Thidathip Wongsurawat1, Sawannee Sutheeworapong2and Vladimir A. Kuznetsov1,3,* 1Department of Genome and Gene Expression Data Analysis, Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01, 138671, Singapore,2Systems Biology and Bioinformatics Research, Pilot Plant Development and Training Institute, King Mongkut’s University of Technology, Thonburi, Bangkok, Thailand and3School of Computer Engineering, Nanyang Technological University, 639798, Singapore Received August 14, 2016; Revised October 04, 2016; Editorial Decision October 20, 2016; Accepted October 20, 2016 ABSTRACT R-loopDB ( http://rloop.bii.a-star.edu.sg ) was origi- nally constructed as a collection of computationally predicted R-loop forming sequences (RLFSs) in the human genic regions.",OADS,/arxiv_data1/oa_pdf/8e/97/gkw1054.PMC5210542.pdf
Datasources We collected all genome assembly data from the UCSC genome browser ( https://genome.ucsc.edu/ )(27).,OADS,/arxiv_data1/oa_pdf/8e/97/gkw1054.PMC5210542.pdf
Gene annotation data for these organisms was re-trieved directly from MySQL server of BioMart database build 75 (ensembl mart75;http://www.ensembl.org/info/ data/mysql.html )(25).,OADS,/arxiv_data1/oa_pdf/8e/97/gkw1054.PMC5210542.pdf
Genomic information of the gene structures for these organisms (GTF format) was down- loaded from Ensembl Release 75 ( http://feb2014.archive.,OADS,/arxiv_data1/oa_pdf/8e/97/gkw1054.PMC5210542.pdf
"StatisticsofRLFS-positivegenesaccordingtotheEnsemblgeneannotationsystemandratioofRLFS-positivegenetototalnumberofgenefor eachgenecategoryineachorganism No.ofproteincodinggenes*No.ofpseudogenes*No.oflongnoncodingRNA genes*No.ofshortnoncodingRNA genes* Organism TotalRLFS positive Ratio TotalRLFS positive Ratio TotalRLFS positive Ratio TotalRLFS positive Ratio human 23431 17798 0.76 15934 4433 0.28 14966 9028 0.60 9771 2296 0.23mouse 22835 18201 0.80 6129 2161 0.35 4291 3283 0.77 5924 1950 0.33rat 22771 17529 0.77 1840 662 0.36 79 65 0.82 1714 608 0.35 chimpanzee 18759 15462 0.82 572 213 0.37 0 0 n /a 8681 1870 0.22 chicken 15508 12007 0.77 42 26 0.62 0 0 n /a 1558 546 0.35 frog 18442 9932 0.54 173 44 0.25 0 0 n /a 1306 268 0.21 fruit fly 13863 2423 0.17 200 11 0.06 830 104 0.13 789 30 0.04 yeast 6692 102 0.02 21 4 0.19 15 0 n /a 398 0 n /a Allorganisms 142301 93454 0.66 24911 7554 0.30 20181 12480 0.62 30141 7568 0.25 *The Ensemble gene biotypes were grouped into protein coding genes, pseudogenes, long non-coding RNA genes and short non-coding RNA genes (availableat http://asia.ensembl.org/Help/Faq?id=468 ).Examplesofgenebiotypesin eachgroupareas follows: -Protein coding genes: IGC gene, IGD gene, IG gene, IGJ gene, IGLV gene, IGM gene, IGV gene, IGZ gene, nonsense mediated decay, non-translating CDS,non-stopdecay,polymorphicpseudogene,TRCgene,TRDgene,TRJgene.-Pseudogenes:disrupteddomain,IGCpseudogene,IGJpseudogene,IGpseudogene,IGVpseudogene,processedpseudogene,transcribedprocessedpseu - dogene,transcribedunitarypseudogene,transcribedunprocessedpseudogene,translatedprocessedpseudogene,TRJpseudogene,unprocessedpse udogene -Long non-coding RNA genes: 3-prime overlapping ncRNA, ambiguous ORF, antisense, antisense RNA, lincRNA, ncRNA host, processed transcript, senseintronic,senseoverlapping-Short non-coding RNA genes: miRNA, miRNA pseudogene, miscRNA, miscRNA pseudogene, Mt rRNA, Mt tRNA, rRNA, scRNA, snlRNA, snoRNA,snRNA,tRNA,tRNA pseudogene.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/gkw1054.PMC5210542.pdf
The DisProt server is implemented in Node.js ( https://nodejs.org ) using the REST (Representa- tionalStateTransfer)architecture.Thedatacanbeaccessedthrough the web interface or programmatically exploit- ing the RESTful functionality.,OADS,/arxiv_data1/oa_pdf/9f/64/gkw1056.PMC5210544.pdf
The web interface is built using Angular.js (https://angularjs.org ) and Bootstrap ( http://getbootstrap.,OADS,/arxiv_data1/oa_pdf/9f/64/gkw1056.PMC5210544.pdf
All of these re- sources are publicly available and can be found at http://bigd.big.ac.cn .,OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"In addition, it is well equipped with facilities including both DNA sequencers and high perfor-mancecomputingresources.Therefore,theBIGDataCen- ter is dedicated to constructing and maintaining biologi- cal databases by big data integration and value-added cu-ration, performing basic research by development of ad- vanced methods to aid translation of big data into big discovery and providing freely open access to a suite offeatured data resources in support of worldwide activities in both academia and industry ( http://bigd.big.ac.cn ; Fig- ure1).",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"GENOME SEQUENCE ARCHIVE TheGenomeSequenceArchive(GSA; http://gsa.big.ac.cn ) is a data repository specialized for archiving raw sequence reads.Itsupportsdatageneratedfromavarietyofsequenc-ingplatformsrangingfromSangersequencingmachinesto single-cell sequencing machines and provides data storing and sharing services free of charge for worldwide scientificcommunities.Inadditiontorawsequencingdata,GSAalso accommodates secondary analyzed files in acceptable for- *TowhomcorrespondenceshouldbeaddressedZhangZhang.Tel: +861084097261;Fax:+861084097720;Email:zhangzhang@big.ac.cn CorrespondencemayalsobeaddressedtoWenmingZhao.Tel:+861084097636;Fax:+861084097720;Email:zhaowm@big.ac.cnCorrespondencemayalsobeaddressedtoJingfaXiao.Tel: +861084097443;Fax:+861084097720;Email:xiaojingfa@big.ac.cn ‡Fulllist providedin Appendix.",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"TheGeneExpressionNebulas(GEN; http://bigd.big.ac.cn/gen ) is a data portal of gene expression profiles based entirely on RNA-Seq data (that are retrieved from NCBI SRA(15)),whichcurrentlyhoststwofeaturedresources,namely, Mammalian Transcriptomic Database ( 16) and Rice Ex- pression Database (RED) ( 17).",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"Rice expression database (RED) RED (http://expression.ic4r.org ), a committed project of Information Commons for Rice (IC4R) ( 17), is an inte- grated database hosting rice gene expression profiles de- rived entirely from high-quality RNA-Seq data.",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
GENOME VARIATION MAP The Genome Variation Map (GVM; http://bigd.big.ac.,OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
Dog genome SNP database (DoGSD) Dog genome SNP database (DoGSD) ( http://bigd.big.ac.,Non-OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"As a committed sub-project of Dog 10K Genomes Project(dog10K; http://dog10k.big.ac.cn ), DoGSD is committed toincorporatingmorecomprehensivevariationdataforthe canineresearchcommunity,servingasacriticalresourceforbetter understanding the evolutionary history of dogs, in- vestigating genetic changes associated with domestication and relatinggenetic changes to phenotype.",Non-OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"Rice vari- ationdatabase(RVD)( http://variation.ic4r.org )(17)isbuilt based on a large collection of 5152 re-sequenced rice ac- cessions, which are mainly from published literatures ( 23– 27) and the 3K Rice Genomes Project ( 28), and accord- ingly includes ∼18 million SNPs against Os-Nipponbare- Reference-IRGSP-1.0 pseudomolecule identified by usingunified standard SNP-calling pipeline.",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"GENOME WAREHOUSE TheGenomeWarehouse(GWH; http://bigd.big.ac.cn/gwh ) is a centralized resource housing genome-scale data, with the purpose to archive high-quality genome sequences and geneannotationinformation.Currently,GWHoffersuserswith open access to a featured collection of 26 genomes from economically important plants and animals, which are either publicly available in NCBI ( 34) or sequenced in-house; among them, the genome of Hevea brasiliensis (rubber tree) ( 11) that has been released recently and se- quenced by our institution is a representative example.",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"NucleicAcidsResearch,2017,Vol.45,Databaseissue D21 METHYLATION BANK The Methylation Bank (MethBank; http://bigd.big.ac.cn/ methbank )(35) is a repository that integrates whole- genome single-base resolution methylomes and provides an interactive browser for visualization of high-resolutionDNAmethylationdata.Itincorporateshigh-qualitywhole- genome bisulfite sequencing methylome maps for five eco- nomically important crops ( Oryza sativa ,Glycine max , Manihot esculenta ,Phaseolus vulgaris andSolanum lycop- ersicum) as well as two model animals ( Danio rerio and Mus musculus )(36,37).",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"Spirited by its extraordinary success, Science Wikis ( http://bigd.big.ac.cn/sciencewikis )a r eas e - riesofbiologicaldatabaseswikifiedforcommunitycuration(40),amongwhichLncRNAWikiandRiceWikiaretwofea- tured resources that exploit the full potential of worldwide scientific communities for big data collection, integrationand management.",Non-OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"LncRNAWiki LncRNAWiki ( http://bigd.big.ac.cn/lncrnawiki )(41)i sa wiki-based, open-content and publicly editable platform that employs collective efforts in community curation of human long non-coding RNAs (lncRNAs).",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"RiceWiki RiceWiki ( http://wiki.ic4r.org )(48) is a wiki-based, pub- liclyeditableplatformforcommunitycurationofricegenes.",OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
WeengageintheGenomicsandBioinformaticsTraining(GBT; http://bigd.big.ac.cn/training/gbt ) at various levels ranging from introductory to in-depth and provide GBT courses for researchers and biomedical professionals at postgrad- uate level and above.,Non-OADS,/arxiv_data1/oa_pdf/c6/57/gkw1060.PMC5210546.pdf
"INTRODUCTION neXtProt ( https://www.nextprot.org ;(1–3)) is a knowledge platform that represents the current state of knowledge onhumanproteins.ItcomplementsUniProtKB( 4)byextend- ing the content and tools, with the aim of supporting ap- plications specifically relevant to human proteins.",OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
Changes in protein or mRNA stability are captured with in-house vocabularies availableon our FTP site: ftp://ftp.nextprot.org/pub/current release/ controlled vocabularies/cv proteinproperty.obo .,Non-OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
"The ‘unicity checker’, which uses the pepx program (available at https://github.com/calipho-sib/pepx ), was de- signed to help scientists determine which peptides are un-ambiguousandcanthusbeusedtoconfidentlyidentifypro- teinentries.The‘additionalmappingswithknownvariants’ modetakesintoaccountalltheSNPsanddiseasemutationsinneXtProttoincreasethesearchspace.Makinguseofthis tool for mass spectrometry data interpretation is now part of the recommendations of the HUPO Human Proteome Project (25).",OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
Data and software availability All neXtProt annotations are available as XML and PEFF files (3) on our FTP site ( ftp://ftp.nextprot.org/ ).,OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
The former XML files are no longer pro- videdduetotechnicalconstraints.Annotationscanalsobeaccessed through our API at https://api.nextprot.org and ourSPARQLendpoint( https://www.nextprot.org/proteins/ search?mode=advanced ).,OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
The Cellosaurus – a knowledge resource on cell lines is available at ftp://ftp.expasy.org/ databases/cellosaurus/ (note that the files are no longer on the neXtProt FTP site).,OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
"Our software is freely available from the GitHub repository ( https://github.com/calipho-sib ) or biojs ( http: //www.biojs.io/ ), as described in our documentation ( https: //www.nextprot.org/help/technical-corner/ ).",OADS,/arxiv_data1/oa_pdf/14/09/gkw1062.PMC5210547.pdf
Homepage:http://ccg.vital-it.ch/snp2tfbs/ .,Non-OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
"DataSourcesandSoftwareToolsusedforGeneratingSBP2TFBS SourceData SNPcatalog(1000Genomes) VCFfilefrom1000Genomes(versionv5a.20130502),filteredforminorallelefrequency >0.001 [a] Humanreference genome(UCSC) HumanreferencegenomeGRCh37 /hg19inFASTAformat [b] PWMcollection(JASPAR /MEME) JASPARCore Vertebrate2014PWMfromMEMEmotifdatabaseversion12.1 [c] Geneannotation(RefSEQ,Annovar) FromRefSeq(versionFeb2016)asprovidedbyANNOVARversionv2016-02-0 [d] Externalandin-housesoftwaretools vcf2diploid(v0.2.6) MappingallelesfromVCFinreference togeneratealternategenome [e]GATK(v3.6) Liftovervariantsfromreference toalternateassembly [f] Samtools(v0.1.14) Generatinggenomeassemblyindexfile(requiredforPicard) [g] Picard(v1.131) BuildinggenomedictionaryforGATK [h]ANNOVAR(v2016-02-01) AnnotatingvariantsofinterestwithrefGeneannotation(versionFeb2016) [d]PWMTools(v1.0.0) Scanninga wholegenomewithaPWM(matrix scan)anddeterminingthe P-valuethresholdfor PWMscores(matrix prob.pl)[i] ScriptsavailablefromtheSNP2TFBSFTPsite makeAltGenome.sh Wrappertogeneratealternategenomeassembly makeSNP2TFBS.sh WrapperforscanninggenomeswithPWMsandoutputbothmappedfiles(singlePWMformat) andSNP2TFBSmasterfile makeDerivedFormats.sh Wrappertogeneratederivedformats(BED,SGAandannotated)frombothSNP2TFBSsingle PWMandmasterfiles vcffilter.pl Inputisasingleormulti-samplevcffile(withSNPandindels)andoutputisa singlecolumnvcf filewithAF ≥0.001andalleleswithhighestAF snptable.pl Mergingandindexingvariantsforbothgenomeassemblies variantPWMmatch.pl Mappingvariantsin PWMsitesof bothgenomes filterVariantPWMmatch.pl MergingandfilteringPWMsiteswithvariantsfrombothgenomeassembliesmergeMappedFiles.pl MergingmappedfilesforallthefactorsandoutputasinglefilewithPWMinrowssortedwith absolutescoredifferencebetweenbothgenomeassemblies a1000Genomes: ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/ .",Non-OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
bhg19:http://hgdownload.cse.ucsc.edu/goldenPath/hg19/chromosomes/ .,Non-OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
cMEMEmotifdatabase: http://jaspar2014.genereg.net/html/DOWNLOAD/ .,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
dANNOVAR: http://annovar.openbioinformatics.org/en/latest/ (13).,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
evcf2diploid: http://alleleseq.gersteinlab.org/vcf2diploid v0.2.6.zip (15).,Non-OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
fsamtools: https://sourceforge.net/projects/samtools/files/samtools/ (17).,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
gpicard:https://github.com/broadinstitute/picard/releases/download/1.131/picard-tools-1.131.zip .,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
hGATK:https://software.broadinstitute.org/gatk/download/ (16).,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
iPWMTools: https://sourceforge.net/projects/pwmscan/ .,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
Examples ofentryURLs areshown below: •http://ccg.vital-it.ch/cgi-bin/snp2tfbs/ snpviewer formparser.cgi?snpid=rs11603840 •http://ccg.vital-it.ch/cgi-bin/snp2tfbs/pwmviewer?ID= MA0139.1&name=CTCF The SNP viewer displays a list of transcription factor binding sites affected by the sequence variation along with thebindingscoresforthetwoalleles.ThePWMviewerdis- plays the binding specificity matrix in text form (exactly as used by the SNP2TFBS data generation pipeline) and as a,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
DATABASE AVAILABILITY SNP2TFBS is freely available without registration at ftp:// ccg.vital-it.ch/snp2tfbs/ andhttp://ccg.vital-it.ch/snp2tfbs/ .,OADS,/arxiv_data1/oa_pdf/56/0b/gkw1064.PMC5210548.pdf
"HmtDB is accessible at http://www.hmtdb.uniba.it/ .INTRODUCTION TheinvestigationofhumanmitochondrialDNA(mtDNA) variation and genetics over the past decades has provided unique and often startling insights into human evolution, degenerative diseases and aging ( 1,2).",Non-OADS,/arxiv_data1/oa_pdf/1a/3a/gkw1066.PMC5210550.pdf
"The whole website is built upon the W3.CSS framework ( http://www.w3schools.com/w3css/default.asp ) that allows a safe and consistent page rendering on everyplatform and web browser, including mobile devices.",OADS,/arxiv_data1/oa_pdf/1a/3a/gkw1066.PMC5210550.pdf
"HmtDB tracks on MseqDR GBrowse MSeqDR ( http://mseqdr.org/ ) is a central data resource for mitochondrial diseases, supported by the United Mito-chondrial Disease Foundation and the National Institutes ofHealth.Itswebsiteisaninnovativeinternationalgenomic dataresourceformitochondrialdiseasecommunitythatfa-cilitatesthecoherentcompilation,organization,annotation and analysis of sequence data from both nuclear and mito- chondrialgenomes( 10,30).TheMSeqDRwebsiteprovides accesstoawiderangeofweb-basedbioinformaticstools,in- cluding the GBrowse instance that enables integrated visu-alizationandanalysisofheterogeneousvariationandother genomic datacontained inoptimized annotation tracks.",OADS,/arxiv_data1/oa_pdf/1a/3a/gkw1066.PMC5210550.pdf
This manuscript describes TransportDB 2.0 ( http://www.membranetransport.,Non-OADS,/arxiv_data1/oa_pdf/9d/21/gkw1068.PMC5210551.pdf
"Data sources The transporter annotation pipeline uses data sources including NCBI’s RefSeq ( ftp://ftp.ncbi.nih.gov/genomes/ refseq/bacteria )(12)a n dC O G( 13) databases, the Trans- porterClassificationDatabase(TCDB; www.tcdb.org )(11) as well as selected HMMs for transporter protein families from the TIGRfam and Pfam databases ( 14,15).",OADS,/arxiv_data1/oa_pdf/9d/21/gkw1068.PMC5210551.pdf
"BioRxiv: http://dx.doi.org/10.1101/033142 ).Userscansub- mit a DNA or amino acid sequence query sequence toquery against all protein sequences in TransportDB, using BlastxorBlastp,respectively.Followingthe‘Phylogenetics, FASTAfilesandalignments’buttonwillfacilitateaccesstofilesofinformationforeachtransportproteinfamilyorsu- perfamily,includingfastaformattedfilescontainingallpro- tein sequences, multiple sequence alignment files of all se-quenceswithinafamily,aswellas,phylogenetictreesshow- ingtherelationshipsofallsequenceswithineachfamily,us- ingthesoftwaretool Archaeopteryx ( 23).",OADS,/arxiv_data1/oa_pdf/9d/21/gkw1068.PMC5210551.pdf
"Contents TransportDB 2.0 now serves the membrane transporter annotation of 2777 complete genomes, comprising 2557eubacteria, 164 archaea and 56 eukaryota, and is cur- rently available at http://www.membranetransport.org/ transportDB2 .",OADS,/arxiv_data1/oa_pdf/9d/21/gkw1068.PMC5210551.pdf
"Publishedonline28November2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D51–D55 doi:10.1093/nar/gkw1069 The eukaryotic promoter database in its 30th year: focus on non-vertebrate organisms Ren´e Dreos1,*, Giovanna Ambrosini1,2, Romain Groux1, Roua ¨ıda Cavin P ´erier1and Philipp Bucher1,2 1Swiss Institute of Bioinformatics (SIB), CH-1015 Lausanne, Switzerland and2Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, Switzerland Received September 15, 2016; Revised October 21, 2016; Editorial Decision October 24, 2016; Accepted October 24, 2016 ABSTRACT We present an update of the Eukaryotic Promoter Database EPD ( http://epd.vital-it.ch ), more speciﬁ- cally on the EPDnew division, which contains com-prehensive organisms-speciﬁc transcription start site (TSS) collections automatically derived from next generation sequencing (NGS) data.",Non-OADS,/arxiv_data1/oa_pdf/0b/63/gkw1069.PMC5210552.pdf
Web-based access is provided via the EPD web site at http://epd.vital-it.ch/ .,OADS,/arxiv_data1/oa_pdf/0b/63/gkw1069.PMC5210552.pdf
Data files can be down- loaded via FTP from ftp://ccg.vital-it.ch/ .,OADS,/arxiv_data1/oa_pdf/0b/63/gkw1069.PMC5210552.pdf
"This information, combined with bibliographic information from PubMed, is made avail-ableforsearchesviatheGeneExpressionLiteratureQuery form (http://www.informatics.jax.org/gxdlit ).",OADS,/arxiv_data1/oa_pdf/c6/75/gkw1073.PMC5210556.pdf
"We have now migrated GXD to use this new mouse developmentanatomy ontology, and we have developed a new Mouse DevelopmentalAnatomyBrowser( http://www.informatics.",Non-OADS,/arxiv_data1/oa_pdf/c6/75/gkw1073.PMC5210556.pdf
The link ( http://www.mousemine.org/ mousemine/begin.do#Expression ) from the GXD home page leads to the Expression tab of the MouseMine front page.,OADS,/arxiv_data1/oa_pdf/c6/75/gkw1073.PMC5210556.pdf
FAQs (and other useful links) can be foundon the GXD home page ( http://www.informatics.jax.org/ expression.shtml ).,OADS,/arxiv_data1/oa_pdf/c6/75/gkw1073.PMC5210556.pdf
"CITING GXD The following citation format is suggested when refer- ring to data downloaded from GXD: These data were re- trievedfromtheGeneExpressionDatabase(GXD),MouseGenome Informatics, The Jackson Laboratory, Bar Har- bor, Maine, USA (URL: http://www.informatics.jax.org ) on [type in date (month, year) when you retrieved the datacited].",OADS,/arxiv_data1/oa_pdf/c6/75/gkw1073.PMC5210556.pdf
"dbDEMC 2.0 is freely available athttp://www.picb.ac.cn/dbDEMC .INTRODUCTION As the leading cause of human death, cancer continues to represent a huge economic and social burden to society.",Non-OADS,/arxiv_data1/oa_pdf/b2/2f/gkw1079.PMC5210560.pdf
All the information in dbDEMC 2.0 is freely available to the public domain through http://www.picb.ac.,OADS,/arxiv_data1/oa_pdf/b2/2f/gkw1079.PMC5210560.pdf
The limma (Linear Models for Microarray and RNA-seq Data)package( 22)embeddedinR( http://www.r-project.org/ ) wasusedtoselectmiRNAswhosemeanexpressionlevel is significantly different between case and control sam-ples.,OADS,/arxiv_data1/oa_pdf/b2/2f/gkw1079.PMC5210560.pdf
"D818NucleicAcidsResearch,2017,Vol.45,Databaseissue TCGA Research Network: http://cancergenome.nih.gov/ forthe availability ofthedata.",OADS,/arxiv_data1/oa_pdf/b2/2f/gkw1079.PMC5210560.pdf
"Peptidome ( 7) and Tranche (8),havebeenclosedowingtoissueswiththesustainability ofdatabasemaintenance.ThedatabasesPRoteomicsIDEn- tifications(PRIDE)( 9),massspectrometryInteractiveVir- tualEnvironment(MassIVE, http://massive.ucsd.edu/ )and PeptideAtlas SRM Experiment Libraries (PASSEL) ( 10) are currentlyavailable publicdatarepositories.",OADS,/arxiv_data1/oa_pdf/75/7c/gkw1080.PMC5210561.pdf
"To avoid this problem, web services for accelerating transfer speed, such as the Aspera ( http://asperasoft.com/ ) file transfer protocol, are often used; however, these services are expensive and can havedisadvantageswithregardtothesustainabilityofdata repository maintenance.",Non-OADS,/arxiv_data1/oa_pdf/75/7c/gkw1080.PMC5210561.pdf
"mzML ( 18)a n dM a s - cotGenericFormat(MGF; http://www.matrixscience.com/ help/data filehelp.html ); database-search result files, i.e.",OADS,/arxiv_data1/oa_pdf/75/7c/gkw1080.PMC5210561.pdf
"Systemimplementation The file upload system in our repository employs an open-source JavaScript library, flow.js ( https://github.com/ flowjs/).",OADS,/arxiv_data1/oa_pdf/75/7c/gkw1080.PMC5210561.pdf
"The visualization system of the corresponding re- lationships of mass peaks and peptides for the completesubmissionemploysanopen-sourcelibrary,Lorikeet( http: //uwpr.github.io/Lorikeet/ ), which is a plugin of the jQuery library(https://jquery.com/ )toviewMS /MSspectraanno- tatedwith fragment ions.",OADS,/arxiv_data1/oa_pdf/75/7c/gkw1080.PMC5210561.pdf
"PathDIP ( http://ophid.utoronto.ca/pathdip ) annotates 17 070 protein-coding genes with 4678 pathways, and provides multiple query, analysis andoutput options.",OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
"D420NucleicAcidsResearch,2017,Vol.45,Databaseissue tions.Wehavedeveloped pathway DataIntegration Portal, pathDIP ( http://ophid.utoronto.ca/pathdip ), for compre- hensive gene enrichment analysis, which annotates 17 070 human protein-codinggenes with4,678 pathways.",OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
GeneOntology( GO).Wedownloadedhumangeneanno- tationsfilefromGOwebsite( http://geneontology.org )asof 12 October 2015.,Non-OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
"While pathDIP provides simplewordcloudbasedonwordenrichmentscores,words andtheirenrichmentscoresarealsoavailablefordownloadas a text file, which could be visualized using customisable wordcloudvisualizersuchas http://www.wordle.net ,https: //www.jasondavies.com/wordcloud/ , and wordcloud pack- age in R. Resulting word clouds do not represent simple word frequencies, rather, they reflect the significance of ap-pearance of each word intitlesof enrichedpathways.",OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
Core and Extended pathways are available for down- load and enrichment analysis can be performed online atpathDIP portal: http://ophid.utoronto.ca/pathdip .,OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
Integrating curated pathways with PPI data and compu- tationalpathway-associationpredictionsprovidesthemost sensibleapproachtodecreasingbiasesandimprovingpath-wayannotationcoverageforprotein-codinggenes.PathDIP (http://ophid.utoronto.ca/pathdip )offerssuchrichresource for pathwayannotation and pathway enrichmentanalysis.,OADS,/arxiv_data1/oa_pdf/75/42/gkw1082.PMC5210562.pdf
ChimerDB 3.0 is available at http://ercsb.ewha.ac.kr/fusiongene/ .,OADS,/arxiv_data1/oa_pdf/94/1e/gkw1083.PMC5210563.pdf
We have re-analyzed RNA-Seq data from the TCGA with 4569 tumor samples in 23 cancer typesusingFusionScan( http://fusionscan.ewha.ac.kr/ )and TopHat-Fusion ( 17) that we selected based on the bench- mark test of precision and recall rates.,OADS,/arxiv_data1/oa_pdf/94/1e/gkw1083.PMC5210563.pdf
"RNA-Seq is the most popular source of data to pre- dictfusiontranscriptsandanumberoftoolshavebeenpub-lishedsofar.Wehavecomparedtheperformanceofseveral toolsincludingSOAPfuse( 21),deFuse( 22),FusionHunter (23),FusionMap( 24),TopHat-Fusion( 17)andFusionScan (our in-house developed program; http://fusionscan.ewha.",OADS,/arxiv_data1/oa_pdf/94/1e/gkw1083.PMC5210563.pdf
"In the updated YM500v3database ( http://ngs.ym.edu.tw/ym500/ ) presented herein, we not only focus on miRNAs but also on other functional small non-coding RNAs (sncRNAs),such as PIWI-interacting RNAs (piRNAs), tRNA- derived fragments (tRFs), small nuclear RNAs (snR- NAs) and small nucleolar RNAs (snoRNAs).",Non-OADS,/arxiv_data1/oa_pdf/59/27/gkw1084.PMC5210564.pdf
"Publishedonline29November2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D353–D361 doi:10.1093/nar/gkw1092 KEGG: new perspectives on genomes, pathways, diseases and drugs Minoru Kanehisa1,*, Miho Furumichi1, Mao Tanabe1, Yoko Sato2and Kanae Morishima1 1Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan and2Healthcare Solutions Department, Fujitsu Kyushu Systems Ltd., Hakata-ku, Fukuoka 812-0007, Japan Received October 09, 2016; Editorial Decision October 25, 2016; Accepted October 26, 2016 ABSTRACT KEGG ( http://www.kegg.jp/ orhttp://www.genome.jp/ kegg/ ) is an encyclopedia of genes and genomes.",OADS,/arxiv_data1/oa_pdf/6c/83/gkw1092.PMC5210567.pdf
"TheKEGGdatabases Category Databasename Content KEGGidentifier SystemsInformation KEGGPATHWAY KEGGpathway maps Map number KEGGBRITE BRITE hierarchies and tables br /konumber KEGGMODULE KEGGmodules M number GenomicInformation KEGGORTHOLOGY (KO) KOgroupsforfunctional orthologs K number KEGGGENOME KEGGorganisms (completegenomes) andselected viruses orgcode /T number KEGGGENES Genecatalogs of KEGGorganisms, viruses, and addendumcategory org:geneKEGGSSDB Sequencesimilarity amongGENESentries (computationallygenerated) Chemical Information KEGGCOMPOUND Metabolites and other small molecules C number(KEGGLIGAND) KEGGGLYCAN Glycans G number KEGGREACTION Biochemical reactions Rnumber KEGGRCLASS Reaction class RC numberKEGGENZYME Enzymenomenclature EC number Health Information KEGGDISEASE Humandiseases H number(KEGGMEDICUS a)K E G G D R U G D r u g s D number KEGGDGROUP Druggroups DGnumberKEGGENVIRON Crudedrugs and health-related substances E number aKEGGMEDICUSalsoincludesJapanesedruglabelsobtainedfromtheJAPICdatabase( http://www.japic.or.jp )andFDAdruglabelsobtainedfromtheDailyMeddatabase (http://dailymed.nlm.nih.gov ).",OADS,/arxiv_data1/oa_pdf/6c/83/gkw1092.PMC5210567.pdf
AccessingKEGG KEGG is made available at both the KEGG main site (http://www.kegg.jp/ )andtheGenomeNetmirrorsite( http: //www.genome.jp/kegg/ ).,OADS,/arxiv_data1/oa_pdf/6c/83/gkw1092.PMC5210567.pdf
"To effectively detect viruses, the MRPrimerV database (http://MRPrimerV.com ) contains 152 380 247 PCR primer pairs for detection of 1818 viruses, covering 7144 coding sequences (CDSs), representing 100% of the RNA viruses in the most up-to-date NCBIRefSeq database.",OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"The NCBI Probe Database ( http://www.ncbi.nlm.nih.gov/probe/ )p r o - vides nucleic acid reagents for use in a wide variety of biomedical research applications such as RNAi, PCR and microarray, as well as primers and probes for the detec-tion of some viruses.",Non-OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
The last updated versionofVirOligo( http://viroligo.okstate.edu/index.html ) supports 109 RNA /DNA viruses.,Non-OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"ToeffectivelydetectandidentifyRNAviruses,wepresent a new database, MRPrimerV, which contains a collection of 152 380 247 high-quality PCR primer pairs for detec-tionof1818RNAviruses.These insilicoprimerscandetect 100%ofRNAvirusesinthemostup-to-dateversionofthe NCBI RefSeq database (Release 76, http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"WeconvertedtheresultsofMRPrimerprocessing,along with an annotation database downloaded from GenBank (ftp://ftp.ncbi.nlm.nih.gov/genomes/ ), to the MRPrimerV database in key–value format.",OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"TheMRPrimerVdatabaseconsistsofninekey–valueta- bles: one table for PCR primers, one table for TaqMan probes, five partial annotation tables for five query types,onefullannotationtableforviralgenomes,andonefullan- notationtableforviralCDSs.Thepartialannotationtables areusedtoidentifyuserinputforeachquerytype.Thefullannotationtablesareusedtogeneratetheoutputpage.The database is physically stored using Redis ( http://redis.io/ ), an in-memory key–value store that supports various kindsof data structures for various types of values, including string, hash, list, setand sortedset.",OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"MRPrimerV contains not only primers and probes, but also validation results for some viruses, in particular 12 RNAvirusesfromtheCentersforDiseaseControlandPre- vention (CDC) of Korea ( http://www.cdc.go.kr/CDC/eng/ main.jsp).",Non-OADS,/arxiv_data1/oa_pdf/56/6c/gkw1095.PMC5210568.pdf
"Launched in 2005, the MicroScope platform (http://www.genoscope.cns.fr/agc/microscope )i sa n integrative resource that supports systematic andefﬁcient revision of microbial genome annotation, data management and comparative analysis.",OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
"Thesepipelinesareorganizedinarobustautomatedtask managementsystemusingthejBPMframework(JavaBusi- ness Process Management; http://www.jbpm.org ) which al- lowsustohandlesimultaneouslytheanalysisofseveralnew microbialgenomes.Indeed,genomesarecontinuouslyinte- grated into MicroScope in batches of hundred of new ge-nomic sequences (see the ‘DATA GROWTH CONTENT ANDMICROSCOPEUSERS’section).Moreover,alarge part of these analyses are updated at regular intervals totakeintoaccountprimarydatabasesgrowthandnewexpert annotations.",OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
"Visualization system: MaGe (Magnifying Genome) All this data is made accessible to users through the Mi- croScope Web interface ( http://www.genoscope.cns.fr/agc/ microscope )viasecureoranonymousconnectionasappro- priate.DevelopedusingtheApache /PHPserver-basedlan- guage,itconsistsofnumerousdynamicwebpagescontain-ing textual and graphical representations for accessing and querying data.",OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
"D520NucleicAcidsResearch,2017,Vol.45,Databaseissue user submission fully automated, we have developed a dedicatedWebinterface( https://www.genoscope.cns.fr/agc/ microscope/about/services.php ).",OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
More information is available on our website: http://www.genoscope.cns.fr/agc/ microscope/training .,Non-OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
"NucleicAcidsResearch,2017,Vol.45,Databaseissue D527 at the programmatic level via a RESTful API (http://rest-microscope.genoscope.cns.fr ).",OADS,/arxiv_data1/oa_pdf/4d/2a/gkw1101.PMC5210572.pdf
"Publishedonline14December2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D369–D379 doi:10.1093/nar/gkw1102 The BioGRID interaction database: 2017 update Andrew Chatr-aryamontri1, Rose Oughtred2, Lorrie Boucher3, Jennifer Rust2, Christie Chang2, Nadine K. Kolas3, Lara O’Donnell3, Sara Oster3, Chandra Theesfeld2, Adnane Sellam4, Chris Stark3, Bobby-Joe Breitkreutz3, Kara Dolinski2and Mike Tyers1,3,* 1Institute for Research in Immunology and Cancer, Universit ´e de Montr ´eal, Montr ´eal, Quebec H3T 1J4, Canada, 2Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA,3The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada and4Centre Hospitalier de l’Universit ´e Laval (CHUL), Qu ´ebec, Qu ´ebec G1V 4G2, Canada Received September 29, 2016; Revised October 25, 2016; Editorial Decision October 26, 2016; Accepted October 27, 2016 ABSTRACT The Biological General Repository for Interaction Datasets (BioGRID: https://thebiogrid.org ) is an open access database dedicated to the annotation and archival of protein, genetic and chemical interac- tions for all major model organism species and hu- mans.",OADS,/arxiv_data1/oa_pdf/31/a2/gkw1102.PMC5210573.pdf
"The Biological General Repository for Interaction Datasets (BioGRID: https://thebiogrid.org ) was originally implemented in 2003 ( 16) to provide open access to high- throughput (HTP) interaction datasets ( 1–3), and subse- quentlytoaugmentandbenchmarkHTPdatawithinterac- tions drawn from focused low-throughput (LTP) studies inthebiomedicalliterature( 17).Sinceitsinceptionasayeast- specific database ( 16), BioGRID has grown to cover inter- actionsfrom66differentspecies,includingallmajormodel organisms and humans.",OADS,/arxiv_data1/oa_pdf/31/a2/gkw1102.PMC5210573.pdf
"RefSeq protein identi- fiers are used for the annotation of PTMs, which are typ-ically mapped to RefSeq by mass spectrometry search en- gines(seetheBioGRIDWikiPageforfurtherdetails;URL: https://wiki.thebiogrid.org/doku.php/identifiers ).",OADS,/arxiv_data1/oa_pdf/31/a2/gkw1102.PMC5210573.pdf
We have contin- ued to update our online Wiki documentation with de-tailedinformationonallaspectsofBioGRIDtoolsandre- sources (see https://wiki.thebiogrid.org ).,Non-OADS,/arxiv_data1/oa_pdf/31/a2/gkw1102.PMC5210573.pdf
com/BioGRID )andwecontinuetoupdatebothourTwitter (https://twitter.com/biogrid ) and YouTube Channel ( https: //www.youtube.com/user/TheBioGRID ) with the latest Bi- oGRID newsand featureupdates.,Non-OADS,/arxiv_data1/oa_pdf/31/a2/gkw1102.PMC5210573.pdf
"In order to advance the exploration of mi-crobial secondary metabolism, we developed the largest publically available database of experimen- tally veriﬁed and predicted BCs, the Integrated Mi-crobial Genomes Atlas of Biosynthetic gene Clus- ters (IMG-ABC) ( https://img.jgi.doe.gov/abc/ ).",OADS,/arxiv_data1/oa_pdf/6c/a0/gkw1103.PMC5210574.pdf
"NEW FEATURES AND UPDATES Openaccess tobrowsing IMG-ABC can be accessed at https://img.jgi.doe.gov/abc/ andcanbebrowsedwithoutaloginrequirement.However, creating a free IMG account enables users to utilize IMG-ABC’s ‘BC Set’ feature, which allows saving groups of BCs on theserver side forfutureretrievaland sharing.",OADS,/arxiv_data1/oa_pdf/6c/a0/gkw1103.PMC5210574.pdf
"This matrix is filtered to include only the pairs with an Adjusted Jaccard Score equal or >0.5, and BCs without a single score above thisthresholdarenotrepresentedinthenetworkgraph.The visualization of this network is based on an implementa- tion of linkurious ( http://linkurio.us/ ), which enables users to quickly navigate and inspect the BC similarity network, and to visualize a set of relevant metadata through a selec-",OADS,/arxiv_data1/oa_pdf/6c/a0/gkw1103.PMC5210574.pdf
", http://digitalcommons.wou.edu/aes event/2013/biol/10 .",Non-OADS,/arxiv_data1/oa_pdf/6c/a0/gkw1103.PMC5210574.pdf
"Publishedonline28November2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D581–D591 doi:10.1093/nar/gkw1105 EuPathDB: the eukaryotic pathogen genomics database resource Cristina Aurrecoechea1, Ana Barreto2,3, Evelina Y. Basenko1, John Brestelli2,3,B r i a n P. Brunk2,4, Shon Cade4, Kathryn Crouch5, Ryan Doherty2,4, Dave Falke1, Steve Fischer2,3, Bindu Gajria2,4,O m a rS .H a r b2,4,*, Mark Heiges1, Christiane Hertz-Fowler6, Sufen Hu2,4, John Iodice2,3, Jessica C. Kissinger1,7,8, Cris Lawrence2,4, Wei Li2,4, Deborah F. Pinney2,3, Jane A. Pulman9, David S. Roos4, Achchuthan Shanmugasundram9, Fatima Silva-Franco9, Sascha Steinbiss10, Christian J. Stoeckert, Jr2,3, Drew Spruill1, Haiming Wang1, Susanne Warrenfeltz1and Jie Zheng2,3 1Center for Tropical & Emerging Global Diseases, University of Georgia, Athens, GA 30602, USA,2Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA, 3Department of Genetics, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA, 4Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA,5Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, Glasgow G12 8TA, UK,6Centre for Genomic Research, University of Liverpool, Liverpool L69 7ZB, UK,7Department of Genetics, University of Georgia, Athens, GA 30602, USA, 8Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA,9Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK and10Wellcome Trust Sanger Institute, Parasite Genomics, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK Received October 13, 2016; Editorial Decision October 25, 2016; Accepted October 28, 2016 ABSTRACT The Eukaryotic Pathogen Genomics Database Re- source (EuPathDB, http://eupathdb.org )i sac o l - lection of databases covering 170+ eukaryotic pathogens (protists & fungi), along with relevant free-living and non-pathogenic species, and select pathogen hosts.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/gkw1105.PMC5210576.pdf
"INTRODUCTION A unique infrastructure and search strategy system dis- tinguish the Eukaryotic Pathogen Database Resource (EuPathDB, http://eupathdb.org ) from other organism databases.",OADS,/arxiv_data1/oa_pdf/b1/5a/gkw1105.PMC5210576.pdf
"EuPathDBresourcesandorganismssupported Database Webaddress Linktoaccesslistoforganismssupported EuPathDB http://eupathdb.org EuPathDBorganisms AmoebaDB http://amoebadb.org AmoebaDBorganisms CryptoDB http://cryptodb.org CryptoDBorganisms FungiDB http://fungidb.org FungiDBorganisms GiardiaDB http://giardiadb.org GiardiaDBorganisms HostDB http://hostdb.org HostDBorganisms MicrosporidiaDB http://microsporidiadb.org MicrosporidiaDBorganisms PiroplasmaDB http://piroplasmadb.org PiroplasmaDBorganisms PlasmoDB http://plasmodb.org PlasmoDBorganisms ToxoDB http://toxodb.org ToxoDBorganisms TrichDB http://trichdb.org TrichDBorganisms TriTrypDB http://tritrypdb.org TriTrypDBorganisms OrthoMCL http://orthomcl.org Includesproteinsfromover150organismsacross bacteria,archaeaandeukarya EuPathDBfacilitatesthediscoveryofmeaningfulbiolog- ical relationships between genomic features such as genes or SNPs by integrating pre-analyzed data with sophisti-cated data mining, visualization and analysis tools that are designed to be used by wet-bench researchers.",Non-OADS,/arxiv_data1/oa_pdf/b1/5a/gkw1105.PMC5210576.pdf
"Databases EuPathDB resources have been expanded to include FungiDB( http://fungidb.org )(8),whichsupportsfungiand oomycetes, and HostDB ( http://hostdb.org ), for interroga- tion of host responses to infection.",OADS,/arxiv_data1/oa_pdf/b1/5a/gkw1105.PMC5210576.pdf
"INTRODUCTION For the last third of a century, the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena ) has served as a cornerstoneoftheworld’sbioinformaticsinfrastructure.In 2016, the resource continues as a broad and heavily usedplatform for the sharing, publication, safeguarding and reuseofgloballycomprehensivepublicnucleotidesequence dataand associated information.",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"As a member of the International Nucleotide Sequence Database Collaboration (INSDC; http://www.insdc.org/ )(1), ENA partners with the National Institute of Genet- ics’ DNA DataBank of Japan ( 2) and the National Center for Biotechnology’s GenBank and Sequence Read archive (NCBIGenBankandSRA)( 3)toprovidegloballycompre- hensive coverage through routine data exchange, to buildthe scientific standards for data exchange and to promote thetimelysharing of well-structuredsequencedata.",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"Primary data (such as reads) and several de-rived data types (sequence, assembly and analysis) are sub- mitted, while remaining derived data types (coding, non- coding, marker and environmental) are derived from sub-mitted content as part of processing and indexing within ENA.Furtherinformationisprovidedfrom http://www.ebi.",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"Further discoverability and reusability are afforded through collaborations with exter- nal expert communities, in which we work on the develop-ment and implementation in ENA of reporting standards initiatives such as the Minimal Information about a Se- quencing Experiment ( 5) and the Global Microbial Iden- tifier(http://www.globalmicrobialidentifier.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"For new applications, our ‘analy- sis’ data type has been put in place to allow us rapidly to respond to new derived data types; indeed, reference readalignmentsandgenomicvariationdataareexamplesofex- tended data types that have been supported using this ap- proach.SUBMISSION ENA offers a comprehensive range of submission op- tions through the Webin system ( http://www.ebi.ac.uk/ena/ submit).",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"For depositions of multi-omics data, submitters should first contact our helpdesk with a brief outline ofthe data set in question and we will work with colleagues within the European Molecular Biology Laboratory, Eu- ropean Bioinformatics Institute (EMBL-EBI) BioStudies(https://www.ebi.ac.uk/biostudies/ ) and BioSamples ( http: //www.ebi.ac.uk/biosamples )(6) data resources to provide instructions on howto proceed.",Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"Threesearchservicesaresupported:Asimpletextsearch box,availableintheheaderofallpagesontheENAwebsite (http://www.ebi.ac.uk/ena ),providesrapidsearchacrossall data and web content and, when ENA accession num-bers are searched, directly links to views of the requested records.",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
The Advanced search service ( http://www.ebi.ac.,Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"Finally, se- quence similarity searches ( http://www.ebi.ac.uk/ena/data/ sequence/search ) are provided based on BLAST ( 7)a n d other toolssupported centrallybyEMBL-EBI.",OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
http://www.ebi.ac.uk/ena/data/ view/BN000065 ) allows users to navigate ENA data.,OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"The main communication channel for the helpdeskise-mail(contactdatasubs@ebi.ac.uk),whichop- eratesthroughacentralticketingsystemthatallowspriori-tizationandcoverduringstaffabsenceinordertomaximize responsiveness.Weencourageuserstoparticipateinourin- personoronline‘surgery’events( http://www.ebi.ac.uk/ena/ support/ena-surgeries )whichallowmoresynchronoussup- portinsmallusergroupsettings.Thehelpdeskteambuilds documentation(availableontheENAwebsite)andanum-ber of downloadable training materials ( http://www.ebi.ac.",Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"(see, for example, http://www.ebi.ac.uk/ena/data/view/ERC000038 ).",Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
The work was done by a different group than the original genomes; RNA-seq was also used to improve the annotation with novel transcript features.The new genome assembly of Neospora caninum contains 14 chromosomes and 1 unplaced scaffold ( http://www.ebi.,Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
Both variant genomes received new ENA accession numbers ( http://www.ebi.ac.uk/ena/ data/view/LN846618-LN846619 ) and the alignment files (in BAM format) for both assemblies are also available in the ENA Browser ( http://www.ebi.ac.uk/ena/data/view/ ERZ112709-ERZ112710 ).,OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"Each sub- mitted leptin-like gene received an ENA accession number ( d u c kl e p t i nm R N A , http://www.ebi.ac.uk/ena/data/view/ LN794245 ; chicken leptin mRNA, http://www.ebi.ac.uk/ ena/data/view/LN794246 ).",Non-OADS,/arxiv_data1/oa_pdf/57/05/gkw1106.PMC5210577.pdf
"To learn more, visit http://geneontology.org/ .",Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
The GO and associatedproductsareavailableunderaCreativeCommonsAttribu- tion licensefrom http://geneontology.org .,Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
Writtendis- cussions are audited through the GitHub issue trackingmechanism and guidelines for submitting new requests are postedhere: https://github.com/geneontology/go-ontology/ blob/master/CONTRIBUTING.md .,OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"In our last update ( 1), we reported on the go-plus edition of GO, which includes OWL (Web Ontology Language) equiva-lence axioms connecting GO to external Open Biomedical Ontology (OBO) classes (see http://geneontology.org/page/ download-ontology ).",OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"In the gene-centric file, each member of a com-plex is annotated with the functions of the entire complex whenappropriate(theseareflaggedwiththecontributes to qualifier, see http://geneontology.org/page/go-annotation- conventions#contri formore details).",OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
Other highlights include: (i) an integrated PubMed ID search that retrieves both annotations and interme- diary PubMed information pages (see below); (ii) a new Matrix Tool that allows users to explore the overlapsbetween gene sets annotated to different GO classes (http://amigo.geneontology.org/matrix#order ); (iii) new integration capabilities to connect the GO resources intocustomized workflows via a public bookmarking API and Galaxy ( 17); a Solr ( https://cwiki.apache.org/confluence/ display/solr/Apache+Solr+Reference+Guide ) document store search environment which offers more powerful means to query the GO data; and (v) much improved inte- grated and interactive statistics and graphics summarizingtheentiretyofthe GOannotations.,OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"Gene set enrichment analysis ThegenesetenrichmentanalysistoolontheGOhomepage nowlinksdirectlytotheinterfaceatthePANTHERwebsite(http://go.pantherdb.org/ ).Thisenablesuserstotakeadvan- tage of the PANTHER visualization tools, such as the new hierarchicalviewthatorganizesenrichmentanalysisresults using the relations in the GO ( 18).",OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
An initial announcement can be found on http://geneontology.org/article/gaf-gpad-and-lego .,Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"Users may also be interested in brows- ing and viewing published models, which are available at: http://noctua.berkeleybop.org .",Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"Currently the GOC is in the process of transitioning to Noctua( http://noctua.berkeleybop.org )astheprimaryGO curationtool.SeveralGOannotationprovidersarealready usingtheNoctuasoftwaretocreateLEGOmodels,andthe GOC expects the number and utility of such models to in-creaserapidlyinthecomingperiod.Wehaveconductedfive annotation workshops in the past year to introduce biocu- rators to the Noctua annotation tool and the principles ofOWL-based LEGO curation.",OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
Learn more about how to contribute your work to the GO resource athttp://geneontology.org/page/contributing-go .,Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"org/page/acknowledgments-contributors ), and as authors of published papers that provide the basis for GO annota- tions (see http://geneontology.org/page/acknowledgments- authors).",Non-OADS,/arxiv_data1/oa_pdf/a9/10/gkw1108.PMC5210579.pdf
"),andthesequencetargetingreagents(Red,STRs)whenapplicable.FishIDshavetheformZDB-FISH-######-#####.FishZDB-FISH-150901-11301( https://zfin.org/ZDB-FISH-150901-11301 )includesahomozygous hand2 c99/c99geneontheABgeneticbackgroundplusthree morpholinostargetingthe dlx3b,dlx5a anddlx4bgenes.",OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
https://zfin.org/ZDB-FIG-151214-52#expDetail shows examples of EaP and non-EaP phenotypesdisplayedin thePhenotypecolumnofthePhenotypeDetailssectionforthefigure.Imagecapturedon18August2016.,Non-OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
"(https://zfin.org/search ) Anewfacet––‘MisexpressedGene’,aidsEaPdiscoveryin five different data categories: Gene /Transcript, Phenotype, Fish, Mutation /Tg and Figure.",OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
Gene Expression Phenotypes https://zfin.org/ downloads/gene expression phenotype.txt 2.,OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
"Antibody Labeling Phenotypes https://zfin.org/ downloads/antibody labelingphenotype.txtHUMAN DISEASE The zebrafish has become a well-established vertebrate modelorganism.Theopticalclarity,accessibilityandrapid development of the zebrafish embryo allow organ systemsand tissues to be closely observed as they form.",Non-OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
The community wiki is powered by Atlassian Confluence software ( http://www.altassian.com/software/confluence/ ).,OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
"org(https://github.com/ZebrafishMine/intermine ), which alsoservesZFINdataviawebservices( 15).InterMinesoft- wareisproducedbytheGenericModelOrganismDatabase (GMOD; http://gmod.org ) project ( 22).",OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
A detailed and browsable view of the current ZFIN data model can befound at http://zfin.org/schemaSpy/index.html .,OADS,/arxiv_data1/oa_pdf/cd/2e/gkw1116.PMC5210580.pdf
"D888–D895 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline28November2016 doi:10.1093/nar/gkw1123 DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database Yichun Xiong1,†, Yanjun Wei1,†,Y u eG u1,†, Shumei Zhang1,J i eL y u2, Bin Zhang1, Chuangeng Chen1, Jiang Zhu1, Yihan Wang1, Hongbo Liu1,*and Yan Zhang1,* 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China and2Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA Received August 15, 2016; Revised October 24, 2016; Editorial Decision October 25, 2016; Accepted October 31, 2016 ABSTRACT The human disease methylation database (DiseaseMeth, http://bioinfo.hrbmu.edu.cn/ diseasemeth/ ) is an interactive database that aims to present the most complete collection and annotation of aberrant DNA methylation in human diseases, especially various cancers.",OADS,/arxiv_data1/oa_pdf/3d/cd/gkw1123.PMC5210584.pdf
"The enhancedChiTaRS-3.1 database ( http://chitars.md.biu.ac.il )i s designed to make widely accessible a wealth of mined data on chimeric RNAs, with easy-to-use ana-lytical tools built-in.",OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
"We have built a computational tool for analyzing changes to the PPI networks of chimeric (or ‘fusion’) proteins, called ‘ChiPPI’ (Chimeric PPI), whichwe have incorporated into the ChiTaRS database, provid- ing a pre-calculated analysis for every human fusion event (http://chitars.md.biu.ac.il ,s e e‘ Full Collection ’).",OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
The ChiPPI method ( http://chippi.md.biu.ac.,Non-OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
"To this end, we have assembled a tool for analyzing PPI networks that focuses on individual protein domains as the mediators of PPIs ( http://chippi.md.biu.ac.",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
"Particu- larly,thisnewfeatureprovidesuserswiththeabilitytostudytheproteininteractionnetworksofdifferentcancerfusions (http://chippi.md.biu.ac.il/ ).",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
AVAILABILITY The ChiTaRS-3.1 content will be continuously maintained andupdatedeverysixmonths.Thedatabaseisnowpublicly accessible at http://chitars.md.biu.ac.il and its old version 2.1 is accessibleat http://chitars.bioinfo.cnio.es/ .SUPPLEMENTARY DATA SupplementaryData are available at NAR Online.,OADS,/arxiv_data1/oa_pdf/9a/e1/gkw1127.PMC5210585.pdf
"In this update of CyanoBase, the number of genome projects included was increasedfrom39to376,anddraftgenomeswerealsointro-ducedasdatabaseentriesforthefirsttime.Wealsoprovided anewuserinterfaceforgenomeprojects(Figure 2)andap- plied TogoStanza ( http://togostanza.org ) for visualization of the list of genome projects––a generic web framework that enables reusable web components to be developed to assist the development of Semantic Web components suchasqueryingSPARQLendpointsandvisualizingtheretuned results.",OADS,/arxiv_data1/oa_pdf/8e/c7/gkw1131.PMC5210588.pdf
http://www.ebi.ac.uk/gwas/search?query=cardiovascular%20disease .Thediagramcanbereachedfrom http://www.ebi.ac.uk/gwas/diagram .,OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
All software for the Catalog’s infrastructure is open source and made available via a public GitHub repository(https://github.com/EBISPOT/goci )usinganApache2.0li-,OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
"To improve the quality and accuracy of the SNP and as- sociated genomic data in the Catalog, we have redeveloped thevariantmappingpipeline.ThenewpipelineaccessesEn- sembl’s RESTAPI ( https://rest.ensembl.org/ )(18) enabling livevalidationwithinthecurationsystemfor:SNPIDvali- dation;reportedgeneIDvalidation;checkingthattheSNP and reported gene are on the same chromosome.",OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
"We have harmonized the GWAS Catalog data re- lease strategy, with all available elements (searchable data, spreadsheetsanddiagram)nowbeingreleasedweekly.Thishasallowedustointroducedate-basedversioningandpro- vide all weekly data releases since March 2016 on the project’s FTP site ( ftp://ftp.ebi.ac.uk/pub/databases/gwas/ releases/).",OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
"The interactive GWAS diagram uses the Web Ontology Language / ResourceDescriptionFramework(OWL /RDF, https://www.w3.org/OWL/ ) for representation of the Cat- alog data and was previously hosted separately from themain GWAS Catalog.",OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
During the past year we have also delivered our first face-to-face training workshops (training materials available at ftp://ftp.ebi.ac.,Non-OADS,/arxiv_data1/oa_pdf/4b/76/gkw1133.PMC5210590.pdf
URL: http://snp-seek.irri.org .,OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"Additional and updated anal-yses of the 3k varieties from the 3k Rice Genome Project (8) resulted in five SNP sets: All (32M positions), All bial- lelic (29M), Base (18M), Filtered (4.8M) and Core (404k).The details of these are described at the Download page (http://snp-seek.irri.org/ download.zul ).",Non-OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
Datasourcesforgenomicsdata Data Source URL Reference Genemodel MSUv7 http://rice.plantbiology.msu.edu (16) Genemodel RAP http://rapdb.dna.affrc.go.jp (17) Genenames /symbols Oryzabase http://shigen.nig.ac.jp/rice/oryzabase (20) Geneontology MSUv7 http://rice.plantbiology.msu.edu (16) Traitgenes OGRO http://qtaro.abr.affrc.go.jp/ogro/table (21) Traitontology-genes Oryzabase http://shigen.nig.ac.jp/rice/oryzabase (20) Plantontology-genes Oryzabase http://shigen.nig.ac.jp/rice/oryzabase (20) QTL Q-TARO http://qtaro.abr.affrc.go.jp (26) Sequence MSUv7 http://rice.plantbiology.msu.edu (16),OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"In variety queries, phenotypes are mapped to Trait Ontology ( http://browser.planteome.org/amigo/term/ TO:0000387 )andCropOntology(Rice)terms( http://www.",OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"To accommodate large queries, we im- plemented an asynchronous query engine, utilizing Spring (https://spring.io ) @Async annotation to manage parallel processes.",OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
Web services We defined a set of RESTful web-service calls for internal use and shared to collaborators through our development site (http://snp-seek.irri.org/dev ).,OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"Another set ofcalls were implemented for SNP-Seek for compliance to the Breeding API (BrAPI, http://docs.brapi.apiary.io )f o r Germplasm, Phenotypes, Maps, Studies and Genotypes.The web services documentation can be accessed from the Helpmenu.Mostcallsareopenbutsomerequireloginand password.Interestedcollaboratorsmaycontacttheauthorsto usethe protectedcalls.",OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"FUNDING Global Rice Science Partnership (GRiSP); International Rice Informatics Consortium ( http://iric.irri.org ); Cirad, BayerCropSciencesandSyngenta(toIRIC);TaiwanGov- ernmentGrant(toIRRI).Fundingforopenaccesscharge: IRRIandtheCGIARResearchProgramCRP3.3(Global Rice SciencePartnership).",Non-OADS,/arxiv_data1/oa_pdf/93/4c/gkw1135.PMC5210592.pdf
"of Biomedical Sciences, University of Padua, 35121 Padova, Italy,2Departamento de Ingenier ´ıa, Pontiﬁcia Universidad Cat ´olica del Per ´u, 32 Lima, Per ´u,3Institute of Molecular Biology, Faculty of Biology, Johannes Gutenberg University of Mainz, 55128 Mainz, Germany,4Centre de Recherches de Biochimie Macromol ´eculaire, CNRS, Universit ´e Montpellier, 34293 Montpellier, France,5Institut de Biologie Computationnelle (IBC), 34293 Montpellier, France,6Institute of Bioengineering, University ITMO, 197101 St. Petersburg, Russia and7CNR Institute of Neuroscience, 35121 Padova, Italy Received September 15, 2016; Revised October 20, 2016; Editorial Decision October 21, 2016; Accepted October 31, 2016 ABSTRACT RepeatsDB 2.0 (URL: http://repeatsdb.bio.unipd.it/ ) is an update of the database of annotated tan- dem repeat protein structures.",Non-OADS,/arxiv_data1/oa_pdf/83/8e/gkw1136.PMC5210593.pdf
"Publishedonline28November2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D183–D189 doi:10.1093/nar/gkw1138 PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and dataanalysis tool enhancements Huaiyu Mi*, Xiaosong Huang, Anushya Muruganujan, Haiming Tang, Caitlin Mills, Diane Kang and Paul D. Thomas* Division of Bioinformatics, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA Received October 05, 2016; Revised October 27, 2016; Editorial Decision October 28, 2016; Accepted November 16, 2016 ABSTRACT The PANTHER database (Protein ANalysis THrough Evolutionary Relationships, http://pantherdb.org ) contains comprehensive information on the evolu- tion and function of protein-coding genes from 104completely sequenced genomes.",OADS,/arxiv_data1/oa_pdf/d6/a8/gkw1138.PMC5210595.pdf
Fullstatisticsareavailableat http://pantherdb.org/panther/ summaryStats.jsp .,OADS,/arxiv_data1/oa_pdf/d6/a8/gkw1138.PMC5210595.pdf
"Detailed statistics, such as coverage of each aspect, for all genomes in PANTHER can be f ound at http://pantherdb.org/panther/summaryStats.jsp .",OADS,/arxiv_data1/oa_pdf/d6/a8/gkw1138.PMC5210595.pdf
The software package can be downloaded fromftp://ftp.pantherdb.org//hmm scoring/current release.,OADS,/arxiv_data1/oa_pdf/d6/a8/gkw1138.PMC5210595.pdf
The Reactome pathway data were downloaded from the Reactome website ( http://www.reactome.org/pages/ download-data/ ).,OADS,/arxiv_data1/oa_pdf/d6/a8/gkw1138.PMC5210595.pdf
"Here, we present SoyNet ( http://www.inetbio.org/soynet ), a database of soy- beanco-functionalnetworksandacompanionwebtoolfor network-based functional predictions.",OADS,/arxiv_data1/oa_pdf/6f/b0/gkw704.PMC5210602.pdf
"To appreciate the diverse roles of ADP- ribosylation across the proteome, we have createdADPriboDB – a database of ADP-ribosylated proteins (http://ADPriboDB.leunglab.org ).",OADS,/arxiv_data1/oa_pdf/6f/65/gkw706.PMC5210603.pdf
The database is freely accessible at http://membranome.org .,OADS,/arxiv_data1/oa_pdf/5a/e1/gkw712.PMC5210604.pdf
DATABASE CONTENT The Membranome database ( http://membranome.org )w a s createdtofacilitatethelarge-scalemodelingandanalysisof individual TM /H9251-helices that serve as structural and evo- lutionary units of membrane proteins.,OADS,/arxiv_data1/oa_pdf/5a/e1/gkw712.PMC5210604.pdf
( http://membranome.org/about.,Non-OADS,/arxiv_data1/oa_pdf/5a/e1/gkw712.PMC5210604.pdf
The method is available through the FMAP web server ( http://membranome.org/server.,OADS,/arxiv_data1/oa_pdf/5a/e1/gkw712.PMC5210604.pdf
"To help the first-time user, the database has an ‘ABOUT Membranome’ section that introduces general database features, such as protein sets and classification, and de-scribes the underlying FMAP method and its verifica- tion (http://membranome.org/about.php ).",OADS,/arxiv_data1/oa_pdf/5a/e1/gkw712.PMC5210604.pdf
The database is available at http://www.rna-society.org/ rnalocate/ .,OADS,/arxiv_data1/oa_pdf/d7/39/gkw728.PMC5210605.pdf
"To complement with related research in RNA subcellu- lar localization, we developed a web-accessible database (RNALocate, http://www.rna-society.org/rnalocate/ ), aimedtocollectexpandingcatalogofdiversespecies’RNA subcellular localization in multiple biological processes by manually curating the literature.",OADS,/arxiv_data1/oa_pdf/d7/39/gkw728.PMC5210605.pdf
"Here, we present REDIportal, available online at http://srv00.recas.ba.infn.it/atlas/ , the largest and comprehensive collection of RNAediting in humans including more than 4.5 millions of A-to-I events detected in 55 body sites from thou- sands of RNAseq experiments.",OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
"Currently, RNA editing events are annotated in three main databases: DARNED ( http://darned.ucc.ie/ )(10), RADAR ( http://rnaedit.com/ )(11) and REDIdb ( http: //srv00.recas.ba.infn.it/py script/REDIdb/ )(12,13).",OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
GTEx datasets were downloaded from the database of Genotypes and Phenotypes (dbGaP) with accession phs000424.v6.p1 in sra format and converted in standardfastq by means of fastq-dump program that is part of the SRAtoolkit ( http://trace.ncbi.nlm.nih.gov/Traces/sra ).,OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
"WEB INTERFACE AND INTERROGATION REDIportal is easily accessible through an ad hocweb interface developed in Bootstrap, a JavaScript frame- work including HTML, CSS and JavaScript code de- signed for creating responsive websites and web ap-plications ( http://getbootstrap.com/ ).",OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
"Server side opera- tions including MySQL querying and retrieval are per- formed in Python (v2.7.2) with the support of dedicatedmodules, such as MySQLdb ( https://pypi.python.org/pypi/ MySQL-python/1.2.5 ) for quick connections to MySQL server and mxTextTools ( http://www.egenix.com/products/ python/mxBase/mxTextTools/ ) for high-performance text manipulation.REDIportal allows RNA editing searches providing a genomic region, in the format chr:start-end, or a specificgene symbol, in combination with user-defined filters to restrict the number of retrieved sites to those of interest.",OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
"Retrieved sites are shown in a dynamic and sortable table automatically generated by means of DataTables (https://datatables.net/ ), a powerful plug-in for the jQuery JavaScriptlibraryenablingthecreationofadvancedHTMLtables(Figure 3).InREDIportal,DataTablesisusedserver- side through specific Ajax requests in order to handle and display tables consistingofmillions of rows withease.",OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
We also acknowl- edgetheEuropeanElixirinfrastructure( https://www.elixir- europe.org/ ) for supporting the development and mainte- nance ofREDIportal.,Non-OADS,/arxiv_data1/oa_pdf/56/72/gkw767.PMC5210607.pdf
"A number of individual publications (Biochemistry, Biophysical Journal) and publishers (Nature PublishingGroup, and PLOS journals), research councils and fund- ing agencies (i.e., http://www.bbsrc.ac.uk/funding/apply/ application-guidance/justification-resources/resources/ ) suggest that PCDDB depositions be made in as- sociation with their publications or funding.",Non-OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
ing.org ( https://biosharing.org/biodbcore-000613 ).,OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
"To aid new depositors, tutorials about deposition, both online –(http://www.youtube.com/user/ThePcddb ) and in print (10), have beencreated.",Non-OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
"There is also a link to the ValiDichro standalone data testing website ( http://valispec.cryst.bbk.ac.uk/circularDichroism/ ValiDichro/upload.html )(15), which enables users to per- form validation analyses equivalent to the data checking software utilised in the curation of PCDDB entries (but inthiscase,notrequiringdeposition),asanaidtoexperimen- tal good practice.",OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
"The channel may be accessed from the PCDDB home page or from the YouTubeicononthefooterofallpages.Thevideosnowin- cludethefollowingtopics:AnIntroductiontothePCDDB,and information on how to make depositions ( https: //www.youtube.com/watch?v=NTblyIhwjog ), information on analysing CD spectra using the DichroWeb server(https://www.youtube.com/watch?v=QZat Wr2NGM ), how to calibrate CD spectra ( https://www.youtube.com/ watch?v=ovY6yVxw-tI ), how to calibrate CD instruments (https://www.youtube.com/watch?v=PEIDelWvSsg ), how to calibrate the pathlengths of CD sample cells (https://www.youtube.com/watch?v=PEIDelWvSsg ), and how to clean and load CD cells ( https://www.youtube.",Non-OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
ACKNOWLEDGEMENTS The PCDDB would like to acknowledge the advice and support of members of its International Advisory Boards (http://pcddb.cryst.bbk.ac.uk/about.php ).FUNDING U.K. Biotechnology and Biological Research Council [Bioinformatics and Biological Resources Fund grants J019135 and F010346 to B.A.W.,Non-OADS,/arxiv_data1/oa_pdf/a7/47/gkw796.PMC5210608.pdf
"Rovisco Pais, 1049-001 Lisbon, Portugal Received July 20, 2016; Revised September 02, 2016; Accepted September 05, 2016 ABSTRACT We present the PATHOgenic YEAst Search for Transcriptional Regulators And Consensus Track- ing (PathoYeastract - http://pathoyeastract.org ) database, a tool for the analysis and prediction oftranscription regulatory associations at the gene and genomic levels in the pathogenic yeasts Can- dida albicans and C. glabrata .",OADS,/arxiv_data1/oa_pdf/cc/b6/gkw817.PMC5210609.pdf
"This new information system follows the footsteps of the YEAS-TRACT ( http://yeastract.com ) database that has provided to the public up-to-date information on documented regu- latory associations between TFs and target genes, as well as between TFs and DNA binding sites, in S. cerevisiae (14–17).",Non-OADS,/arxiv_data1/oa_pdf/cc/b6/gkw817.PMC5210609.pdf
ACKNOWLEDGEMENTS ThePathoYeastractdatabasewasconstructedbasedonthe YEASTRACT database structure ( http://yeastract.com ).,OADS,/arxiv_data1/oa_pdf/cc/b6/gkw817.PMC5210609.pdf
"All the data were compiled into LNCediting,a user-friendly database ( http://bioinfo.life.hust.edu.",OADS,/arxiv_data1/oa_pdf/5b/79/gkw835.PMC5210611.pdf
The LNCediting database is freely accessible at http://bioinfo.life.hust.edu.cn/LNCediting/ .,OADS,/arxiv_data1/oa_pdf/5b/79/gkw835.PMC5210611.pdf
"D972–D978 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline19September2016 doi:10.1093/nar/gkw838 The Comparative Toxicogenomics Database: update 2017 Allan Peter Davis1,*, Cynthia J. Grondin1, Robin J. Johnson1, Daniela Sciaky1, Benjamin L. King2, Roy McMorran2, Jolene Wiegers1, Thomas C. Wiegers1and Carolyn J. Mattingly1,3 1Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA,2Department of Bioinformatics, The Mount Desert Island Biological Laboratory, Salisbury Cove, ME 04672, USA and3Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA Received August 9, 2016; Accepted September 9, 2016 ABSTRACT The Comparative Toxicogenomics Database (CTD; http://ctdbase.org/ ) provides information about inter- actions between chemicals and gene products, and their relationships to diseases.",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"Additionally, as part of our continued, active engagement with the scientific com-munity, CTD plays a significant role in advancing text- mining methods for biomedical information as part of the BioCreativeconsortium( 8–12),facilitatesthedevelopment of semantic standards for the environmental health science community ( 13), complies with reporting standards set by the BioSharing Information Resources ( 14) and is a regis- teredmember( https://biosharing.org/biodbcore-000173 )of BioDBcore ( 15).",Non-OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"First, at least 72 external resources now include and dis-play CTD information as part of their own databases, a 44% increase from the 50 sources since our last re- port (http://ctdbase.org/about/publications/#use ).",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"For this endeavor, we helped develop a large corpus of manually curated annotations for chemicals, diseases and their interactions from 1500PubMed articles ( 12); this corpus is freely available (down- load by clicking: http://sourceforge.net/projects/bioc/files/ CDR Data.zip/download ), as are many of the associated text-mining tools developed by the 25 teams that partici- pated.",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"Additionally, investigators can use CTD’s new ex- posurestudyquerypage( http://ctdbase.org/query.go?type= expStudies ) to quickly retrieve information aggregated at the study (research article) level (Figure 2A) using param- eters for a chemical stressor (e.g.",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"As well, an ‘Exposure Details’ query page is also available ( http://ctdbase.org/query.go?type=expDetails )t o retrieve records at the highly granular exposure statement level.",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"In July 2016, CTD included more than 70 600 man- ually curated exposure statements for 803 chemicals, 153 biomarkergenes,301diseasesand181phenotypes(GO-BP terms) from over 1250 exposure scientific articles (Figure 2C).Exposuredataisalsofreelyavailabletousersindown- load files ( http://ctdbase.org/downloads/#exposureevents ).",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"( A)CTD’snew‘ExposureStudies’querypage( http://ctdbase.org/query.go?type=expStudies )allowsusers toretrievestudyinformationusingavarietyofsearchparameters,includingexposurechemicalstressor(e.g.airpollutants,bluecircle),recep tordescription (e.g.",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
( C) Data status for CTD exposure module as of July 2016 includes over 70 600 manually curated statements from more than 1250 references(updatedmonthlyat: http://ctdbase.org/about/dataStatus.go ).,OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
We will continue to ex- pand our core and exposure curation modules with new data content added every month ( http://ctdbase.org/about/ dataStatus.go ).,Non-OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
CTD’s files for ‘GO-Disease-Gene Inference Networks’ (as well as all CTD curated content) are freely available from our ‘Data Downloads’ pag e (http://ctdbase.org/downloads/ ).,OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"CITING AND LINKING TO CTD To cite CTD data, please see: http://ctdbase.org/about/ publications/#citing .",OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
"If you are interested in establishing linkstoCTDdata,pleasenotifyus( http://ctdbase.org/help/ contact.go ) and follow these instructions: http://ctdbase.",Non-OADS,/arxiv_data1/oa_pdf/f4/d7/gkw838.PMC5210612.pdf
The data from each paper was then aggregated into a study table with a yaml ( http://www.yaml.org/ ) configura- tion file corresponding to information in the file required for our pipeline.,OADS,/arxiv_data1/oa_pdf/ba/e3/gkw865.PMC5210614.pdf
"Finally, the annotated data was loaded intoaPostgreSQL relational database viafivetables.Website denovo-db is available at http://denovo-db.gs.washington.",OADS,/arxiv_data1/oa_pdf/ba/e3/gkw865.PMC5210614.pdf
The link listed in the paper does not seemto work anymore ( http://122.228.158.106/NPdenovo/ )b u t this appears to be the new link http://www.wzgenomics.,Non-OADS,/arxiv_data1/oa_pdf/ba/e3/gkw865.PMC5210614.pdf
"The second is the Developmental Brain Disorder (DBD) Gene Database ( 54)(http://geisingeradmi.org/care- innovation/studies/dbd-genes/ ), which collects information on variants in developmental brain disorders.",Non-OADS,/arxiv_data1/oa_pdf/ba/e3/gkw865.PMC5210614.pdf
We found that the combination of low-dose cyclophosphamide and anti-CTLA4 blockade (ipilimumab) for melanoma is currently under clinical trial (https://clinicaltrials.gov/ ID: NCT01740401).,Non-OADS,/arxiv_data1/oa_pdf/98/03/gkw868.PMC5210615.pdf
"D104–D114 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline5October2016 doi:10.1093/nar/gkw888 POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins Boqin Hu1,†, Yu-Cheng T. Yang1,2,†, Yiming Huang1, Yumin Zhu1and Zhi John Lu1,* 1MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Center for Plant Biology and Tsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China and2Department of Statistics, University of California Los Angeles, Los Angeles, CA 90095-1554, USA Received July 08, 2016; Revised September 23, 2016; Accepted September 27, 2016 ABSTRACT We present POSTAR ( http://POSTAR.ncrnalab.org ), a resource of POST-tr Anscriptional Regulation coordi- nated by RNA-binding proteins (RBPs).",OADS,/arxiv_data1/oa_pdf/27/e8/gkw888.PMC5210617.pdf
"Finally,itisoftendesirabletoknowwhetherRBPscaninteractwith RNA molecules, especially novel lncRNAs; however, only a few online tools ( 21,22) are available for predicting RBP bindingsites ongiven RNAsequences.Previously,wedevelopedCLIPdb( 20),whichsimplypro- vided RBP binding sites without further annotation and interpretation ( http://CLIPdb.ncrnalab.org ).",OADS,/arxiv_data1/oa_pdf/27/e8/gkw888.PMC5210617.pdf
AVAILABILITY POSTARisfreelyavailableat http://POSTAR.ncrnalab.org (redirected to http://lulab.life.tsinghua.edu.cn/POSTAR ).,OADS,/arxiv_data1/oa_pdf/27/e8/gkw888.PMC5210617.pdf
The CeNDRdata are accessible through a freely available web portal located at http://www.elegansvariation.org or through an application programming interface.,OADS,/arxiv_data1/oa_pdf/92/49/gkw893.PMC5210618.pdf
"CeNDR organizes meta-data on natural strains, provides tools to disseminate these strains to the community, offers whole-genome sequence and variant data for each strain, and enables users to per-formGWAmappingsandanalyzetheresults.CeNDRalso buildsupontheideasofexistingresourceswithanapplica- tionprogramminginterface(API).CeNDRisfreelyaccessi-blewithoutregistrationat http://www.elegansvariation.org .",OADS,/arxiv_data1/oa_pdf/92/49/gkw893.PMC5210618.pdf
"SoftwareusedtorunCeNDRisopensourceandisavailable athttp://www.elegansvariation.org/Software .Below ,wede- scribe how CeNDR is implemented, relevant applications, theoptimized toolkit,and futureplans.",OADS,/arxiv_data1/oa_pdf/92/49/gkw893.PMC5210618.pdf
Data were processed using additional scripts available at http://www.github.com/Andersenlab/vcf-kit .,OADS,/arxiv_data1/oa_pdf/92/49/gkw893.PMC5210618.pdf
Wecollectedannotationsofbrainenhancersandpromot- ersfromtheRoadmapEpigenomicsproject.BEDfileswith coordinates for each region type were downloaded from http://egg2.wustl.edu/roadmap/data/byDataType/dnase/ .,OADS,/arxiv_data1/oa_pdf/e1/1a/gkw902.PMC5210619.pdf
"After our substan- tialexpansionfromourSZGR1.0( https://bioinfo.uth.edu/ SZGR1/),itwasdesignedasaone-stopshopofschizophre- nia variants and genes.",OADS,/arxiv_data1/oa_pdf/e1/1a/gkw902.PMC5210619.pdf
"RSC thus provides a unique system of identifiers for strains.The27thversionof‘Referencestraincatalogueper-tainingtoorganismsforperformancetestingculturemedia’ was published online ( http://refs.wdcm.org/pdf/WDCM% 20Catalogue%20Version V27.1.pdf ).Thedatabaselists194 strains of 126 species from 47 culture collections, and cov- ers65internationalandnationalstandards,20ofwhichare ISOstandards.",OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
"•Data from public data sources such as the US Na- tional Library of Medicine (PubMed) ( 10), World Intel- lectual Property Organization (WIPO, http://www.wipo.",OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
"They may have a different field name even forthesamebiologicalcontents.Therefore,itiscrucialtohave adatastandardtointegratethecatalogueinformation.Af- teracomprehensivecomparisonofexistingdatastandardsandtheonlinecatalogue,GCMdevelopedtheWDCMmin- imum datasets (MDS) and recommended datasets (RDS) based on widely applied standards such as the OECD Best Practice Guidelines for Biological Resource Centres (15), the Microbial Information Network Europe (MINE) (16), WFCC recommended data standards, as well as the Common Access to Biological Resources and Information (CABRI) ( http://www.cabri.org/ ).",OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
"A detailed description, together with examples of 15 WDCM MDS items can be foundat ( http://gcm.wfcc.info/datastandards/ ).",OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
Another reason why track- ingstrains and theirutilisationisusefulisinmeetingbene-fit sharing requirements since the ‘Nagoya protocol on ac- cess to genetic resources and the fair and equitable shar- ing of benefits arising from their utilization (Nagoya pro-tocol)’ (https://www.cbd.int/abs/about/default.shtml )c a m e intoforce.,Non-OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
http://www.wfcc.info/guidelines/ .,Non-OADS,/arxiv_data1/oa_pdf/aa/71/gkw903.PMC5210620.pdf
All aforementioned entries and annotation dataareavailableforbrowsingandsearchingonthemutLB-Sgenes web site ( http://zhaobioinfo.org/mutLBSgeneDB ).,OADS,/arxiv_data1/oa_pdf/ab/c3/gkw905.PMC5210621.pdf
Correlationbetweendrugresponseandgeneexpressionusing CCLE data Drug response data in 714 cell lines on 142 drugs was extracted from Genomics of Drug Sensitivity in Cancer (http://www.cancerrxgene.org/ )(36) (October 2012).,OADS,/arxiv_data1/oa_pdf/ab/c3/gkw905.PMC5210621.pdf
"PMDBase will be updated reg- ularly with new available genome data and can beaccessed freely via the address http://www.sesame- bioinfo.org/PMDBase .INTRODUCTION Microsatellites, also known as Simple Sequence Repeats (SSRs), are sequence blocks containing 1 to 6 nucleotideunitsrepeatedintandemandflankedbysequencesthatare generallyuniqueinthegenome,butconservedinorganisms (1,2).",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"Until now, different microsatellite DNA databases have been developed, including UgMicroSatdb ( http:// veenuash.info/web1/index.htm )(18), EuMicroSatdb ( http: //veenuash.info/ )(19), Kazusa Marker DataBase ( http:// marker.kazusa.or.jp/ )(20), Gramene Markers Database (http://archive.gramene.org/markers/ )(21) et al.",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"Out of the 110 plant species, genome data of 53 species were downloaded from species-specific genomic databases, such as the Arabidopsis Information Resource(http://www.arabidopsis.org/ )(23)andtheBrassicaoleracea Genome Database ( http://ocrigenomics.org/bolbase/ )(24) et al.",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"The cotton diploid ancestral species and tetraploidcultivarsofcottonweredownloadedfromCottonGenome Project (CGP, http://cgp.genomics.org.cn/ ).Vitis vinifera andBrassica napus were downloaded from Genoscope (http://www.genoscope.cns.fr/ ).Thetwopeanutdiploidan- cestral species were downloaded from PeanutBase ( http: //www.peanutbase.org/ )(25).",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"glabriusculum) were downloaded from The Pepper Genome Database ( http://peppersequence.genomics.cn )(27).Dianthus caryophyllus , Solanum melongena ,Jatropha curcas ,Lotus japonicas and Fragaria ananassa were downloaded from Kazusa DNA Res.",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"(KDRI, http://www.kazusa.or.jp ).",Non-OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"Firstly, the MISA (MIcroSAtellite identification tool, http://pgrc.ipk- gatersleben.de/misa/ ) was used to identify normal mi- crosatellite DNAs, as well as compound microsatellite DNAswhichwereinterruptedbyacertainnumberofbases, and offer supplemental Perl tools for designing flanking markers of the microsatellite loci ( 31).",OADS,/arxiv_data1/oa_pdf/06/86/gkw906.PMC5210622.pdf
"Finally, we have constructed an online ccNET database ( http://structuralbiology.cau.",Non-OADS,/arxiv_data1/oa_pdf/52/4a/gkw910.PMC5210623.pdf
"David1,2, Jacques Rougemont1,2,*and Bart Deplancke2,3,* 1Bioinformatics and Biostatistics Core Facility, School of Life Sciences, Ecole Polytechnique F ´ed´erale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland,2Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland and 3Laboratory of Systems Biology and Genetics, Institute of Bio-engineering, School of Life Sciences, Ecole Polytechnique F ´ed´erale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland Received August 15, 2016; Accepted October 04, 2016 ABSTRACT GETPrime ( http://bbcftools.epﬂ.ch/getprime )i sa database with a web frontend providing gene- and transcript-speciﬁc, pre-computed qPCR primerpairs.",Non-OADS,/arxiv_data1/oa_pdf/15/87/gkw913.PMC5210624.pdf
It also implements a RESTful API that allows programmers to access thedatadirectly(seedocumentationat http://bbcftools.epfl.ch/ getprime/api documentation ).,OADS,/arxiv_data1/oa_pdf/15/87/gkw913.PMC5210624.pdf
"We have developed a Plant ceRNA database (PceRBase, http://bis.zju.",OADS,/arxiv_data1/oa_pdf/e5/dc/gkw916.PMC5210625.pdf
"MATERIALS AND METHODS Data collection RNA transcript information, including sequence, genome location, protein-coding potential and length were re-trieved for 24 plant species from Phytozome10 ( 22) (http://phytozome.jgi.doe.gov/pz/portal.html ) and from TAIR10 ( 23)(http://www.arabidopsis.org/ ) and MSU RGCP7 ( 24)(http://rice.plantbiology.msu.edu/index.shtml ) forArabidopsisthaliana andOrysasativa respectively.Withthe exception of A. thaliana andO.",OADS,/arxiv_data1/oa_pdf/e5/dc/gkw916.PMC5210625.pdf
mays were predicted from RNA-sequencing datasets that were obtained from SRA ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/e5/dc/gkw916.PMC5210625.pdf
"Publishedonline13October2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D687–D690 doi:10.1093/nar/gkw923 HieranoiDB: a database of orthologs inferred by Hieranoid Mateusz Kaduk1,*, Christian Riegler1,2, Oliver Lemp1,2and Erik L. L. Sonnhammer1 1Stockholm Bioinformatics Center, Department of Biochemistry and Biophysics, Stockholm University, Science for Life Laboratory, Box 1031, 17121 Solna, Sweden and2FH O ¨O - University of Applied Sciences Upper Austria, Hagenberg 4232, Austria Received September 01, 2016; Revised September 30, 2016; Accepted October 05, 2016 ABSTRACT HieranoiDB ( http://hieranoiDB.sbc.su.se ) is a freely available on-line database for hierarchical groups of orthologs inferred by the Hieranoid algorithm.",OADS,/arxiv_data1/oa_pdf/8a/d2/gkw923.PMC5210627.pdf
"MATERIALS AND METHODS Hieranoid Hieranoid 2.0 was executed with BLAST (2.2.18) for sim- ilarity searching ( 15) and with MUSCLE (3.8.31) ( 16)f o r building alignments, on the 66 species ( http://www.ebi.ac.",OADS,/arxiv_data1/oa_pdf/8a/d2/gkw923.PMC5210627.pdf
Thefullybifurcated speciesguidetreerequiredbytheHieranoidalgorithmwas based on the NCBI taxonomy ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/8a/d2/gkw923.PMC5210627.pdf
"Processing ortholog trees Hieranoidorthologtreeswereslightlymodifiedasrequired for input to the Environment for Tree Exploration (ETE) package(3.0.0b32)( http://etetoolkit.org/ )(20).ETEisused formosttreemanipulationssuchasextractingproteiniden- tifiers, adding duplication nodes, and editing node labels.",OADS,/arxiv_data1/oa_pdf/8a/d2/gkw923.PMC5210627.pdf
"All DNA sequences for the entire chromosomes, coding andnon-coding regions, as well as translation products, are available for download at http://www.candidagenome.org/ download/ .",OADS,/arxiv_data1/oa_pdf/55/59/gkw924.PMC5210628.pdf
"DATABASE Data acquisition The most recent available (Ensembl Version 84) releases of reference genome assemblies for species already annotated inL1Base: Homosapiens,Musmusculus,Rattusnorvegicus, aswellasnewlyaddedspecies: Pantroglodytes,Macacamu- latta,Pongoabelii,Gorillagorilla andBosTaurus (PT 2.19,MMUL 1.0, PPYG2, gorGor3.1, UMD3.1) were down- loaded from the Ensembl internet resource ( 27) along with the MySQL annotation databases containing the currentgenomicandRepeatMasker( http://www.repeatmasker.org , (28)) annotations for the respective genome versions.",OADS,/arxiv_data1/oa_pdf/8c/66/gkw925.PMC5210629.pdf
"These .BED annotations can be easily included in custom UCSC genome browser views, to enable integra- tion with other annotation data ( https://genome.ucsc.edu/ goldenpath/help/customTrack.html )(30).",OADS,/arxiv_data1/oa_pdf/8c/66/gkw925.PMC5210629.pdf
DATABASE ACCESS L1base has been moved from http://l1base.molgen.mpg.de tohttp://l1base.charite.de .,OADS,/arxiv_data1/oa_pdf/8c/66/gkw925.PMC5210629.pdf
"Here, we introduce the miRNAPathway Dictionary Database (miRPathDB), freely accessible at https://mpd.bioinf.uni-sb.de/ .W i t ht h e database we aim to complement available targetpathway web-servers by providing researchers easy access to the information which pathways are reg- ulated by a miRNA, which miRNAs target a path-way and how speciﬁc these regulations are.",OADS,/arxiv_data1/oa_pdf/aa/53/gkw926.PMC5210630.pdf
"All results have beenstored in the miRNA Pathway Dictionary Database (miR- PathDB), freely accessible at https://mpd.bioinf.uni-sb.de/ .",OADS,/arxiv_data1/oa_pdf/aa/53/gkw926.PMC5210630.pdf
The update routines currently re- quire900CPUhoursofcomputingtime.Allcomputeinten-sive tasks are performed using the GeneTrail2 C++ library (https://github.com/unisb-bioinf/genetrail2 )andGNUPar- allel (27).,OADS,/arxiv_data1/oa_pdf/aa/53/gkw926.PMC5210630.pdf
Project data is presented through the HipSci data portal ( http: //www.hipsci.org/lines ) and is downloadable from the associated FTP site ( ftp://ftp.hipsci.ebi.ac.uk/vol1/ ftp).,OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"Analysis results are also available in aTrack Hub, allowing visualization in the context of public genomic annotations ( http://www.hipsci.org/ data/trackhubs ).",OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"There have been previous large-scale efforts to generate and charac- terize pluripotent stem cells ( 4)(https://www.cirm.ca.gov/ researchers/ipsc-initiative ),buttheseotherprojectshaveei- ther not systematically derived human iPSCs at the scale of HipSci or have not focused on characterizing the phe-notypesrelatedtonaturalgeneticvariation( 5).TheHipSci projectfulfilsapressingneedwithinthecommunitytopro- vide a large, well-characterized collection of human iPSCsthat are systematically generated using a single experimen- tal pipeline.",Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"In order to meet the conditions of the managed-accessconsentsignedbyotherdonors,theequiv- alent data types are submitted to the European Genome Phenome Archive (EGA) ( 10), where the data is only ac- cessible to bona fide researchers who have been granted permission to access the data by the HipSci Data Ac- cess Committee ( http://www.sanger.ac.uk/about/who-we- are/policies/open-access-science ).",Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
We therefore distribute these dataviaourprojectFTPsite( ftp://ftp.hipsci.ebi.ac.uk/vol1/ ftp).WeareworkingwiththearchiveshostedatEMBL-EBI toestablish thebest locationfor thisdata.,OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
Cell line availability HipSci cell lines are made available to purchase from the European Collection of Authenticated Cell Cul-tures (ECACC) ( https://www.phe-culturecollections.org.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
HipSci celllines are releasedunder a not-for-profit material transfer agreement for aca- demic non-commercial use; commercial entities can pur-chase a significant subset of HipSci cell lines through the EuropeanBankofinducedPluripotentStemCells(EBiSC; https://ebisc.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
Website The HipSci website ( http://www.hipsci.org ) provides sum- mary information about the HipSci project.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
Cell lines and data browser The browser presented in HipSci’s dedicated web portal is designedforuserstobrowsecelllinesandtheirrelateddata(http://www.hipsci.org/lines )( F i g u r e 2).,OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"Thebrowseralsohasacelllinedetailview,whichdisplays comprehensive information about a single chosen cell line, forexample http://www.hipsci.org/lines/#/lines/HPSI0114i- eipl 1.Thisdetailcanbereachedbyclickingonthecellline name in the cell line table.",OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"This allows users to com-pose many complex queries with no restrictions; for exam- ple, to search for cell lines matching a query string ‘dia- betes’, whilst filtering for lines from female donors in theagerange35–39.TheHipSciwebsitehasdocumentationde- scribing use oftheAPI ( http://www.hipsci.org/lines/#/api ).",Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
HipSci also has its own FTP site ( ftp://ftp.hipsci.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"ebi.ac.uk/vol1/ftp )tofacilitatethedownloadofpreliminary data and of new data types, such as high content cellularphenotyping, for which there is no well-established assay archive (ftp://ftp.hipsci.ebi.ac.uk/vol1/ftp/data/ ).",OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
Our hub is registered in the Track Hub registry ( http://trackhubregistry.org/ )t oe n - ablebroaddiscoveryandreuse.Thehubitselfishostedfrom,OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"D696NucleicAcidsResearch,2017,Vol.45,Databaseissue our FTP site ( ftp://ftp.hipsci.ebi.ac.uk/vol1/ftp/track hub/ hipscihub/) and we provide users with direct links to the UCSC and Ensembl genome browsers along with instruc- tions for use from our website.",OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"Thedepthofgenomicsequencevariationdataavailablefor thesecelllinesmeansthatthedatasetscanbechallengingtosearchbecauseofthevolumeofsamplesandgenomicvari- ant sites which need to be queried: currently, theonly solu- tiontothisrequiresausertodownloadalloftheVCFfileswepresentandtoqueryacrossallofthem.Weareworking withtheEuropeanVariationArchive(EVA)totakeadvan- tageoftheir‘variantsearch’API( http://www.ebi.ac.uk/eva/ ?API),andoncetheopenlyconsentedHipScigenotypedata isloadedintotheEVAvariationdatabase,wewillbuildthe relevant search tools into the HipSci data portal.",OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
Specific questionsaboutpurchasingHipScicelllinesshouldbesent to ECACC using culturecollections.technical@phe.gov.uk.The source code supporting our data portal and website can be found on Github https://github.com/hipsci/hipsci.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/gkw928.PMC5210631.pdf
"Publishedonline30October2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D1029–D1039 doi:10.1093/nar/gkw932 Plant Reactome: a resource for plant pathways and comparative analysis Sushma Naithani1, Justin Preece1, Peter D’Eustachio2, Parul Gupta1, Vindhya Amarasinghe1, Palitha D. Dharmawardhana1, Guanming Wu3,4, Antonio Fabregat5, Justin L. Elser1, Joel Weiser3,M a r i aK e a y s5, Alfonso Munoz-Pomer Fuentes5, Robert Petryszak5, Lincoln D. Stein3, Doreen Ware6,7and Pankaj Jaiswal1,* 12082 Cordley Hall, Department of Botany & Plant Pathology, Oregon State University, Corvallis, OR 97331, USA, 2Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY 10016, USA, 3Ontario Institute of Cancer Research, Toronto, ON M5G 0A3, Canada,4Oregon Health & Science University, Portland, OR 97239, USA,5European Molecular Biology Laboratory - European Bioinformatics Institute, Hinxton, Cambridge CB10 1SD, UK,6Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA and7United States Department of Agriculture – Agriculture Research Service, Robert W. Holley Center for Agriculture and Health,Ithaca, NY 14853, USA Received August 22, 2016; Editorial Decision October 04, 2016; Accepted October 27, 2016 ABSTRACT Plant Reactome ( http://plantreactome.gramene.org/ ) is a free, open-source, curated plant pathway database portal, provided as part of the Gramene project.",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"The Plant Reactome database (http://plantreactome.gramene.org ),thePathwaysportalof Gramene,hostsmetabolic,transport,genetic,signalinganddevelopmentalpathwaysfor63plantspeciesincludingvari- ouscrops,experimentalmodelsandotherspeciesimportant tounderstandtheevolutionofpathwaynetworks(Table 1).",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"PLANT REACTOME SEARCH The quick search box is powered by the Solr search plat- form (http://lucene.apache.org/solr/ ), designed for highly scalable, load-balanced, and dynamically indexed full-text searches.",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"The Plant Reactome implementation makes par- ticular use of the auto-completion feature and facetedsearch result filters, which aid the user with search sugges- tions and the ability to narrow down results with preci- sion.Thequicksearchtoolontheright-mostuppersideofPlant Reactome homepage ( http://plantreactome.gramene.",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
The additional small molecule search avail- able from http://plantreactome.gramene.org/cgi-bin/ small molecule searchallows searches of various chemical compoundentities.Thequeryformallowstheusertoillus-trate a molecule and submit searches to the remote ChEBI database of small molecules ( 16).,OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"We used a similar approach, to construct pathway projec-tions for 62 plant species ( http://plantreactome.gramene.",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
( A) The analysis tool is accessible from the project website’s homepage (http://plantreactome.gramene.org ) by clicking on the Analyze Data icon or if the users are on the pathway browser click on the Analyze your data icon (red box).,OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"Using case studies from a vari-ety of crops and model plant species, we show how to use the available resources, data, and tools for plant compara- tivegenomicsandpathwayanalysis.TherecordedwebinarsalsoserveasvideotutorialsandcanbefoundonGramene’s YouTube channel ( https://goo.gl/qQ2Pjn ).",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"Currently, the curation of reference pathways is ongo- ing, and we continue to develop projections for more plantspecieswitheachdatabaserelease.Weupdateourdatabase 3–5 times per year, and post the current statistics and notes on new or updated data, tools and website content athttp://plantreactome.gramene.org/pages/content/release- summary .OurplansincludeadoptingtheReactome3.5or",OADS,/arxiv_data1/oa_pdf/a2/8b/gkw932.PMC5210633.pdf
"The STRING re- source is available online, at http://string-db.org/ .",OADS,/arxiv_data1/oa_pdf/81/46/gkw937.PMC5210637.pdf
"This is helpful whenqueryingforproteinsidentifiedinaproteomicsortranscrip- tomics study, since it facilitates subsequent import of tabu- lardatafromthestudy(Figure 2).Ifavailablefortheorgan- ism in question, the App also fetches information on the subcellular localization and tissue expression of each pro- tein from the COMPARTMENTS ( 47) and TISSUES ( 48) databases as well as drug target information from Pharos (http://pharos.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/81/46/gkw937.PMC5210637.pdf
The database is available at http://tstmp.enzim.ttk.mta.hu .,OADS,/arxiv_data1/oa_pdf/11/40/gkw939.PMC5210638.pdf
The database is available athttp://tstmp.enzim.ttk.mta.hu .,OADS,/arxiv_data1/oa_pdf/11/40/gkw939.PMC5210638.pdf
"A recently launched database, called Membranome(http://membranome.org ) of single TMS proteins provides models fortheseTMPs ( 29).",OADS,/arxiv_data1/oa_pdf/11/40/gkw939.PMC5210638.pdf
VENNY.AnInteract.toolComp.List.with VennDiagrams .http://bioinfogp.cnb.csic.es/tools/venny/index.html .,OADS,/arxiv_data1/oa_pdf/11/40/gkw939.PMC5210638.pdf
"The Bio-TDS (Bioscience Query Tool Discovery Systems, http://biotds.org/ ) has been developed to assist researchers in retriev- ing the most applicable analytic tools by allowing them to formulate their questions as free text.",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"This problem has acceler- ated the growth of community based discussion platformssuch as SEQAnswer Wiki ( http://SEQAnswers.com/wiki/ SEQAnswers ), Biostars ( https://www.biostars.org/ )a n dARAPORT( https://www.araport.org/ )(3–5).Thedevelop- ment of Natural Language Processing (NLP) applications in bioscience ( 6) offers an opportunity to combine ontolo- gies (i.e.",Non-OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"The BETS descriptions cur-rentlyincludeaugmentedspecificationsfromGalaxy( http: //galaxy.org/ ), CyVerse (formerly named the iPlant Col- laborative) ( http://www.cyverse.org/ ), Bioinformatics Link Directory(BLD)( http://bioinformatics.ca/links directory/ ) which contains the Nucleic Acid Research Tool List, SEQAnswers ( http://SEQAnswers.com/ ) and Bio-Soft Net (http://en.bio-soft.net/ )(24–27).",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"The module’s BETS con- verter, implemented in Java, allows users to convert any of the tool specification from the five listed repositoriesinto the BETS standard in JSON ( http://json.org/ ) format and /orrevertthembackintotheoriginalsourcerepository format.",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"The Bio-TDS repos- itory includes structured data stored using the open source database MySQL ( https://www.mysql.com/ ), unstructured datastoredinafilessystem,andindexeddatausingApache Lucene(https://lucene.apache.org/core/ ).TheMySQLrela- tional database stores the most commonly used attributessuchas‘Name,version,description’.Theunstructureddata file system consists of the BETS specification in JSON for- mat, the tool annotation data, and any images associatedwith a tool such as the tool icon.",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
TONER uses the National Center for Biomed-ical Ontology (NCBO) ( http://www.bioontology.org/ ) on- line annotation service to provide suggested concept an- notations from selected domain ontologies ( 28).,OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"These ontologies are: EDAM, an ontology of concepts that are prevalent within bioin- formatics, including types of data, data identifiers, dataformats, operations and topics ( http://edamontology.org/ ) (22); SWO, a resource for describing analytic tools, their types, tasks, versions, data requirements and provenance(http://theswo.sourceforge.net/ )(23);andNGSOnto,anon- tology to describe workflows from DNA extraction to contigs in a Whole Genome Sequence experiment ( http: //darwin.phyloviz.net/ ~msilva/NGSonto/ ).Attributevalues within each BETS document are queried against these on-tologies and the located terms are used to annotate the an- alytic tool.",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"Supporting materials available at http://biotds.org/help/ supporting.xhtml S1 BETSSpecificationdescriptionandmanipulation S2 Resourcesextractionandsemi-automaticscurationS3 TONER:Toolsontology-basedannotation S4 BioQueryToolqueryprocessingworkflowand programmaticaccess S5 BioQueryToolEvaluationandcomparison ‘NS’ value in a given evaluation criteria (Precision, Recall, ...)indicates limiteddatapoint(missing >40%datapointscomparethevariabledataset size)tocomputeanaccuratemeaningfulcriteriavalue.Thisisduetoalowretrievalrateintherelatedrepository(e.g.noresult returnforthequery).",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"In addition, the Bio-TDS repository will be enhanced by integrating more user do- mainsandontologies,suchastheBioconductorcommunity(https://www.bioconductor.org/ ).TheBio-TDStestsetwill beexpandedtocontainmoreuserquestionsandmoretools per question.",OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
AVAILABILITY Bio-TDS is open source project freely available at ( http:// biotds.org/ )underGNUPublicLicense.Thesourcecodeis available at https://bitbucket.org/USDBioinformatics/tds- v1-sources .,OADS,/arxiv_data1/oa_pdf/73/d0/gkw940.PMC5210639.pdf
"To provide the community with a resource free of these hurdles, we have developed DisGeNET(http://www.disgenet.org ), one of the largest avail- able collections of genes and variants involved in human diseases.",Non-OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
"The DisGeNET release 4.0 includes the following resources (for more details about the data processing, and versions, please check the Sup-plementary Data and http://disgenet.org/web/DisGeNET/ menu/dbinfo ): - The Comparative Toxicogenomics Database (CTD) that providesinformationaboutchemicalsandgenes,andtheir effectin human health and disease ( 3) - UniProt, a repository centred on protein sequence and function, that also include disease annotations from OMIM, and from expert curation of the scientific litera- ture(4) -ClinVar*,apublicarchiveofrelationshipsbetweenhuman variants and phenotypes,includingdiseases ( 5) -Orphanet*, a portal on rare diseases and theirgenes ( 6) - The GWAS Catalog*, a curated collection of published GWAS results( 7) - The Rat Genome Database (RGD), a repository for the genetic, genomic and phenotypic data of the laboratory rat (8) -TheMouseGenomeDatabase(MGD),themaincommu- nity resource for the laboratory mouse, that includes in- formation about mouse models ofdisease ( 9) - The Genetic Association Database (GAD), an archive of genetic association studies ( 10) Additionally,DisGeNETincludestwodatasetsobtained using differenttext-miningapproaches - The Literature Human Gene Derived Network (LHGDN), a data set of gene-disease associations obtained by text-mining the Entrez Gene Reference Into Function(GeneRIFs)usingaConditionalRandomField approach ( 11)- BeFree data, obtained using the BeFree System, which extracts gene-disease associations from MEDLINE ab- stracts(12,13) *Newsources withrespecttothelast published release The data in DisGeNET are aggregated according to the original source in: CURATED , that includes data from UniProt,ClinVar,Orphanet,theGWASCatalogandCTD (human data), PREDICTED , including RGD, MGD and CTD (mouse and rat data), and ALL.",OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
The DisGeNET score takes into account the number of sources supporting the asso- ciation and the reliability of each of them (for fur-ther details see http://disgenet.org/web/DisGeNET/menu/ dbinfo#score ).,OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
Access- ing the data using Semantic Web technologies enables tocombineDisGeNETdatawithothertypesofbiologicalin- formation available in the Linked Open Data (LOD) cloud (http://lod-cloud.net/ ).,OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
"The DisGeNET CytoscapeApp, and a detailed tutorial on how to use it, are available for download at http://disgenet.org/web/DisGeNET/menu/ app.",Non-OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
"NucleicAcidsResearch,2017,Vol.45,Databaseissue D837 sources such as Wikipathways ( 27), ChEMBL ( 28) and the Gene Expression Atlas ( 29) are available at the RDF page in the website ( http://www.disgenet.org/web/DisGeNET/ menu/rdf#sparql-queries ).",OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
Thesourcecodeanddocumentationofdisgenet2rpackageare available at https://bitbucket.org/ibi group/disgenet2r .,OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
A full list of contributing groups canbe foundat http://exac.broadinstitute.org/about .,Non-OADS,/arxiv_data1/oa_pdf/0a/1e/gkw943.PMC5210640.pdf
"D74–D78 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline23October2016 doi:10.1093/nar/gkw945 LincSNP 2.0: an updated database for linking disease-associated SNPs to human long non-codingRNAs and their TFBSs Shangwei Ning†,M i n gY u e†, Peng Wang†, Yue Liu, Hui Zhi, Yan Zhang, Jizhou Zhang, Yue Gao, Maoni Guo, Dianshuang Zhou, Xin Li and Xia Li* College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China Received August 14, 2016; Revised September 27, 2016; Editorial Decision October 08, 2016; Accepted October 19, 2016 ABSTRACT We describe LincSNP 2.0 ( http://bioinfo.hrbmu.edu.",OADS,/arxiv_data1/oa_pdf/44/c2/gkw945.PMC5210641.pdf
"We hope that this direct calcu- lationcancapturethelncRNAsmostlikelytobeinvolvedin specific diseases, providing disease lncRNA candidates for researchers.DATABASE CONSTRUCTION AND IMPROVED USER INTERFACE All data in LincSNP 2.0 were stored and managed using MySQL(version5.5.58).Thewebinterfaceswereupgraded by applying Linux, Apache, MySQL and PHP (pre hy-pertextprocessor)(LAMP)technologies.TheLincSNP2.0 database is freely available at http://bioinfo.hrbmu.edu.cn/ LincSNP orhttp://210.46.80.146/lincsnp .",OADS,/arxiv_data1/oa_pdf/44/c2/gkw945.PMC5210641.pdf
The database is freely ac-cessible at http://biokb.ncpsb.org/aagatlas/ .W eb e - lieve this database will be a valuable resource to track and understand human autoantigens as well as toinvestigate their functions in basic and translational research.,OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"Numberofnewpublicationsforautoantigenandautoantibodiesfrom1945to2016.Thesearchwasperformedusingthekeywordofeither( A) autoantigen or ( B) autoantibody in PubMed ( https://www.ncbi.nlm.nih.gov/pubmed/ ) on July 9, 2016; the total number was calculated using the sum of publicationsforautoantigenandautoantibody,respectively.",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"Toaddressthisneed,Wang etal.constructedaHumanPo- tential Tumor Associated Antigen (HPtaa) database that collected 3518 potential tumor antigens identified by in silicocomputing ( http://www.hptaa.org ) based on tumor- specificexpression,codingcapacity,chromosomallocation, subcellular location and the knowledge of gene function(18).",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"Almeida et al.constructed a cancer testis antigen database, CTdatabase ( http://www.cta.lncc.br ), which con- tains 276 genes that were compiled manually from the lit-erature and computational prediction ( 19).",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
( A) Classification of all human autoantigens using PANTHER (http://pantherdb.org/ )(42).,OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"DATA SEARCH AND NAVIGATION We provide a user-friendly web interface that facilitates searching,exploringinformationandupdatingtheAAgAt- las 1.0 database ( http://biokb.ncpsb.org/aagatlas/ )( F i g u r e 4).",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
(B)ProteinclassanalysisusingPANTHER( http://pantherdb.org/ )(42).,OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"The web interface is available online athttp://biokb.ncpsb.org/aagatlas/ .DISCUSSION AND CONCLUSION Since the first AAg paper appeared in 1945, more than 120 000 papers have been published and 1000 AAgs have been identified.",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"We built the AAgAtlas 1.0 database and website ( http://biokb.ncpsb.org/aagatlas/ ) thatisfreelyavailabletothescientificcommunitytobrowse, searchanddownload.Italsoprovidesasimplecommunity curation interface for future enhancements.",OADS,/arxiv_data1/oa_pdf/73/3e/gkw946.PMC5210642.pdf
"Also, we report signiﬁcant new de-velopments in FINDbase, namely (i) the release of a new version of the ETHNOS software that cat- alyzes development curation of national /ethnic ge- netic databases, (ii) the migration of all FINDbase data content into 90 distinct national /ethnic mutation databases, all built around Microsoft’s PivotViewer(http://www.getpivot.com ) software (iii) new data vi- sualization tools and (iv) the interrelation of FIND- base with DruGeVar database with direct implica-tions in clinical pharmacogenomics.",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"In 2006, our group established FINDbase (Frequency of INherited Disordersdatabase; http://www.findbase.org ), a worldwide database with the vision to comprehensively document the preva- lenceofclinicallyrelevantgenomicvariationallelefrequen-ciesinvariouspopulationsandethnicgroupsworldwide( 6).",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"Also,specialattentionwasgiventothedatamoduledoc- umenting PGx marker allele frequencies, which was sig-nificantly enriched with the prevalence of 36 clinically ac- tionable PGx biomarkers in 21, mostly European, popula- tions, resulting from a large multicenter study mapping the prevalenceofPGxbiomarkersinEurope( 11).Dataenrich- ment was based on the contributor’s unique ResearcherID(http://www.researcherid.com ) and follows the microattri- butionapproach( 12),allowingunambiguousidentification of curated data when data update or correction is needed and,atthesametime,providingincentivestopotentialdata contributors to share their data with the broader scientificcommunity.",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"UPGRADE OF THE ETHNOS SOFTWARE In the last FINDbase update, we have built a new mod- ule for rare genetic disease summaries ( 10), in which we migrated all genetic disease summary data collection fromfive previously developed NEGDBs (Hellenic, Lebanese, Cypriot,EgyptianandMoroccan).Basedonthisfunction- ality, and given that the component services of all threemodules homogeneously follow the Service Oriented Ar- chitecture (SOA; 13) and are built around the same data visualizationtool(PivotViewer; http://www.microsoft.com/ silverlight/pivotviewer ), we have decided to (i) completely restructure and upgrade the previous version of the ETH- NOSsoftware ( 2), to include improved data submission, querying and curation functionalities, standing as an ‘off- the-shelf’ web application that would allow the develop- ment of new NEGDBs, (ii) exploit the entire FINDbasedata content, subdivided into 3 modules, to migrate the entire FINDbase data collection to establish 90 individ- ualETHNOS -based NEGDBs in all 5 continents (Ta- ble1).",Non-OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"microsoft.com/silverlight/pivotviewer ), which is based on Microsoft Silverlight technology ( http://www.silverlight.",Non-OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
The front end environment was developed using AngularJS frame- work (https://angularjs.org ) and the architecture of the ap- plication is based on the AngularJS components adding reusable elements to the application and the ability of the configuration of the new features.,OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"The (i) and (ii) were developed us-ing D3.js ( https://d3js.org ) and (iii), (iv) and (v) using C3.js (http://c3js.org ).",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"In that case, the information pro- vided includes a table, with filtering, ordering and pagina- tion of the fields of the related drugs (Figure 2Aa n dB ) developed using Smart Table ( http://lorenzofox3.github.io/ smart-tablewebsite ).",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"Stacked bar charts, donut charts and barchartsareusedtomeasuretherelationbetweentheba-siccomponents;thepercentageoftherelatedPGxbiomark- ers,thenumberofrelatedPGxbiomarkerstodrugsandthe number oftherelated drugs bypopulation.EstablishingtheminimumNEGDBinformationspecification withVarioML As of early 2007, immediately after its first launch, FIND- base established synergies with other related genomic databases (Human Gene Mutation Database (HGMD);http://www.hgmd.org ;3),orresources(Caf ´eVariome( http: //www.cafevariome.org );10).",OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
These open source tools and libraries are made available onGitHub ( https://github.com/VarioML ).,OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
All VarioML elements can hold nec- essary attributes for unambiguously linking the elements into relevant ontologies using for example either URIs orMIRIAM identifiers ( http://www.ebi.ac.uk/miriam ).,OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"This was made possible thanks tothe uninterrupted funding of this database since 2005, as part of major research Consortia, such as GEN2PHEN (http://www.gen2phen.org ), RD-Connect ( http://www.rd- connect.eu ) and the Genomic Medicine Alliance ( http:// www.genomicmedicinealliance.org ), also ensuring fruitful interactions withthe field’s leadingexperts.",Non-OADS,/arxiv_data1/oa_pdf/9d/d6/gkw949.PMC5210643.pdf
"MethSMRT is publicly available at http://sysbio.sysu.edu.cn/methsmrt/ without use re- striction.INTRODUCTION DNA methylation is an important type of epigenetic mod- ifications, which greatly expands the information content of DNA.",Non-OADS,/arxiv_data1/oa_pdf/c1/9b/gkw950.PMC5210644.pdf
MethSMRT is publicly available at http://sysbio.sysu.edu.cn/methsmrt/ withoutuserestriction.,OADS,/arxiv_data1/oa_pdf/c1/9b/gkw950.PMC5210644.pdf
MATERIALS AND METHODS Data sources The SMRT sequencing data sets were downloaded from NCBI Gene Expression Omnibus ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/c1/9b/gkw950.PMC5210644.pdf
DNA modification detection We used the PacBio SMRT analysis platform (version: 2.3.0) for DNA 6mA and 4mC modification detection(http://www.pacb.com/products-and-services/analytical- software/smrt-analysis/analysis-applications/epigenetics/ ).,OADS,/arxiv_data1/oa_pdf/c1/9b/gkw950.PMC5210644.pdf
"To provide a smooth andfriendlyusersinterface,weusedBootstrapframeworkfrom thefront-endtoolkit( http://getbootstrap.com/ ).Thegraphs in the Browse pages were produced by D3.js library ( https: //d3js.org/ ).",OADS,/arxiv_data1/oa_pdf/c1/9b/gkw950.PMC5210644.pdf
"A fast up-to-date overview on sequence annotations of nearly 16 million genes improved by man- ually created organism-specific enzyme information fromBRENDA,sequencepatternsearcheswithBrEPS( 21)and afilteredsequencebasedsimilarityanalysisbyBLAST( 22) is provided by the web service at http://edbs.tu-bs.de and linked to BRENDA.",OADS,/arxiv_data1/oa_pdf/f3/6e/gkw952.PMC5210646.pdf
"Additional databases like KEGG or- thology data and PATRIC ( 23) are integrated as anno- tation sources as well as sequence comparisons with pre-compiledfunctionspecificPfam( 24)HiddenMarkovMod- els(HMMs)( 25)tosupportthedecisionforthemostprob- able enzymatic function of a gene of interest out of morethan 4000 unique assigned enzyme classes.BRENDA training, tutorials and videos BRENDA provides online training materials for new and advanced users, including handouts, practice exercises and video tutorials ( http://www.brenda-enzymes.org/tutorial.",OADS,/arxiv_data1/oa_pdf/f3/6e/gkw952.PMC5210646.pdf
ACCESSIBILITY All described databases and features are accessible via the main BRENDA website: http://www.brenda-enzymes.,OADS,/arxiv_data1/oa_pdf/f3/6e/gkw952.PMC5210646.pdf
The EnzymeDetector can also be accessed via http: //edbs.tu-bs.de/ and a direct link to BKM-react is provided viahttp://bkm-react.tu-bs.de/ .,OADS,/arxiv_data1/oa_pdf/f3/6e/gkw952.PMC5210646.pdf
"D282–D288 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline26October2016 doi:10.1093/nar/gkw962 Protein Data Bank Japan (PDBj): updated user interfaces, resource description framework, analysistools for large structures Akira R. Kinjo*, Gert-Jan Bekker, Hirofumi Suzuki, Yuko Tsuchiya, Takeshi Kawabata, Yasuyo Ikegawa and Haruki Nakamura Institute for Protein Research, Osaka University, 3-2 Y amadaoka, Suita, Osaka 565-0871, Japan Received September 15, 2016; Revised October 06, 2016; Editorial Decision October 07, 2016; Accepted October 11, 2016 ABSTRACT The Protein Data Bank Japan (PDBj, http://pdbj.org ), a member of the worldwide Protein Data Bank (ww-PDB), accepts and processes the deposited data of experimentally determined macromolecular struc- tures.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"Accordingly, depo-sitions from Asia and the Middle East are directed to the PDBj deposition site ( http://deposit-pdbj.wwpdb.org )a n d are annotated bytheannotators atPDBj.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"For thenovice user, we have created a series of interactive tutorials for PDBj’s search services ( http://pdbj.org/help/tutorials ).",Non-OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
The user can download the mmJSON file of PDB entries viaa REST service (see http://pdbj.org/help/file-formats ).,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
The summarypageofeachentryissemanticallyannotatedwith schema.org vocabulary ( http://schema.org/ ) in a microfor- mat.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
The Sagace search engine ( http://sagace.nibiohn.go.,Non-OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"AlongwiththegraphicalinterfacesonWebbrowsers,we havealsorenewedourRESTfulwebservices.Infact,allser- vicesprovidedbythemainPDBjwebsitearealsoavailable asaRESTserviceasdescribedon http://pdbj.org/help/rest- interface.",Non-OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
Chemie ( http://pdbj.org/chemie-search ) is a new service offered by PDBj.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"Much like its counterparts, RCSB PDB’sLigand Expo ( http://ligand-expo.rcsb.org/ )a n dP D B e ’ s PDBeChem ( http://www.ebi.ac.uk/pdbe-srv/pdbechem/ ), PDBj’s Chemie offers users an interface to search andexplore the Chemical Component Dictionary of the wwPDB via text search of various fields, as well as sub- structure search via SMILES with Tanimoto scoring usingfingerprints ( 10) generated by the Open Babel software (11).PDBj Mine RDB The most basic infrastructure underlying PDBj’s web ser- vices is the PDBj Mine relational database (RDB) which has been completely redesigned in recent years.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"In a nutshell, each table in the PDBj Mine RDB schema corresponds to a category as defined in thePDBx /mmCIF dictionary and different tables are cross- referencedviaforeignkeyswhentheyaredefinedinthedic- tionaryandmakesenseintheRDB.Acompletedocumen-tation of the schema is provided at http://pdbj.org/mine- rdb-docs .TheRDBisimplementedinPostgreSQL(version 9.3)(http://www.postgresql.org/ )andthecompletedatabase dump and weekly updates are available at our ftp site (ftp://ftp.pdbj.org/mine2/ and see also http://pdbj.org/help/ mine2-rdb-local-install for installation instruction) along with an extensive list of example SQL queries ( http://pdbj.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
SQL queries can be executed on the webbrowser( http://pdbj.org/mine/sql/ )orviatheRESTin- terfaces withseveral options fortheoutputfile formats.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"D284NucleicAcidsResearch,2017,Vol.45,Databaseissue mary files provided for ‘quick access’ ( https://www.ebi.ac.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
Example queries that combine the PDB and SIFTS data are also provided at http://pdbj.org/help/mine2-sql .,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
The PDB /RDF data has become one of the standard formats ofthewwPDBandisnowcalledwwPDB /RDFprovidedat http://rdf.wwpdb.org/pdb/ onthewebaswellasonourFTP site atftp://ftp.pdbj.org/RDF .,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
We also provide the Chemi- cal Component Dictionary as RDF ( http://rdf.wwpdb.org/ cc/).,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"The structureofthewwPDB /RDFis mostlyunchanged from that which was previously described ( 1)e x c e p tf o r t h eb a s eU R I( n o w http://rdf.wwpdb.org/ rather than http: //pdbj.org/rdf/ ).Thatis,the‘ontology’ofthewwPDB /RDF is based on the PDBx /mmCIF dictionary ( http://mmcif.",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"Second, many exter-nal resources are referred to by the URI’s based on the Identifiers.org ( http://identifiers.org/ ) hosted at European Bioinformatics Institute ( 21).",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
These changes were recom- mended in the guideline proposed by the Database Cen- ter for Life Science (DBCLS) ( http://wiki.lifesciencedb.jp/ mw/RDFizingDatabaseGuideline [in Japanese]) that coor- dinates a database integration project in Japan.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"SIFTS enhancement Similarly to the PDBj Mine RDB, wwPDB /RDF is also supplemented with the SIFTS resource ( 15)b a s e do ntheSIFTS‘Quickaccess’files( https://www.ebi.ac.uk/pdbe/ docs/sifts/quick.html ).",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
Our SIFTS RDF data are dis- tributed as a separate release from the wwPDB /RDF at our FTP site ( ftp://ftp.pdbj.org/RDF/sifts/ ).,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"Nevertheless, thanks to the very design of the Semantic Web technolo- gies of which RDF constitutes the core, integration of the SIFTSresourceandwwPDB /RDFaswellasotherdatare- sourcesshouldbetrivial.Toensuretheconnectivityofvar- ious data, the links to external resources described in the SIFTS data are also based on the URI’s provided by theIdentifiers.org ( http://identifiers.org/ ).",OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
SPARQL endpoint at National Bioscience Database Center (NBDC RDF Portal) The National Bioscience Database Center of Japan (NBDC) provides the RDF Portal ( http://integbio.jp/rdf/ ) where they publish various resources (mostly developed in Japan) in the RDF format and provide a SPARQLendpoint to query these resources.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
Some example SPARQL queries arealsoprovidedat http://integbio.jp/rdf/?view=detail&id= pdbj.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
We at the PDBj have been pro- viding the EM Navigator ( http://pdbj.org/emnavi/ ) for aid- ing the animated visualization of EM structures.,Non-OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
The EMNavigator is now integrated with the Yorodumi browser (http://pdbj.org/emnavi/viewtop.php ) so that entries in the PDB and EMDB can be browsed in a single integrated in-terface (Figure 3A).,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
( A)TheEMNavigator /Yorodumi( http://pdbj.org/emnavi )providesanintegratedinterfacetothePDB andEMDBcombined.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
( B)TheOmokagesearch( http://pdbj.org/emnavi/omo-search.php )performsshapesimilaritysearchesthroughboththePDBand EMDB.,OADS,/arxiv_data1/oa_pdf/65/93/gkw962.PMC5210648.pdf
"In this study, we developed ChIPBase v2.0 ( http://rna.sysu.edu.",OADS,/arxiv_data1/oa_pdf/55/35/gkw965.PMC5210649.pdf
AVAILABILITY ChIPBase v2.0 is freely available at http://rna.sysu.edu.cn/ chipbase/ .AllthedatafilesinChIPBasecanbedownloaded and used in accordance with the GNU Public License and thelicenseof primary datasources.,OADS,/arxiv_data1/oa_pdf/55/35/gkw965.PMC5210649.pdf
"In or-der to help the research community to better ex- plore the similarities and differences of genomic re- sponse between human inﬂammatory diseases and murine models, we developed KERIS: kaleidoscope of gene responses to inﬂammation between species(available at http://www.igenomed.org/keris/ ).",OADS,/arxiv_data1/oa_pdf/58/79/gkw974.PMC5210651.pdf
"For example, in the multiple genes report page for the ‘Biocarta Th1 /Th2 pathway’ ( http://www.igenomed.org/ immune/summary?pathway=M6705 ),theusercanexamine the PCA plot and the heatmap of correlations, and find that different human inflammatory diseases such as Burns,Trauma and Sepsis show highly similar genomic responses for this pathway, while the mouse Infection and mouse Trauma model mimic the human infection response to acertain extent.",Non-OADS,/arxiv_data1/oa_pdf/58/79/gkw974.PMC5210651.pdf
The LinkProtdatabase ( http://linkprot.cent.uw.edu.pl ) collects and displays information about protein links –– topo- logically non-trivial structures made by up to four chains and complexes of chains (e.g.,OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"However, up to now, such structures have never been assembled, analyzed and classi-fiedinawaythatwouldenabletheirsystematicanalysis.The LinkProt database ( http://linkprot.cent.uw.edu.pl ) aims to fill this gap.",OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"The databaseis compatible with other databases and servers concern- ing non-trivial topologies in proteins, such as KnotProt ( 7) (http://knotprot.cent.uw.edu.pl ) and LassoProt ( 3)(http:// lassoprot.cent.uw.edu.pl ), facilitating its easy use in con- junctionwiththem.",OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"Hoste- Thistlethwaite notation ( http://katlas.org ,http://indiana.",Non-OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"Mathematical link databases, such as the Knot At-las(http://katlas.org )donotshowinformationfordifferent chiralitiesororientationsofthecomponentswithinagiven linktype.Inphysicalsettings,suchinformationmaybecrit-icalandLinkProt’sclassificationissensitivetochiralityand componentorientations.",OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"In comparison to other databases of knotted structures, such as ProteinKnots (http://knots.mit.edu/ ), pKNOT ( http://pknot.life.",OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"nctu.edu.tw )andKnotProt( http://linkprot.cent.uw.edu.pl ) thisdatabase:(i)presentsalldetectedlinking,deterministicand probabilistic, for all molecular complexes in the PDB, (ii)offerssearchoptionsusingmolecularkeywords,molec- ular tags, PFAM access code and CATH topology, (iii) de-tectsbrokenproteinchainsandusesthisinformationinthe analysis, and (iv) allows for user submission of structures forlinking analysis.",OADS,/arxiv_data1/oa_pdf/3b/99/gkw976.PMC5210653.pdf
"D672–D678 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline23October2016 doi:10.1093/nar/gkw977 FlyRNAi.org––the database of the Drosophila RNAi screening center and transgenic RNAi project: 2017update Yanhui Hu1,2, Aram Comjean1,2, Charles Roesel1,2,3, Arunachalam Vinayagam1,2, Ian Flockhart1,2, Jonathan Zirin1,2, Lizabeth Perkins1,2, Norbert Perrimon1,2,4and Stephanie E. Mohr1,2,* 1Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA,2Drosophila RNAi Screening Center and Transgenic RNAi Project, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA,3Marine Science Center, Northeastern University, 430 Nahant Rd., Nahant, MA 01908, USA and 4Howard Hughes Medical Institute, 77 Avenue Louis Pasteur, Boston, MA 02115, USA Received August 15, 2016; Revised October 05, 2016; Editorial Decision October 07, 2016; Accepted October 11, 2016 ABSTRACT The FlyRNAi database of the Drosophila RNAi Screening Center (DRSC) and Transgenic RNAi Project (TRiP) at Harvard Medical School and associated DRSC /TRiP Functional Genomics Re- sources website ( http://fgr.hms.harvard.edu ) serve as a reagent production tracking system, screen data repository, and portal to the community.",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"Navigatingresources atDRSC /TRiPrelevantto Drosophila andotherspecies Question Speciessupported Resource WherecanIviewanoverviewoftheonline tools?Overviewpage http://fgr.hms.harvard.edu/tools WhatmiRNA-likeseedsequencetargetsare enrichedinmylarge-scalesiRNAorshRNA screendata?fly, human,mouse(andotherifareferencefile is provided)OnlineGESS http://www.flyrnai.org/gess/ Whatknownandpredictedproteincomplexes areenrichedinmyhigh-throughputfunctionalgenomicsdataset?fly, buddingyeast,human COMPLEAT http://www.flyrnai.org/compleat/ HasGeneX beenconservedacrossspecies?",Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"Overviewpage http://fgr.hms.harvard.edu/tools Inwhatcells,stages,ortissuesisGeneXexpressed?",Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
DGET http://flyrnai.org/tools/dget/web/ Towhat functionalgroupsdoesGeneXbelong?aGLADhttp://flyrnai.org/tools/glad/web/ WherecanIdesigndsRNAsagainstGeneX?,OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
SnapDragon http://flyrnai.org/cgi-bin/RNAi findprimers.pl WherecanIlearnifGeneXscored inacell-basedscreen?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
GeneLookup http://flyrnai.org/cgi-bin/DRSC genelookup.pl WherecanIviewallpublicDRSCcell-basedscreensanddata?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
ScreenSummary http://flyrnai.org/screensummary WherecanIfindallexistingcellRNAireagentstargetingGeneX?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
UP-TORR http://flyrnai.org/up-torr/ WherecanIfindallexisting invivoRNAifly stockstargetingGeneX?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
UP-TORR http://flyrnai.org/up-torr/ WherecanIlearnifexisting invivoRNAifly stockshavephenotypes?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
RSVP http://flyrnai.org/cgi-bin/RSVP search.pl WherecanIfindqPCRprimersforGeneX?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
FlyPrimerBank http://flyrnai.org/FlyPrimerBank W her ecanIvie wgRN Asintheconte xtofGeneX?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
FindCRISPR http://flyrnai.org/crispr2/ WherecanIevaluatepredictedefficiencyofa givengRNA?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
CRISPRefficiency http://flyrnai.org/evaluateCrispr WherecanIfindprotocolsfor Drosophila research?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
Drosophila ProtocolsPortal http://flyrnai.org/tools/protocols/web/ Howdomyhitsconnectwitheachotherphysicallyandphenotypically?,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"SignedPPI http://flyrnai.org/SignedPPI/ aAlsorecommended,FlyBaseGeneGroups( http://flybase.org/static pages/FBgg/browse.html ).",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"Major additions in terms of RNAi reagents and data since 2012 include the reagents and data for new focused cell-basedRNAi sub-libraries, for example, genes that encode RNA- binding proteins (complete list at http://fgr.hms.harvard.",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
The newDRSC /TRiP-FunctionalGenomicsResourceswebsite (http://fgr.hms.harvard.edu/ ) serves as a portal to the Fly- RNAi database and other resources.,OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"Foreachtool,wenowhaveanoverviewpageaimedatnewusers (e.g.http://fgr.hms.harvard.edu/compleat ) and a more de- taileddocumentationpage(e.g.",Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"http://fgr.hms.harvard.edu/ compleat-documentation ).Thewebsiteishostedbyathird partyinthecloud.SincetheFlyRNAidatabaseandonline toolsthemselvesremainhostedbytheHMSResearchCom- puting Group, the tools remain at their original flyrnai.org URLs (e.g.",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
http://www.flyrnai.org/compleat/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"We performed a complete re- designandreorganizationofourwebsite( http://fgr.hms.harvard.edu ),whichprovidesinformationaboutourRNAiandCRISPRplatformsfor Drosophila cell-basedandinvivosystems,aswellasprovidinginformationaboutandaccesstoourdatabaseandonlinetools.",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"orthoDB (9), Panther ( 10) and manually assembled ortholog rela- tionshipsfromHGNC( 11)andZfin( 12).Notably,DIOPT wasrecentlyintegratedintoFlyBase.Thus,researcherscan initiate a DIOPT-based ortholog search either at our site (http://www.flyrnai.org/diopt ) or from the FlyBase home page(http://flybase.org/ ).DIOPToriginallysupportedpair- wise searches (species A vs. species B).",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"At the Drosophila Gene Expres- sion Tool,DGET(http://biorxiv.org/content/early/2016/09/ 15/075358 ),ausercanretrieveexpressionprofiledatafrom RNAseqstudiesbythemodENCODEconsortiumandspe- cific laboratories ( 14–16)f o rDrosophila cell lines, tissues, developmental stages and treatments.",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"As mentioned above, RSVP provides data submission user interface that allows researchers toprovideqPCRknockdownefficiencyorphenotypedatafor RNAiflystocks.Moreover,asstatedabove,FlyPrimerBank provides a feedback submission page that allows users toprovide feedback as to whether or not qPCR primers meet certainqualitystandards.Tohighlightandencouragefeed- back submissions, our new website treats the ‘Add Feed-back’functionsofthesetoolsasseparateonlinetoolsonthe listof Online Tools (see http://fgr.hms.harvard.edu/tools ).",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"To address a need for a cen- tralizedresource,webuiltatestversionofa Drosophila Pro- tocols Portal ( http://www.flyrnai.org/tools/protocols/web/ ).",Non-OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"In addition, we use data from other groups as sources of information for specific online tools;for example, DGET ( http://biorxiv.org/content/early/2016/ 09/15/075358 ), includes data from the modENCODE con- sortium and individual labs ( 14–16).",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"Regarding im- agedata,wefoundapracticalandfreewaytoprovideaccess to images for a small-scale screen, using Flickr as a reposi- tory for the images and a look-up table to help researchersview images for specific reagents or genes of interest ( 27) (seehttp://www.flyrnai.org/DRSC-RBP data.php ).",OADS,/arxiv_data1/oa_pdf/73/27/gkw977.PMC5210654.pdf
"The database, avail-able at http://isoelectricpointdb.org allows the re- trieval of virtual 2D-PAGE plots and the develop- ment of customised fractions of proteome basedon isoelectric point and molecular weight.",OADS,/arxiv_data1/oa_pdf/3e/c0/gkw978.PMC5210655.pdf
"Publishedonline24October2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D979–D984 doi:10.1093/nar/gkw980 Exposome-Explorer: a manually-curated database on biomarkers of exposure to dietary and environmental factors Vanessa Neveu1, Alice Moussy1,H´elo¨ıse Rouaix1, Roland Wedekind1, Allison Pon2, Craig Knox2, David S. Wishart2and Augustin Scalbert1,* 1International Agency for Research on Cancer (IARC), Nutrition and Metabolism Section, Biomarkers Group, 150 Cours Albert Thomas, F-69372 Lyon Cedex 08, France and2Department of Computing Science, University of Alberta, Edmonton, AB T6G 2E8, Canada Received August 10, 2016; Revised October 07, 2016; Editorial Decision October 11, 2016; Accepted October 12, 2016 ABSTRACT Exposome-Explorer ( http://exposome-explorer.iarc.",Non-OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
"The ExpoCastDB database contains in- formation on exposure to environmental chemicals such as PAHs, PCBs, nonylphenols, or pesticides(http://actor.epa.gov/actor/faces/ExpoCastDB/Home.jsp ).",OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
"Full-record citations from the WOS were downloaded in the BibTeX format ( http://www.bibtex.org/ ) and han- dled with BibDesk, an open-source bibliography manager forBibTeXlibraries( http://bibdesk.sourceforge.net/ ).Cita- tions were initially screened by title and abstract to assessrelevance.",OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
DATABASE IMPLEMENTATION Exposome-Explorer was developed using Ruby on Rails (http://rubyonrails.org/ ).,OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
"Hierarchical associations of records (‘trees’) are implemented as a nested set model inside a single database column of the tables using the Rails gem An- cestry(https://github.com/stefankroes/ancestry ).Highlydi- verseunitsandtheirconversionsaretransparentlyhandled with the Phys-Units library ( https://github.com/masa16/ phys-units/ ), which is a Ruby implementation of the GNUUnitssoftware( http://www.gnu.org/software/units/ ).",OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
"Chemical structures are hosted on the Wishart’s MolDB structureserver.WebsiteglobalsearchisimplementedusingtheWishart’sUnearthgem,whichusesElasticsearchindex- ing(https://www.elastic.co/ ).Thewebinterfaceisbuiltwith the Bootstrap front-end framework ( http://getbootstrap.",OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
com/).Tablesonthedifferentwebpagesareformattedusing jQueryDataTables ( http://www.datatables.net/ ).,OADS,/arxiv_data1/oa_pdf/81/f3/gkw980.PMC5210656.pdf
"China Received September 30, 2016; Editorial Decision October 11, 2016; Accepted October 12, 2016 ABSTRACT With the goal of providing a comprehensive, high- quality resource for both plant transcription factors (TFs) and their regulatory interactions with target genes, we upgraded plant TF database PlantTFDB toversion 4.0 ( http://planttfdb.cbi.pku.edu.cn/ ).",OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"Finally,we set up a novel companion portal PlantRegMap (http://plantregmap.cbi.pku.edu.cn ) for users to ac- cess the regulation resource and analysis tools con-veniently.",OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"To meet the urgent demand of our user com-munity for transcriptional regulation information, we up- gradedPlantTFDBtoversion4.0( http://planttfdb.cbi.pku.",Non-OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
Using our established TF predic- tion pipeline ( 16) and protein sequences downloaded from JointGenomeInstituteandotherplantgenomesequencingand annotation projects (see http://planttfdb.cbi.pku.edu.,OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"As histone modifi- cationandnucleosomepositioningalsoprovideusefulclues forthestudyoftranscriptionalregulation,suchinformationis also incorporated (Table 1, Supplementary Tables S6–S8 andSupplementaryText2).Inaddition,wesetupagenome browserforuserstoaccesstheseregulatoryelementsconve-niently(http://plantregmap.cbi.pku.edu.cn/cis-map.php ).",OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"Resource availability For users to access our resource conveniently, we set up a new portal PlantRegMap ( http://plantregmap.cbi.pku.edu.",OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"cn/)forPlantTFDB( http://planttfdb.cbi.pku.edu.cn/ ),with PlantTFDB focusing on TF identification and annotation and the new portal for regulation prediction and analyses (Table3).Allofdatainourdatabasecanbefreelyaccessed and downloaded online.FURTHER DIRECTION WehaveupgradedourPlantTFDBtoversion4.0withanew portal PlantRegMap, which provides genomic TF reper- toires covering the main lineages of green plants, sets of high-qualitybindingmotifs,genome-wideregulatoryinter-actionsandrichanalysistools.TheinformationforTFsand transcriptional regulation are useful resources for users to explore the functional mechanisms of TFs and plant tran-scriptional regulatory system ( 24).",OADS,/arxiv_data1/oa_pdf/27/42/gkw982.PMC5210657.pdf
"The re- sulting Cistrome DB (Cistrome Data Browser), avail-able online at http://cistrome.org/db , is expected to become a valuable resource for transcriptional and epigenetic regulation studies.INTRODUCTION Genome-wide identification of transcription factor (TF) and chromatin regulator binding sites, histone modifica-tions and chromatin accessibility is important for under- standing transcriptional control governing biological pro- cesses such as differentiation, oncogenesis and cellular re-sponse to environmental perturbations ( 1–3).",OADS,/arxiv_data1/oa_pdf/9b/0b/gkw983.PMC5210658.pdf
"To this end, we generated the Human Inte- grated Protein–Protein Interaction rEference or HIP- PIE ( http://cbdm.uni-mainz.de/hippie/ ).",OADS,/arxiv_data1/oa_pdf/cb/11/gkw985.PMC5210659.pdf
GTEx provides gene- level expression quantifications (for the technical detailssee their documentation: http://www.gtexportal.org/home/ documentationPage ).,OADS,/arxiv_data1/oa_pdf/cb/11/gkw985.PMC5210659.pdf
Detailedinformationaboutthisservicecanbeconsulted athttp://cbdm-01.zdv.uni-mainz.de/ ~mschaefer/hippie/ information.php#api .,Non-OADS,/arxiv_data1/oa_pdf/cb/11/gkw985.PMC5210659.pdf
"To leverage these data for meta analyses, AraPheno ( https://arapheno.1001genomes.org )p r o - vide a central repository of population-scale pheno- types for A. thaliana inbred lines.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"Nowadays, full genome information for over 1000 different natural inbred lines are available ( 6, http://1001genomes.org/tools/ ).",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"The persistent DOIs will be assigned by DataCite (https://www.datacite.org ), a non-profit organization that provides persistentidentifiers(DOIs) for researchdata.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"AraPhenoishostedunderthe1001genomesorganization (http://1001genomes.org ), and its framework will be made available as open source (see Implementation) and under the Arabidopsis Information Portal ( https://www.araport.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
Screenshotofthedetailedviewforaphenotypeofinterest( https://arapheno.1001genomes.org/phenotype/43/ ).,OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"IMPLEMENTATION AraPheno has been implemented using the Django web framework ( https://www.djangoproject.com/ ), an open- source and popular web-application framework based on Python and Django REST ( http://www.django-rest- framework.org ), an open-source REST framework based on Django fortheREST endpoints.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"Documentation of the REST endpoints are done with the django-rest-swagger ( https://github.com/marcgibbons/ django-rest-swagger ),anopen-sourceswaggerimplementa- tion forDjango REST.The data are stored in PostgreSQL ( https://www.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"The interactive charts were developed using the google charts library ( https://developers.google.com/chart ), a free librarydevelopedbyGoogleandD3.js( https://d3js.org ),an open-source and popular JavaScript library for manipulat-ingdocumentsbased ondata.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"numpy.org ), an open-source library for scientific comput- ingforPython,andSciPy( https://www.scipy.org ),anopen-",Non-OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
Screenshot of the detailed view for a specific accession ( https://arapheno.1001genomes.org/accession/6909/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"Screenshot of the Phenotype-Correlation results ( https://arapheno.1001genomes.org/correlation/6,29,30,31,49,102,99,53,86,39/ ).",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
"sourcelibraryformathematics,scienceandengineeringfor Python, as well as Pandas ( http://pandas.pydata.org ), an open-source library providing high-performance, easy-to-use datastructuresand dataanalysis tools forPython.",OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
AraPhenoisdeployedusingdocker( https://www.docker.,Non-OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
The code for AraPheno is open-source and hosted on github ( https://github.com/1001genomes/AraPheno ) that allows theuser toreportissues withthedatabase.CONCLUSIONS AND FUTURE DIRECTIONS AraPheno is the first comprehensive database to store phe- notypic information for the model plant A.thaliana .A sA.,OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
An automatic submission of published studies and phe- notypes from easyGWAS ( https://easygwas.ethz.ch/ )a n d GWA-Portal ( https://gwas.gmi.oeaw.ac.at/ ) is planned to prevent fragmentation of phenotypic data.,Non-OADS,/arxiv_data1/oa_pdf/68/a7/gkw986.PMC5210660.pdf
The current version of PlaMoM compiles atotal of 17 991 mobile macromolecules from 14 plant species /ecotypes from published data and literature.PlaMoM is available at http://www.systembioinfo.org/ plamom/ .,OADS,/arxiv_data1/oa_pdf/6c/6a/gkw988.PMC5210661.pdf
"D932–D939 NucleicAcidsResearch,2017,Vol.45,Databaseissue Publishedonline26October2016 doi:10.1093/nar/gkw993 DrugCentral: online drug compendium Oleg Ursu1,J a y m eH o l m e s1, Jeffrey Knockel2, Cristian G. Bologa1, Jeremy J. Yang1, Stephen L. Mathias1, Stuart J. Nelson1and Tudor I. Oprea1,* 1Translational Informatics Division, Department of Internal Medicine, The University of New Mexico Health Science Center, Albuquerque, NM 87131, USA and2Department of Computer Science, University of New Mexico, Albuquerque, NM 87131, USA Received August 10, 2016; Revised September 27, 2016; Editorial Decision October 12, 2016; Accepted October 24, 2016 ABSTRACT DrugCentral ( http://drugcentral.org ) is an open- access online drug compendium.",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"DrugCentral is based on a curated list of 4444 APIs, with an unambiguous list of over 20 617 drug synonyms and research codes that are continu- ouslyupdatedbyautomatedmonitoringofregulatoryagen-cies approvals from U.S. Food and Drug Administration (FDA) (http://www.fda.gov ), European Medicines Agency (EMA) ( http://www.ema.europa.eu ) and Japan Pharma- ceutical and Medical Devices Agency (PMDA) ( http:// www.pmda.go.jp/english ).",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Pharmacological actions are compiled from theAnatomicalTherapeuticChemical(ATC)classification system (http://www.whocc.no ), the FDA Established Phar- macologic Class (EPC) ( http://purl.access.gpo.gov/GPO/ LPS118712 ), Medical Subject Headings (MeSH) ( 4)a n d Chemical Entities of Biological Interest (ChEBI) ontology(5), respectively.",Non-OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Indications in DrugCentral were collated from OMOP vocabularies ( http://omop.org/Vocabularies ) for those drugs approved before 2012; for drugs approvedafter2012,indicationswereextractedfromdruglabels,and mapped to SNOMED-CT ( 6) concepts.",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Chemical structure representation for small organic molecules and peptides were manually entered us- ing depictions and information from the following sourceslisted in decreasing order of precedence: WHO INN (http://www.who.int/medicines/services/inn/en ), USAN (http://www.ama-assn.org/ama/pub/physician-resources/ medical-science/united-states-adopted-names-council.",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"page), FDA SRS ( http://fdasis.nlm.nih.gov ), CAS (9)a n d F D Ad r u gl a b e l s( http://www.fda.gov ), respectively.",Non-OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Fur- ther investigations revealed that WHO INN corrected the initially published 2, 2-dimethylethyl structure, toresolve to 2-(dimethylamino)-1, 1-dimethylethyl benzilate (https://mednet-communities.net/inn/db/media/docs/r- innlist24.pdf ), the amended structure confirmed by CAS is currently the version stored in DrugCentral.",Non-OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
DrugCentraldatabaseentitiesandstatistics Entities(AnnotatedAPIs) Activepharmaceuticalingredients 4444 FDAdrugs 2021DrugsapprovedoutsideUS 2423Smallmolecules 3799 Saltsandinorganicmolecules 112 Biologicsandpeptides 239Otherdrugs 294Parent molecules 199(308) Drugefficacytargets 837(1689) Humanproteintargets 600(1387)Infectiousagentstargets 194(221)Metabolites&biopolymers 43(89) Protein–drugcrystalcomplex(PDB) 48(82) Drug–proteincrystalcomplex(PDB) 1452(283) Bioactivitydatapoints 13825(1792) Humanproteins 10427(1605) Otherspecies 3398(1002)PharmacologicalactionWHOATCcode 4195(2941) FDAEstablishedPharmacologicClass 428(1165) MeSHpharmacologicalaction 424(2529)ChEBIontologyroles 285(1487)Drugindications 2224(2247) Drugcontra-indications 1458(1376) Drugoff-labeluses 847(646) Pharmaceuticalproducts 67064(1660) Rxpharmaceuticalproducts 29665(1561) OTC pharmaceuticalproducts 37399(286) Externalidentifiers 61349(4444) CASregistrynumber 6072(4444)PubChemCompoundId 4175(4175) FDAUniqueIngredientIdentifier(UNII) 4304(4304) ChEMBL-dbid 5615(4075)WHOINNid 3519(3519) SNOMED-CT 4745(2637) KEGGDRUG 3501(3501)NDFRT 4171(2406)RxNormRxCUI 2897(2897) IUPHAR /BPSligandid 1345(1345) UMLSCUI 2839(2839)CHEBI 2557(2557)MeSH 4063(3846) DrugBank 2473(2388) Proteindatabankligandid 646(618) by MDL V3000 format ( http://accelrys.com/products/ collaborative-science/biovia-draw/ctfile-no-fee.html ).,Non-OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"CommercialdrugcollectionsoverlapwithFDAsmallmoleculesdrugssubset(1608structures) Chemicalcatalog TotalnumberofchemicalsFDAsmallmoleculedrugs overlapwith stereochemistryspecified(%)FDAsmallmoleculedrugs overlapwith stereochemistryomitted(%) URL PrestwickChemicalLibrary1280 740(46%) 824(51%) http: //www.prestwickchemical.com/prestwick-chemical- library.html SelleckchemFDA-approvedDrug Library978 595(37%) 670(42%) http://www.selleckchem.com/ MicroSourceDiscovery USDrugCollection1385 687(43%) 929(58%) http://msdiscovery.com eMolecules 8129798 1208(75%) 1313(82%) https://www.emolecules.com/ tions stored between two databases, and a small number of different (N =23) structures having discrepancies at the connectivitymatrix level.",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Drug indications Indications (10 707), contra-indications (27 851) and off- labelindications(2496)wereinitiallyextractedfromOMOP data model version 4.4 ( http://omop.org/Vocabularies ).",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
WEB APPPLICATION AND DATA AVAILABILITY DrugCentral can be accessed using a web browser at http://drugcentral.org from desktop or mobile devices.,OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"The web application was implemented using the Django Web framework ( http://www.djangoproject.com ) and Post- greSQL ( http://www.postgresql.org ) database as backend, with jQuery ( http://jquery.com ) and Bootstrap ( http:// getbootstrap.com ) for a customized frontend.",OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
database ( https://open.fda.gov/ ) and SIDER ( 21) will be used to enhance the drug safety profile of existing drug re- ports.,OADS,/arxiv_data1/oa_pdf/38/9f/gkw993.PMC5210665.pdf
"Database website:http://bioinfo2.ugr.es/NGSmethDB .INTRODUCTION DNA methylation at the cytosine carbon 5 position (5mC) is the main epigenetic mark, being able to modify gene ex- pression patterns without entail DNA sequence changes (1,2).",OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
"DATABASE BACK-END Single-cytosinemethylation,methylationsegmentsanddif- ferentialmethylationdataarestoredhierarchicallyin Mon- goDB(https://www.mongodb.com/ ), a NoSQL databasethat avoids the traditional table-based relational database structure in favor of JSON-formatted documents with dy- namicschemas.Thismakestheprogrammaticdatacompar- ison of different samples easier and faster.",OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
Online image: https://goo.gl/ElXE4t .,Non-OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
"This is a multiplatform Python script (http://bioinfo2.ugr.es/NGSmethDB API/ NGSmethDB APIclient.py) running on Linux, Mac OS X and other UNIX systems.",OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
TheNGSmethDBAPIClient hasbeenencapsulated in aVirtualBox (https://www.virtualbox.org/ )p r e - configured Virtual Machine on which all the de- pendencies are already installed.,OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
"The NGSmethDB APIVM (http://bioinfo2.ugr.es/NGSmethDB API/ NGSmethDB API.ova) is platform independent, being able to run on Windows, Linux or Mac desk-tops.",OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
"The NGSmethDB API client has been already implemented within two mul- tiplatform preconfigured virtual machines coming withall the dependencies installed: (i) the NGSmethDB API virtual machine (http://bioinfo2.ugr.es/NGSmethDB API/ NGSmethDB API.ova), described in this paper, which allow downloading all the NGSmethDB data (single- cytosine methylation, methylation segments and differen- tially methylated cytosines); and (ii) MethFlowVM(http:// bioinfo2.ugr.es:8080/MethFlow/ ) that can be used to ob- tain methylomes from private WGBS short-read data sets andcomparethemtothedownloaded NGSmethDB methy- lomes.Withthesetwotools,theuserwillnolongerneedto upload private data to any public server to carry out com-parative analyses against NGSmethDB data.",OADS,/arxiv_data1/oa_pdf/71/0b/gkw996.PMC5210667.pdf
"Finally, sequence, genomic loca- tionandsequencingreadcounts(aproxyformutantabun- danceinpooledformats)wereextractedforallsgRNAsus-ingscriptsdepositedin https://github.com/boutroslab/ Sup- plementary Material as reported with E-CRISP ( 21).",OADS,/arxiv_data1/oa_pdf/7a/f9/gkw997.PMC5210668.pdf
A more detailed docu-mentation service is available at http://genomecrispr.dkfz.,Non-OADS,/arxiv_data1/oa_pdf/7a/f9/gkw997.PMC5210668.pdf
"Publishedonline24October2016 NucleicAcidsResearch,2017,Vol.45,Databaseissue D707–D711 doi:10.1093/nar/gkw999 New data and features for advanced data mining in Manteia Olivier Tassy1,2,3,* 1Institut de G ´en´etique et de Biologie Mol ´eculaire et Cellulaire (IGBMC), Inserm U964, France,2CNRS (UMR 7104), Inserm U964, France and3Universit ´e de Strasbourg, Illkirch F-67400, France Received September 5, 2016; Revised October 13, 2016; Editorial Decision October 14, 2016; Accepted October 17, 2016 ABSTRACT Manteia is an integrative database available online athttp://manteia.igbmc.fr which provides a large ar- ray of OMICs data related to the development of the mouse, chicken, zebraﬁsh and human.",OADS,/arxiv_data1/oa_pdf/01/a2/gkw999.PMC5210669.pdf
Available at: http://www.jaam.jp/html/english/english-top.htm.,Non-OADS,/arxiv_data1/oa_pdf/9d/58/ta-82-126.PMC5213014.pdf
Availableat: http://direct.kenkyuukai.jp/about/.,Non-OADS,/arxiv_data1/oa_pdf/9d/58/ta-82-126.PMC5213014.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
"12, e1221556 (14 pages)http://dx.doi.org/10.1080/2162402X.2016.1221556",Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
(5):579-86; PMID:11342768; http://dx.doi.org/10.1097/00000478- 200105000-00003 2.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Gut 2015; 64(9):1476- 84; PMID:25994217; http://dx.doi.org/10.1136/gutjnl-2015-309304 3.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cell 2012; 20148(1 –2):349-61; PMID:22265420; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
JGastroenterol Hepatol 2015; 30 Suppl 1:78-84; PMID:25827809; http://dx.doi.org/10.1111/jgh.12752 5.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Tissue Barriers 2014; 8; 2(4):e969112; PMID:25610757; http://dx.doi.org/10.4161/21688362.2014.969112 6.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Br J Cancer 2015; 112(4):613-20; PMID: 25611303; http://dx.doi.org/ 10.1038/bjc.2014.658 7.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Mol Cancer Res 2014; 12(10):1430-9; PMID:24850902;http://dx.doi.org/10.1158/1541-7786.MCR-13-0557-T 8.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Nat Rev Cancer 2013; 13(11):788-99; PMID: 24132110; http://dx.doi.org/10.1038/nrc3603 9.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
The Lancet Oncology 2007; 8(4):349-357; PMID: 17395108;http://dx.doi.org/10.1016/S1470-2045(07)70104-3 10.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncotarget 2014; 5(22):11054-63; PMID:25373410; http://dx.do i.org/10.18632/oncotarget.2609 11.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
AnnuRev Cell Dev Biol 2003; 19:541-564; PMID:14570581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Neuron 1999; 22(2):313-25; PMID:10069337; http://dx.doi.org/10.1016/S0896-6273(00)81092-2 13.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Clin Cancer Res 2006; 12(5):1470-8; PMID:16533770; http://dx.doi.org/10.1158/1078-0432.CCR-05-2027 14.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cancer Res 2007; 67(6):2657-2665; PMID:17363586; http://dx.doi.org/10.1158/0008-5472.CAN-06-1997 17.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncogene 2016; 35(7):887- 96; PMID:25961924; http://dx.doi.org/10.1038/onc.2015.143 18.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Mol Cell 2009; 33(5):591-601; PMID:19285943; http://dx.doi.org/ 10.1016/j.molcel.2009.01.025 19.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Clin Cancer Res 2008; 14(15):4943-50;PMID:18676769; http://dx.doi.org/10.1158/1078-0432.CCR-08-0436 20.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Mol Cell Oncol 2016; 3:2; e1083648;PMID:27308605; http://dx.doi.org/10.1080/23723556.2015.1083648 21.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Clin Exp Metastasis 2011; 28(6):515-27; PMID:21484349; http://dx.doi.org/10.1007/ s10585-011-9388-6 22.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Am J Pathol 2010; 177(2):698-712; PMID:20566751; http://dx.doi.org/10.2353/ajpath.2010.091226 23.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cancer Metastasis Rev2009; 28(1 –2):151-66; PMID:19153669; http://dx.doi.org/10.1007/ s10555-008-9179-y 24.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
J Cell Biol 1997; 139(7):1861-72; PMID:9412478; http://dx.doi.org/10.1083/jcb.139.7.1861 25.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncotarget 2014; 5(1):78-94;PMID:24393789; http://dx.doi.org/10.18632/oncotarget.1569 26.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Am J Pathol 2004; 165:1955-1967; PMID:15579439; http://dx.doi.org/ 10.1016/S0002-9440(10)63247-6 27.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
"Najafov A, Seker T, Even I, Hoxhaj G, Selvi O, Ozel DE, Koman A, Birg €ul-_Iyison N. MENA is a transcriptional target of the Wnt/beta- catenin pathway PLoS One 2012; 7(5):e37013; PMID:22615875; http://dx.doi.org/10.1371/journal.pone.0037013 29.",Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Nature Cell Biol 1999; 1:472-8; PMID:10587642; http://dx.doi.org/10.1038/70258 30.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cytokine Growth Factor Rev 2006; 17(1 –2):3-7; PMID:16290110; http://dx.doi.org/10.1016/j.cytogfr.2005.09.012ONCOIMMUNOLOGY e1221556-13,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
J. Pathol 2002; 160:1619-28; PMID:12000714; http://dx.doi.org/ 10.1016/S0002-9440(10)61109-1 32.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncogene 2012; 31(26):3190-201; PMID:22037216;http://dx.doi.org/10.1038/onc.2011.493 34.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cancer Res2013; 73(15):4909-22; PMID:23761328; http://dx.doi.org/10.1158/0008-5472.CAN-12-4384 35.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Gastroenterology 2014; 146(5):1386-96; PMID:24462734; http://dx.doi.org/10.1053/j.gastro.2014.01.046 36.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Curr Opin Cell Biol 2014; 31:56-66; PMID:25240174; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Nat Cell Biol2000; 2(2):84-9; PMID:10655587; http://dx.doi.org/10.1038/35000034 38.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Nat Rev Mol Cell Biol 2010; 11(5):353-65; PMID:20414257; http://dx.doi.org/10.1038/nrm2890 39.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Cell 2003; 113(6):685-700;PMID:12809600; http://dx.doi.org/10.1016/S0092-8674(03)00432-X 40.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncogene 2009; 28(7):983-93; PMID:19079344; http://dx.doi.org/10.1038/onc.2008.449 41.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
PLoS One 2010; 5(12):e15852; PMID:21209853; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Oncoimmunology 2013; 2(8):e25961; PMID: 24083084; http://dx.doi.org/10.4161/onci.25961 43.,Non-OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
Genome Biol 2002; 18; 3(7):RESEARCH0034; PMID:12184808; http://dx.doi.org/ 10.1186/gb-2002-3-7-research0034.e1221556-14 R. MELCHIONNA ET AL.,OADS,/arxiv_data1/oa_pdf/40/1c/koni-05-12-1221556.PMC5213039.pdf
